activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	34281	CHEMBL678692	Selectivity for Fibroblast growth factor receptor 2 over (KDR) kinase insert domain receptor	B	Cc1ccc(Nc2ncc(-c3ccccc3)s2)nc1		CHEMBL330621	=	Selectivity		70.0	CHEMBL4142	Homo sapiens	Selectivity		70.0
	34281	CHEMBL678692	Selectivity for Fibroblast growth factor receptor 2 over (KDR) kinase insert domain receptor	B	Cc1ccc(Nc2ncc(-c3ccccc3)s2)nc1		CHEMBL330621	=	Selectivity		70.0	CHEMBL4142	Homo sapiens	Selectivity		70.0
	37867	CHEMBL678692	Selectivity for Fibroblast growth factor receptor 2 over (KDR) kinase insert domain receptor	B	Cc1ccnc(Nc2ncc(-c3ccccc3)s2)c1		CHEMBL319065	=	Selectivity		50.0	CHEMBL4142	Homo sapiens	Selectivity		50.0
	40262	CHEMBL678692	Selectivity for Fibroblast growth factor receptor 2 over (KDR) kinase insert domain receptor	B	Cc1cccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL98385	=	Selectivity		210.0	CHEMBL4142	Homo sapiens	Selectivity		210.0
	42687	CHEMBL678692	Selectivity for Fibroblast growth factor receptor 2 over (KDR) kinase insert domain receptor	B	O=C(Nc1ncc(-c2ccccc2)s1)c1ccccc1		CHEMBL98633	=	Selectivity		14.0	CHEMBL4142	Homo sapiens	Selectivity		14.0
	46273	CHEMBL678692	Selectivity for Fibroblast growth factor receptor 2 over (KDR) kinase insert domain receptor	B	Cc1cccnc1Nc1ncc(-c2ccccc2)s1		CHEMBL329713	=	Selectivity		200.0	CHEMBL4142	Homo sapiens	Selectivity		200.0
	48772	CHEMBL678692	Selectivity for Fibroblast growth factor receptor 2 over (KDR) kinase insert domain receptor	B	CCCCN(C)c1ccc(/N=N/c2ncc([N+](=O)[O-])s2)c(C)c1		CHEMBL100174	>	Selectivity		130.0	CHEMBL4142	Homo sapiens	Selectivity		130.0
	50207	CHEMBL678692	Selectivity for Fibroblast growth factor receptor 2 over (KDR) kinase insert domain receptor	B	c1ccc(-c2cnc(Nc3ccccn3)s2)cc1		CHEMBL98538	=	Selectivity		51.0	CHEMBL4142	Homo sapiens	Selectivity		51.0
	53972	CHEMBL678692	Selectivity for Fibroblast growth factor receptor 2 over (KDR) kinase insert domain receptor	B	Brc1cccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL101464	=	Selectivity		400.0	CHEMBL4142	Homo sapiens	Selectivity		400.0
	55135	CHEMBL678692	Selectivity for Fibroblast growth factor receptor 2 over (KDR) kinase insert domain receptor	B	Clc1ccc(Nc2ncc(-c3ccccc3)s2)nc1		CHEMBL319789	>	Selectivity		580.0	CHEMBL4142	Homo sapiens	Selectivity		580.0
	66861	CHEMBL678692	Selectivity for Fibroblast growth factor receptor 2 over (KDR) kinase insert domain receptor	B	N#Cc1cnc(Nc2ccccn2)s1		CHEMBL101544	=	Selectivity		107.0	CHEMBL4142	Homo sapiens	Selectivity		107.0
	506179	CHEMBL678693	Inhibition of Fibroblast growth factor receptor 2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	IC50	nM	940.0	CHEMBL4142	Homo sapiens	IC50	uM	0.94
	633825	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2nccc(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)cc3F)c2cc1OC		CHEMBL169837	=	IC50	nM	54.0	CHEMBL4142	Homo sapiens	IC50	nM	54.0
	636086	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2nccc(Oc3ccc(C(=O)c4ccc(C(C)(C)C)cc4)cc3)c2cc1OC		CHEMBL171413	=	IC50	nM	190.0	CHEMBL4142	Homo sapiens	IC50	nM	190.0
	636087	CHEMBL678590	Ex vivo inhibition of fibroblast growth factor receptor (FGF-R2) autophosphorylation 5 hr after the oral administration at 100 mg/kg	F	COc1cc2nccc(Oc3ccc(C(=O)c4ccc(C(C)(C)C)cc4)cc3)c2cc1OC		CHEMBL171413	=	Inhibition	%	40.0	CHEMBL4142	Homo sapiens	Inhibition	%	40.0
	641018	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2c(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)c(F)c3)ccnc2cc1OCCNCCO		CHEMBL354224	=	IC50	nM	260.0	CHEMBL4142	Homo sapiens	IC50	nM	260.0
	642324	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2nccc(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)c(C)c3C)c2cc1OC		CHEMBL167425	=	IC50	nM	130.0	CHEMBL4142	Homo sapiens	IC50	nM	130.0
	642325	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2c(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)cc3)ccnc2cc1OCCN1CCOCC1		CHEMBL354902	=	IC50	nM	200.0	CHEMBL4142	Homo sapiens	IC50	nM	200.0
	645873	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2nccc(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)c(C)c3)c2cc1OC		CHEMBL169854	=	IC50	nM	100.0	CHEMBL4142	Homo sapiens	IC50	nM	100.0
	645874	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2c(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)cc3)ccnc2cc1OCCN1CCC(CO)CC1		CHEMBL171509	=	IC50	nM	23.0	CHEMBL4142	Homo sapiens	IC50	nM	23.0
	647048	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2nccc(Oc3ccc(NC4CCC(C(C)(C)C)CC4)cc3)c2cc1OC		CHEMBL352534	=	IC50	nM	3400.0	CHEMBL4142	Homo sapiens	IC50	nM	3400.0
	651902	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2c(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)cc3)ccnc2cc1OCCCN1CCCCC1		CHEMBL355436	=	IC50	nM	350.0	CHEMBL4142	Homo sapiens	IC50	nM	350.0
	651904	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2c(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)cc3)ccnc2cc1OCC(O)CN1CCCCC1		CHEMBL169397	=	IC50	nM	200.0	CHEMBL4142	Homo sapiens	IC50	nM	200.0
	653051	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2c(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)cc3)ccnc2cc1OCCNCCO		CHEMBL352308	=	IC50	nM	88.0	CHEMBL4142	Homo sapiens	IC50	nM	88.0
	654161	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2nccc(Oc3ccc(Nc4ccc(-c5ccccc5)cc4)cc3)c2cc1OC		CHEMBL352342	=	IC50	nM	4600.0	CHEMBL4142	Homo sapiens	IC50	nM	4600.0
	654162	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2c(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)cc3)ccnc2cc1OCCN(CCO)CCO		CHEMBL414643	=	IC50	nM	71.0	CHEMBL4142	Homo sapiens	IC50	nM	71.0
	655350	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2nccc(Oc3ccc(Nc4cccc(-c5ccccc5)c4)cc3)c2cc1OC		CHEMBL353884	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	657709	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2nccc(Oc3ccc(Oc4ccc(C(C)(C)C)cc4)cc3)c2cc1OC		CHEMBL170415	=	IC50	nM	440.0	CHEMBL4142	Homo sapiens	IC50	nM	440.0
Not Determined	657710	CHEMBL678591	Ex vivo inhibition of fibroblast growth factor receptor (FGF-R2) autophosphorylation 5 hr after the oral administration at 100 mg/kg (not tested)	F	COc1cc2nccc(Oc3ccc(Oc4ccc(C(C)(C)C)cc4)cc3)c2cc1OC		CHEMBL170415		Inhibition	%		CHEMBL4142	Homo sapiens	Inhibition	%	
	660258	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2c(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)cc3F)ccnc2cc1OCCNCCO		CHEMBL354898	=	IC50	nM	70.0	CHEMBL4142	Homo sapiens	IC50	nM	70.0
	662619	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2nccc(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)cc3)c2cc1OC		CHEMBL170519	=	IC50	nM	40.0	CHEMBL4142	Homo sapiens	IC50	nM	40.0
	662620	CHEMBL678590	Ex vivo inhibition of fibroblast growth factor receptor (FGF-R2) autophosphorylation 5 hr after the oral administration at 100 mg/kg	F	COc1cc2nccc(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)cc3)c2cc1OC		CHEMBL170519	=	Inhibition	%	70.0	CHEMBL4142	Homo sapiens	Inhibition	%	70.0
	664131	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2nccc(Oc3ccc(Cc4ccc(C(C)(C)C)cc4)cc3)c2cc1OC		CHEMBL353668	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	664132	CHEMBL678590	Ex vivo inhibition of fibroblast growth factor receptor (FGF-R2) autophosphorylation 5 hr after the oral administration at 100 mg/kg	F	COc1cc2nccc(Oc3ccc(Cc4ccc(C(C)(C)C)cc4)cc3)c2cc1OC		CHEMBL353668	=	Inhibition	%	5.0	CHEMBL4142	Homo sapiens	Inhibition	%	5.0
	664133	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2c(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)cc3)ccnc2cc1OCC(O)CN1CCOCC1		CHEMBL168335	=	IC50	nM	71.0	CHEMBL4142	Homo sapiens	IC50	nM	71.0
	665265	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2nccc(Oc3ccc(Nc4ccccc4)cc3)c2cc1OC		CHEMBL172746	=	IC50	nM	8900.0	CHEMBL4142	Homo sapiens	IC50	nM	8900.0
	665266	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2nccc(Oc3ccc(Nc4ccc(C(C)C)cc4)cc3)c2cc1OC		CHEMBL276125	=	IC50	nM	200.0	CHEMBL4142	Homo sapiens	IC50	nM	200.0
	666617	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1ccc(Nc2ccc(Oc3ccnc4cc(OC)c(OC)cc34)cc2)cc1		CHEMBL354830	=	IC50	nM	780.0	CHEMBL4142	Homo sapiens	IC50	nM	780.0
	667898	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2nccc(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)c(C(F)(F)F)c3)c2cc1OC		CHEMBL171161	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	669137	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2nccc(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)cc3C)c2cc1OC		CHEMBL353991	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	669138	CHEMBL678691	In vitro inhibition against autophosphorylation of Fibroblast growth factor receptor 2 in the human scirrhous gastric carcinoma cell line	B	COc1cc2nccc(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)c(F)c3)c2cc1OC		CHEMBL170907	=	IC50	nM	63.0	CHEMBL4142	Homo sapiens	IC50	nM	63.0
	1400130	CHEMBL832880	Inhibition of fibroblast growth factor receptor 2	B	OCCCNc1cncc(-c2cncc(Nc3cccc(Cl)c3)n2)c1		CHEMBL177688	=	IC50	nM	210.0	CHEMBL4142	Homo sapiens	IC50	uM	0.21
	1418362	CHEMBL831103	Inhibition of fibroblast growth factor receptor 2 in cell-intact assay	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)c(F)c3)c2cc1OC		CHEMBL178455	=	IC50	nM	170.0	CHEMBL4142	Homo sapiens	IC50	nM	170.0
	1481565	CHEMBL832877	Inhibitory concentration against Fibroblast growth factor receptor 2	B	Clc1cccc(Nc2cncc(-c3cncc(NCCCn4cccn4)c3)n2)c1		CHEMBL371169	=	IC50	nM	326.0	CHEMBL4142	Homo sapiens	IC50	uM	0.326
	1481685	CHEMBL832877	Inhibitory concentration against Fibroblast growth factor receptor 2	B	Clc1cccc(Nc2cncc(-c3cncc(NCCCn4cncn4)c3)n2)c1		CHEMBL372657	=	IC50	nM	153.0	CHEMBL4142	Homo sapiens	IC50	uM	0.153
	1482874	CHEMBL832877	Inhibitory concentration against Fibroblast growth factor receptor 2	B	OCCCNc1cncc(-c2cncc(Nc3cccc(Cl)c3)n2)c1		CHEMBL177688	=	IC50	nM	210.0	CHEMBL4142	Homo sapiens	IC50	uM	0.21
	1483039	CHEMBL832877	Inhibitory concentration against Fibroblast growth factor receptor 2	B	OCCCCNc1cncc(-c2cncc(Nc3cccc(Cl)c3)n2)c1		CHEMBL188386	=	IC50	nM	2360.0	CHEMBL4142	Homo sapiens	IC50	uM	2.36
	1483174	CHEMBL832877	Inhibitory concentration against Fibroblast growth factor receptor 2	B	CN(C)CCNc1cncc(-c2cncc(Nc3cccc(Cl)c3)n2)c1		CHEMBL190984	=	IC50	nM	1400.0	CHEMBL4142	Homo sapiens	IC50	uM	1.4
	1483440	CHEMBL832877	Inhibitory concentration against Fibroblast growth factor receptor 2	B	Clc1cccc(Nc2cncc(-c3cncc(NCCCc4cccnc4)c3)n2)c1		CHEMBL188502	>	IC50	nM	293.0	CHEMBL4142	Homo sapiens	IC50	uM	0.293
	1487626	CHEMBL831579	Inhibition of Fibroblast growth factor receptor 2	B	Cc1ccc(F)c(C(=O)n2nc(Nc3ccc(S(N)(=O)=O)cc3)nc2C)c1F		CHEMBL363607	=	IC50	nM	270.0	CHEMBL4142	Homo sapiens	IC50	uM	0.27
	1487659	CHEMBL831579	Inhibition of Fibroblast growth factor receptor 2	B	Cc1ccsc1C(=O)n1nc(Nc2ccc(S(N)(=O)=O)cc2)nc1N		CHEMBL363130	=	IC50	nM	180.0	CHEMBL4142	Homo sapiens	IC50	uM	0.18
Not Determined	1487893	CHEMBL828034	Inhibition of Fibroblast growth factor receptor 2; Not determined	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720		IC50			CHEMBL4142	Homo sapiens	IC50		
	1489546	CHEMBL832735	Inhibition of Fibroblast growth factor receptor 2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	IC50	nM	220.0	CHEMBL4142	Homo sapiens	IC50	uM	0.22
	1490911	CHEMBL832464	Inhibition of Fibroblast growth factor receptor 2	B	OCCCNc1cc(-c2ncnc(Nc3cccc(Cl)c3)n2)ccn1		CHEMBL191336	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
Not Active	1650765	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4142	Homo sapiens	Kd		
Not Active	1650766	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL4142	Homo sapiens	Kd		
Not Active	1650767	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL4142	Homo sapiens	Kd		
	1650768	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	530.0	CHEMBL4142	Homo sapiens	Kd	uM	0.53
Not Active	1650769	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL4142	Homo sapiens	Kd		
Not Active	1650770	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL4142	Homo sapiens	Kd		
Not Active	1650771	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL4142	Homo sapiens	Kd		
Not Active	1650772	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL4142	Homo sapiens	Kd		
Not Active	1650773	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL4142	Homo sapiens	Kd		
	1651577	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	160.0	CHEMBL4142	Homo sapiens	Kd	uM	0.16
Not Active	1651578	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL4142	Homo sapiens	Kd		
Not Active	1651579	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL4142	Homo sapiens	Kd		
Not Active	1651580	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL4142	Homo sapiens	Kd		
Not Active	1651581	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL4142	Homo sapiens	Kd		
Not Active	1651582	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL4142	Homo sapiens	Kd		
Not Active	1651583	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL4142	Homo sapiens	Kd		
Not Active	1651584	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL4142	Homo sapiens	Kd		
	1651585	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1900.0	CHEMBL4142	Homo sapiens	Kd	uM	1.9
	1651586	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	5500.0	CHEMBL4142	Homo sapiens	Kd	uM	5.5
Not Active	1651587	CHEMBL860912	Average Binding Constant for FGFR2; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL4142	Homo sapiens	Kd		
	1769392	CHEMBL910912	Inhibition of FGFR2	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	uM	1.0
	1891428	CHEMBL905852	Inhibition of FGFR2	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	Ki	nM	493.0	CHEMBL4142	Homo sapiens	Ki	nM	493.0
	2081790	CHEMBL928813	Inhibition of FGFR2 at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL4142	Homo sapiens	Inhibition	%	20.0
	2121149	CHEMBL933001	Inhibition of FGFR2	B	COc1cc2nccc(Oc3ccc4c(C(=O)Nc5ccc(Cl)cc5)cccc4c3)c2cc1OC		CHEMBL429743	=	IC50	nM	55.0	CHEMBL4142	Homo sapiens	IC50	nM	55.0
	2147262	CHEMBL921852	Activity of human FGFR2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	52.0	CHEMBL4142	Homo sapiens	Activity	%	52.0
	2206821	CHEMBL990523	Inhibition of FGFR2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	530.0	CHEMBL4142	Homo sapiens	Kd	nM	530.0
	2251201	CHEMBL1009900	Inhibition of FGFR2	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	1.0	CHEMBL4142	Homo sapiens	IC50	nM	1.0
	2251212	CHEMBL1009910	Inhibition of FGFR2 N549H mutant	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	10.0	CHEMBL4142	Homo sapiens	IC50	nM	10.0
	2361183	CHEMBL970659	Inhibition of FGFRK2	B	COc1cc2c(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL505896	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	2361205	CHEMBL970659	Inhibition of FGFRK2	B	COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL453737	=	IC50	nM	140.0	CHEMBL4142	Homo sapiens	IC50	nM	140.0
Not Determined	2361228	CHEMBL970659	Inhibition of FGFRK2	B	COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)nc3)ccnc2cc1OCCCN1CCOCC1		CHEMBL447602		IC50			CHEMBL4142	Homo sapiens	IC50		
	2470220	CHEMBL983622	Inhibition of FGFR2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4142	Homo sapiens	INH	%	10.0
	2476620	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	7.9	CHEMBL4142	Homo sapiens	Activity	%	7.9
Not Evaluated	2476823	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4142	Homo sapiens	Activity		
Not Evaluated	2478662	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4142	Homo sapiens	Activity		
	2478865	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	9.0	CHEMBL4142	Homo sapiens	Activity	%	9.0
Not Evaluated	2479720	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL4142	Homo sapiens	Activity		
	2480719	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.1	CHEMBL4142	Homo sapiens	Activity	%	0.1
	2511581	CHEMBL972539	Inhibition of FGFR2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	34.0	CHEMBL4142	Homo sapiens	IC50	uM	0.034
	2560080	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	Oc1ccc(C[C@@]2(O)COc3c(ccc(O)c3O)[C@@H]2O)cc1O		CHEMBL445196	=	Inhibition	%	75.5	CHEMBL4142	Homo sapiens	INH	%	75.5
	2560081	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2		CHEMBL477197	=	Inhibition	%	73.6	CHEMBL4142	Homo sapiens	INH	%	73.6
	2560082	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	O=C1COc2c(ccc(O)c2O)-c2cc(O)c(O)cc2C1		CHEMBL475940	=	Inhibition	%	54.8	CHEMBL4142	Homo sapiens	INH	%	54.8
	2560083	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	O=C1COc2cc(O)ccc2-c2cc(O)c(O)cc2C1		CHEMBL447427	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
Not Determined	2560084	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	CC(C)=CCc1c(O)ccc(C(=O)/C=C/c2ccc(O)cc2)c1O		CHEMBL253467		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	2560085	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	COc1cc(O)ccc1C(=O)/C=C/c1ccc(O)cc1		CHEMBL253777	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	2560086	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O		CHEMBL129795	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	2560087	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	COc1cc(O)ccc1C(=O)/C=C/c1ccc(O)c(O)c1		CHEMBL476986	=	Inhibition	%	48.5	CHEMBL4142	Homo sapiens	INH	%	48.5
	2560088	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(O)cc1O		CHEMBL128000	=	Inhibition	%	3.0	CHEMBL4142	Homo sapiens	INH	%	3.0
	2560089	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	COc1ccc(/C=C2\COc3cc(O)cc(O)c3C2=O)cc1		CHEMBL476776	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	2560090	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	COc1ccc(/C=C2\COc3cc(O)ccc3C2=O)cc1		CHEMBL450675	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	2560091	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	O=C1/C(=C/c2ccc(O)c(O)c2)COc2cc(O)ccc21		CHEMBL249002	=	Inhibition	%	17.7	CHEMBL4142	Homo sapiens	INH	%	17.7
	2560092	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	O=C1/C(=C/c2ccc(O)cc2)COc2cc(O)ccc21		CHEMBL250414	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	2560093	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	CO[C@H]1c2ccc(O)cc2OC[C@]1(O)Cc1ccc(O)cc1		CHEMBL518739	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	2560094	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	CO[C@H]1c2ccc(O)cc2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL477780	=	Inhibition	%	8.8	CHEMBL4142	Homo sapiens	INH	%	8.8
Not Determined	2560095	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	Oc1ccc2c(c1)OC[C@](O)(Cc1ccc(O)c(O)c1)[C@H]2O		CHEMBL477779		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Not Determined	2560096	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	O=C1c2ccc(O)cc2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL477778		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	2560097	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	Oc1ccc2c(c1O)OC[C@]1(O)Cc3ccc(O)c(O)c3[C@H]21		CHEMBL447506	=	Inhibition	%	35.2	CHEMBL4142	Homo sapiens	INH	%	35.2
	2560098	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	CO[C@H]1C23C=CC(=O)C(O)=C2OC[C@]1(O)Cc1cc(O)c(O)cc13		CHEMBL477781	=	Inhibition	%	35.2	CHEMBL4142	Homo sapiens	INH	%	35.2
	2560099	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	CO[C@@H]1C23C=CC(=O)C(O)=C2OC[C@]1(O)Cc1cc(O)c(O)cc13		CHEMBL514559	=	Inhibition	%	3.1	CHEMBL4142	Homo sapiens	INH	%	3.1
	2560100	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	O=C1c2ccc(O)c(O)c2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL477768	=	Inhibition	%	91.5	CHEMBL4142	Homo sapiens	INH	%	91.5
	2560101	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	Oc1ccc(CC2=Cc3ccc(O)c(O)c3OC2)cc1O		CHEMBL477560	=	Inhibition	%	62.6	CHEMBL4142	Homo sapiens	INH	%	62.6
	2560102	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	Oc1ccc(CC2=Cc3ccc(O)cc3OC2)cc1		CHEMBL477559	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
Not Determined	2560103	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	CO[C@@H]1c2ccc(O)c(O)c2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL518432		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	2560104	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	CO[C@H]1c2ccc(O)c(O)c2OC[C@]1(O)Cc1ccc(O)c(O)c1		CHEMBL477769	=	Inhibition	%	60.3	CHEMBL4142	Homo sapiens	INH	%	60.3
	2560105	CHEMBL986526	Inhibition of FGFR2 at 10 uM by ELISA	B	Oc1ccc(C[C@@]2(O)COc3c(ccc(O)c3O)[C@H]2O)cc1O		CHEMBL478611	=	Inhibition	%	84.9	CHEMBL4142	Homo sapiens	INH	%	84.9
Not Evaluated	2577341	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4142	Homo sapiens	Activity		
Not Evaluated	2577544	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4142	Homo sapiens	Activity		
	2593546	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	4.3	CHEMBL4142	Homo sapiens	Activity	%	4.3
Not Evaluated	2593749	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL4142	Homo sapiens	Activity		
Not Evaluated	2594015	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL4142	Homo sapiens	Activity		
Not Evaluated	2594958	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4142	Homo sapiens	Activity		
Not Evaluated	2595161	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4142	Homo sapiens	Activity		
Not Evaluated	2595227	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4142	Homo sapiens	Activity		
Not Evaluated	2596358	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL4142	Homo sapiens	Activity		
Not Evaluated	2597627	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4142	Homo sapiens	Activity		
Not Evaluated	2597830	CHEMBL1035884	Binding affinity to human FGFR2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4142	Homo sapiens	Activity		
	2603069	CHEMBL1023864	Inhibition of FGFR2	B	Cc1cccc(C(=O)Nc2cccc([C@H](C)Nc3cncc(Cl)n3)c2)c1		CHEMBL504075	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
Active	2719510	CHEMBL1058292	Inhibition of FGFR2 expressed in mouse BA/F3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1[nH]cnc2ncnc1-2		CHEMBL563577		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	2721607	CHEMBL1057436	Inhibition of FGFR2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	2907149	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907150	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907151	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1900.0	CHEMBL4142	Homo sapiens	Kd	nM	1900.0
	2907152	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907153	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907154	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907155	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	410.0	CHEMBL4142	Homo sapiens	Kd	nM	410.0
	2907156	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907157	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907158	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907159	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907160	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	1400.0	CHEMBL4142	Homo sapiens	Kd	nM	1400.0
	2907161	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907162	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907163	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907164	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907165	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907166	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	210.0	CHEMBL4142	Homo sapiens	Kd	nM	210.0
	2907167	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907168	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	680.0	CHEMBL4142	Homo sapiens	Kd	nM	680.0
	2907169	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907170	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907171	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907172	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1700.0	CHEMBL4142	Homo sapiens	Kd	nM	1700.0
	2907173	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907174	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	2400.0	CHEMBL4142	Homo sapiens	Kd	nM	2400.0
	2907175	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907176	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907177	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907178	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907179	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907180	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2700.0	CHEMBL4142	Homo sapiens	Kd	nM	2700.0
	2907181	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	100.0	CHEMBL4142	Homo sapiens	Kd	nM	100.0
	2907182	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	790.0	CHEMBL4142	Homo sapiens	Kd	nM	790.0
	2907183	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	570.0	CHEMBL4142	Homo sapiens	Kd	nM	570.0
	2907184	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	570.0	CHEMBL4142	Homo sapiens	Kd	nM	570.0
	2907185	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	2907186	CHEMBL1048161	Binding constant for FGFR2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1100.0	CHEMBL4142	Homo sapiens	Kd	nM	1100.0
	2921337	CHEMBL1053728	Inhibition of FGFR2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	38.0	CHEMBL4142	Homo sapiens	Activity	%	38.0
	2928474	CHEMBL1049972	Binding affinity to FGFR2 assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	94.0	CHEMBL4142	Homo sapiens	Activity	%	94.0
	2938506	CHEMBL1041359	Inhibition of FGFR2 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	12.0	CHEMBL4142	Homo sapiens	INH	%	12.0
	2943675	CHEMBL1044070	Inhibition of FGFR2	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCCOC		CHEMBL569880	=	IC50	nM	2000.0	CHEMBL4142	Homo sapiens	IC50	microM	2.0
	2943678	CHEMBL1044070	Inhibition of FGFR2	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCOC		CHEMBL571040	=	IC50	nM	4100.0	CHEMBL4142	Homo sapiens	IC50	microM	4.1
	3052610	CHEMBL1037586	Residual activity of FGFR2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	120.0	CHEMBL4142	Homo sapiens	Residual activity	%	120.0
	3053919	CHEMBL1045129	Residual activity of FGFR2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	86.0	CHEMBL4142	Homo sapiens	Residual activity	%	86.0
	3054171	CHEMBL1040639	Residual activity of FGFR2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	101.0	CHEMBL4142	Homo sapiens	Residual activity	%	101.0
	3055458	CHEMBL1037586	Residual activity of FGFR2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	111.0	CHEMBL4142	Homo sapiens	Residual activity	%	111.0
	3055710	CHEMBL1045129	Residual activity of FGFR2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	136.0	CHEMBL4142	Homo sapiens	Residual activity	%	136.0
	3057015	CHEMBL1040639	Residual activity of FGFR2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	103.0	CHEMBL4142	Homo sapiens	Residual activity	%	103.0
	3058335	CHEMBL1037586	Residual activity of FGFR2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	107.0	CHEMBL4142	Homo sapiens	Residual activity	%	107.0
	3058587	CHEMBL1045129	Residual activity of FGFR2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	113.0	CHEMBL4142	Homo sapiens	Residual activity	%	113.0
	3062466	CHEMBL1037149	Binding affinity to human FGFR2 at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	66.0	CHEMBL4142	Homo sapiens	Activity	%	66.0
	3063601	CHEMBL1074867	Binding affinity to human FGFR2 at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	27.0	CHEMBL4142	Homo sapiens	Activity	%	27.0
	3063691	CHEMBL1047843	Binding affinity to human FGFR2 at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	86.0	CHEMBL4142	Homo sapiens	Activity	%	86.0
	3065870	CHEMBL1069302	Inhibition of FGFR2 at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	3066936	CHEMBL1069302	Inhibition of FGFR2 at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	42.0	CHEMBL4142	Homo sapiens	INH	%	42.0
	3072933	CHEMBL1040639	Residual activity of FGFR2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	105.0	CHEMBL4142	Homo sapiens	Residual activity	%	105.0
	3104122	CHEMBL1066400	Inhibition of recombinant FGFR2 by TR-FRET assay	B	C[C@@H](Oc1ccc2ncc(/C=C/C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL602471	=	IC50	nM	6900.0	CHEMBL4142	Homo sapiens	IC50	uM	6.9
	3104148	CHEMBL1066400	Inhibition of recombinant FGFR2 by TR-FRET assay	B	C[C@@H](Oc1ccc2ncccc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL600795	=	IC50	nM	24000.0	CHEMBL4142	Homo sapiens	IC50	uM	24.0
	3104195	CHEMBL1066400	Inhibition of recombinant FGFR2 by TR-FRET assay	B	C[C@@H](Oc1ccc2ncc(C3CC3C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL602472	=	IC50	nM	12000.0	CHEMBL4142	Homo sapiens	IC50	uM	12.0
	3121098	CHEMBL1065598	Inhibition of FGFR2	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	=	IC50	nM	3430.0	CHEMBL4142	Homo sapiens	IC50	nM	3430.0
	3213811	CHEMBL1108398	Inhibition of FGFR2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	4.0	CHEMBL4142	Homo sapiens	INH	%	4.0
	3224820	CHEMBL1099657	Inhibition of FGFR2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	3225070	CHEMBL1099657	Inhibition of FGFR2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	3331942	CHEMBL1169232	Inhibition of FGFR2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	3333357	CHEMBL1169232	Inhibition of FGFR2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	3334762	CHEMBL1169232	Inhibition of FGFR2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	3336182	CHEMBL1169232	Inhibition of FGFR2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	3337529	CHEMBL1169232	Inhibition of FGFR2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	3337779	CHEMBL1169232	Inhibition of FGFR2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	3339113	CHEMBL1169232	Inhibition of FGFR2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	3340415	CHEMBL1169232	Inhibition of FGFR2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	3340710	CHEMBL1169232	Inhibition of FGFR2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	3342126	CHEMBL1169232	Inhibition of FGFR2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	3358577	CHEMBL1174422	Inhibition of FGFR2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.5	CHEMBL4142	Homo sapiens	INH	%	0.5
	3359019	CHEMBL1174422	Inhibition of FGFR2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.5	CHEMBL4142	Homo sapiens	INH	%	0.5
	3359779	CHEMBL1177624	Inhibition FGFR2 at 10 uM	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172957	=	Inhibition	%	4.1	CHEMBL4142	Homo sapiens	INH	%	4.1
	3359780	CHEMBL1177623	Inhibition FGFR2	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172957	=	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	3441500	CHEMBL1244083	Inhibition of human FGFR2	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	37.0	CHEMBL4142	Homo sapiens	IC50	nmol/L	37.0
	3443397	CHEMBL1244430	Inhibition of FGFR2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	72.0	CHEMBL4142	Homo sapiens	INH	%	72.0
	3443614	CHEMBL1244430	Inhibition of FGFR2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	91.0	CHEMBL4142	Homo sapiens	INH	%	91.0
	3444769	CHEMBL1244430	Inhibition of FGFR2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	28.0	CHEMBL4142	Homo sapiens	INH	%	28.0
	3445117	CHEMBL1244839	Binding affinity to FGFR2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	660.0	CHEMBL4142	Homo sapiens	Kd	nM	660.0
	3445393	CHEMBL1244430	Inhibition of FGFR2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	7.0	CHEMBL4142	Homo sapiens	INH	%	7.0
	3445610	CHEMBL1244430	Inhibition of FGFR2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	21.0	CHEMBL4142	Homo sapiens	INH	%	21.0
	3445819	CHEMBL1244430	Inhibition of FGFR2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	76.0	CHEMBL4142	Homo sapiens	INH	%	76.0
	3446009	CHEMBL1244430	Inhibition of FGFR2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	47.0	CHEMBL4142	Homo sapiens	INH	%	47.0
	3448435	CHEMBL1244839	Binding affinity to FGFR2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	3448927	CHEMBL1244839	Binding affinity to FGFR2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	2400.0	CHEMBL4142	Homo sapiens	Kd	nM	2400.0
	3449173	CHEMBL1244839	Binding affinity to FGFR2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	570.0	CHEMBL4142	Homo sapiens	Kd	nM	570.0
	3449433	CHEMBL1244839	Binding affinity to FGFR2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2700.0	CHEMBL4142	Homo sapiens	Kd	nM	2700.0
	3449670	CHEMBL1244839	Binding affinity to FGFR2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	3451003	CHEMBL1244839	Binding affinity to FGFR2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	uM	10.0
	3463230	CHEMBL1252418	Inhibition of FGFR2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	3.0	CHEMBL4142	Homo sapiens	INH	%	3.0
	3463449	CHEMBL1252418	Inhibition of FGFR2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	12.0	CHEMBL4142	Homo sapiens	INH	%	12.0
	3463993	CHEMBL1252418	Inhibition of FGFR2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	51.0	CHEMBL4142	Homo sapiens	INH	%	51.0
	3556499	CHEMBL1285584	Inhibition of FGFR2 at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	66.0	CHEMBL4142	Homo sapiens	INH	%	66.0
Not Active	3599535	CHEMBL1291151	Displacement of radiolabeled Poly(Glu:Tyr) from FGFR2 at 1 to 3 uM	B	Oc1ccc2c(c1)CCN(CCCCc1ccccc1)CC2O		CHEMBL1289626		Activity			CHEMBL4142	Homo sapiens	Activity		
	5120274	CHEMBL1645965	Inhibition of human FGFR2 N549H mutant at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	91.0	CHEMBL4142	Homo sapiens	INH	%	91.0
	5120276	CHEMBL1645964	Inhibition of human FGFR2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	92.0	CHEMBL4142	Homo sapiens	INH	%	92.0
	5243706	CHEMBL1685669	Inhibition of FGFR2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	51.0	CHEMBL4142	Homo sapiens	INH	%	51.0
	5243814	CHEMBL1685918	Inhibition of FGFR2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	4.0	CHEMBL4142	Homo sapiens	INH	%	4.0
	5243927	CHEMBL1685669	Inhibition of FGFR2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	8.0	CHEMBL4142	Homo sapiens	INH	%	8.0
	5244035	CHEMBL1685918	Inhibition of FGFR2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	1.0	CHEMBL4142	Homo sapiens	INH	%	1.0
	5244908	CHEMBL1685669	Inhibition of FGFR2 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	71.0	CHEMBL4142	Homo sapiens	INH	%	71.0
	5245016	CHEMBL1685918	Inhibition of FGFR2 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	23.0	CHEMBL4142	Homo sapiens	INH	%	23.0
	5245167	CHEMBL1685669	Inhibition of FGFR2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	79.0	CHEMBL4142	Homo sapiens	INH	%	79.0
	5245997	CHEMBL1685918	Inhibition of FGFR2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	63.0	CHEMBL4142	Homo sapiens	INH	%	63.0
	6167562	CHEMBL1769035	Binding affinity to human Fgfr2 assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	92.0	CHEMBL4142	Homo sapiens	Activity	%	92.0
	6167578	CHEMBL1769052	Binding affinity to human Fgfr2 assessed as residual binding at 10 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	100.0	CHEMBL4142	Homo sapiens	Activity	%	100.0
	6201872	CHEMBL1781375	Inhibition of FGFR2 assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CC1(C)c2cc(C3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779202	=	IC50	nM	360.0	CHEMBL4142	Homo sapiens	IC50	uM	0.36
	6212359	CHEMBL1785929	Inhibition of FGFR2 using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784725	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	6219893	CHEMBL1785581	Inhibition of human FGFR2 using poly[Glu:Tyr] peptide substrate by Hotspot assay	B	CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C		CHEMBL1784637	=	IC50	nM	1.5	CHEMBL4142	Homo sapiens	IC50	nM	1.5
	6265545	CHEMBL1798254	Inhibition of FGFR2 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL4142	Homo sapiens	INH	%	65.0
	6265649	CHEMBL1798254	Inhibition of FGFR2 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	=	Inhibition	%	99.0	CHEMBL4142	Homo sapiens	INH	%	99.0
	6281541	CHEMBL1804194	Inhibition of human FGFR2	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	=	IC50	nM	39.0	CHEMBL4142	Homo sapiens	IC50	nM	39.0
	6339249	CHEMBL1828190	Inhibition of FGFR2 activity by TR-FRET assay	B	CCc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1823221	>	IC50	nM	50000.0	CHEMBL4142	Homo sapiens	IC50	uM	50.0
	6339250	CHEMBL1828190	Inhibition of FGFR2 activity by TR-FRET assay	B	CC1(C)c2cc(C3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779202	=	IC50	nM	360.0	CHEMBL4142	Homo sapiens	IC50	uM	0.36
	6339938	CHEMBL1826621	Activity of FGFR2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	77.0	CHEMBL4142	Homo sapiens	Activity	%	77.0
	6375425	CHEMBL1840255	Inhibition of FGFR2 at 1 uM by radiometric assay	B	CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)NCCNC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)CC[C@]3(C)CC[C@]21C		CHEMBL1836927	=	Inhibition	%	67.0	CHEMBL4142	Homo sapiens	INH	%	67.0
	6386438	CHEMBL1838067	Inhibition of wild type FGFR2 expressed in HEK293 cells assessed as inhibition of autophosphorylation of tyrosine residue after 40 mins by ELISA assay	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	4.9	CHEMBL4142	Homo sapiens	IC50	nM	4.9
	6386453	CHEMBL1837855	Inhibition of FGFR2 juxtamembrane domain-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	2.0	CHEMBL4142	Homo sapiens	IC50	nM	2.0
	6386462	CHEMBL1837846	Inhibition of recombinant FGFR2	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	1.4	CHEMBL4142	Homo sapiens	IC50	uM	0.0014
	7567550	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7568021	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7568489	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	31.0	CHEMBL4142	Homo sapiens	Kd	nM	31.0
	7568921	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	790.0	CHEMBL4142	Homo sapiens	Kd	nM	790.0
	7569064	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	35.0	CHEMBL4142	Homo sapiens	Kd	nM	35.0
	7569524	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7569996	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7570459	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	5200.0	CHEMBL4142	Homo sapiens	Kd	nM	5200.0
	7570886	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	570.0	CHEMBL4142	Homo sapiens	Kd	nM	570.0
	7571040	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7571497	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7571973	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7572436	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7573021	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7573478	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	1400.0	CHEMBL4142	Homo sapiens	Kd	nM	1400.0
	7573954	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	3600.0	CHEMBL4142	Homo sapiens	Kd	nM	3600.0
	7574389	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	250.0	CHEMBL4142	Homo sapiens	Kd	nM	250.0
	7574999	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	350.0	CHEMBL4142	Homo sapiens	Kd	nM	350.0
	7575460	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7575954	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	2400.0	CHEMBL4142	Homo sapiens	Kd	nM	2400.0
	7576362	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7576973	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7577432	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	800.0	CHEMBL4142	Homo sapiens	Kd	nM	800.0
	7577468	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7577938	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	3100.0	CHEMBL4142	Homo sapiens	Kd	nM	3100.0
	7578343	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	470.0	CHEMBL4142	Homo sapiens	Kd	nM	470.0
	7578981	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7579355	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7579837	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	850.0	CHEMBL4142	Homo sapiens	Kd	nM	850.0
	7580306	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	210.0	CHEMBL4142	Homo sapiens	Kd	nM	210.0
	7580709	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1100.0	CHEMBL4142	Homo sapiens	Kd	nM	1100.0
	7581727	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7582198	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7582662	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7583062	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	570.0	CHEMBL4142	Homo sapiens	Kd	nM	570.0
	7583243	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7583640	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7584085	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7584556	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7585018	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	73.0	CHEMBL4142	Homo sapiens	Kd	nM	73.0
	7585422	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7585573	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7585981	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7586427	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7586898	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7587352	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7587534	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7587953	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	110.0	CHEMBL4142	Homo sapiens	Kd	nM	110.0
	7588406	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7588877	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7589499	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	110.0	CHEMBL4142	Homo sapiens	Kd	nM	110.0
	7589923	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	660.0	CHEMBL4142	Homo sapiens	Kd	nM	660.0
	7590390	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7590873	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7591472	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7591894	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	410.0	CHEMBL4142	Homo sapiens	Kd	nM	410.0
	7592366	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7592397	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7592850	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7593439	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1900.0	CHEMBL4142	Homo sapiens	Kd	nM	1900.0
	7593874	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7594377	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1700.0	CHEMBL4142	Homo sapiens	Kd	nM	1700.0
	7594829	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7595407	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7595883	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7596354	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7596801	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2700.0	CHEMBL4142	Homo sapiens	Kd	nM	2700.0
	7597379	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7597390	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7597863	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
	7598333	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	210.0	CHEMBL4142	Homo sapiens	Kd	nM	210.0
	7598775	CHEMBL1908828	Binding constant for FGFR2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	100.0	CHEMBL4142	Homo sapiens	Kd	nM	100.0
	7922710	CHEMBL1919205	Inhibition of human recombinant FGFR2 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	7.0	CHEMBL4142	Homo sapiens	INH	%	7.0
	7943733	CHEMBL1921576	Inhibition of FGFR2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.36	CHEMBL4142	Homo sapiens	IC50	nM	3.36
	7943773	CHEMBL1921430	Inhibition of FGFR2 at 10 uM	B	O=C1CC(c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)=Nc2cnn(Cc3ccccc3)c2N1		CHEMBL1917776	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	7959767	CHEMBL1932858	Inhibition of FGFR2	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL4142	Homo sapiens	IC50	uM	30.0
	7959768	CHEMBL1932858	Inhibition of FGFR2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	24000.0	CHEMBL4142	Homo sapiens	IC50	uM	24.0
	7989251	CHEMBL1936345	Inhibition of human FGFR2 at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)C(C)(C)CNC4=O)nc1C(=O)NC1CCCC1		CHEMBL1933142	>=	Inhibition	%	80.0	CHEMBL4142	Homo sapiens	INH	%	80.0
	7989252	CHEMBL1936345	Inhibition of human FGFR2 at 3 uM	B	Cc1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933143	<	Inhibition	%	80.0	CHEMBL4142	Homo sapiens	INH	%	80.0
	7989253	CHEMBL1936345	Inhibition of human FGFR2 at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)cn1		CHEMBL1933148	<	Inhibition	%	80.0	CHEMBL4142	Homo sapiens	INH	%	80.0
	7989254	CHEMBL1936345	Inhibition of human FGFR2 at 3 uM	B	Cn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933279	>=	Inhibition	%	80.0	CHEMBL4142	Homo sapiens	INH	%	80.0
	7989388	CHEMBL1937082	Inhibition of human FGFR2	B	C[C@@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21		CHEMBL1933288	=	IC50	nM	320.0	CHEMBL4142	Homo sapiens	IC50	nM	320.0
	8013067	CHEMBL1947854	Inhibition of FGFR2 using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	8039274	CHEMBL1953266	Inhibition of FGFR2	B	COc1ccc(C(=O)NC[C@@H](O)CO)cc1/C=C/c1ccc(Cl)cc1		CHEMBL1949788	>	IC50	nM	50000.0	CHEMBL4142	Homo sapiens	IC50	uM	50.0
	8039275	CHEMBL1953266	Inhibition of FGFR2	B	COc1ccc(C(=O)NC[C@H](O)CO)cc1/C=C/c1ccc(Cl)cc1		CHEMBL1949789	>	IC50	nM	50000.0	CHEMBL4142	Homo sapiens	IC50	uM	50.0
	8047118	CHEMBL1958859	Inhibition of FGFR2 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	8061556	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-2.01	CHEMBL4142	Homo sapiens	Inhibition	%	-2.01
	8061663	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.32	CHEMBL4142	Homo sapiens	Inhibition	%	2.32
	8061887	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.35	CHEMBL4142	Homo sapiens	Inhibition	%	4.35
	8062078	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	9.78	CHEMBL4142	Homo sapiens	Inhibition	%	9.78
	8062418	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.83	CHEMBL4142	Homo sapiens	Inhibition	%	2.83
	8062580	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.81	CHEMBL4142	Homo sapiens	Inhibition	%	2.81
	8062902	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	4.73	CHEMBL4142	Homo sapiens	Inhibition	%	4.73
	8063034	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.38	CHEMBL4142	Homo sapiens	Inhibition	%	-0.38
	8063258	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	6.76	CHEMBL4142	Homo sapiens	Inhibition	%	6.76
	8063425	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.72	CHEMBL4142	Homo sapiens	Inhibition	%	1.72
	8063757	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.95	CHEMBL4142	Homo sapiens	Inhibition	%	0.95
	8063939	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	42.19	CHEMBL4142	Homo sapiens	Inhibition	%	42.19
	8064278	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.91	CHEMBL4142	Homo sapiens	Inhibition	%	1.91
	8064488	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.19	CHEMBL4142	Homo sapiens	Inhibition	%	0.19
	8064850	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	1.29	CHEMBL4142	Homo sapiens	Inhibition	%	1.29
	8065016	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.97	CHEMBL4142	Homo sapiens	Inhibition	%	2.97
	8065356	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.31	CHEMBL4142	Homo sapiens	Inhibition	%	1.31
	8065531	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.92	CHEMBL4142	Homo sapiens	Inhibition	%	1.92
	8065755	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	9.05	CHEMBL4142	Homo sapiens	Inhibition	%	9.05
	8065870	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	-0.14	CHEMBL4142	Homo sapiens	Inhibition	%	-0.14
	8066080	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	4.88	CHEMBL4142	Homo sapiens	Inhibition	%	4.88
	8066304	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-1.59	CHEMBL4142	Homo sapiens	Inhibition	%	-1.59
	8066440	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	19.44	CHEMBL4142	Homo sapiens	Inhibition	%	19.44
	8066606	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.09	CHEMBL4142	Homo sapiens	Inhibition	%	0.09
	8066830	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.42	CHEMBL4142	Homo sapiens	Inhibition	%	0.42
	8066954	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.09	CHEMBL4142	Homo sapiens	Inhibition	%	1.09
	8067353	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.63	CHEMBL4142	Homo sapiens	Inhibition	%	2.63
	8067474	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	3.9	CHEMBL4142	Homo sapiens	Inhibition	%	3.9
	8067908	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	3.19	CHEMBL4142	Homo sapiens	Inhibition	%	3.19
	8068043	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	1.71	CHEMBL4142	Homo sapiens	Inhibition	%	1.71
	8068431	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.66	CHEMBL4142	Homo sapiens	Inhibition	%	2.66
	8068556	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.33	CHEMBL4142	Homo sapiens	Inhibition	%	3.33
	8068780	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.6	CHEMBL4142	Homo sapiens	Inhibition	%	1.6
	8068954	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	7.81	CHEMBL4142	Homo sapiens	Inhibition	%	7.81
	8069079	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.01	CHEMBL4142	Homo sapiens	Inhibition	%	-0.01
	8069303	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	6.38	CHEMBL4142	Homo sapiens	Inhibition	%	6.38
	8069374	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	23.02	CHEMBL4142	Homo sapiens	Inhibition	%	23.02
	8069598	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	1.8	CHEMBL4142	Homo sapiens	Inhibition	%	1.8
	8069759	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	7.1	CHEMBL4142	Homo sapiens	Inhibition	%	7.1
	8070109	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	3.48	CHEMBL4142	Homo sapiens	Inhibition	%	3.48
	8070281	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.38	CHEMBL4142	Homo sapiens	Inhibition	%	3.38
	8070630	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.22	CHEMBL4142	Homo sapiens	Inhibition	%	-0.22
	8070928	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	19.08	CHEMBL4142	Homo sapiens	Inhibition	%	19.08
	8071085	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.45	CHEMBL4142	Homo sapiens	Inhibition	%	1.45
	8071435	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.62	CHEMBL4142	Homo sapiens	Inhibition	%	0.62
	8071608	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	5.85	CHEMBL4142	Homo sapiens	Inhibition	%	5.85
	8071957	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	3.83	CHEMBL4142	Homo sapiens	Inhibition	%	3.83
	8072271	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-1.71	CHEMBL4142	Homo sapiens	Inhibition	%	-1.71
	8072428	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.49	CHEMBL4142	Homo sapiens	Inhibition	%	3.49
	8072652	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.69	CHEMBL4142	Homo sapiens	Inhibition	%	1.69
	8072777	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	5.35	CHEMBL4142	Homo sapiens	Inhibition	%	5.35
	8072944	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.01	CHEMBL4142	Homo sapiens	Inhibition	%	2.01
	8073168	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	7.9	CHEMBL4142	Homo sapiens	Inhibition	%	7.9
	8073293	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	2.26	CHEMBL4142	Homo sapiens	Inhibition	%	2.26
	8073636	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.39	CHEMBL4142	Homo sapiens	Inhibition	%	2.39
	8073869	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	2.62	CHEMBL4142	Homo sapiens	Inhibition	%	2.62
	8074245	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	4.03	CHEMBL4142	Homo sapiens	Inhibition	%	4.03
	8074375	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	2.76	CHEMBL4142	Homo sapiens	Inhibition	%	2.76
	8074756	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.69	CHEMBL4142	Homo sapiens	Inhibition	%	1.69
	8074883	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	29.7	CHEMBL4142	Homo sapiens	Inhibition	%	29.7
	8075107	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-2.09	CHEMBL4142	Homo sapiens	Inhibition	%	-2.09
	8075218	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	27.21	CHEMBL4142	Homo sapiens	Inhibition	%	27.21
	8075455	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.04	CHEMBL4142	Homo sapiens	Inhibition	%	-0.04
	8075820	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	8.43	CHEMBL4142	Homo sapiens	Inhibition	%	8.43
	8075962	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	20.78	CHEMBL4142	Homo sapiens	Inhibition	%	20.78
	8076186	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-2.58	CHEMBL4142	Homo sapiens	Inhibition	%	-2.58
	8076334	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	5.26	CHEMBL4142	Homo sapiens	Inhibition	%	5.26
	8076692	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.97	CHEMBL4142	Homo sapiens	Inhibition	%	1.97
	8076794	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-1.34	CHEMBL4142	Homo sapiens	Inhibition	%	-1.34
	8077018	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.45	CHEMBL4142	Homo sapiens	Inhibition	%	2.45
	8077041	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.42	CHEMBL4142	Homo sapiens	Inhibition	%	0.42
	8077265	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	0.17	CHEMBL4142	Homo sapiens	Inhibition	%	0.17
	8077393	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	20.59	CHEMBL4142	Homo sapiens	Inhibition	%	20.59
	8077768	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	5.48	CHEMBL4142	Homo sapiens	Inhibition	%	5.48
	8077911	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.97	CHEMBL4142	Homo sapiens	Inhibition	%	1.97
	8078274	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-4.17	CHEMBL4142	Homo sapiens	Inhibition	%	-4.17
	8078600	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-1.99	CHEMBL4142	Homo sapiens	Inhibition	%	-1.99
	8078850	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	1.12	CHEMBL4142	Homo sapiens	Inhibition	%	1.12
	8078966	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.7	CHEMBL4142	Homo sapiens	Inhibition	%	1.7
	8079190	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.97	CHEMBL4142	Homo sapiens	Inhibition	%	4.97
	8079348	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-1.37	CHEMBL4142	Homo sapiens	Inhibition	%	-1.37
	8079490	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.63	CHEMBL4142	Homo sapiens	Inhibition	%	3.63
	8079714	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.34	CHEMBL4142	Homo sapiens	Inhibition	%	1.34
	8079853	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	9.61	CHEMBL4142	Homo sapiens	Inhibition	%	9.61
	8080182	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	5.39	CHEMBL4142	Homo sapiens	Inhibition	%	5.39
	8080434	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-0.6	CHEMBL4142	Homo sapiens	Inhibition	%	-0.6
	8080773	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.22	CHEMBL4142	Homo sapiens	Inhibition	%	1.22
	8080937	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	8.23	CHEMBL4142	Homo sapiens	Inhibition	%	8.23
	8081296	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.9	CHEMBL4142	Homo sapiens	Inhibition	%	3.9
	8081440	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	3.25	CHEMBL4142	Homo sapiens	Inhibition	%	3.25
	8081767	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	3.82	CHEMBL4142	Homo sapiens	Inhibition	%	3.82
	8082019	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	17.31	CHEMBL4142	Homo sapiens	Inhibition	%	17.31
	8082356	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.56	CHEMBL4142	Homo sapiens	Inhibition	%	2.56
	8082529	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.3	CHEMBL4142	Homo sapiens	Inhibition	%	-3.3
	8082876	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.36	CHEMBL4142	Homo sapiens	Inhibition	%	2.36
	8083032	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	6.48	CHEMBL4142	Homo sapiens	Inhibition	%	6.48
	8083256	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	3.11	CHEMBL4142	Homo sapiens	Inhibition	%	3.11
	8083355	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	32.48	CHEMBL4142	Homo sapiens	Inhibition	%	32.48
	8083609	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-6.69	CHEMBL4142	Homo sapiens	Inhibition	%	-6.69
	8083943	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.68	CHEMBL4142	Homo sapiens	Inhibition	%	1.68
	8084128	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.58	CHEMBL4142	Homo sapiens	Inhibition	%	-3.58
	8084352	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	27.48	CHEMBL4142	Homo sapiens	Inhibition	%	27.48
	8084470	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.31	CHEMBL4142	Homo sapiens	Inhibition	%	3.31
	8084855	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	8.85	CHEMBL4142	Homo sapiens	Inhibition	%	8.85
	8084953	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-3.44	CHEMBL4142	Homo sapiens	Inhibition	%	-3.44
	8085177	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	5.34	CHEMBL4142	Homo sapiens	Inhibition	%	5.34
	8085209	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-0.47	CHEMBL4142	Homo sapiens	Inhibition	%	-0.47
	8085433	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-7.09	CHEMBL4142	Homo sapiens	Inhibition	%	-7.09
	8085541	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	4.49	CHEMBL4142	Homo sapiens	Inhibition	%	4.49
	8085954	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	69.75	CHEMBL4142	Homo sapiens	Inhibition	%	69.75
	8086069	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.03	CHEMBL4142	Homo sapiens	Inhibition	%	2.03
	8086293	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.51	CHEMBL4142	Homo sapiens	Inhibition	%	2.51
	8086455	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-0.3	CHEMBL4142	Homo sapiens	Inhibition	%	-0.3
	8086778	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-0.14	CHEMBL4142	Homo sapiens	Inhibition	%	-0.14
	8086989	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.82	CHEMBL4142	Homo sapiens	Inhibition	%	3.82
	8087147	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	10.52	CHEMBL4142	Homo sapiens	Inhibition	%	10.52
	8087371	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.64	CHEMBL4142	Homo sapiens	Inhibition	%	3.64
	8087485	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	56.11	CHEMBL4142	Homo sapiens	Inhibition	%	56.11
	8087847	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.91	CHEMBL4142	Homo sapiens	Inhibition	%	4.91
	8087989	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	11.77	CHEMBL4142	Homo sapiens	Inhibition	%	11.77
	8088213	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	7.87	CHEMBL4142	Homo sapiens	Inhibition	%	7.87
	8088361	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.73	CHEMBL4142	Homo sapiens	Inhibition	%	1.73
	8088713	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	7.05	CHEMBL4142	Homo sapiens	Inhibition	%	7.05
	8088806	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.75	CHEMBL4142	Homo sapiens	Inhibition	%	0.75
	8089030	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.22	CHEMBL4142	Homo sapiens	Inhibition	%	4.22
	8089158	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-2.81	CHEMBL4142	Homo sapiens	Inhibition	%	-2.81
	8089530	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	3.88	CHEMBL4142	Homo sapiens	Inhibition	%	3.88
	8089650	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.6	CHEMBL4142	Homo sapiens	Inhibition	%	1.6
	8090054	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	2.87	CHEMBL4142	Homo sapiens	Inhibition	%	2.87
	8090219	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	5.89	CHEMBL4142	Homo sapiens	Inhibition	%	5.89
	8090610	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.94	CHEMBL4142	Homo sapiens	Inhibition	%	3.94
	8090749	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	7.12	CHEMBL4142	Homo sapiens	Inhibition	%	7.12
	8091178	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.26	CHEMBL4142	Homo sapiens	Inhibition	%	3.26
	8091315	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	7.15	CHEMBL4142	Homo sapiens	Inhibition	%	7.15
	8091694	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	5.39	CHEMBL4142	Homo sapiens	Inhibition	%	5.39
	8091810	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	6.35	CHEMBL4142	Homo sapiens	Inhibition	%	6.35
	8092034	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	13.7	CHEMBL4142	Homo sapiens	Inhibition	%	13.7
	8092171	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.63	CHEMBL4142	Homo sapiens	Inhibition	%	-0.63
	8092546	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	7.79	CHEMBL4142	Homo sapiens	Inhibition	%	7.79
	8092694	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	4.95	CHEMBL4142	Homo sapiens	Inhibition	%	4.95
	8093047	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	21.92	CHEMBL4142	Homo sapiens	Inhibition	%	21.92
	8093359	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.64	CHEMBL4142	Homo sapiens	Inhibition	%	0.64
	8093499	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	3.3	CHEMBL4142	Homo sapiens	Inhibition	%	3.3
	8093862	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	36.81	CHEMBL4142	Homo sapiens	Inhibition	%	36.81
	8093982	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	6.83	CHEMBL4142	Homo sapiens	Inhibition	%	6.83
	8094206	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	33.03	CHEMBL4142	Homo sapiens	Inhibition	%	33.03
	8094386	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.69	CHEMBL4142	Homo sapiens	Inhibition	%	1.69
	8094561	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.93	CHEMBL4142	Homo sapiens	Inhibition	%	0.93
	8094785	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	7.72	CHEMBL4142	Homo sapiens	Inhibition	%	7.72
	8094941	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	11.83	CHEMBL4142	Homo sapiens	Inhibition	%	11.83
	8095081	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	16.16	CHEMBL4142	Homo sapiens	Inhibition	%	16.16
	8095305	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	53.86	CHEMBL4142	Homo sapiens	Inhibition	%	53.86
	8095508	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.3	CHEMBL4142	Homo sapiens	Inhibition	%	4.3
	8095649	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	6.37	CHEMBL4142	Homo sapiens	Inhibition	%	6.37
	8095873	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	7.35	CHEMBL4142	Homo sapiens	Inhibition	%	7.35
	8096021	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.33	CHEMBL4142	Homo sapiens	Inhibition	%	3.33
	8096362	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	7.58	CHEMBL4142	Homo sapiens	Inhibition	%	7.58
	8096501	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-3.24	CHEMBL4142	Homo sapiens	Inhibition	%	-3.24
	8096881	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	8.79	CHEMBL4142	Homo sapiens	Inhibition	%	8.79
	8097028	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.92	CHEMBL4142	Homo sapiens	Inhibition	%	2.92
	8097252	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	3.32	CHEMBL4142	Homo sapiens	Inhibition	%	3.32
	8097339	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	5.18	CHEMBL4142	Homo sapiens	Inhibition	%	5.18
	8097559	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.29	CHEMBL4142	Homo sapiens	Inhibition	%	3.29
	8097709	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-3.01	CHEMBL4142	Homo sapiens	Inhibition	%	-3.01
	8097933	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	0.85	CHEMBL4142	Homo sapiens	Inhibition	%	0.85
	8098066	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-3.37	CHEMBL4142	Homo sapiens	Inhibition	%	-3.37
	8098410	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.92	CHEMBL4142	Homo sapiens	Inhibition	%	-0.92
	8098590	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.54	CHEMBL4142	Homo sapiens	Inhibition	%	1.54
	8098999	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	3.84	CHEMBL4142	Homo sapiens	Inhibition	%	3.84
	8099143	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.27	CHEMBL4142	Homo sapiens	Inhibition	%	3.27
	8099509	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.27	CHEMBL4142	Homo sapiens	Inhibition	%	3.27
	8099703	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.16	CHEMBL4142	Homo sapiens	Inhibition	%	1.16
	8100074	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	9.23	CHEMBL4142	Homo sapiens	Inhibition	%	9.23
	8100220	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	7.69	CHEMBL4142	Homo sapiens	Inhibition	%	7.69
	8100560	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	11.04	CHEMBL4142	Homo sapiens	Inhibition	%	11.04
	8100700	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.85	CHEMBL4142	Homo sapiens	Inhibition	%	0.85
	8100924	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	3.74	CHEMBL4142	Homo sapiens	Inhibition	%	3.74
	8101084	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	7.42	CHEMBL4142	Homo sapiens	Inhibition	%	7.42
	8101450	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	4.47	CHEMBL4142	Homo sapiens	Inhibition	%	4.47
	8101635	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.16	CHEMBL4142	Homo sapiens	Inhibition	%	-0.16
	8101888	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	1.79	CHEMBL4142	Homo sapiens	Inhibition	%	1.79
	8102267	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-1.94	CHEMBL4142	Homo sapiens	Inhibition	%	-1.94
	8102398	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	5.77	CHEMBL4142	Homo sapiens	Inhibition	%	5.77
	8102742	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	3.02	CHEMBL4142	Homo sapiens	Inhibition	%	3.02
	8102920	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.65	CHEMBL4142	Homo sapiens	Inhibition	%	1.65
	8103144	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	8.16	CHEMBL4142	Homo sapiens	Inhibition	%	8.16
	8103340	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.95	CHEMBL4142	Homo sapiens	Inhibition	%	4.95
	8103478	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	4.29	CHEMBL4142	Homo sapiens	Inhibition	%	4.29
	8103702	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.81	CHEMBL4142	Homo sapiens	Inhibition	%	2.81
	8103852	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	9.16	CHEMBL4142	Homo sapiens	Inhibition	%	9.16
	8104037	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	2.21	CHEMBL4142	Homo sapiens	Inhibition	%	2.21
	8104409	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	7.12	CHEMBL4142	Homo sapiens	Inhibition	%	7.12
	8104555	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-0.2	CHEMBL4142	Homo sapiens	Inhibition	%	-0.2
	8104779	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	15.23	CHEMBL4142	Homo sapiens	Inhibition	%	15.23
	8104893	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.13	CHEMBL4142	Homo sapiens	Inhibition	%	3.13
	8105257	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.39	CHEMBL4142	Homo sapiens	Inhibition	%	0.39
	8105423	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	8.69	CHEMBL4142	Homo sapiens	Inhibition	%	8.69
	8105785	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	26.97	CHEMBL4142	Homo sapiens	Inhibition	%	26.97
	8106065	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.27	CHEMBL4142	Homo sapiens	Inhibition	%	2.27
	8106230	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	9.49	CHEMBL4142	Homo sapiens	Inhibition	%	9.49
	8106610	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	13.1	CHEMBL4142	Homo sapiens	Inhibition	%	13.1
	8106739	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	14.96	CHEMBL4142	Homo sapiens	Inhibition	%	14.96
	8106963	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	54.61	CHEMBL4142	Homo sapiens	Inhibition	%	54.61
	8107084	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.49	CHEMBL4142	Homo sapiens	Inhibition	%	-0.49
	8107480	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.24	CHEMBL4142	Homo sapiens	Inhibition	%	2.24
	8107681	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.18	CHEMBL4142	Homo sapiens	Inhibition	%	4.18
	8108040	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	12.99	CHEMBL4142	Homo sapiens	Inhibition	%	12.99
	8108198	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.22	CHEMBL4142	Homo sapiens	Inhibition	%	4.22
	8108373	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.67	CHEMBL4142	Homo sapiens	Inhibition	%	2.67
	8108597	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.53	CHEMBL4142	Homo sapiens	Inhibition	%	2.53
	8108744	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	9.46	CHEMBL4142	Homo sapiens	Inhibition	%	9.46
	8109110	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.62	CHEMBL4142	Homo sapiens	Inhibition	%	-0.62
	8109224	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	6.84	CHEMBL4142	Homo sapiens	Inhibition	%	6.84
	8109448	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.52	CHEMBL4142	Homo sapiens	Inhibition	%	5.52
	8109578	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.95	CHEMBL4142	Homo sapiens	Inhibition	%	-0.95
	8109749	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	4.51	CHEMBL4142	Homo sapiens	Inhibition	%	4.51
	8109973	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	8.58	CHEMBL4142	Homo sapiens	Inhibition	%	8.58
	8110105	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.62	CHEMBL4142	Homo sapiens	Inhibition	%	3.62
	8110384	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	5.67	CHEMBL4142	Homo sapiens	Inhibition	%	5.67
	8110550	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.72	CHEMBL4142	Homo sapiens	Inhibition	%	-2.72
	8110774	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.99	CHEMBL4142	Homo sapiens	Inhibition	%	0.99
	8110932	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.49	CHEMBL4142	Homo sapiens	Inhibition	%	-1.49
	8111279	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.25	CHEMBL4142	Homo sapiens	Inhibition	%	3.25
	8111406	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.34	CHEMBL4142	Homo sapiens	Inhibition	%	0.34
	8111630	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-1.27	CHEMBL4142	Homo sapiens	Inhibition	%	-1.27
	8111796	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%		CHEMBL4142	Homo sapiens	Inhibition	%	
	8112001	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	6.15	CHEMBL4142	Homo sapiens	Inhibition	%	6.15
	8112362	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	3.14	CHEMBL4142	Homo sapiens	Inhibition	%	3.14
	8112530	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	7.4	CHEMBL4142	Homo sapiens	Inhibition	%	7.4
	8112926	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.37	CHEMBL4142	Homo sapiens	Inhibition	%	-0.37
	8113078	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	12.46	CHEMBL4142	Homo sapiens	Inhibition	%	12.46
	8113438	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	3.75	CHEMBL4142	Homo sapiens	Inhibition	%	3.75
	8113786	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	7.26	CHEMBL4142	Homo sapiens	Inhibition	%	7.26
	8113902	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.39	CHEMBL4142	Homo sapiens	Inhibition	%	1.39
	8114302	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	6.07	CHEMBL4142	Homo sapiens	Inhibition	%	6.07
	8114434	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	11.69	CHEMBL4142	Homo sapiens	Inhibition	%	11.69
	8114710	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.75	CHEMBL4142	Homo sapiens	Inhibition	%	2.75
	8115100	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	14.05	CHEMBL4142	Homo sapiens	Inhibition	%	14.05
	8115265	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.4	CHEMBL4142	Homo sapiens	Inhibition	%	0.4
	8115609	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	8.89	CHEMBL4142	Homo sapiens	Inhibition	%	8.89
	8115966	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.8	CHEMBL4142	Homo sapiens	Inhibition	%	0.8
	8116125	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.16	CHEMBL4142	Homo sapiens	Inhibition	%	0.16
	8116328	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	6.52	CHEMBL4142	Homo sapiens	Inhibition	%	6.52
	8116552	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	9.23	CHEMBL4142	Homo sapiens	Inhibition	%	9.23
	8116686	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.1	CHEMBL4142	Homo sapiens	Inhibition	%	-0.1
	8116858	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	8.86	CHEMBL4142	Homo sapiens	Inhibition	%	8.86
	8117082	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	32.83	CHEMBL4142	Homo sapiens	Inhibition	%	32.83
	8117253	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.62	CHEMBL4142	Homo sapiens	Inhibition	%	2.62
	8117411	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	5.4	CHEMBL4142	Homo sapiens	Inhibition	%	5.4
	8117635	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	6.92	CHEMBL4142	Homo sapiens	Inhibition	%	6.92
	8117765	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.57	CHEMBL4142	Homo sapiens	Inhibition	%	0.57
	8118127	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.37	CHEMBL4142	Homo sapiens	Inhibition	%	0.37
	8118243	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.01	CHEMBL4142	Homo sapiens	Inhibition	%	0.01
	8118467	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.92	CHEMBL4142	Homo sapiens	Inhibition	%	5.92
	8118639	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	14.2	CHEMBL4142	Homo sapiens	Inhibition	%	14.2
	8118775	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.08	CHEMBL4142	Homo sapiens	Inhibition	%	4.08
	8118999	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	8.41	CHEMBL4142	Homo sapiens	Inhibition	%	8.41
	8119046	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	6.2	CHEMBL4142	Homo sapiens	Inhibition	%	6.2
	8119270	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.12	CHEMBL4142	Homo sapiens	Inhibition	%	0.12
	8119429	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	52.2	CHEMBL4142	Homo sapiens	Inhibition	%	52.2
	8119596	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-4.24	CHEMBL4142	Homo sapiens	Inhibition	%	-4.24
	8119820	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.03	CHEMBL4142	Homo sapiens	Inhibition	%	0.03
	8119939	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.9	CHEMBL4142	Homo sapiens	Inhibition	%	1.9
	8120302	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-1.07	CHEMBL4142	Homo sapiens	Inhibition	%	-1.07
	8120462	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	6.9	CHEMBL4142	Homo sapiens	Inhibition	%	6.9
	8120887	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	11.4	CHEMBL4142	Homo sapiens	Inhibition	%	11.4
	8121015	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.48	CHEMBL4142	Homo sapiens	Inhibition	%	0.48
	8121411	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.52	CHEMBL4142	Homo sapiens	Inhibition	%	2.52
	8121578	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	7.6	CHEMBL4142	Homo sapiens	Inhibition	%	7.6
	8121965	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.8	CHEMBL4142	Homo sapiens	Inhibition	%	5.8
	8122086	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	5.46	CHEMBL4142	Homo sapiens	Inhibition	%	5.46
	8122310	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	7.78	CHEMBL4142	Homo sapiens	Inhibition	%	7.78
	8122448	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.12	CHEMBL4142	Homo sapiens	Inhibition	%	2.12
	8122792	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.85	CHEMBL4142	Homo sapiens	Inhibition	%	5.85
	8122959	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	10.76	CHEMBL4142	Homo sapiens	Inhibition	%	10.76
	8123325	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	2.62	CHEMBL4142	Homo sapiens	Inhibition	%	2.62
	8123603	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	4.39	CHEMBL4142	Homo sapiens	Inhibition	%	4.39
	8123753	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.0	CHEMBL4142	Homo sapiens	Inhibition	%	3.0
	8124144	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-3.25	CHEMBL4142	Homo sapiens	Inhibition	%	-3.25
	8124263	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	5.07	CHEMBL4142	Homo sapiens	Inhibition	%	5.07
	8124487	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	1.68	CHEMBL4142	Homo sapiens	Inhibition	%	1.68
	8124626	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.36	CHEMBL4142	Homo sapiens	Inhibition	%	0.36
	8124791	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.61	CHEMBL4142	Homo sapiens	Inhibition	%	-0.61
	8125015	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.52	CHEMBL4142	Homo sapiens	Inhibition	%	-0.52
	8125216	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	9.05	CHEMBL4142	Homo sapiens	Inhibition	%	9.05
	8125346	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	5.04	CHEMBL4142	Homo sapiens	Inhibition	%	5.04
	8125570	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.85	CHEMBL4142	Homo sapiens	Inhibition	%	-0.85
	8125738	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.51	CHEMBL4142	Homo sapiens	Inhibition	%	1.51
	8125902	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	18.25	CHEMBL4142	Homo sapiens	Inhibition	%	18.25
	8126126	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.41	CHEMBL4142	Homo sapiens	Inhibition	%	-0.41
	8126290	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.79	CHEMBL4142	Homo sapiens	Inhibition	%	4.79
	8126629	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	43.77	CHEMBL4142	Homo sapiens	Inhibition	%	43.77
	8126765	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	18.8	CHEMBL4142	Homo sapiens	Inhibition	%	18.8
	8127111	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	6.96	CHEMBL4142	Homo sapiens	Inhibition	%	6.96
	8127278	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	12.44	CHEMBL4142	Homo sapiens	Inhibition	%	12.44
	8127502	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	40.53	CHEMBL4142	Homo sapiens	Inhibition	%	40.53
	8127644	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	20.87	CHEMBL4142	Homo sapiens	Inhibition	%	20.87
	8127932	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.66	CHEMBL4142	Homo sapiens	Inhibition	%	0.66
	8128084	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	9.48	CHEMBL4142	Homo sapiens	Inhibition	%	9.48
	8128308	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	4.82	CHEMBL4142	Homo sapiens	Inhibition	%	4.82
	8128475	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	10.7	CHEMBL4142	Homo sapiens	Inhibition	%	10.7
	8128818	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	16.61	CHEMBL4142	Homo sapiens	Inhibition	%	16.61
	8128955	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.92	CHEMBL4142	Homo sapiens	Inhibition	%	0.92
	8129350	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-2.17	CHEMBL4142	Homo sapiens	Inhibition	%	-2.17
	8129539	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	5.8	CHEMBL4142	Homo sapiens	Inhibition	%	5.8
	8129902	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.69	CHEMBL4142	Homo sapiens	Inhibition	%	-0.69
	8130063	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	4.25	CHEMBL4142	Homo sapiens	Inhibition	%	4.25
	8130459	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-2.18	CHEMBL4142	Homo sapiens	Inhibition	%	-2.18
	8130619	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	4.18	CHEMBL4142	Homo sapiens	Inhibition	%	4.18
	8130959	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.58	CHEMBL4142	Homo sapiens	Inhibition	%	1.58
	8131098	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	53.31	CHEMBL4142	Homo sapiens	Inhibition	%	53.31
	8131322	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	6.73	CHEMBL4142	Homo sapiens	Inhibition	%	6.73
	8131442	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	5.56	CHEMBL4142	Homo sapiens	Inhibition	%	5.56
	8131833	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	69.79	CHEMBL4142	Homo sapiens	Inhibition	%	69.79
	8131974	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	15.76	CHEMBL4142	Homo sapiens	Inhibition	%	15.76
	8132260	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	5.14	CHEMBL4142	Homo sapiens	Inhibition	%	5.14
	8132631	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	5.81	CHEMBL4142	Homo sapiens	Inhibition	%	5.81
	8132799	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-1.98	CHEMBL4142	Homo sapiens	Inhibition	%	-1.98
	8133144	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.2	CHEMBL4142	Homo sapiens	Inhibition	%	0.2
	8133282	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	21.66	CHEMBL4142	Homo sapiens	Inhibition	%	21.66
	8133506	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.64	CHEMBL4142	Homo sapiens	Inhibition	%	0.64
	8133678	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.7	CHEMBL4142	Homo sapiens	Inhibition	%	-0.7
	8133858	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	6.7	CHEMBL4142	Homo sapiens	Inhibition	%	6.7
	8134230	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.74	CHEMBL4142	Homo sapiens	Inhibition	%	-1.74
	8134390	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.09	CHEMBL4142	Homo sapiens	Inhibition	%	3.09
	8134614	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.64	CHEMBL4142	Homo sapiens	Inhibition	%	0.64
	8134798	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	1.04	CHEMBL4142	Homo sapiens	Inhibition	%	1.04
	8134958	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	8.8	CHEMBL4142	Homo sapiens	Inhibition	%	8.8
	8135297	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.83	CHEMBL4142	Homo sapiens	Inhibition	%	3.83
	8135662	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	8.24	CHEMBL4142	Homo sapiens	Inhibition	%	8.24
	8135783	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	5.52	CHEMBL4142	Homo sapiens	Inhibition	%	5.52
	8136007	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.13	CHEMBL4142	Homo sapiens	Inhibition	%	0.13
	8136175	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	5.34	CHEMBL4142	Homo sapiens	Inhibition	%	5.34
	8136319	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	52.55	CHEMBL4142	Homo sapiens	Inhibition	%	52.55
	8136543	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	6.16	CHEMBL4142	Homo sapiens	Inhibition	%	6.16
	8136609	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-2.28	CHEMBL4142	Homo sapiens	Inhibition	%	-2.28
	8136968	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.22	CHEMBL4142	Homo sapiens	Inhibition	%	0.22
	8137131	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	4.23	CHEMBL4142	Homo sapiens	Inhibition	%	4.23
	8137355	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	2.19	CHEMBL4142	Homo sapiens	Inhibition	%	2.19
	8137475	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.7	CHEMBL4142	Homo sapiens	Inhibition	%	1.7
	8137847	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.38	CHEMBL4142	Homo sapiens	Inhibition	%	3.38
	8138013	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-3.13	CHEMBL4142	Homo sapiens	Inhibition	%	-3.13
	8138192	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	12.8	CHEMBL4142	Homo sapiens	Inhibition	%	12.8
	8138416	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	6.08	CHEMBL4142	Homo sapiens	Inhibition	%	6.08
	8138564	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-4.78	CHEMBL4142	Homo sapiens	Inhibition	%	-4.78
	8138946	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.44	CHEMBL4142	Homo sapiens	Inhibition	%	3.44
	8139131	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	27.13	CHEMBL4142	Homo sapiens	Inhibition	%	27.13
	8139290	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.22	CHEMBL4142	Homo sapiens	Inhibition	%	4.22
	8139514	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	7.33	CHEMBL4142	Homo sapiens	Inhibition	%	7.33
	8139628	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.74	CHEMBL4142	Homo sapiens	Inhibition	%	3.74
	8139993	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	7.74	CHEMBL4142	Homo sapiens	Inhibition	%	7.74
	8140340	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	9.0	CHEMBL4142	Homo sapiens	Inhibition	%	9.0
	8140499	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	6.12	CHEMBL4142	Homo sapiens	Inhibition	%	6.12
	8140866	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	12.04	CHEMBL4142	Homo sapiens	Inhibition	%	12.04
	8140944	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-2.01	CHEMBL4142	Homo sapiens	Inhibition	%	-2.01
	8141168	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.56	CHEMBL4142	Homo sapiens	Inhibition	%	0.56
	8141298	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	20.45	CHEMBL4142	Homo sapiens	Inhibition	%	20.45
	8141682	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	19.35	CHEMBL4142	Homo sapiens	Inhibition	%	19.35
	8141801	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-3.46	CHEMBL4142	Homo sapiens	Inhibition	%	-3.46
	8142025	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-2.09	CHEMBL4142	Homo sapiens	Inhibition	%	-2.09
	8142186	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	3.13	CHEMBL4142	Homo sapiens	Inhibition	%	3.13
	8142354	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.53	CHEMBL4142	Homo sapiens	Inhibition	%	-2.53
	8142754	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	5.8	CHEMBL4142	Homo sapiens	Inhibition	%	5.8
	8142903	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-4.22	CHEMBL4142	Homo sapiens	Inhibition	%	-4.22
	8143282	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.89	CHEMBL4142	Homo sapiens	Inhibition	%	3.89
	8143469	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	8.24	CHEMBL4142	Homo sapiens	Inhibition	%	8.24
	8143852	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	6.45	CHEMBL4142	Homo sapiens	Inhibition	%	6.45
	8143966	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	6.37	CHEMBL4142	Homo sapiens	Inhibition	%	6.37
	8144190	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.07	CHEMBL4142	Homo sapiens	Inhibition	%	1.07
	8144329	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	9.73	CHEMBL4142	Homo sapiens	Inhibition	%	9.73
	8144683	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	8.13	CHEMBL4142	Homo sapiens	Inhibition	%	8.13
	8144836	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	9.77	CHEMBL4142	Homo sapiens	Inhibition	%	9.77
	8145197	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	7.23	CHEMBL4142	Homo sapiens	Inhibition	%	7.23
	8145510	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	6.55	CHEMBL4142	Homo sapiens	Inhibition	%	6.55
	8145634	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.33	CHEMBL4142	Homo sapiens	Inhibition	%	-0.33
	8145858	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	5.26	CHEMBL4142	Homo sapiens	Inhibition	%	5.26
	8146019	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	3.91	CHEMBL4142	Homo sapiens	Inhibition	%	3.91
	8146363	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.25	CHEMBL4142	Homo sapiens	Inhibition	%	0.25
	8146523	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	22.09	CHEMBL4142	Homo sapiens	Inhibition	%	22.09
	8146690	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-3.05	CHEMBL4142	Homo sapiens	Inhibition	%	-3.05
	8146914	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	7.56	CHEMBL4142	Homo sapiens	Inhibition	%	7.56
	8147083	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	14.47	CHEMBL4142	Homo sapiens	Inhibition	%	14.47
	8147225	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.57	CHEMBL4142	Homo sapiens	Inhibition	%	-3.57
	8147449	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.56	CHEMBL4142	Homo sapiens	Inhibition	%	1.56
	8147602	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	4.27	CHEMBL4142	Homo sapiens	Inhibition	%	4.27
	8147789	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	7.14	CHEMBL4142	Homo sapiens	Inhibition	%	7.14
	8148013	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	7.19	CHEMBL4142	Homo sapiens	Inhibition	%	7.19
	8148171	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	9.52	CHEMBL4142	Homo sapiens	Inhibition	%	9.52
	8148509	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	4.45	CHEMBL4142	Homo sapiens	Inhibition	%	4.45
	8148648	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.22	CHEMBL4142	Homo sapiens	Inhibition	%	2.22
	8148872	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.69	CHEMBL4142	Homo sapiens	Inhibition	%	3.69
	8149010	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	11.32	CHEMBL4142	Homo sapiens	Inhibition	%	11.32
	8149169	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	5.71	CHEMBL4142	Homo sapiens	Inhibition	%	5.71
	8149393	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-1.21	CHEMBL4142	Homo sapiens	Inhibition	%	-1.21
	8149527	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	11.59	CHEMBL4142	Homo sapiens	Inhibition	%	11.59
	8149849	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.21	CHEMBL4142	Homo sapiens	Inhibition	%	0.21
	8150198	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-3.04	CHEMBL4142	Homo sapiens	Inhibition	%	-3.04
	8150358	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	13.36	CHEMBL4142	Homo sapiens	Inhibition	%	13.36
	8150702	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	4.0	CHEMBL4142	Homo sapiens	Inhibition	%	4.0
	8150867	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.41	CHEMBL4142	Homo sapiens	Inhibition	%	1.41
	8151254	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.95	CHEMBL4142	Homo sapiens	Inhibition	%	-3.95
	8151431	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	5.43	CHEMBL4142	Homo sapiens	Inhibition	%	5.43
	8151793	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.34	CHEMBL4142	Homo sapiens	Inhibition	%	3.34
	8151947	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.73	CHEMBL4142	Homo sapiens	Inhibition	%	2.73
	8152171	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.17	CHEMBL4142	Homo sapiens	Inhibition	%	0.17
	8152359	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	8.86	CHEMBL4142	Homo sapiens	Inhibition	%	8.86
	8152517	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	6.37	CHEMBL4142	Homo sapiens	Inhibition	%	6.37
	8152855	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	18.8	CHEMBL4142	Homo sapiens	Inhibition	%	18.8
	8153218	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.18	CHEMBL4142	Homo sapiens	Inhibition	%	3.18
	8153355	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	8.04	CHEMBL4142	Homo sapiens	Inhibition	%	8.04
	8153736	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-2.13	CHEMBL4142	Homo sapiens	Inhibition	%	-2.13
	8153869	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.81	CHEMBL4142	Homo sapiens	Inhibition	%	3.81
	8154093	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.33	CHEMBL4142	Homo sapiens	Inhibition	%	5.33
	8154190	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	10.17	CHEMBL4142	Homo sapiens	Inhibition	%	10.17
	8154540	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	33.23	CHEMBL4142	Homo sapiens	Inhibition	%	33.23
	8154699	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.94	CHEMBL4142	Homo sapiens	Inhibition	%	0.94
	8154923	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	8.07	CHEMBL4142	Homo sapiens	Inhibition	%	8.07
	8155043	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.46	CHEMBL4142	Homo sapiens	Inhibition	%	0.46
	8155219	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	0.97	CHEMBL4142	Homo sapiens	Inhibition	%	0.97
	8155443	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.61	CHEMBL4142	Homo sapiens	Inhibition	%	0.61
	8155604	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.78	CHEMBL4142	Homo sapiens	Inhibition	%	-3.78
	8155782	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	8.21	CHEMBL4142	Homo sapiens	Inhibition	%	8.21
	8156006	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	10.67	CHEMBL4142	Homo sapiens	Inhibition	%	10.67
	8156144	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.04	CHEMBL4142	Homo sapiens	Inhibition	%	3.04
	8156356	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	8.42	CHEMBL4142	Homo sapiens	Inhibition	%	8.42
	8156730	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	52.59	CHEMBL4142	Homo sapiens	Inhibition	%	52.59
	8156873	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	7.74	CHEMBL4142	Homo sapiens	Inhibition	%	7.74
	8157097	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	16.07	CHEMBL4142	Homo sapiens	Inhibition	%	16.07
	8157217	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	4.48	CHEMBL4142	Homo sapiens	Inhibition	%	4.48
	8157582	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	1.87	CHEMBL4142	Homo sapiens	Inhibition	%	1.87
	8157712	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	18.76	CHEMBL4142	Homo sapiens	Inhibition	%	18.76
	8157936	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.53	CHEMBL4142	Homo sapiens	Inhibition	%	1.53
	8158097	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	6.83	CHEMBL4142	Homo sapiens	Inhibition	%	6.83
	8158347	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	6.16	CHEMBL4142	Homo sapiens	Inhibition	%	6.16
	8158505	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.81	CHEMBL4142	Homo sapiens	Inhibition	%	1.81
	8158729	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	7.09	CHEMBL4142	Homo sapiens	Inhibition	%	7.09
	8158898	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.35	CHEMBL4142	Homo sapiens	Inhibition	%	1.35
	8159257	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	6.97	CHEMBL4142	Homo sapiens	Inhibition	%	6.97
	8159377	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.56	CHEMBL4142	Homo sapiens	Inhibition	%	3.56
	8159601	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-1.78	CHEMBL4142	Homo sapiens	Inhibition	%	-1.78
	8159732	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	15.88	CHEMBL4142	Homo sapiens	Inhibition	%	15.88
	8160097	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.92	CHEMBL4142	Homo sapiens	Inhibition	%	1.92
	8160234	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.03	CHEMBL4142	Homo sapiens	Inhibition	%	3.03
	8160608	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-2.57	CHEMBL4142	Homo sapiens	Inhibition	%	-2.57
	8160678	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	6.04	CHEMBL4142	Homo sapiens	Inhibition	%	6.04
	8160902	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	10.7	CHEMBL4142	Homo sapiens	Inhibition	%	10.7
	8161052	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	7.93	CHEMBL4142	Homo sapiens	Inhibition	%	7.93
	8161419	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	6.35	CHEMBL4142	Homo sapiens	Inhibition	%	6.35
	8161544	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	13.44	CHEMBL4142	Homo sapiens	Inhibition	%	13.44
	8161768	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.39	CHEMBL4142	Homo sapiens	Inhibition	%	3.39
	8161906	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	10.57	CHEMBL4142	Homo sapiens	Inhibition	%	10.57
	8162260	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	6.4	CHEMBL4142	Homo sapiens	Inhibition	%	6.4
	8162420	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-1.49	CHEMBL4142	Homo sapiens	Inhibition	%	-1.49
	8162673	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.48	CHEMBL4142	Homo sapiens	Inhibition	%	2.48
	8163045	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	31.53	CHEMBL4142	Homo sapiens	Inhibition	%	31.53
	8163214	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	6.04	CHEMBL4142	Homo sapiens	Inhibition	%	6.04
	8163572	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.24	CHEMBL4142	Homo sapiens	Inhibition	%	4.24
	8163919	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.6	CHEMBL4142	Homo sapiens	Inhibition	%	0.6
	8164053	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	4.31	CHEMBL4142	Homo sapiens	Inhibition	%	4.31
	8164417	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.84	CHEMBL4142	Homo sapiens	Inhibition	%	-0.84
	8164572	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	7.88	CHEMBL4142	Homo sapiens	Inhibition	%	7.88
	8164940	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.23	CHEMBL4142	Homo sapiens	Inhibition	%	1.23
	8165234	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	6.69	CHEMBL4142	Homo sapiens	Inhibition	%	6.69
	8165375	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	14.83	CHEMBL4142	Homo sapiens	Inhibition	%	14.83
	8165599	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.56	CHEMBL4142	Homo sapiens	Inhibition	%	4.56
	8165742	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	15.88	CHEMBL4142	Homo sapiens	Inhibition	%	15.88
	8166092	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	-3.75	CHEMBL4142	Homo sapiens	Inhibition	%	-3.75
	8166230	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	0.78	CHEMBL4142	Homo sapiens	Inhibition	%	0.78
	8166584	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.0	CHEMBL4142	Homo sapiens	Inhibition	%	4.0
	8166909	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	39.78	CHEMBL4142	Homo sapiens	Inhibition	%	39.78
	8166997	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.96	CHEMBL4142	Homo sapiens	Inhibition	%	4.96
	8167221	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	4.83	CHEMBL4142	Homo sapiens	Inhibition	%	4.83
	8167362	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	63.79	CHEMBL4142	Homo sapiens	Inhibition	%	63.79
	8167526	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.68	CHEMBL4142	Homo sapiens	Inhibition	%	1.68
	8167750	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.84	CHEMBL4142	Homo sapiens	Inhibition	%	4.84
	8167883	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.98	CHEMBL4142	Homo sapiens	Inhibition	%	5.98
	8168231	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.51	CHEMBL4142	Homo sapiens	Inhibition	%	3.51
	8168372	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	5.74	CHEMBL4142	Homo sapiens	Inhibition	%	5.74
	8168596	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.29	CHEMBL4142	Homo sapiens	Inhibition	%	4.29
	8168732	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.31	CHEMBL4142	Homo sapiens	Inhibition	%	-0.31
	8168896	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	7.31	CHEMBL4142	Homo sapiens	Inhibition	%	7.31
	8169120	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	23.43	CHEMBL4142	Homo sapiens	Inhibition	%	23.43
	8169262	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.37	CHEMBL4142	Homo sapiens	Inhibition	%	3.37
	8169566	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	6.99	CHEMBL4142	Homo sapiens	Inhibition	%	6.99
	8169924	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	7.38	CHEMBL4142	Homo sapiens	Inhibition	%	7.38
	8170069	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	23.27	CHEMBL4142	Homo sapiens	Inhibition	%	23.27
	8170418	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	7.75	CHEMBL4142	Homo sapiens	Inhibition	%	7.75
	8170558	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	9.22	CHEMBL4142	Homo sapiens	Inhibition	%	9.22
	8170782	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-1.71	CHEMBL4142	Homo sapiens	Inhibition	%	-1.71
	8170917	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	9.16	CHEMBL4142	Homo sapiens	Inhibition	%	9.16
	8171114	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.51	CHEMBL4142	Homo sapiens	Inhibition	%	1.51
	8171338	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	7.33	CHEMBL4142	Homo sapiens	Inhibition	%	7.33
	8171555	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.45	CHEMBL4142	Homo sapiens	Inhibition	%	3.45
	8171696	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	5.74	CHEMBL4142	Homo sapiens	Inhibition	%	5.74
	8172073	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-3.24	CHEMBL4142	Homo sapiens	Inhibition	%	-3.24
	8172205	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.55	CHEMBL4142	Homo sapiens	Inhibition	%	4.55
	8172429	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	9.08	CHEMBL4142	Homo sapiens	Inhibition	%	9.08
	8172557	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	18.4	CHEMBL4142	Homo sapiens	Inhibition	%	18.4
	8172923	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	9.62	CHEMBL4142	Homo sapiens	Inhibition	%	9.62
	8173059	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.77	CHEMBL4142	Homo sapiens	Inhibition	%	-1.77
	8173448	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.98	CHEMBL4142	Homo sapiens	Inhibition	%	4.98
	8173589	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	8.17	CHEMBL4142	Homo sapiens	Inhibition	%	8.17
	8173900	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	7.55	CHEMBL4142	Homo sapiens	Inhibition	%	7.55
	8174256	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.05	CHEMBL4142	Homo sapiens	Inhibition	%	4.05
	8174404	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	68.76	CHEMBL4142	Homo sapiens	Inhibition	%	68.76
	8174628	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.33	CHEMBL4142	Homo sapiens	Inhibition	%	3.33
	8174750	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.25	CHEMBL4142	Homo sapiens	Inhibition	%	3.25
	8175117	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	3.89	CHEMBL4142	Homo sapiens	Inhibition	%	3.89
	8175253	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.37	CHEMBL4142	Homo sapiens	Inhibition	%	0.37
	8175509	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	5.38	CHEMBL4142	Homo sapiens	Inhibition	%	5.38
	8175733	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	24.95	CHEMBL4142	Homo sapiens	Inhibition	%	24.95
	8175896	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	5.4	CHEMBL4142	Homo sapiens	Inhibition	%	5.4
	8176049	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	13.52	CHEMBL4142	Homo sapiens	Inhibition	%	13.52
	8176273	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	6.5	CHEMBL4142	Homo sapiens	Inhibition	%	6.5
	8176422	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-0.48	CHEMBL4142	Homo sapiens	Inhibition	%	-0.48
	8176778	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	34.96	CHEMBL4142	Homo sapiens	Inhibition	%	34.96
	8176908	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.47	CHEMBL4142	Homo sapiens	Inhibition	%	0.47
	8177274	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.54	CHEMBL4142	Homo sapiens	Inhibition	%	1.54
	8177412	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.15	CHEMBL4142	Homo sapiens	Inhibition	%	-1.15
	8177636	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	4.75	CHEMBL4142	Homo sapiens	Inhibition	%	4.75
	8177800	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	14.54	CHEMBL4142	Homo sapiens	Inhibition	%	14.54
	8177940	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.81	CHEMBL4142	Homo sapiens	Inhibition	%	3.81
	8178164	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	5.51	CHEMBL4142	Homo sapiens	Inhibition	%	5.51
	8178252	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	11.49	CHEMBL4142	Homo sapiens	Inhibition	%	11.49
	8178476	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.11	CHEMBL4142	Homo sapiens	Inhibition	%	2.11
	8178603	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	7.59	CHEMBL4142	Homo sapiens	Inhibition	%	7.59
	8178976	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	10.09	CHEMBL4142	Homo sapiens	Inhibition	%	10.09
	8179099	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.71	CHEMBL4142	Homo sapiens	Inhibition	%	2.71
	8179467	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.27	CHEMBL4142	Homo sapiens	Inhibition	%	1.27
	8179604	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	7.86	CHEMBL4142	Homo sapiens	Inhibition	%	7.86
	8179828	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-0.3	CHEMBL4142	Homo sapiens	Inhibition	%	-0.3
	8180085	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.82	CHEMBL4142	Homo sapiens	Inhibition	%	5.82
	8180239	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	20.69	CHEMBL4142	Homo sapiens	Inhibition	%	20.69
	8180619	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	9.9	CHEMBL4142	Homo sapiens	Inhibition	%	9.9
	8180767	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	5.56	CHEMBL4142	Homo sapiens	Inhibition	%	5.56
	8181124	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	5.74	CHEMBL4142	Homo sapiens	Inhibition	%	5.74
	8181255	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	2.51	CHEMBL4142	Homo sapiens	Inhibition	%	2.51
	8181479	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.2	CHEMBL4142	Homo sapiens	Inhibition	%	0.2
	8181619	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	13.34	CHEMBL4142	Homo sapiens	Inhibition	%	13.34
	8181982	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	16.42	CHEMBL4142	Homo sapiens	Inhibition	%	16.42
	8182145	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.62	CHEMBL4142	Homo sapiens	Inhibition	%	4.62
	8182509	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	5.3	CHEMBL4142	Homo sapiens	Inhibition	%	5.3
	8182825	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	7.78	CHEMBL4142	Homo sapiens	Inhibition	%	7.78
	8182947	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	6.26	CHEMBL4142	Homo sapiens	Inhibition	%	6.26
	8183320	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	30.94	CHEMBL4142	Homo sapiens	Inhibition	%	30.94
	8183449	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.31	CHEMBL4142	Homo sapiens	Inhibition	%	4.31
	8183673	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.74	CHEMBL4142	Homo sapiens	Inhibition	%	6.74
	8183815	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	11.9	CHEMBL4142	Homo sapiens	Inhibition	%	11.9
	8184175	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.2	CHEMBL4142	Homo sapiens	Inhibition	%	2.2
	8184441	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.58	CHEMBL4142	Homo sapiens	Inhibition	%	5.58
	8184588	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.83	CHEMBL4142	Homo sapiens	Inhibition	%	-1.83
	8184969	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	5.02	CHEMBL4142	Homo sapiens	Inhibition	%	5.02
	8185118	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	31.56	CHEMBL4142	Homo sapiens	Inhibition	%	31.56
	8185342	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-2.84	CHEMBL4142	Homo sapiens	Inhibition	%	-2.84
	8185473	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	14.48	CHEMBL4142	Homo sapiens	Inhibition	%	14.48
	8185828	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	21.07	CHEMBL4142	Homo sapiens	Inhibition	%	21.07
	8185967	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.3	CHEMBL4142	Homo sapiens	Inhibition	%	3.3
	8186332	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	5.14	CHEMBL4142	Homo sapiens	Inhibition	%	5.14
	8186496	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	11.78	CHEMBL4142	Homo sapiens	Inhibition	%	11.78
	8186720	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.11	CHEMBL4142	Homo sapiens	Inhibition	%	4.11
	8186859	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	6.72	CHEMBL4142	Homo sapiens	Inhibition	%	6.72
	8187181	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.08	CHEMBL4142	Homo sapiens	Inhibition	%	2.08
	8187305	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	8.02	CHEMBL4142	Homo sapiens	Inhibition	%	8.02
	8187529	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	11.58	CHEMBL4142	Homo sapiens	Inhibition	%	11.58
	8187677	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	68.17	CHEMBL4142	Homo sapiens	Inhibition	%	68.17
	8188030	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	11.05	CHEMBL4142	Homo sapiens	Inhibition	%	11.05
	8188173	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.43	CHEMBL4142	Homo sapiens	Inhibition	%	2.43
	8188532	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-2.62	CHEMBL4142	Homo sapiens	Inhibition	%	-2.62
	8188806	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.5	CHEMBL4142	Homo sapiens	Inhibition	%	3.5
	8188954	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.05	CHEMBL4142	Homo sapiens	Inhibition	%	0.05
	8189178	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.99	CHEMBL4142	Homo sapiens	Inhibition	%	1.99
	8189334	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	23.53	CHEMBL4142	Homo sapiens	Inhibition	%	23.53
	8189707	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.08	CHEMBL4142	Homo sapiens	Inhibition	%	-0.08
	8189839	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.4	CHEMBL4142	Homo sapiens	Inhibition	%	1.4
	8190195	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	6.66	CHEMBL4142	Homo sapiens	Inhibition	%	6.66
	8190335	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	7.98	CHEMBL4142	Homo sapiens	Inhibition	%	7.98
	8190559	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.47	CHEMBL4142	Homo sapiens	Inhibition	%	5.47
	8190696	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.4	CHEMBL4142	Homo sapiens	Inhibition	%	7.4
	8191084	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	6.4	CHEMBL4142	Homo sapiens	Inhibition	%	6.4
	8191222	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	5.38	CHEMBL4142	Homo sapiens	Inhibition	%	5.38
	8191542	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	7.34	CHEMBL4142	Homo sapiens	Inhibition	%	7.34
	8191888	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	6.91	CHEMBL4142	Homo sapiens	Inhibition	%	6.91
	8192037	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	5.9	CHEMBL4142	Homo sapiens	Inhibition	%	5.9
	8192390	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	3.51	CHEMBL4142	Homo sapiens	Inhibition	%	3.51
	8192534	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	14.67	CHEMBL4142	Homo sapiens	Inhibition	%	14.67
	8192758	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.42	CHEMBL4142	Homo sapiens	Inhibition	%	2.42
	8192894	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	4.85	CHEMBL4142	Homo sapiens	Inhibition	%	4.85
	8193166	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.73	CHEMBL4142	Homo sapiens	Inhibition	%	4.73
	8193535	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	7.97	CHEMBL4142	Homo sapiens	Inhibition	%	7.97
	8193692	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	7.77	CHEMBL4142	Homo sapiens	Inhibition	%	7.77
	8194065	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-4.0	CHEMBL4142	Homo sapiens	Inhibition	%	-4.0
	8194196	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.36	CHEMBL4142	Homo sapiens	Inhibition	%	2.36
	8194420	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	5.64	CHEMBL4142	Homo sapiens	Inhibition	%	5.64
	8194551	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	17.98	CHEMBL4142	Homo sapiens	Inhibition	%	17.98
	8194918	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	8.42	CHEMBL4142	Homo sapiens	Inhibition	%	8.42
	8195051	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.73	CHEMBL4142	Homo sapiens	Inhibition	%	3.73
	8195275	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	6.49	CHEMBL4142	Homo sapiens	Inhibition	%	6.49
	8195439	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	6.09	CHEMBL4142	Homo sapiens	Inhibition	%	6.09
	8195578	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	8.82	CHEMBL4142	Homo sapiens	Inhibition	%	8.82
	8195802	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	5.49	CHEMBL4142	Homo sapiens	Inhibition	%	5.49
	8195900	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	4.37	CHEMBL4142	Homo sapiens	Inhibition	%	4.37
	8196241	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.23	CHEMBL4142	Homo sapiens	Inhibition	%	5.23
	8196391	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	9.23	CHEMBL4142	Homo sapiens	Inhibition	%	9.23
	8196615	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	7.81	CHEMBL4142	Homo sapiens	Inhibition	%	7.81
	8196743	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	5.88	CHEMBL4142	Homo sapiens	Inhibition	%	5.88
	8197108	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	4.95	CHEMBL4142	Homo sapiens	Inhibition	%	4.95
	8197245	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-1.84	CHEMBL4142	Homo sapiens	Inhibition	%	-1.84
	8197469	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	3.9	CHEMBL4142	Homo sapiens	Inhibition	%	3.9
	8197520	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.81	CHEMBL4142	Homo sapiens	Inhibition	%	1.81
	8197744	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.41	CHEMBL4142	Homo sapiens	Inhibition	%	4.41
	8197884	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%		CHEMBL4142	Homo sapiens	Inhibition	%	
	8198041	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	26.92	CHEMBL4142	Homo sapiens	Inhibition	%	26.92
	8198265	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-0.33	CHEMBL4142	Homo sapiens	Inhibition	%	-0.33
	8198403	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.03	CHEMBL4142	Homo sapiens	Inhibition	%	-1.03
	8198757	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	15.85	CHEMBL4142	Homo sapiens	Inhibition	%	15.85
	8198888	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	6.84	CHEMBL4142	Homo sapiens	Inhibition	%	6.84
	8199112	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	13.99	CHEMBL4142	Homo sapiens	Inhibition	%	13.99
	8199260	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.58	CHEMBL4142	Homo sapiens	Inhibition	%	5.58
	8199618	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.03	CHEMBL4142	Homo sapiens	Inhibition	%	4.03
	8199781	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	25.78	CHEMBL4142	Homo sapiens	Inhibition	%	25.78
	8200143	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	10.11	CHEMBL4142	Homo sapiens	Inhibition	%	10.11
	8200247	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	9.66	CHEMBL4142	Homo sapiens	Inhibition	%	9.66
	8200471	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.58	CHEMBL4142	Homo sapiens	Inhibition	%	0.58
	8200586	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	7.58	CHEMBL4142	Homo sapiens	Inhibition	%	7.58
	8200960	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	12.98	CHEMBL4142	Homo sapiens	Inhibition	%	12.98
	8201090	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	1.75	CHEMBL4142	Homo sapiens	Inhibition	%	1.75
	8201314	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	15.3	CHEMBL4142	Homo sapiens	Inhibition	%	15.3
	8201449	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.27	CHEMBL4142	Homo sapiens	Inhibition	%	2.27
	8201806	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.56	CHEMBL4142	Homo sapiens	Inhibition	%	-0.56
	8202085	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.18	CHEMBL4142	Homo sapiens	Inhibition	%	3.18
	8202225	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	13.22	CHEMBL4142	Homo sapiens	Inhibition	%	13.22
	8202616	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.72	CHEMBL4142	Homo sapiens	Inhibition	%	1.72
	8202741	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.36	CHEMBL4142	Homo sapiens	Inhibition	%	5.36
	8203095	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	10.39	CHEMBL4142	Homo sapiens	Inhibition	%	10.39
	8203450	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	49.97	CHEMBL4142	Homo sapiens	Inhibition	%	49.97
	8203596	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	10.43	CHEMBL4142	Homo sapiens	Inhibition	%	10.43
	8203954	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	5.85	CHEMBL4142	Homo sapiens	Inhibition	%	5.85
	8204120	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.65	CHEMBL4142	Homo sapiens	Inhibition	%	1.65
	8204344	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	5.08	CHEMBL4142	Homo sapiens	Inhibition	%	5.08
	8204481	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	12.83	CHEMBL4142	Homo sapiens	Inhibition	%	12.83
	8204810	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	10.29	CHEMBL4142	Homo sapiens	Inhibition	%	10.29
	8204925	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.76	CHEMBL4142	Homo sapiens	Inhibition	%	4.76
	8205149	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	16.92	CHEMBL4142	Homo sapiens	Inhibition	%	16.92
	8205298	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	4.74	CHEMBL4142	Homo sapiens	Inhibition	%	4.74
	8205658	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.59	CHEMBL4142	Homo sapiens	Inhibition	%	3.59
	8205797	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.78	CHEMBL4142	Homo sapiens	Inhibition	%	3.78
	8206153	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.09	CHEMBL4142	Homo sapiens	Inhibition	%	2.09
	8206429	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.51	CHEMBL4142	Homo sapiens	Inhibition	%	4.51
	8206572	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.12	CHEMBL4142	Homo sapiens	Inhibition	%	-1.12
	8206796	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	1.88	CHEMBL4142	Homo sapiens	Inhibition	%	1.88
	8206976	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.86	CHEMBL4142	Homo sapiens	Inhibition	%	2.86
	8207102	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.13	CHEMBL4142	Homo sapiens	Inhibition	%	5.13
	8207326	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.51	CHEMBL4142	Homo sapiens	Inhibition	%	5.51
	8207456	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	8.86	CHEMBL4142	Homo sapiens	Inhibition	%	8.86
	8207812	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	69.88	CHEMBL4142	Homo sapiens	Inhibition	%	69.88
	8207957	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.0	CHEMBL4142	Homo sapiens	Inhibition	%	1.0
	8208181	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.87	CHEMBL4142	Homo sapiens	Inhibition	%	3.87
	8208313	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	1.91	CHEMBL4142	Homo sapiens	Inhibition	%	1.91
	8208703	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	5.6	CHEMBL4142	Homo sapiens	Inhibition	%	5.6
	8208836	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	43.18	CHEMBL4142	Homo sapiens	Inhibition	%	43.18
	8209165	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	29.33	CHEMBL4142	Homo sapiens	Inhibition	%	29.33
	8209505	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.92	CHEMBL4142	Homo sapiens	Inhibition	%	3.92
	8209655	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	11.41	CHEMBL4142	Homo sapiens	Inhibition	%	11.41
	8210015	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	10.64	CHEMBL4142	Homo sapiens	Inhibition	%	10.64
	8210156	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.09	CHEMBL4142	Homo sapiens	Inhibition	%	1.09
	8210380	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.24	CHEMBL4142	Homo sapiens	Inhibition	%	4.24
	8210516	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-4.3	CHEMBL4142	Homo sapiens	Inhibition	%	-4.3
	8210775	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.07	CHEMBL4142	Homo sapiens	Inhibition	%	0.07
	8211143	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.5	CHEMBL4142	Homo sapiens	Inhibition	%	3.5
	8211313	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	6.36	CHEMBL4142	Homo sapiens	Inhibition	%	6.36
	8211660	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	7.42	CHEMBL4142	Homo sapiens	Inhibition	%	7.42
	8211789	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	7.18	CHEMBL4142	Homo sapiens	Inhibition	%	7.18
	8212013	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	17.92	CHEMBL4142	Homo sapiens	Inhibition	%	17.92
	8212145	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	9.37	CHEMBL4142	Homo sapiens	Inhibition	%	9.37
	8212510	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.37	CHEMBL4142	Homo sapiens	Inhibition	%	1.37
	8212643	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.55	CHEMBL4142	Homo sapiens	Inhibition	%	4.55
	8213037	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	31.65	CHEMBL4142	Homo sapiens	Inhibition	%	31.65
	8213166	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.07	CHEMBL4142	Homo sapiens	Inhibition	%	5.07
	8213390	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	8.58	CHEMBL4142	Homo sapiens	Inhibition	%	8.58
	8213494	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	60.59	CHEMBL4142	Homo sapiens	Inhibition	%	60.59
	8213831	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	7.02	CHEMBL4142	Homo sapiens	Inhibition	%	7.02
	8213978	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	7.91	CHEMBL4142	Homo sapiens	Inhibition	%	7.91
	8214202	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	6.0	CHEMBL4142	Homo sapiens	Inhibition	%	6.0
	8214339	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	12.33	CHEMBL4142	Homo sapiens	Inhibition	%	12.33
	8214697	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	1.51	CHEMBL4142	Homo sapiens	Inhibition	%	1.51
	8214849	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.25	CHEMBL4142	Homo sapiens	Inhibition	%	-0.25
	8215100	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	11.13	CHEMBL4142	Homo sapiens	Inhibition	%	11.13
	8215477	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	22.98	CHEMBL4142	Homo sapiens	Inhibition	%	22.98
	8215641	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.95	CHEMBL4142	Homo sapiens	Inhibition	%	3.95
	8215984	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.11	CHEMBL4142	Homo sapiens	Inhibition	%	1.11
	8216327	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.53	CHEMBL4142	Homo sapiens	Inhibition	%	4.53
	8216463	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	15.61	CHEMBL4142	Homo sapiens	Inhibition	%	15.61
	8216825	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.08	CHEMBL4142	Homo sapiens	Inhibition	%	3.08
	8216959	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.95	CHEMBL4142	Homo sapiens	Inhibition	%	4.95
	8217183	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.08	CHEMBL4142	Homo sapiens	Inhibition	%	5.08
	8217357	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.12	CHEMBL4142	Homo sapiens	Inhibition	%	1.12
	8217712	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	8.86	CHEMBL4142	Homo sapiens	Inhibition	%	8.86
	8217813	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-2.69	CHEMBL4142	Homo sapiens	Inhibition	%	-2.69
	8218037	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	2.13	CHEMBL4142	Homo sapiens	Inhibition	%	2.13
	8218152	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.67	CHEMBL4142	Homo sapiens	Inhibition	%	4.67
	8218503	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	5.08	CHEMBL4142	Homo sapiens	Inhibition	%	5.08
	8218646	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	44.91	CHEMBL4142	Homo sapiens	Inhibition	%	44.91
	8219001	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	26.62	CHEMBL4142	Homo sapiens	Inhibition	%	26.62
	8219161	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.12	CHEMBL4142	Homo sapiens	Inhibition	%	4.12
	8219385	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	7.12	CHEMBL4142	Homo sapiens	Inhibition	%	7.12
	8219411	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.81	CHEMBL4142	Homo sapiens	Inhibition	%	2.81
	8219635	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	5.14	CHEMBL4142	Homo sapiens	Inhibition	%	5.14
	8219796	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.85	CHEMBL4142	Homo sapiens	Inhibition	%	3.85
	8219965	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.22	CHEMBL4142	Homo sapiens	Inhibition	%	4.22
	8220189	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.01	CHEMBL4142	Homo sapiens	Inhibition	%	5.01
	8220318	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.86	CHEMBL4142	Homo sapiens	Inhibition	%	1.86
	8220656	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.28	CHEMBL4142	Homo sapiens	Inhibition	%	4.28
	8220794	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	9.87	CHEMBL4142	Homo sapiens	Inhibition	%	9.87
	8221018	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	31.28	CHEMBL4142	Homo sapiens	Inhibition	%	31.28
	8221154	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-2.09	CHEMBL4142	Homo sapiens	Inhibition	%	-2.09
	8221511	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	7.3	CHEMBL4142	Homo sapiens	Inhibition	%	7.3
	8221676	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.49	CHEMBL4142	Homo sapiens	Inhibition	%	3.49
	8222031	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	31.65	CHEMBL4142	Homo sapiens	Inhibition	%	31.65
	8222353	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	17.18	CHEMBL4142	Homo sapiens	Inhibition	%	17.18
	8222487	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.48	CHEMBL4142	Homo sapiens	Inhibition	%	4.48
	8222829	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	10.69	CHEMBL4142	Homo sapiens	Inhibition	%	10.69
	8222973	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	31.25	CHEMBL4142	Homo sapiens	Inhibition	%	31.25
	8223197	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	75.93	CHEMBL4142	Homo sapiens	Inhibition	%	75.93
	8223326	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.19	CHEMBL4142	Homo sapiens	Inhibition	%	2.19
	8223711	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.46	CHEMBL4142	Homo sapiens	Inhibition	%	1.46
	8223961	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.92	CHEMBL4142	Homo sapiens	Inhibition	%	3.92
	8224123	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	10.11	CHEMBL4142	Homo sapiens	Inhibition	%	10.11
	8224517	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.0	CHEMBL4142	Homo sapiens	Inhibition	%	6.0
	8224652	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	6.63	CHEMBL4142	Homo sapiens	Inhibition	%	6.63
	8224876	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.8	CHEMBL4142	Homo sapiens	Inhibition	%	5.8
	8224990	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.38	CHEMBL4142	Homo sapiens	Inhibition	%	3.38
	8225348	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	8.82	CHEMBL4142	Homo sapiens	Inhibition	%	8.82
	8225486	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-2.64	CHEMBL4142	Homo sapiens	Inhibition	%	-2.64
	8225710	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-0.68	CHEMBL4142	Homo sapiens	Inhibition	%	-0.68
	8225845	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	9.34	CHEMBL4142	Homo sapiens	Inhibition	%	9.34
	8226003	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.04	CHEMBL4142	Homo sapiens	Inhibition	%	0.04
	8226227	CHEMBL1962291	GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.03	CHEMBL4142	Homo sapiens	Inhibition	%	1.03
	8226352	CHEMBL1962290	GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.45	CHEMBL4142	Homo sapiens	Inhibition	%	4.45
	10838583	CHEMBL2014206	Inhibition of FGFR2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	10978472	CHEMBL2066236	Inhibition of human recombinant FGFR2 using ulight-CAGAGAIETDKEYYTVKD as substrate assessed as residual activity at 1 uM after 15 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL4142	Homo sapiens	Activity	%	80.0
	10986198	CHEMBL2072345	Inhibition of FGFR2 by TR-FRET analysis	B	Cn1cc(Nc2ncc(Br)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)cn1		CHEMBL2071201	=	IC50	nM	2.0	CHEMBL4142	Homo sapiens	IC50	nM	2.0
	11018499	CHEMBL2091528	Inhibition of FGFR2 at 10 uM	B	Nc1n[nH]c2nc(Nc3cccc(NC(=O)Nc4ccc(F)c(Cl)c4)c3)ncc12		CHEMBL2089212	=	Inhibition	%	35.0	CHEMBL4142	Homo sapiens	INH	%	35.0
	12046305	CHEMBL2156635	Inhibition of FGFR2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	8.3	CHEMBL4142	Homo sapiens	INH	%	8.3
	12060925	CHEMBL2157043	Binding affinity to FGFR2 at 1 uM by high throughput binding assay relative to control	B	Nc1cc(NS(=O)(=O)c2cccc(C(F)(F)F)c2)cc(-c2cnc3[nH]cc(-c4ccncc4)c3c2)c1		CHEMBL2152288	=	Activity	%	61.0	CHEMBL4142	Homo sapiens	Activity	%	61.0
	12074633	CHEMBL2161195	Inhibition of FGFR2 at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	12138520	CHEMBL2186462	Inhibition of FGFR2	B	COc1cc2c(Oc3ccc(Nc4ccc(C(C)(C)C)cc4)cc3)ccnc2cc1OCCNCCO		CHEMBL352308	=	IC50	nM	69.0	CHEMBL4142	Homo sapiens	IC50	nM	69.0
	12138549	CHEMBL2186462	Inhibition of FGFR2	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12.Cl		CHEMBL2180605	=	IC50	nM	82.5	CHEMBL4142	Homo sapiens	IC50	nM	82.5
	12173613	CHEMBL2213552	Inhibition of FGFR2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL4142	Homo sapiens	Activity	%	100.0
	12195615	CHEMBL2212864	Inhibition of human recombinant FGFR2 using Ulight-CAGAGAIETDKEYYTVKD as substrate assessed as residual activity at 1 uM after 15 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	100.1	CHEMBL4142	Homo sapiens	Activity	%	100.1
	12205240	CHEMBL2217232	Inhibition of FGFR2	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830	=	IC50	nM	6.2	CHEMBL4142	Homo sapiens	IC50	nM	6.2
	12245189	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	99.0	CHEMBL4142	Homo sapiens	Residual Activity	%	99.0
	12245190	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	37.0	CHEMBL4142	Homo sapiens	Residual Activity	%	37.0
	12245191	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	94.0	CHEMBL4142	Homo sapiens	Residual Activity	%	94.0
	12245192	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	107.0	CHEMBL4142	Homo sapiens	Residual Activity	%	107.0
	12245193	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	89.0	CHEMBL4142	Homo sapiens	Residual Activity	%	89.0
	12245194	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	96.0	CHEMBL4142	Homo sapiens	Residual Activity	%	96.0
	12245195	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	10.0	CHEMBL4142	Homo sapiens	Residual Activity	%	10.0
	12247789	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	101.0	CHEMBL4142	Homo sapiens	Residual Activity	%	101.0
	12247790	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	72.0	CHEMBL4142	Homo sapiens	Residual Activity	%	72.0
	12247791	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	92.0	CHEMBL4142	Homo sapiens	Residual Activity	%	92.0
	12247792	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	91.0	CHEMBL4142	Homo sapiens	Residual Activity	%	91.0
	12247793	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	92.0	CHEMBL4142	Homo sapiens	Residual Activity	%	92.0
	12247794	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	105.0	CHEMBL4142	Homo sapiens	Residual Activity	%	105.0
	12247795	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	62.0	CHEMBL4142	Homo sapiens	Residual Activity	%	62.0
	12247796	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	100.0	CHEMBL4142	Homo sapiens	Residual Activity	%	100.0
	12247797	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	83.0	CHEMBL4142	Homo sapiens	Residual Activity	%	83.0
	12247798	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	93.0	CHEMBL4142	Homo sapiens	Residual Activity	%	93.0
	12247799	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	105.0	CHEMBL4142	Homo sapiens	Residual Activity	%	105.0
	12247800	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	86.0	CHEMBL4142	Homo sapiens	Residual Activity	%	86.0
	12247801	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	79.0	CHEMBL4142	Homo sapiens	Residual Activity	%	79.0
	12247802	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	97.0	CHEMBL4142	Homo sapiens	Residual Activity	%	97.0
	12247803	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	101.0	CHEMBL4142	Homo sapiens	Residual Activity	%	101.0
	12247804	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	108.0	CHEMBL4142	Homo sapiens	Residual Activity	%	108.0
	12247805	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	96.0	CHEMBL4142	Homo sapiens	Residual Activity	%	96.0
	12247806	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	114.0	CHEMBL4142	Homo sapiens	Residual Activity	%	114.0
	12247807	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	98.0	CHEMBL4142	Homo sapiens	Residual Activity	%	98.0
	12247808	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	83.0	CHEMBL4142	Homo sapiens	Residual Activity	%	83.0
	12247809	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	94.0	CHEMBL4142	Homo sapiens	Residual Activity	%	94.0
	12247810	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	105.0	CHEMBL4142	Homo sapiens	Residual Activity	%	105.0
	12247811	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	113.0	CHEMBL4142	Homo sapiens	Residual Activity	%	113.0
	12247812	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	101.0	CHEMBL4142	Homo sapiens	Residual Activity	%	101.0
	12247813	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	25.0	CHEMBL4142	Homo sapiens	Residual Activity	%	25.0
	12247814	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	111.0	CHEMBL4142	Homo sapiens	Residual Activity	%	111.0
	12247815	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	111.0	CHEMBL4142	Homo sapiens	Residual Activity	%	111.0
	12247816	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	112.0	CHEMBL4142	Homo sapiens	Residual Activity	%	112.0
	12247817	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	105.0	CHEMBL4142	Homo sapiens	Residual Activity	%	105.0
	12247818	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	91.0	CHEMBL4142	Homo sapiens	Residual Activity	%	91.0
	12247819	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	115.0	CHEMBL4142	Homo sapiens	Residual Activity	%	115.0
	12247820	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	108.0	CHEMBL4142	Homo sapiens	Residual Activity	%	108.0
	12247821	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	63.0	CHEMBL4142	Homo sapiens	Residual Activity	%	63.0
	12247822	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	108.0	CHEMBL4142	Homo sapiens	Residual Activity	%	108.0
	12247823	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	120.0	CHEMBL4142	Homo sapiens	Residual Activity	%	120.0
	12247824	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	53.0	CHEMBL4142	Homo sapiens	Residual Activity	%	53.0
	12247825	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	49.0	CHEMBL4142	Homo sapiens	Residual Activity	%	49.0
	12247826	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	84.0	CHEMBL4142	Homo sapiens	Residual Activity	%	84.0
	12247827	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	111.0	CHEMBL4142	Homo sapiens	Residual Activity	%	111.0
	12247828	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	112.0	CHEMBL4142	Homo sapiens	Residual Activity	%	112.0
	12247829	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	66.0	CHEMBL4142	Homo sapiens	Residual Activity	%	66.0
	12247830	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	118.0	CHEMBL4142	Homo sapiens	Residual Activity	%	118.0
	12247831	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	122.0	CHEMBL4142	Homo sapiens	Residual Activity	%	122.0
	12247832	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	72.0	CHEMBL4142	Homo sapiens	Residual Activity	%	72.0
	12247833	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	37.0	CHEMBL4142	Homo sapiens	Residual Activity	%	37.0
	12247834	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	18.0	CHEMBL4142	Homo sapiens	Residual Activity	%	18.0
	12247835	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	101.0	CHEMBL4142	Homo sapiens	Residual Activity	%	101.0
	12247836	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	103.0	CHEMBL4142	Homo sapiens	Residual Activity	%	103.0
	12247837	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	85.0	CHEMBL4142	Homo sapiens	Residual Activity	%	85.0
	12247838	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	120.0	CHEMBL4142	Homo sapiens	Residual Activity	%	120.0
	12247839	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	119.0	CHEMBL4142	Homo sapiens	Residual Activity	%	119.0
	12247840	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	103.0	CHEMBL4142	Homo sapiens	Residual Activity	%	103.0
	12247841	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	107.0	CHEMBL4142	Homo sapiens	Residual Activity	%	107.0
	12247842	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	80.0	CHEMBL4142	Homo sapiens	Residual Activity	%	80.0
	12247843	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	21.0	CHEMBL4142	Homo sapiens	Residual Activity	%	21.0
	12247844	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	113.0	CHEMBL4142	Homo sapiens	Residual Activity	%	113.0
	12247845	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	104.0	CHEMBL4142	Homo sapiens	Residual Activity	%	104.0
	12247846	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	119.0	CHEMBL4142	Homo sapiens	Residual Activity	%	119.0
	12247847	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	94.0	CHEMBL4142	Homo sapiens	Residual Activity	%	94.0
	12247848	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	104.0	CHEMBL4142	Homo sapiens	Residual Activity	%	104.0
	12247849	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	106.0	CHEMBL4142	Homo sapiens	Residual Activity	%	106.0
	12247850	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	98.0	CHEMBL4142	Homo sapiens	Residual Activity	%	98.0
	12247851	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	65.0	CHEMBL4142	Homo sapiens	Residual Activity	%	65.0
	12247852	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	114.0	CHEMBL4142	Homo sapiens	Residual Activity	%	114.0
	12247853	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	99.0	CHEMBL4142	Homo sapiens	Residual Activity	%	99.0
	12247854	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	88.0	CHEMBL4142	Homo sapiens	Residual Activity	%	88.0
	12247855	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	100.0	CHEMBL4142	Homo sapiens	Residual Activity	%	100.0
	12247856	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	80.0	CHEMBL4142	Homo sapiens	Residual Activity	%	80.0
	12247857	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	62.0	CHEMBL4142	Homo sapiens	Residual Activity	%	62.0
	12247858	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	92.0	CHEMBL4142	Homo sapiens	Residual Activity	%	92.0
	12247859	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	14.0	CHEMBL4142	Homo sapiens	Residual Activity	%	14.0
	12247860	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	100.0	CHEMBL4142	Homo sapiens	Residual Activity	%	100.0
	12247861	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL4142	Homo sapiens	Residual Activity	%	1.0
	12247862	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	97.0	CHEMBL4142	Homo sapiens	Residual Activity	%	97.0
	12247863	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	36.0	CHEMBL4142	Homo sapiens	Residual Activity	%	36.0
	12247864	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	99.0	CHEMBL4142	Homo sapiens	Residual Activity	%	99.0
	12247865	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	102.0	CHEMBL4142	Homo sapiens	Residual Activity	%	102.0
	12247866	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	51.0	CHEMBL4142	Homo sapiens	Residual Activity	%	51.0
	12247867	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	99.0	CHEMBL4142	Homo sapiens	Residual Activity	%	99.0
	12247868	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	87.0	CHEMBL4142	Homo sapiens	Residual Activity	%	87.0
	12247869	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	99.0	CHEMBL4142	Homo sapiens	Residual Activity	%	99.0
	12247870	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	106.0	CHEMBL4142	Homo sapiens	Residual Activity	%	106.0
	12247871	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	22.0	CHEMBL4142	Homo sapiens	Residual Activity	%	22.0
	12247872	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	97.0	CHEMBL4142	Homo sapiens	Residual Activity	%	97.0
	12247873	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	98.0	CHEMBL4142	Homo sapiens	Residual Activity	%	98.0
	12247874	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	24.0	CHEMBL4142	Homo sapiens	Residual Activity	%	24.0
	12247875	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	100.0	CHEMBL4142	Homo sapiens	Residual Activity	%	100.0
	12247876	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	103.0	CHEMBL4142	Homo sapiens	Residual Activity	%	103.0
	12247877	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	103.0	CHEMBL4142	Homo sapiens	Residual Activity	%	103.0
	12247878	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	109.0	CHEMBL4142	Homo sapiens	Residual Activity	%	109.0
	12247879	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	108.0	CHEMBL4142	Homo sapiens	Residual Activity	%	108.0
	12247880	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	100.0	CHEMBL4142	Homo sapiens	Residual Activity	%	100.0
	12247881	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	95.0	CHEMBL4142	Homo sapiens	Residual Activity	%	95.0
	12247882	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	72.0	CHEMBL4142	Homo sapiens	Residual Activity	%	72.0
	12247883	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	20.0	CHEMBL4142	Homo sapiens	Residual Activity	%	20.0
	12247884	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	102.0	CHEMBL4142	Homo sapiens	Residual Activity	%	102.0
	12247885	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	83.0	CHEMBL4142	Homo sapiens	Residual Activity	%	83.0
	12247886	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	106.0	CHEMBL4142	Homo sapiens	Residual Activity	%	106.0
	12247887	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	111.0	CHEMBL4142	Homo sapiens	Residual Activity	%	111.0
	12247888	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	108.0	CHEMBL4142	Homo sapiens	Residual Activity	%	108.0
	12247889	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	107.0	CHEMBL4142	Homo sapiens	Residual Activity	%	107.0
	12247890	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	102.0	CHEMBL4142	Homo sapiens	Residual Activity	%	102.0
	12247891	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	106.0	CHEMBL4142	Homo sapiens	Residual Activity	%	106.0
	12247892	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	112.0	CHEMBL4142	Homo sapiens	Residual Activity	%	112.0
	12247893	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	86.0	CHEMBL4142	Homo sapiens	Residual Activity	%	86.0
	12247894	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	104.0	CHEMBL4142	Homo sapiens	Residual Activity	%	104.0
	12247895	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	119.0	CHEMBL4142	Homo sapiens	Residual Activity	%	119.0
	12247896	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	108.0	CHEMBL4142	Homo sapiens	Residual Activity	%	108.0
	12247897	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	108.0	CHEMBL4142	Homo sapiens	Residual Activity	%	108.0
	12247898	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	50.0	CHEMBL4142	Homo sapiens	Residual Activity	%	50.0
	12247899	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	110.0	CHEMBL4142	Homo sapiens	Residual Activity	%	110.0
	12247900	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	113.0	CHEMBL4142	Homo sapiens	Residual Activity	%	113.0
	12247901	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	109.0	CHEMBL4142	Homo sapiens	Residual Activity	%	109.0
	12247902	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	85.0	CHEMBL4142	Homo sapiens	Residual Activity	%	85.0
	12247903	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	103.0	CHEMBL4142	Homo sapiens	Residual Activity	%	103.0
	12247904	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	101.0	CHEMBL4142	Homo sapiens	Residual Activity	%	101.0
	12247905	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	99.0	CHEMBL4142	Homo sapiens	Residual Activity	%	99.0
	12247906	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	20.0	CHEMBL4142	Homo sapiens	Residual Activity	%	20.0
	12247907	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	105.0	CHEMBL4142	Homo sapiens	Residual Activity	%	105.0
	12247908	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	104.0	CHEMBL4142	Homo sapiens	Residual Activity	%	104.0
	12247909	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	119.0	CHEMBL4142	Homo sapiens	Residual Activity	%	119.0
	12247910	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	88.0	CHEMBL4142	Homo sapiens	Residual Activity	%	88.0
	12247911	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	1.0	CHEMBL4142	Homo sapiens	Residual Activity	%	1.0
	12247912	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	101.0	CHEMBL4142	Homo sapiens	Residual Activity	%	101.0
	12247913	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	100.0	CHEMBL4142	Homo sapiens	Residual Activity	%	100.0
	12247914	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	52.0	CHEMBL4142	Homo sapiens	Residual Activity	%	52.0
	12247915	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	100.0	CHEMBL4142	Homo sapiens	Residual Activity	%	100.0
	12247916	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	21.0	CHEMBL4142	Homo sapiens	Residual Activity	%	21.0
	12247917	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	84.0	CHEMBL4142	Homo sapiens	Residual Activity	%	84.0
	12247918	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	122.0	CHEMBL4142	Homo sapiens	Residual Activity	%	122.0
	12247919	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	56.0	CHEMBL4142	Homo sapiens	Residual Activity	%	56.0
	12247920	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	16.0	CHEMBL4142	Homo sapiens	Residual Activity	%	16.0
	12247921	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	103.0	CHEMBL4142	Homo sapiens	Residual Activity	%	103.0
	12247922	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	100.0	CHEMBL4142	Homo sapiens	Residual Activity	%	100.0
	12247923	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	113.0	CHEMBL4142	Homo sapiens	Residual Activity	%	113.0
	12247924	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	110.0	CHEMBL4142	Homo sapiens	Residual Activity	%	110.0
	12247925	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	90.0	CHEMBL4142	Homo sapiens	Residual Activity	%	90.0
	12247926	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	117.0	CHEMBL4142	Homo sapiens	Residual Activity	%	117.0
	12247927	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	108.0	CHEMBL4142	Homo sapiens	Residual Activity	%	108.0
	12247928	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	73.0	CHEMBL4142	Homo sapiens	Residual Activity	%	73.0
	12247929	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	100.0	CHEMBL4142	Homo sapiens	Residual Activity	%	100.0
	12247930	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	91.0	CHEMBL4142	Homo sapiens	Residual Activity	%	91.0
	12247931	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	121.0	CHEMBL4142	Homo sapiens	Residual Activity	%	121.0
	12247932	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	53.0	CHEMBL4142	Homo sapiens	Residual Activity	%	53.0
	12247933	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	115.0	CHEMBL4142	Homo sapiens	Residual Activity	%	115.0
	12247934	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	114.0	CHEMBL4142	Homo sapiens	Residual Activity	%	114.0
	12247935	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	91.0	CHEMBL4142	Homo sapiens	Residual Activity	%	91.0
	12247936	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	111.0	CHEMBL4142	Homo sapiens	Residual Activity	%	111.0
	12247937	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	77.0	CHEMBL4142	Homo sapiens	Residual Activity	%	77.0
	12247938	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	115.0	CHEMBL4142	Homo sapiens	Residual Activity	%	115.0
	12247939	CHEMBL2219064	Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	48.0	CHEMBL4142	Homo sapiens	Residual Activity	%	48.0
	12247940	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	105.0	CHEMBL4142	Homo sapiens	Residual Activity	%	105.0
	12247941	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	9.0	CHEMBL4142	Homo sapiens	Residual Activity	%	9.0
	12247942	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	101.0	CHEMBL4142	Homo sapiens	Residual Activity	%	101.0
	12247943	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	114.0	CHEMBL4142	Homo sapiens	Residual Activity	%	114.0
	12247944	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	88.0	CHEMBL4142	Homo sapiens	Residual Activity	%	88.0
	12247945	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	83.0	CHEMBL4142	Homo sapiens	Residual Activity	%	83.0
	12247946	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	3.0	CHEMBL4142	Homo sapiens	Residual Activity	%	3.0
	12247947	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	66.0	CHEMBL4142	Homo sapiens	Residual Activity	%	66.0
	12247948	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	30.0	CHEMBL4142	Homo sapiens	Residual Activity	%	30.0
	12247949	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	89.0	CHEMBL4142	Homo sapiens	Residual Activity	%	89.0
	12247950	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	113.0	CHEMBL4142	Homo sapiens	Residual Activity	%	113.0
	12247951	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	96.0	CHEMBL4142	Homo sapiens	Residual Activity	%	96.0
	12247952	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	99.0	CHEMBL4142	Homo sapiens	Residual Activity	%	99.0
	12247953	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	18.0	CHEMBL4142	Homo sapiens	Residual Activity	%	18.0
	12247954	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	80.0	CHEMBL4142	Homo sapiens	Residual Activity	%	80.0
	12247955	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	85.0	CHEMBL4142	Homo sapiens	Residual Activity	%	85.0
	12247956	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	123.0	CHEMBL4142	Homo sapiens	Residual Activity	%	123.0
	12247957	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	98.0	CHEMBL4142	Homo sapiens	Residual Activity	%	98.0
	12247958	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	99.0	CHEMBL4142	Homo sapiens	Residual Activity	%	99.0
	12247959	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	76.0	CHEMBL4142	Homo sapiens	Residual Activity	%	76.0
	12247960	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	108.0	CHEMBL4142	Homo sapiens	Residual Activity	%	108.0
	12247961	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	82.0	CHEMBL4142	Homo sapiens	Residual Activity	%	82.0
	12247962	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	97.0	CHEMBL4142	Homo sapiens	Residual Activity	%	97.0
	12247963	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	47.0	CHEMBL4142	Homo sapiens	Residual Activity	%	47.0
	12247964	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	113.0	CHEMBL4142	Homo sapiens	Residual Activity	%	113.0
	12247965	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	88.0	CHEMBL4142	Homo sapiens	Residual Activity	%	88.0
	12247966	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	24.0	CHEMBL4142	Homo sapiens	Residual Activity	%	24.0
	12247967	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	67.0	CHEMBL4142	Homo sapiens	Residual Activity	%	67.0
	12247968	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	102.0	CHEMBL4142	Homo sapiens	Residual Activity	%	102.0
	12247969	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	57.0	CHEMBL4142	Homo sapiens	Residual Activity	%	57.0
	12247970	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	97.0	CHEMBL4142	Homo sapiens	Residual Activity	%	97.0
	12247971	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	5.0	CHEMBL4142	Homo sapiens	Residual Activity	%	5.0
	12247972	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	78.0	CHEMBL4142	Homo sapiens	Residual Activity	%	78.0
	12247973	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	101.0	CHEMBL4142	Homo sapiens	Residual Activity	%	101.0
	12247974	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	76.0	CHEMBL4142	Homo sapiens	Residual Activity	%	76.0
	12247975	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	93.0	CHEMBL4142	Homo sapiens	Residual Activity	%	93.0
	12247976	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	70.0	CHEMBL4142	Homo sapiens	Residual Activity	%	70.0
	12247977	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	114.0	CHEMBL4142	Homo sapiens	Residual Activity	%	114.0
	12247978	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	95.0	CHEMBL4142	Homo sapiens	Residual Activity	%	95.0
	12247979	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	53.0	CHEMBL4142	Homo sapiens	Residual Activity	%	53.0
	12247980	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	112.0	CHEMBL4142	Homo sapiens	Residual Activity	%	112.0
	12247981	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	121.0	CHEMBL4142	Homo sapiens	Residual Activity	%	121.0
	12247982	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	46.0	CHEMBL4142	Homo sapiens	Residual Activity	%	46.0
	12247983	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	9.0	CHEMBL4142	Homo sapiens	Residual Activity	%	9.0
	12247984	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	40.0	CHEMBL4142	Homo sapiens	Residual Activity	%	40.0
	12247985	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	87.0	CHEMBL4142	Homo sapiens	Residual Activity	%	87.0
	12247986	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	99.0	CHEMBL4142	Homo sapiens	Residual Activity	%	99.0
	12247987	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	32.0	CHEMBL4142	Homo sapiens	Residual Activity	%	32.0
	12247988	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	135.0	CHEMBL4142	Homo sapiens	Residual Activity	%	135.0
	12247989	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	123.0	CHEMBL4142	Homo sapiens	Residual Activity	%	123.0
	12247990	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	18.0	CHEMBL4142	Homo sapiens	Residual Activity	%	18.0
	12247991	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	3.0	CHEMBL4142	Homo sapiens	Residual Activity	%	3.0
	12247992	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	3.0	CHEMBL4142	Homo sapiens	Residual Activity	%	3.0
	12247993	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	68.0	CHEMBL4142	Homo sapiens	Residual Activity	%	68.0
	12247994	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	120.0	CHEMBL4142	Homo sapiens	Residual Activity	%	120.0
	12247995	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	105.0	CHEMBL4142	Homo sapiens	Residual Activity	%	105.0
	12247996	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	92.0	CHEMBL4142	Homo sapiens	Residual Activity	%	92.0
	12247997	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	62.0	CHEMBL4142	Homo sapiens	Residual Activity	%	62.0
	12247998	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	52.0	CHEMBL4142	Homo sapiens	Residual Activity	%	52.0
	12247999	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	90.0	CHEMBL4142	Homo sapiens	Residual Activity	%	90.0
	12248000	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	39.0	CHEMBL4142	Homo sapiens	Residual Activity	%	39.0
	12248001	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	7.0	CHEMBL4142	Homo sapiens	Residual Activity	%	7.0
	12248002	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	104.0	CHEMBL4142	Homo sapiens	Residual Activity	%	104.0
	12248003	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	107.0	CHEMBL4142	Homo sapiens	Residual Activity	%	107.0
	12248004	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	116.0	CHEMBL4142	Homo sapiens	Residual Activity	%	116.0
	12248005	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	38.0	CHEMBL4142	Homo sapiens	Residual Activity	%	38.0
	12248006	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	105.0	CHEMBL4142	Homo sapiens	Residual Activity	%	105.0
	12248007	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	105.0	CHEMBL4142	Homo sapiens	Residual Activity	%	105.0
	12248008	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	101.0	CHEMBL4142	Homo sapiens	Residual Activity	%	101.0
	12248009	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	33.0	CHEMBL4142	Homo sapiens	Residual Activity	%	33.0
	12248010	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	102.0	CHEMBL4142	Homo sapiens	Residual Activity	%	102.0
	12248011	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	37.0	CHEMBL4142	Homo sapiens	Residual Activity	%	37.0
	12248012	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	33.0	CHEMBL4142	Homo sapiens	Residual Activity	%	33.0
	12248013	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	109.0	CHEMBL4142	Homo sapiens	Residual Activity	%	109.0
	12248014	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	28.0	CHEMBL4142	Homo sapiens	Residual Activity	%	28.0
	12248015	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	25.0	CHEMBL4142	Homo sapiens	Residual Activity	%	25.0
	12248016	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	101.0	CHEMBL4142	Homo sapiens	Residual Activity	%	101.0
	12248017	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	3.0	CHEMBL4142	Homo sapiens	Residual Activity	%	3.0
	12248018	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	93.0	CHEMBL4142	Homo sapiens	Residual Activity	%	93.0
	12248019	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL4142	Homo sapiens	Residual Activity	%	0.0
	12248020	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	74.0	CHEMBL4142	Homo sapiens	Residual Activity	%	74.0
	12248021	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	7.0	CHEMBL4142	Homo sapiens	Residual Activity	%	7.0
	12250689	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	82.0	CHEMBL4142	Homo sapiens	Residual Activity	%	82.0
	12250690	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	82.0	CHEMBL4142	Homo sapiens	Residual Activity	%	82.0
	12250691	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	30.0	CHEMBL4142	Homo sapiens	Residual Activity	%	30.0
	12250692	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	99.0	CHEMBL4142	Homo sapiens	Residual Activity	%	99.0
	12250693	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	68.0	CHEMBL4142	Homo sapiens	Residual Activity	%	68.0
	12250694	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	81.0	CHEMBL4142	Homo sapiens	Residual Activity	%	81.0
	12250695	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	81.0	CHEMBL4142	Homo sapiens	Residual Activity	%	81.0
	12250696	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	2.0	CHEMBL4142	Homo sapiens	Residual Activity	%	2.0
	12250697	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	85.0	CHEMBL4142	Homo sapiens	Residual Activity	%	85.0
	12250698	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	83.0	CHEMBL4142	Homo sapiens	Residual Activity	%	83.0
	12250699	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	2.0	CHEMBL4142	Homo sapiens	Residual Activity	%	2.0
	12250700	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	79.0	CHEMBL4142	Homo sapiens	Residual Activity	%	79.0
	12250701	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	86.0	CHEMBL4142	Homo sapiens	Residual Activity	%	86.0
	12250702	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	85.0	CHEMBL4142	Homo sapiens	Residual Activity	%	85.0
	12250703	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	73.0	CHEMBL4142	Homo sapiens	Residual Activity	%	73.0
	12250704	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	89.0	CHEMBL4142	Homo sapiens	Residual Activity	%	89.0
	12250705	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	92.0	CHEMBL4142	Homo sapiens	Residual Activity	%	92.0
	12250706	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	91.0	CHEMBL4142	Homo sapiens	Residual Activity	%	91.0
	12250707	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	32.0	CHEMBL4142	Homo sapiens	Residual Activity	%	32.0
	12250708	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	2.0	CHEMBL4142	Homo sapiens	Residual Activity	%	2.0
	12250709	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	92.0	CHEMBL4142	Homo sapiens	Residual Activity	%	92.0
	12250710	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	78.0	CHEMBL4142	Homo sapiens	Residual Activity	%	78.0
	12250711	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	86.0	CHEMBL4142	Homo sapiens	Residual Activity	%	86.0
	12250712	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	87.0	CHEMBL4142	Homo sapiens	Residual Activity	%	87.0
	12250713	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	93.0	CHEMBL4142	Homo sapiens	Residual Activity	%	93.0
	12250714	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	84.0	CHEMBL4142	Homo sapiens	Residual Activity	%	84.0
	12250715	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	90.0	CHEMBL4142	Homo sapiens	Residual Activity	%	90.0
	12250716	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	73.0	CHEMBL4142	Homo sapiens	Residual Activity	%	73.0
	12250717	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	99.0	CHEMBL4142	Homo sapiens	Residual Activity	%	99.0
	12250718	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	74.0	CHEMBL4142	Homo sapiens	Residual Activity	%	74.0
	12250719	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	48.0	CHEMBL4142	Homo sapiens	Residual Activity	%	48.0
	12250720	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	79.0	CHEMBL4142	Homo sapiens	Residual Activity	%	79.0
	12250721	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	103.0	CHEMBL4142	Homo sapiens	Residual Activity	%	103.0
	12250722	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	98.0	CHEMBL4142	Homo sapiens	Residual Activity	%	98.0
	12250723	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	10.0	CHEMBL4142	Homo sapiens	Residual Activity	%	10.0
	12250724	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	81.0	CHEMBL4142	Homo sapiens	Residual Activity	%	81.0
	12250725	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	67.0	CHEMBL4142	Homo sapiens	Residual Activity	%	67.0
	12250726	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	97.0	CHEMBL4142	Homo sapiens	Residual Activity	%	97.0
	12250727	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	59.0	CHEMBL4142	Homo sapiens	Residual Activity	%	59.0
	12250728	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	34.0	CHEMBL4142	Homo sapiens	Residual Activity	%	34.0
	12250729	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	37.0	CHEMBL4142	Homo sapiens	Residual Activity	%	37.0
	12250730	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	82.0	CHEMBL4142	Homo sapiens	Residual Activity	%	82.0
	12250731	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	2.0	CHEMBL4142	Homo sapiens	Residual Activity	%	2.0
	12250732	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	90.0	CHEMBL4142	Homo sapiens	Residual Activity	%	90.0
	12250733	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	56.0	CHEMBL4142	Homo sapiens	Residual Activity	%	56.0
	12250734	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	93.0	CHEMBL4142	Homo sapiens	Residual Activity	%	93.0
	12250735	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	60.0	CHEMBL4142	Homo sapiens	Residual Activity	%	60.0
	12250736	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-1.0	CHEMBL4142	Homo sapiens	Residual Activity	%	-1.0
	12250737	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	80.0	CHEMBL4142	Homo sapiens	Residual Activity	%	80.0
	12250738	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	78.0	CHEMBL4142	Homo sapiens	Residual Activity	%	78.0
	12250739	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	12.0	CHEMBL4142	Homo sapiens	Residual Activity	%	12.0
	12250740	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	89.0	CHEMBL4142	Homo sapiens	Residual Activity	%	89.0
	12250741	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	2.0	CHEMBL4142	Homo sapiens	Residual Activity	%	2.0
	12250742	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	22.0	CHEMBL4142	Homo sapiens	Residual Activity	%	22.0
	12250743	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	84.0	CHEMBL4142	Homo sapiens	Residual Activity	%	84.0
	12250744	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	9.0	CHEMBL4142	Homo sapiens	Residual Activity	%	9.0
	12250745	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	18.0	CHEMBL4142	Homo sapiens	Residual Activity	%	18.0
	12250746	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	76.0	CHEMBL4142	Homo sapiens	Residual Activity	%	76.0
	12250747	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	82.0	CHEMBL4142	Homo sapiens	Residual Activity	%	82.0
	12250748	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	60.0	CHEMBL4142	Homo sapiens	Residual Activity	%	60.0
	12250749	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	78.0	CHEMBL4142	Homo sapiens	Residual Activity	%	78.0
	12250750	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	21.0	CHEMBL4142	Homo sapiens	Residual Activity	%	21.0
	12250751	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	82.0	CHEMBL4142	Homo sapiens	Residual Activity	%	82.0
	12250752	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	86.0	CHEMBL4142	Homo sapiens	Residual Activity	%	86.0
	12250753	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	18.0	CHEMBL4142	Homo sapiens	Residual Activity	%	18.0
	12250754	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	45.0	CHEMBL4142	Homo sapiens	Residual Activity	%	45.0
	12250755	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	60.0	CHEMBL4142	Homo sapiens	Residual Activity	%	60.0
	12250756	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	88.0	CHEMBL4142	Homo sapiens	Residual Activity	%	88.0
	12250757	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	12.0	CHEMBL4142	Homo sapiens	Residual Activity	%	12.0
	12250758	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	94.0	CHEMBL4142	Homo sapiens	Residual Activity	%	94.0
	12250759	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	92.0	CHEMBL4142	Homo sapiens	Residual Activity	%	92.0
	12250760	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	81.0	CHEMBL4142	Homo sapiens	Residual Activity	%	81.0
	12250761	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	81.0	CHEMBL4142	Homo sapiens	Residual Activity	%	81.0
	12250762	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	48.0	CHEMBL4142	Homo sapiens	Residual Activity	%	48.0
	12250763	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	87.0	CHEMBL4142	Homo sapiens	Residual Activity	%	87.0
	12250764	CHEMBL2219065	Millipore: Percentage of residual kinase activity of FGFR2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	30.0	CHEMBL4142	Homo sapiens	Residual Activity	%	30.0
	12626722	CHEMBL2316994	Inhibition of FGFR2 (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>	Inhibition	%	95.0	CHEMBL4142	Homo sapiens	INH	%	95.0
	12675484	CHEMBL2344407	Inhibition of FGFR2 (unknown origin)	B	O=C(Nc1ccc(Oc2ncnc3[nH]ncc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL2332840	=	IC50	nM	1805.0	CHEMBL4142	Homo sapiens	IC50	uM	1.805
	12693267	CHEMBL2343953	Inhibition of FGFR2 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	12721818	CHEMBL2353803	Inhibition of FGFR2 (unknown origin) at 1 uM relative to control	B	CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1		CHEMBL2347710	=	Inhibition	%	100.0	CHEMBL4142	Homo sapiens	INH	%	100.0
	12728835	CHEMBL2352908	Inhibition of FGFR2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	93.0	CHEMBL4142	Homo sapiens	Activity	%	93.0
	12729080	CHEMBL2352258	Inhibition of FGFR2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	105.0	CHEMBL4142	Homo sapiens	Activity	%	105.0
	12729776	CHEMBL2350021	Inhibition of FGFR2 N549H mutant (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	102.0	CHEMBL4142	Homo sapiens	Activity	%	102.0
	12729960	CHEMBL2352196	Inhibition of FGFR2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	87.0	CHEMBL4142	Homo sapiens	Activity	%	87.0
	12730223	CHEMBL2352908	Inhibition of FGFR2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	86.0	CHEMBL4142	Homo sapiens	Activity	%	86.0
	13301917	CHEMBL2383377	Inhibition of human FGFR2 N549H mutant at 1 uM relative to control	B	Cn1cc(-c2cc3[nH]nc(-c4cccc(S(N)(=O)=O)c4)c3cc2NC2CCCCC2)cn1		CHEMBL2380586	>	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
Not Active	13349236	CHEMBL2399727	Inhibition of recombinant FGFR-2 (unknown origin) at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1		CHEMBL2397148		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Not Active	13349237	CHEMBL2399727	Inhibition of recombinant FGFR-2 (unknown origin) at 10 uM	B	O=C(NC12CC3CC(CC(C3)C1)C2)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1		CHEMBL242459		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	13367222	CHEMBL2406342	Inhibition of FGFR2 (unknown origin) after 60 mins	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	260.0	CHEMBL4142	Homo sapiens	IC50	uM	0.26
	13375865	CHEMBL2405127	Inhibition of FGFR2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-1.0	CHEMBL4142	Homo sapiens	INH	%	-1.0
	13388120	CHEMBL2412038	Inhibition of FGFR2 (unknown origin) at 1 uM	B	CNC(=O)c1ccccc1Nc1ncnc(Nc2cc(OC)c(OC)c(OC)c2)n1		CHEMBL2409605	=	Inhibition	%	82.0	CHEMBL4142	Homo sapiens	INH	%	82.0
	13419610	CHEMBL2422076	Inhibition of FGFR2 N549H mutant (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	15.0	CHEMBL4142	Homo sapiens	INH	%	15.0
	13419611	CHEMBL2422076	Inhibition of FGFR2 N549H mutant (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	22.0	CHEMBL4142	Homo sapiens	INH	%	22.0
	13419612	CHEMBL2422076	Inhibition of FGFR2 N549H mutant (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	20.0	CHEMBL4142	Homo sapiens	INH	%	20.0
	13419613	CHEMBL2422077	Inhibition of FGFR2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	20.0	CHEMBL4142	Homo sapiens	INH	%	20.0
	13419614	CHEMBL2422077	Inhibition of FGFR2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	18.0	CHEMBL4142	Homo sapiens	INH	%	18.0
	13419615	CHEMBL2422077	Inhibition of FGFR2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	15.0	CHEMBL4142	Homo sapiens	INH	%	15.0
	13442358	CHEMBL2427790	Competitive binding affinity to FGFR2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	13445493	CHEMBL2427790	Competitive binding affinity to FGFR2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	13448548	CHEMBL2427790	Competitive binding affinity to FGFR2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	13448684	CHEMBL2427790	Competitive binding affinity to FGFR2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	13451479	CHEMBL2427790	Competitive binding affinity to FGFR2 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	13454664	CHEMBL2427790	Competitive binding affinity to FGFR2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	13836301	CHEMBL3090909	Inhibition of FGFR2 (unknown origin) after 90 mins by TR-FRET/IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(Cl)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3086065	>	IC50	nM	50000.0	CHEMBL4142	Homo sapiens	IC50	uM	50.0
	13872146	CHEMBL3101771	Inhibition of human FGFR2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	125.0	CHEMBL4142	Homo sapiens	Activity	%	125.0
Not Active	13907189	CHEMBL3118664	Inhibition of FGFR2 (unknown origin) at 10 uM	B	CCCCCCCCCC(NC(=O)CNC(=O)OCc1ccccc1)C(=O)NCCc1ccccc1		CHEMBL3113587		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	13953355	CHEMBL3130684	Inhibition of human FGFR2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	88.0	CHEMBL4142	Homo sapiens	Activity	%	88.0
	13954674	CHEMBL3130684	Inhibition of human FGFR2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	100.0	CHEMBL4142	Homo sapiens	Activity	%	100.0
	13954703	CHEMBL3130684	Inhibition of human FGFR2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	90.0	CHEMBL4142	Homo sapiens	Activity	%	90.0
	13965705	CHEMBL3135917	Inhibition of human FGFR2 N549H mutant catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	35.5	CHEMBL4142	Homo sapiens	INH	%	35.5
	13965706	CHEMBL3135918	Inhibition of human FGFR2 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	27.0	CHEMBL4142	Homo sapiens	INH	%	27.0
	13966083	CHEMBL3137071	Inhibition of human FGFR2 N549H mutant catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	42.0	CHEMBL4142	Homo sapiens	INH	%	42.0
	13966084	CHEMBL3137072	Inhibition of human FGFR2 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	62.0	CHEMBL4142	Homo sapiens	INH	%	62.0
	13973985	CHEMBL3135885	Inhibition of human FGFR2 N549H mutant catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	7.5	CHEMBL4142	Homo sapiens	INH	%	7.5
	13973986	CHEMBL3135886	Inhibition of human FGFR2 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	13974076	CHEMBL3134914	Inhibition of human FGFR2 N549H mutant catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	6.5	CHEMBL4142	Homo sapiens	INH	%	6.5
	13974077	CHEMBL3134915	Inhibition of human FGFR2 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	13974167	CHEMBL3136504	Inhibition of human FGFR2 N549H mutant catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	47.5	CHEMBL4142	Homo sapiens	INH	%	47.5
	13974168	CHEMBL3136505	Inhibition of human FGFR2 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	30.0	CHEMBL4142	Homo sapiens	INH	%	30.0
	13974258	CHEMBL3136114	Inhibition of human FGFR2 N549H mutant catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	42.5	CHEMBL4142	Homo sapiens	INH	%	42.5
	13974259	CHEMBL3136115	Inhibition of human FGFR2 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	7.0	CHEMBL4142	Homo sapiens	INH	%	7.0
	13974996	CHEMBL3135292	Inhibition of human FGFR2 N549H mutant catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	89.5	CHEMBL4142	Homo sapiens	INH	%	89.5
	13974997	CHEMBL3135293	Inhibition of human FGFR2 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	93.0	CHEMBL4142	Homo sapiens	INH	%	93.0
	13975087	CHEMBL3136859	Inhibition of human FGFR2 N549H mutant catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	13975088	CHEMBL3136860	Inhibition of human FGFR2 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	13975178	CHEMBL3135632	Inhibition of human FGFR2 N549H mutant catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	5.0	CHEMBL4142	Homo sapiens	INH	%	5.0
	13975179	CHEMBL3135633	Inhibition of human FGFR2 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	13975269	CHEMBL3137152	Inhibition of human FGFR2 N549H mutant catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	1.0	CHEMBL4142	Homo sapiens	INH	%	1.0
	13975270	CHEMBL3137153	Inhibition of human FGFR2 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	1.5	CHEMBL4142	Homo sapiens	INH	%	1.5
	13975912	CHEMBL3136279	Inhibition of human FGFR2 N549H mutant catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	13975913	CHEMBL3136280	Inhibition of human FGFR2 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	29.5	CHEMBL4142	Homo sapiens	INH	%	29.5
	13976005	CHEMBL3136430	Inhibition of human FGFR2 N549H mutant catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	7.0	CHEMBL4142	Homo sapiens	INH	%	7.0
	13976006	CHEMBL3136431	Inhibition of human FGFR2 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	4.0	CHEMBL4142	Homo sapiens	INH	%	4.0
	13976096	CHEMBL3136767	Inhibition of human FGFR2 N549H mutant catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	40.0	CHEMBL4142	Homo sapiens	INH	%	40.0
	13976097	CHEMBL3136768	Inhibition of human FGFR2 catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	36.0	CHEMBL4142	Homo sapiens	INH	%	36.0
	14533245	CHEMBL3225071	Inhibition of FGFR2 (unknown origin) at 50 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(/C=C/S(=O)(=O)c4ccc(F)cc4)cc32)c1C		CHEMBL3218262	=	Inhibition	%	76.6	CHEMBL4142	Homo sapiens	INH	%	76.6
	14533246	CHEMBL3225071	Inhibition of FGFR2 (unknown origin) at 50 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(/C=C/S(=O)(=O)c4ccc(Br)cc4)cc32)c1C		CHEMBL3218263	=	Inhibition	%	67.8	CHEMBL4142	Homo sapiens	INH	%	67.8
	14533247	CHEMBL3225071	Inhibition of FGFR2 (unknown origin) at 50 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)/C=C/c4ccc(Cl)cc4)cc32)c1C		CHEMBL3218273	=	Inhibition	%	72.0	CHEMBL4142	Homo sapiens	INH	%	72.0
	14533248	CHEMBL3225071	Inhibition of FGFR2 (unknown origin) at 50 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	61.8	CHEMBL4142	Homo sapiens	INH	%	61.8
	14533256	CHEMBL3225071	Inhibition of FGFR2 (unknown origin) at 50 uM	B	O.O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL1173475	=	Inhibition	%	67.3	CHEMBL4142	Homo sapiens	INH	%	67.3
	14582498	CHEMBL3242350	Inhibition of human FGFR2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	99.5	CHEMBL4142	Homo sapiens	Activity	%	99.5
	14992052	CHEMBL3374152	Inhibition of FGFR2 (unknown origin) at 1 uM by ELISA method	B	O=C(Nc1ccc(F)cc1)C1(C(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c(F)c2)CC1		CHEMBL3360678	=	Inhibition	%	37.2	CHEMBL4142	Homo sapiens	INH	%	37.2
	14992121	CHEMBL3374167	Inhibition of FGFR2 (unknown origin) at 10 nM by ELISA method	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	Inhibition	%	82.51	CHEMBL4142	Homo sapiens	INH	%	82.51
	15018593	CHEMBL3362257	Inhibition of FGFR2 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	7.5	CHEMBL4142	Homo sapiens	INH	%	7.5
	15037218	CHEMBL3368339	Inhibition of FGFR2 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1OC		CHEMBL3102948	=	Inhibition	%	100.0	CHEMBL4142	Homo sapiens	INH	%	100.0
	15037219	CHEMBL3368339	Inhibition of FGFR2 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1cc(-c2c[nH]c3ncc(-c4cccc(N)c4)cc23)cc(OC)c1OC		CHEMBL3319457	=	Inhibition	%	100.0	CHEMBL4142	Homo sapiens	INH	%	100.0
	15037220	CHEMBL3368339	Inhibition of FGFR2 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4ccc(C(=O)N5CCOCC5)c(N)c4)cc23)cc1OC		CHEMBL3319467	=	Inhibition	%	89.0	CHEMBL4142	Homo sapiens	INH	%	89.0
	15037221	CHEMBL3368339	Inhibition of FGFR2 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4cc(OC)c(OC)c(OC)c4)cc23)cc1OC		CHEMBL3319468	=	Inhibition	%	100.0	CHEMBL4142	Homo sapiens	INH	%	100.0
	15037222	CHEMBL3368339	Inhibition of FGFR2 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N		CHEMBL3319470	=	Inhibition	%	100.0	CHEMBL4142	Homo sapiens	INH	%	100.0
	15058844	CHEMBL3371398	Inhibition of FGFR2 (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	Activity	%	39.0	CHEMBL4142	Homo sapiens	Activity	%	39.0
	15091094	CHEMBL3381535	Inhibition of human recombinant FGFR2 kinase using Ulight-CAGAGAIETDKEYYTVKD substrate assessed as remaining enzyme activity at 1 uM after 15 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	91.0	CHEMBL4142	Homo sapiens	Activity	%	91.0
	15107864	CHEMBL3385825	Inhibition of wild type FGFR2 (unknown origin) incubated for 5 mins by HTRF assay	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C(F)=C/CN(C)C		CHEMBL3357634	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	15149978	CHEMBL3395927	Inhibition of FGFR2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	15149979	CHEMBL3395927	Inhibition of FGFR2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	15149980	CHEMBL3395927	Inhibition of FGFR2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	15149981	CHEMBL3395927	Inhibition of FGFR2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	15149982	CHEMBL3395927	Inhibition of FGFR2 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	15165362	CHEMBL3404249	Inhibition of FGFR2 (unknown origin) after 90 mins by TR-FRET assay	B	CC(=O)Nc1nc(O)c2nc(-c3c[nH]c4cccc(Br)c34)[nH]c2n1		CHEMBL3401370	=	IC50	nM	6140.0	CHEMBL4142	Homo sapiens	IC50	uM	6.14
	15165363	CHEMBL3404249	Inhibition of FGFR2 (unknown origin) after 90 mins by TR-FRET assay	B	CC(=O)Nc1nc(O)c2nc(-c3c[nH]c4ccccc34)[nH]c2n1		CHEMBL3401369	=	IC50	nM	7620.0	CHEMBL4142	Homo sapiens	IC50	uM	7.62
	15165364	CHEMBL3404249	Inhibition of FGFR2 (unknown origin) after 90 mins by TR-FRET assay	B	CC(=O)Nc1nc(O)c2nc(-c3ccc(C)cc3C)[nH]c2n1		CHEMBL3401368	=	IC50	nM	9130.0	CHEMBL4142	Homo sapiens	IC50	uM	9.13
	15165365	CHEMBL3404249	Inhibition of FGFR2 (unknown origin) after 90 mins by TR-FRET assay	B	COc1cccc(-c2nc3c(O)nc(NC(C)=O)nc3[nH]2)c1OC		CHEMBL3401367	=	IC50	nM	6280.0	CHEMBL4142	Homo sapiens	IC50	uM	6.28
	15165366	CHEMBL3404249	Inhibition of FGFR2 (unknown origin) after 90 mins by TR-FRET assay	B	COc1ccccc1-c1nc2c(O)nc(NC(C)=O)nc2[nH]1		CHEMBL3401366	=	IC50	nM	13470.0	CHEMBL4142	Homo sapiens	IC50	uM	13.47
	15165367	CHEMBL3404249	Inhibition of FGFR2 (unknown origin) after 90 mins by TR-FRET assay	B	CC(=O)Nc1nc(O)c2nc(-c3ccccc3)[nH]c2n1		CHEMBL3401365	=	IC50	nM	16110.0	CHEMBL4142	Homo sapiens	IC50	uM	16.11
	15165368	CHEMBL3404249	Inhibition of FGFR2 (unknown origin) after 90 mins by TR-FRET assay	B	Nc1nc(O)c2nc(-c3c[nH]c4cccc(Br)c34)[nH]c2n1		CHEMBL3401364	=	IC50	nM	9130.0	CHEMBL4142	Homo sapiens	IC50	uM	9.13
	15165369	CHEMBL3404249	Inhibition of FGFR2 (unknown origin) after 90 mins by TR-FRET assay	B	Nc1nc(O)c2nc(-c3c[nH]c4ccccc34)[nH]c2n1		CHEMBL3401363	=	IC50	nM	9580.0	CHEMBL4142	Homo sapiens	IC50	uM	9.58
	15165370	CHEMBL3404249	Inhibition of FGFR2 (unknown origin) after 90 mins by TR-FRET assay	B	Cc1ccc(-c2nc3c(O)nc(N)nc3[nH]2)c(C)c1		CHEMBL3401362	=	IC50	nM	17710.0	CHEMBL4142	Homo sapiens	IC50	uM	17.71
	15165371	CHEMBL3404249	Inhibition of FGFR2 (unknown origin) after 90 mins by TR-FRET assay	B	COc1cccc(-c2nc3c(O)nc(N)nc3[nH]2)c1OC		CHEMBL3401361	=	IC50	nM	8390.0	CHEMBL4142	Homo sapiens	IC50	uM	8.39
	15165372	CHEMBL3404249	Inhibition of FGFR2 (unknown origin) after 90 mins by TR-FRET assay	B	COc1ccccc1-c1nc2c(O)nc(N)nc2[nH]1		CHEMBL3401360	=	IC50	nM	15730.0	CHEMBL4142	Homo sapiens	IC50	uM	15.73
	15165373	CHEMBL3404249	Inhibition of FGFR2 (unknown origin) after 90 mins by TR-FRET assay	B	Nc1nc(O)c2nc(-c3ccccc3)[nH]c2n1		CHEMBL3401359	=	IC50	nM	13460.0	CHEMBL4142	Homo sapiens	IC50	uM	13.46
	15165374	CHEMBL3404249	Inhibition of FGFR2 (unknown origin) after 90 mins by TR-FRET assay	B	CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Cl		CHEMBL57366	=	IC50	nM	130.0	CHEMBL4142	Homo sapiens	IC50	uM	0.13
	15165375	CHEMBL3404249	Inhibition of FGFR2 (unknown origin) after 90 mins by TR-FRET assay	B	CN1CCN(c2ccc(-c3nc4c(N5CCN(CC(=O)Nc6nccs6)CC5)c(Cl)cnc4[nH]3)cc2)CC1		CHEMBL3401358	=	IC50	nM	63.0	CHEMBL4142	Homo sapiens	IC50	uM	0.063
	15165376	CHEMBL3404249	Inhibition of FGFR2 (unknown origin) after 90 mins by TR-FRET assay	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	3.2	CHEMBL4142	Homo sapiens	IC50	uM	0.0032
	15165394	CHEMBL3404245	Inhibition of FGFR2 (unknown origin)	B	CN1CCN(c2ccc(-c3nc4c(N5CCN(CC(=O)Nc6nccs6)CC5)c(Cl)cnc4[nH]3)cc2)CC1		CHEMBL3401358	=	IC50	nM	20.0	CHEMBL4142	Homo sapiens	IC50	nM	20.0
	15193439	CHEMBL3411885	Inhibition of human FGFR2	B	CCS(=O)(=O)O.COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL3039504	=	IC50	nM	37.0	CHEMBL4142	Homo sapiens	IC50	nM	37.0
	15723385	CHEMBL3619997	Inhibition of FGFR2 (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1NC(=O)c1cnoc1C		CHEMBL3616960	=	Inhibition	%	3.6	CHEMBL4142	Homo sapiens	INH	%	3.6
Not Active	15723386	CHEMBL3619997	Inhibition of FGFR2 (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccccc1C(=O)Nc1cnoc1C		CHEMBL3616990		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	15723435	CHEMBL3620027	Inhibition of FGFR2 (unknown origin) after 40 mins by scintillation counting analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.77	CHEMBL4142	Homo sapiens	IC50	nM	1.77
	15736000	CHEMBL3625840	Inhibition of human recombinant FGFR2	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	15755880	CHEMBL3630657	Inhibition of FGFR2 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	56.0	CHEMBL4142	Homo sapiens	Activity	%	56.0
	15756986	CHEMBL3630497	Inhibition of FGFR2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	79.4	CHEMBL4142	Homo sapiens	INH	%	79.4
	15757737	CHEMBL3630497	Inhibition of FGFR2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	64.38	CHEMBL4142	Homo sapiens	INH	%	64.38
	15758716	CHEMBL3630497	Inhibition of FGFR2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	4.14	CHEMBL4142	Homo sapiens	INH	%	4.14
	16421910	CHEMBL3750392	Inhibition of FGFR2 (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	16431833	CHEMBL3748187	Inhibition of human FGFR2 using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	16433837	CHEMBL3756755	Inhibition of human FGFR2 using IGF-1Rtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	CN1CCN(c2ccc(NC(=O)c3ccc(-c4cc(Cl)ccc4Cl)o3)cc2)CC1		CHEMBL3754324	=	Inhibition	%	54.8	CHEMBL4142	Homo sapiens	INH	%	54.8
	16433838	CHEMBL3756755	Inhibition of human FGFR2 using IGF-1Rtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	Cc1c(Cl)cccc1-c1ccc(C(=O)Nc2ccc(S(N)(=O)=O)cc2)o1		CHEMBL3752265	=	Inhibition	%	32.4	CHEMBL4142	Homo sapiens	INH	%	32.4
	16450842	CHEMBL3762698	Inhibition of FGFR2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	54.0	CHEMBL4142	Homo sapiens	INH	%	54.0
	16465832	CHEMBL3767845	Inhibition of human FGFR2 at 10 uM	B	Cc1cncn1-c1cc(C(=O)Nc2cccc(CNc3ccc4c(C(=O)N[C@@H](C)C(N)=O)[nH]nc4c3)c2)cc(C(F)(F)F)c1		CHEMBL3764798	=	Inhibition	%	9.75	CHEMBL4142	Homo sapiens	INH	%	9.75
	16485725	CHEMBL3771574	Inhibition of human recombinant FGFR2 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL4142	Homo sapiens	Activity	%	100.0
	16495993	CHEMBL3778584	Inhibition of N-terminal His6-tagged recombinant human FGFR2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	1.0	CHEMBL4142	Homo sapiens	Activity	%	1.0
	16495994	CHEMBL3779689	Inhibition of N-terminal His6-tagged recombinant human FGFR2 N549H mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-4.0	CHEMBL4142	Homo sapiens	Activity	%	-4.0
	16508180	CHEMBL3778584	Inhibition of N-terminal His6-tagged recombinant human FGFR2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	6.0	CHEMBL4142	Homo sapiens	Activity	%	6.0
	16508181	CHEMBL3779689	Inhibition of N-terminal His6-tagged recombinant human FGFR2 N549H mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	4.0	CHEMBL4142	Homo sapiens	Activity	%	4.0
	16509157	CHEMBL3778584	Inhibition of N-terminal His6-tagged recombinant human FGFR2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-5.0	CHEMBL4142	Homo sapiens	Activity	%	-5.0
	16509158	CHEMBL3779689	Inhibition of N-terminal His6-tagged recombinant human FGFR2 N549H mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-2.0	CHEMBL4142	Homo sapiens	Activity	%	-2.0
Not Active	16514124	CHEMBL3782172	Inhibition of partial length human FGFR2 expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	16540781	CHEMBL3789985	Inhibition of FGFR2 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	=	IC50	nM	2700.0	CHEMBL4142	Homo sapiens	IC50	uM	2.7
	16540782	CHEMBL3789985	Inhibition of FGFR2 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	16580771	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	1.2	CHEMBL4142	Homo sapiens	IC50	nM	1.2
	16580772	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COCCOc1ccc2c(Nc3cc(CCc4cc(OC)cc(OC)c4)[nH]n3)ncnc2c1		CHEMBL3798532	=	IC50	nM	0.9	CHEMBL4142	Homo sapiens	IC50	nM	0.9
	16580773	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COCCNc1ccc2c(Nc3cc(CCc4cc(OC)cc(OC)c4)[nH]n3)ncnc2c1		CHEMBL3798924	=	IC50	nM	2.7	CHEMBL4142	Homo sapiens	IC50	nM	2.7
	16580774	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(NCCN5CCOCC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800352	=	IC50	nM	1.3	CHEMBL4142	Homo sapiens	IC50	nM	1.3
	16580775	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCOCC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3798342	=	IC50	nM	0.4	CHEMBL4142	Homo sapiens	IC50	nM	0.4
	16580776	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(C5CCN(C)CC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800072	=	IC50	nM	0.8	CHEMBL4142	Homo sapiens	IC50	nM	0.8
	16580777	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCC(N(C)C)C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3797594	=	IC50	nM	0.4	CHEMBL4142	Homo sapiens	IC50	nM	0.4
	16580778	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCC(N(C)C)CC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3797845	=	IC50	nM	0.3	CHEMBL4142	Homo sapiens	IC50	nM	0.3
	16580779	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCCN(C)CC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3797998	=	IC50	nM	0.7	CHEMBL4142	Homo sapiens	IC50	nM	0.7
	16580780	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5C[C@H](C)N(C)[C@H](C)C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3798625	=	IC50	nM	0.2	CHEMBL4142	Homo sapiens	IC50	nM	0.2
	16580781	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN6CCCCC6C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800526	=	IC50	nM	0.2	CHEMBL4142	Homo sapiens	IC50	nM	0.2
	16580782	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCNC(C)(C)C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3798911	=	IC50	nM	0.9	CHEMBL4142	Homo sapiens	IC50	nM	0.9
	16580783	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COCCN1CCN(c2ccc3c(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)ncnc3c2)CC1		CHEMBL3798940	=	IC50	nM	0.7	CHEMBL4142	Homo sapiens	IC50	nM	0.7
	16580784	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN(C6CCC6)CC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3799426	=	IC50	nM	0.6	CHEMBL4142	Homo sapiens	IC50	nM	0.6
	16580785	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN(C(C)C)CC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3799403	=	IC50	nM	0.6	CHEMBL4142	Homo sapiens	IC50	nM	0.6
	16580786	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN(C)CC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3799354	=	IC50	nM	1.0	CHEMBL4142	Homo sapiens	IC50	nM	1.0
	16580787	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCN1CCN(c2cccc3c(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)ncnc23)CC1		CHEMBL3798127	=	IC50	nM	4.3	CHEMBL4142	Homo sapiens	IC50	nM	4.3
	16580788	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4c(OC)cccc34)n[nH]2)cc(OC)c1		CHEMBL3797238	=	IC50	nM	3.9	CHEMBL4142	Homo sapiens	IC50	nM	3.9
	16580789	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4c(Cl)cccc34)n[nH]2)cc(OC)c1		CHEMBL3799140	=	IC50	nM	4.8	CHEMBL4142	Homo sapiens	IC50	nM	4.8
	16580790	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cccc(OC)c34)n[nH]2)cc(OC)c1		CHEMBL3798561	=	IC50	nM	100.9	CHEMBL4142	Homo sapiens	IC50	nM	100.9
	16580791	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cccc(Cl)c34)n[nH]2)cc(OC)c1		CHEMBL3799024	=	IC50	nM	16.9	CHEMBL4142	Homo sapiens	IC50	nM	16.9
	16580792	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4ccccc34)n[nH]2)cc(OC)c1		CHEMBL3797268	=	IC50	nM	3.2	CHEMBL4142	Homo sapiens	IC50	nM	3.2
	16580793	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCCc1nc(Nc2cc(CCc3cc(OC)cc(OC)c3)[nH]n2)c2ccc(N3CCN(CC)CC3)cc2n1		CHEMBL3799885	=	IC50	nM	0.7	CHEMBL4142	Homo sapiens	IC50	nM	0.7
	16580794	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCc1nc(Nc2cc(CCc3cc(OC)cc(OC)c3)[nH]n2)c2ccc(N3CCN(CC)CC3)cc2n1		CHEMBL3797416	=	IC50	nM	0.5	CHEMBL4142	Homo sapiens	IC50	nM	0.5
	16580795	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCN1CCN(c2ccc3c(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)nc(C)nc3c2)CC1		CHEMBL3799611	=	IC50	nM	0.6	CHEMBL4142	Homo sapiens	IC50	nM	0.6
	16580796	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCN1CCN(c2ccc3c(Nc4cc(CCc5c(Cl)c(OC)cc(OC)c5Cl)[nH]n4)ncnc3c2)CC1		CHEMBL3797507	=	IC50	nM	0.3	CHEMBL4142	Homo sapiens	IC50	nM	0.3
	16580797	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCN1CCN(c2ccc3c(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)ncnc3c2)CC1		CHEMBL3798997	=	IC50	nM	0.8	CHEMBL4142	Homo sapiens	IC50	nM	0.8
	16580798	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCN1CCN(c2ccc3c(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)nc(NCc4cc(C)no4)nc3c2)CC1		CHEMBL3800190	<	IC50	nM	10.0	CHEMBL4142	Homo sapiens	IC50	nM	10.0
	16580799	CHEMBL3803147	Inhibition of recombinant FGFR2 (unknown origin) at 100 nM using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCN1CCN(c2ccc3c(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)ccnc3c2)CC1		CHEMBL3798714	=	Inhibition	%	29.9	CHEMBL4142	Homo sapiens	INH	%	29.9
	16580800	CHEMBL3803147	Inhibition of recombinant FGFR2 (unknown origin) at 100 nM using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COCCOc1ccc2ncnc(Nc3cc(CCc4cc(OC)cc(OC)c4)[nH]n3)c2c1		CHEMBL3797249	=	Inhibition	%	43.9	CHEMBL4142	Homo sapiens	INH	%	43.9
	16580801	CHEMBL3803147	Inhibition of recombinant FGFR2 (unknown origin) at 100 nM using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCN1CCN(c2ccc3ncnc(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)c3c2)CC1		CHEMBL3799032	=	Inhibition	%	29.9	CHEMBL4142	Homo sapiens	INH	%	29.9
	16580802	CHEMBL3803147	Inhibition of recombinant FGFR2 (unknown origin) at 100 nM using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COCCOc1cc2ncnc(Nc3cc(CCc4cc(OC)cc(OC)c4)[nH]n3)c2cc1OC		CHEMBL3799057	=	Inhibition	%	58.8	CHEMBL4142	Homo sapiens	INH	%	58.8
	16580803	CHEMBL3803147	Inhibition of recombinant FGFR2 (unknown origin) at 100 nM using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCN1CCN(c2cc3ncnc(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)c3cc2OC)CC1		CHEMBL3798842	=	Inhibition	%	66.7	CHEMBL4142	Homo sapiens	INH	%	66.7
	16580804	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	CCN1CCN(c2ccc3c(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)nc(NCc4cc(C)no4)nc3c2)CC1		CHEMBL3800190	>	IC50	nM	100.0	CHEMBL4142	Homo sapiens	IC50	nM	100.0
	16580805	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	CCN1CCN(c2ccc3c(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)ncnc3c2)CC1		CHEMBL3798997	=	IC50	nM	1.2	CHEMBL4142	Homo sapiens	IC50	nM	1.2
	16580806	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	CCN1CCN(c2ccc3c(Nc4cc(CCc5c(Cl)c(OC)cc(OC)c5Cl)[nH]n4)ncnc3c2)CC1		CHEMBL3797507	=	IC50	nM	1.4	CHEMBL4142	Homo sapiens	IC50	nM	1.4
Not Determined	16580807	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	CCN1CCN(c2ccc3c(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)ccnc3c2)CC1		CHEMBL3798714		IC50			CHEMBL4142	Homo sapiens	IC50		
	16580808	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	CCN1CCN(c2ccc3c(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)nc(C)nc3c2)CC1		CHEMBL3799611	=	IC50	nM	105.7	CHEMBL4142	Homo sapiens	IC50	nM	105.7
	16580809	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	CCc1nc(Nc2cc(CCc3cc(OC)cc(OC)c3)[nH]n2)c2ccc(N3CCN(CC)CC3)cc2n1		CHEMBL3797416	=	IC50	nM	24.7	CHEMBL4142	Homo sapiens	IC50	nM	24.7
	16580810	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	CCCc1nc(Nc2cc(CCc3cc(OC)cc(OC)c3)[nH]n2)c2ccc(N3CCN(CC)CC3)cc2n1		CHEMBL3799885	=	IC50	nM	90.0	CHEMBL4142	Homo sapiens	IC50	nM	90.0
	16580811	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4ccccc34)n[nH]2)cc(OC)c1		CHEMBL3797268	>	IC50	nM	200.0	CHEMBL4142	Homo sapiens	IC50	nM	200.0
	16580812	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cccc(Cl)c34)n[nH]2)cc(OC)c1		CHEMBL3799024	>	IC50	nM	200.0	CHEMBL4142	Homo sapiens	IC50	nM	200.0
	16580813	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cccc(OC)c34)n[nH]2)cc(OC)c1		CHEMBL3798561	>	IC50	nM	200.0	CHEMBL4142	Homo sapiens	IC50	nM	200.0
	16580814	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4c(Cl)cccc34)n[nH]2)cc(OC)c1		CHEMBL3799140	>	IC50	nM	200.0	CHEMBL4142	Homo sapiens	IC50	nM	200.0
	16580815	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4c(OC)cccc34)n[nH]2)cc(OC)c1		CHEMBL3797238	>	IC50	nM	200.0	CHEMBL4142	Homo sapiens	IC50	nM	200.0
	16580816	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	CCN1CCN(c2cccc3c(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)ncnc23)CC1		CHEMBL3798127	=	IC50	nM	13.8	CHEMBL4142	Homo sapiens	IC50	nM	13.8
	16580817	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN(C)CC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3799354	=	IC50	nM	0.7	CHEMBL4142	Homo sapiens	IC50	nM	0.7
	16580818	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN(C(C)C)CC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3799403	<	IC50	nM	0.1	CHEMBL4142	Homo sapiens	IC50	nM	0.1
	16580819	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN(C6CCC6)CC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3799426	<	IC50	nM	0.1	CHEMBL4142	Homo sapiens	IC50	nM	0.1
	16580820	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN6CCCCC6C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800526	=	IC50	nM	0.8	CHEMBL4142	Homo sapiens	IC50	nM	0.8
	16580821	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5C[C@H](C)N(C)[C@H](C)C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3798625	<	IC50	nM	0.1	CHEMBL4142	Homo sapiens	IC50	nM	0.1
	16580822	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCCN(C)CC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3797998	=	IC50	nM	10.8	CHEMBL4142	Homo sapiens	IC50	nM	10.8
	16580823	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCC(N(C)C)CC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3797845	=	IC50	nM	17.5	CHEMBL4142	Homo sapiens	IC50	nM	17.5
	16580824	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCC(N(C)C)C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3797594	=	IC50	nM	10.0	CHEMBL4142	Homo sapiens	IC50	nM	10.0
	16580825	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(C5CCN(C)CC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800072	=	IC50	nM	9.0	CHEMBL4142	Homo sapiens	IC50	nM	9.0
	16580826	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCOCC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3798342	=	IC50	nM	3.9	CHEMBL4142	Homo sapiens	IC50	nM	3.9
	16580827	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(NCCN5CCOCC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800352	=	IC50	nM	13.2	CHEMBL4142	Homo sapiens	IC50	nM	13.2
	16580828	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COCCNc1ccc2c(Nc3cc(CCc4cc(OC)cc(OC)c4)[nH]n3)ncnc2c1		CHEMBL3798924	=	IC50	nM	10.3	CHEMBL4142	Homo sapiens	IC50	nM	10.3
Not Determined	16580829	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COCCOc1ccc2ncnc(Nc3cc(CCc4cc(OC)cc(OC)c4)[nH]n3)c2c1		CHEMBL3797249		IC50			CHEMBL4142	Homo sapiens	IC50		
Not Determined	16580830	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	CCN1CCN(c2ccc3ncnc(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)c3c2)CC1		CHEMBL3799032		IC50			CHEMBL4142	Homo sapiens	IC50		
Not Determined	16580831	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COCCOc1cc2ncnc(Nc3cc(CCc4cc(OC)cc(OC)c4)[nH]n3)c2cc1OC		CHEMBL3799057		IC50			CHEMBL4142	Homo sapiens	IC50		
	16580832	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	3.6	CHEMBL4142	Homo sapiens	IC50	nM	3.6
	16580833	CHEMBL3803149	Inhibition of recombinant FGFR2 (unknown origin) at 10 nM using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN(S(=O)(=O)c6ccc(C)cc6)CC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800624	=	Inhibition	%	41.8	CHEMBL4142	Homo sapiens	INH	%	41.8
	16580834	CHEMBL3803149	Inhibition of recombinant FGFR2 (unknown origin) at 10 nM using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(OC)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800554	=	Inhibition	%	73.3	CHEMBL4142	Homo sapiens	INH	%	73.3
	16580835	CHEMBL3804514	Inhibition of FGFR2 (unknown origin) at 1 nM using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCCCC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800629	=	Inhibition	%	87.4	CHEMBL4142	Homo sapiens	INH	%	87.4
	16580836	CHEMBL3804514	Inhibition of FGFR2 (unknown origin) at 1 nM using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(Nc3ncnc4cc(OC)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800554	=	Inhibition	%	16.9	CHEMBL4142	Homo sapiens	INH	%	16.9
	16580837	CHEMBL3804515	Inhibition of FGFR2 in human SNU16 cells assessed as suppression of cell proliferation at 100 nM after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN(S(=O)(=O)c6ccc(C)cc6)CC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800624	=	Inhibition	%	21.2	CHEMBL4142	Homo sapiens	INH	%	21.2
	16580838	CHEMBL3804515	Inhibition of FGFR2 in human SNU16 cells assessed as suppression of cell proliferation at 100 nM after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCCCC5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800629	=	Inhibition	%	36.8	CHEMBL4142	Homo sapiens	INH	%	36.8
	16580839	CHEMBL3804515	Inhibition of FGFR2 in human SNU16 cells assessed as suppression of cell proliferation at 100 nM after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(OC)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800554	=	Inhibition	%	22.3	CHEMBL4142	Homo sapiens	INH	%	22.3
	16580840	CHEMBL3804515	Inhibition of FGFR2 in human SNU16 cells assessed as suppression of cell proliferation at 100 nM after 72 hrs by SRB/CCK-8 assay	B	CCN1CCN(c2cc3ncnc(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)c3cc2OC)CC1		CHEMBL3798842	=	Inhibition	%	9.7	CHEMBL4142	Homo sapiens	INH	%	9.7
	16580841	CHEMBL3804516	Inhibition of FGFR2 in human SNU16 cells assessed as suppression of cell proliferation at 4 nM after 72 hrs by SRB/CCK-8 assay	B	COCCN1CCN(c2ccc3c(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)ncnc3c2)CC1		CHEMBL3798940	=	Inhibition	%	49.6	CHEMBL4142	Homo sapiens	INH	%	49.6
	16580842	CHEMBL3804517	Inhibition of FGFR2 in human SNU16 cells assessed as suppression of cell proliferation at 20 nM after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCNC(C)(C)C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3798911	=	Inhibition	%	63.9	CHEMBL4142	Homo sapiens	INH	%	63.9
	16580843	CHEMBL3804517	Inhibition of FGFR2 in human SNU16 cells assessed as suppression of cell proliferation at 20 nM after 72 hrs by SRB/CCK-8 assay	B	COCCOc1ccc2c(Nc3cc(CCc4cc(OC)cc(OC)c4)[nH]n3)ncnc2c1		CHEMBL3798532	=	Inhibition	%	54.1	CHEMBL4142	Homo sapiens	INH	%	54.1
	16580869	CHEMBL3804529	Inhibition of FGFR2 in human KATO III cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(Nc3ncnc4cc(N5CCN6CCCCC6C5)ccc34)n[nH]2)cc(OC)c1		CHEMBL3800526	<	IC50	nM	0.4	CHEMBL4142	Homo sapiens	IC50	nM	0.4
	16580870	CHEMBL3804529	Inhibition of FGFR2 in human KATO III cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	20.2	CHEMBL4142	Homo sapiens	IC50	nM	20.2
	16580874	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCN1CCN(c2ccc3c(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)nc(Cl)nc3c2)CC1		CHEMBL3799093	=	IC50	nM	0.6	CHEMBL4142	Homo sapiens	IC50	nM	0.6
	16580875	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	CCN1CCN(c2ccc3c(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)nc(Cl)nc3c2)CC1		CHEMBL3799093	=	IC50	nM	108.2	CHEMBL4142	Homo sapiens	IC50	nM	108.2
	16580876	CHEMBL3803146	Inhibition of recombinant FGFR2 (unknown origin) using (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCN1CCN(c2ccc3c(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)nccc3c2)CC1		CHEMBL3800415	=	IC50	nM	1.2	CHEMBL4142	Homo sapiens	IC50	nM	1.2
	16580877	CHEMBL3803148	Inhibition of recombinant FGFR2 in human SNU16 cells assessed as suppression of cell proliferation after 72 hrs by SRB/CCK-8 assay	B	CCN1CCN(c2ccc3c(Nc4cc(CCc5cc(OC)cc(OC)c5)[nH]n4)nccc3c2)CC1		CHEMBL3800415	=	IC50	nM	1.8	CHEMBL4142	Homo sapiens	IC50	nM	1.8
	16588218	CHEMBL3806823	Inhibition of human recombinant FGFR2 expressed in sf21 cells using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP	B	CCN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805771	=	IC50	nM	930.0	CHEMBL4142	Homo sapiens	IC50	uM	0.93
	16588219	CHEMBL3806823	Inhibition of human recombinant FGFR2 expressed in sf21 cells using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP	B	CN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3F)cc2C(F)(F)F)CC1		CHEMBL3806189	=	IC50	nM	272.0	CHEMBL4142	Homo sapiens	IC50	uM	0.272
	16588279	CHEMBL3806848	Inhibition of human recombinant FGFR2 expressed in sf21 cells at 1 uM using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP	B	CCN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805771	>	Inhibition	%	99.0	CHEMBL4142	Homo sapiens	INH	%	99.0
	16588280	CHEMBL3806848	Inhibition of human recombinant FGFR2 expressed in sf21 cells at 1 uM using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP	B	CN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3F)cc2C(F)(F)F)CC1		CHEMBL3806189	>	Inhibition	%	99.0	CHEMBL4142	Homo sapiens	INH	%	99.0
	16593546	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(C)c4)ccc3C)cnc2[nH]1		CHEMBL3809587	=	Inhibition	%	6.0	CHEMBL4142	Homo sapiens	INH	%	6.0
	16593547	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(Br)c4)ccc3C)cnc2[nH]1		CHEMBL3809563	=	Inhibition	%	1.0	CHEMBL4142	Homo sapiens	INH	%	1.0
	16593548	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(C(C)C)c4)ccc3C)cnc2[nH]1		CHEMBL3808990	=	Inhibition	%	15.0	CHEMBL4142	Homo sapiens	INH	%	15.0
	16593549	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3810040	=	Inhibition	%	7.0	CHEMBL4142	Homo sapiens	INH	%	7.0
	16593550	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(OC(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809430	=	Inhibition	%	8.0	CHEMBL4142	Homo sapiens	INH	%	8.0
	16593551	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(C)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808834	=	Inhibition	%	10.0	CHEMBL4142	Homo sapiens	INH	%	10.0
	16593552	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(Cl)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808526	=	Inhibition	%	5.0	CHEMBL4142	Homo sapiens	INH	%	5.0
	16593553	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(O)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809790	=	Inhibition	%	3.0	CHEMBL4142	Homo sapiens	INH	%	3.0
	16593554	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(N(C)C)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809345	=	Inhibition	%	5.0	CHEMBL4142	Homo sapiens	INH	%	5.0
	16593555	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccccc4OC)ccc3C)cnc2[nH]1		CHEMBL3808521	=	Inhibition	%	12.0	CHEMBL4142	Homo sapiens	INH	%	12.0
	16593556	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)Cc4ccccc4Br)ccc3C)cnc2[nH]1		CHEMBL3808744	=	Inhibition	%	8.0	CHEMBL4142	Homo sapiens	INH	%	8.0
	16593557	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)Cc4cccc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809756	=	Inhibition	%	6.0	CHEMBL4142	Homo sapiens	INH	%	6.0
	16593558	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cncc(C)c4)ccc3C)cnc2[nH]1		CHEMBL3808753	=	Inhibition	%	19.0	CHEMBL4142	Homo sapiens	INH	%	19.0
	16593559	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccnc(C)c4)ccc3C)cnc2[nH]1		CHEMBL3809705	=	Inhibition	%	-6.0	CHEMBL4142	Homo sapiens	INH	%	-6.0
	16593560	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cncc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809290	=	Inhibition	%	13.0	CHEMBL4142	Homo sapiens	INH	%	13.0
	16593561	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccnc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809745	=	Inhibition	%	-2.0	CHEMBL4142	Homo sapiens	INH	%	-2.0
	16593562	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(C(F)(F)F)nc4)ccc3C)cnc2[nH]1		CHEMBL3808503	=	Inhibition	%	-7.0	CHEMBL4142	Homo sapiens	INH	%	-7.0
	16593563	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc5c(c4)OCC5)ccc3C)cnc2[nH]1		CHEMBL3808758	=	Inhibition	%	1.0	CHEMBL4142	Homo sapiens	INH	%	1.0
	16593564	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc5c(c4)OCO5)ccc3C)cnc2[nH]1		CHEMBL3809960	=	Inhibition	%	3.0	CHEMBL4142	Homo sapiens	INH	%	3.0
	16593565	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc5nn[nH]c5c4)ccc3C)cnc2[nH]1		CHEMBL3808725	=	Inhibition	%	4.0	CHEMBL4142	Homo sapiens	INH	%	4.0
	16593566	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc5[nH]ccc5c4)ccc3C)cnc2[nH]1		CHEMBL3810116	=	Inhibition	%	-4.0	CHEMBL4142	Homo sapiens	INH	%	-4.0
	16593567	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(-c5csc(C)n5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808982	=	Inhibition	%	-1.0	CHEMBL4142	Homo sapiens	INH	%	-1.0
	16593568	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc[nH]c4)ccc3C)cnc2[nH]1		CHEMBL3809817	=	Inhibition	%	4.0	CHEMBL4142	Homo sapiens	INH	%	4.0
	16593569	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808466	=	Inhibition	%	21.0	CHEMBL4142	Homo sapiens	INH	%	21.0
	16593570	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3810275	=	Inhibition	%	75.0	CHEMBL4142	Homo sapiens	INH	%	75.0
	16593571	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	=	Inhibition	%	52.0	CHEMBL4142	Homo sapiens	INH	%	52.0
	16593572	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808782	=	Inhibition	%	5.0	CHEMBL4142	Homo sapiens	INH	%	5.0
	16593573	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808527	=	Inhibition	%	58.0	CHEMBL4142	Homo sapiens	INH	%	58.0
	16593574	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809066	=	Inhibition	%	13.0	CHEMBL4142	Homo sapiens	INH	%	13.0
	16593575	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1CNc1cnc2[nH]c(C(=O)O)cc2c1		CHEMBL3808858	=	Inhibition	%	14.0	CHEMBL4142	Homo sapiens	INH	%	14.0
	16593576	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	Cc1ccc(NC(=O)c2ccc(CN3CCC(N(C)C)C3)c(C(F)(F)F)c2)cc1CNc1cnc2[nH]c(C(=O)O)cc2c1		CHEMBL3808943	=	Inhibition	%	71.0	CHEMBL4142	Homo sapiens	INH	%	71.0
	16593577	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	Cc1cn(-c2cc(C(=O)Nc3ccc(C)c(CNc4cnc5[nH]c(C(=O)O)cc5c4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL3809813	=	Inhibition	%	49.0	CHEMBL4142	Homo sapiens	INH	%	49.0
	16593578	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CNC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808739	=	Inhibition	%	23.0	CHEMBL4142	Homo sapiens	INH	%	23.0
	16593579	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CNC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809155	=	Inhibition	%	98.0	CHEMBL4142	Homo sapiens	INH	%	98.0
	16593580	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NC(=O)c3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3809041	=	Inhibition	%	8.0	CHEMBL4142	Homo sapiens	INH	%	8.0
	16593581	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NC(=O)c3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3810358	=	Inhibition	%	94.0	CHEMBL4142	Homo sapiens	INH	%	94.0
	16593582	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(CNc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808803	=	Inhibition	%	8.0	CHEMBL4142	Homo sapiens	INH	%	8.0
	16593583	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(COc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3809924	=	Inhibition	%	14.0	CHEMBL4142	Homo sapiens	INH	%	14.0
	16593584	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(COc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809233	=	Inhibition	%	69.0	CHEMBL4142	Homo sapiens	INH	%	69.0
	16593585	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(/C=C/c3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3809631	=	Inhibition	%	2.0	CHEMBL4142	Homo sapiens	INH	%	2.0
	16593586	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(/C=C/c3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808402	=	Inhibition	%	38.0	CHEMBL4142	Homo sapiens	INH	%	38.0
	16593587	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(CCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808428	=	Inhibition	%	35.0	CHEMBL4142	Homo sapiens	INH	%	35.0
	16593588	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(CCc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809462	=	Inhibition	%	101.0	CHEMBL4142	Homo sapiens	INH	%	101.0
	16593589	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CC(=O)c1cc2cc(CCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808681	=	Inhibition	%	18.0	CHEMBL4142	Homo sapiens	INH	%	18.0
	16593590	CHEMBL3811549	Inhibition of His-tagged human recombinant FGFR2 (403 to 822 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CC(=O)c1cc2cc(CCc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808421	=	Inhibition	%	81.0	CHEMBL4142	Homo sapiens	INH	%	81.0
	16594890	CHEMBL3812428	Inhibition of human FGFR2 (457 to 769 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	100.0	CHEMBL4142	Homo sapiens	Activity	%	100.0
	16614476	CHEMBL3816606	Inhibition of human FGFR2 at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-3.0	CHEMBL4142	Homo sapiens	INH	%	-3.0
	16618219	CHEMBL3816335	Inhibition of recombinant human His-tagged cytoplasmic FGFR2 (403 to 822 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
Not Active	16619805	CHEMBL3821677	Agonist activity at FGFR2 in human MDA231 cells assessed as increase in Akt phosphorylation at 15 uM after 10 mins by Western blot analysis	B	C=CCN(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(=O)N[C@@H](CS)C(N)=O)Cc1ccco1)C(=O)CN(Cc1ccco1)C(=O)CN(CC1CCCO1)C(=O)CN(C(=O)CNCCc1ccc(Cl)cc1)C1CCCC1		CHEMBL3818048		Activity			CHEMBL4142	Homo sapiens	Activity		
Active	16619806	CHEMBL3821677	Agonist activity at FGFR2 in human MDA231 cells assessed as increase in Akt phosphorylation at 15 uM after 10 mins by Western blot analysis	B	C=CCN(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(=O)N[C@@H](CS)C(N)=O)[C@H](C)c1ccccc1)C(=O)CN(Cc1ccco1)C(=O)CN(C(=O)CN(Cc1cccc(C(F)(F)F)c1)C(=O)CNCc1ccccc1)C1CCCC1		CHEMBL3817971		Activity			CHEMBL4142	Homo sapiens	Activity		
Active	16619807	CHEMBL3821677	Agonist activity at FGFR2 in human MDA231 cells assessed as increase in Akt phosphorylation at 15 uM after 10 mins by Western blot analysis	B	C=CCN(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(=O)N[C@@H](CS)C(N)=O)C(=O)CN(C(=O)CN(Cc1ccccc1)C(=O)CN(C(=O)CN(Cc1ccccc1)C(=O)CNC1CCCC1)C1CCCC1)[C@H](C)c1ccccc1		CHEMBL3819565		Activity			CHEMBL4142	Homo sapiens	Activity		
Active	16619808	CHEMBL3821677	Agonist activity at FGFR2 in human MDA231 cells assessed as increase in Akt phosphorylation at 15 uM after 10 mins by Western blot analysis	B	C=CCN(CC(=O)N(CC(=O)N(CCCN1CCCC1=O)CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(=O)N[C@@H](CS)C(N)=O)CC1CCCO1)C(=O)CN(C(=O)CN(Cc1cccc(C(F)(F)F)c1)C(=O)CNCCCN1CCCC1=O)[C@H](C)c1ccccc1		CHEMBL4299682		Activity			CHEMBL4142	Homo sapiens	Activity		
Not Active	16619809	CHEMBL3821678	Agonist activity at FGFR2 in human MDA231 cells assessed as increase in ERK phosphorylation at 15 uM after 10 mins by Western blot analysis	B	C=CCN(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(=O)N[C@@H](CS)C(N)=O)Cc1ccco1)C(=O)CN(Cc1ccco1)C(=O)CN(CC1CCCO1)C(=O)CN(C(=O)CNCCc1ccc(Cl)cc1)C1CCCC1		CHEMBL3818048		Activity			CHEMBL4142	Homo sapiens	Activity		
Active	16619810	CHEMBL3821678	Agonist activity at FGFR2 in human MDA231 cells assessed as increase in ERK phosphorylation at 15 uM after 10 mins by Western blot analysis	B	C=CCN(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(=O)N[C@@H](CS)C(N)=O)[C@H](C)c1ccccc1)C(=O)CN(Cc1ccco1)C(=O)CN(C(=O)CN(Cc1cccc(C(F)(F)F)c1)C(=O)CNCc1ccccc1)C1CCCC1		CHEMBL3817971		Activity			CHEMBL4142	Homo sapiens	Activity		
Active	16619811	CHEMBL3821678	Agonist activity at FGFR2 in human MDA231 cells assessed as increase in ERK phosphorylation at 15 uM after 10 mins by Western blot analysis	B	C=CCN(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(=O)N[C@@H](CS)C(N)=O)C(=O)CN(C(=O)CN(Cc1ccccc1)C(=O)CN(C(=O)CN(Cc1ccccc1)C(=O)CNC1CCCC1)C1CCCC1)[C@H](C)c1ccccc1		CHEMBL3819565		Activity			CHEMBL4142	Homo sapiens	Activity		
Active	16619812	CHEMBL3821678	Agonist activity at FGFR2 in human MDA231 cells assessed as increase in ERK phosphorylation at 15 uM after 10 mins by Western blot analysis	B	C=CCN(CC(=O)N(CC(=O)N(CCCN1CCCC1=O)CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(=O)N[C@@H](CS)C(N)=O)CC1CCCO1)C(=O)CN(C(=O)CN(Cc1cccc(C(F)(F)F)c1)C(=O)CNCCCN1CCCC1=O)[C@H](C)c1ccccc1		CHEMBL4299682		Activity			CHEMBL4142	Homo sapiens	Activity		
	16621499	CHEMBL3820492	Inhibition of FGFR2 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL4142	Homo sapiens	IC50	nM	30000.0
	16622214	CHEMBL3820492	Inhibition of FGFR2 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.8	CHEMBL4142	Homo sapiens	IC50	nM	5.8
	16653336	CHEMBL3830172	Inhibition of recombinant human FGFR2 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827178	=	IC50	nM	2.0	CHEMBL4142	Homo sapiens	IC50	nM	2.0
Active	16653365	CHEMBL3830189	Inhibition of FGFR2 phosphorylation in human SNU15 cells at 0.1 to 10 nM after 2 hrs by Western blot method	B	C[C@@H](Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827178		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	16653366	CHEMBL3830190	Inhibition of FGFR2 in human SNU15 cells assessed as reduction of PLCgamma phosphorylation at 0.1 to 10 nM after 2 hrs by Western blot method	B	C[C@@H](Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827178		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	16653367	CHEMBL3830191	Inhibition of FGFR2 in human SNU15 cells assessed as reduction of ERK phosphorylation at 0.1 to 10 nM after 2 hrs by Western blot method	B	C[C@@H](Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827178		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	16760031	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccccc6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681244	=	IC50	nM	41.0	CHEMBL4142	Homo sapiens	IC50	nM	41.0
	16760032	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1ccc2cc(C(=O)c3cnn(-c4ccc5nc(C)[nH]c5c4)c3N)[nH]c2c1		CHEMBL3895337	=	IC50	nM	10.0	CHEMBL4142	Homo sapiens	IC50	nM	10.0
	16760033	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(Br)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676329	=	IC50	nM	19.0	CHEMBL4142	Homo sapiens	IC50	nM	19.0
	16760034	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(S(C)(=O)=O)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681317	=	IC50	nM	21.0	CHEMBL4142	Homo sapiens	IC50	nM	21.0
	16760035	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCC(F)(F)CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681314	=	IC50	nM	9.4	CHEMBL4142	Homo sapiens	IC50	nM	9.4
	16760036	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681278	=	IC50	nM	3.6	CHEMBL4142	Homo sapiens	IC50	nM	3.6
	16760037	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5cc(CN6CCOCC6)ccc5[nH]4)c3N)cc2[nH]1		CHEMBL3891894	=	IC50	nM	5.2	CHEMBL4142	Homo sapiens	IC50	nM	5.2
	16760038	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2[nH]c(=O)[nH]c2c1		CHEMBL3952373	=	IC50	nM	870.0	CHEMBL4142	Homo sapiens	IC50	nM	870.0
	16760039	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1cc2cc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3959997	=	IC50	nM	32.0	CHEMBL4142	Homo sapiens	IC50	nM	32.0
	16760040	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2[nH]ccc2c1		CHEMBL3941474	=	IC50	nM	450.0	CHEMBL4142	Homo sapiens	IC50	nM	450.0
	16760041	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	CCc1nc2cc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681287	=	IC50	nM	65.0	CHEMBL4142	Homo sapiens	IC50	nM	65.0
	16760042	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	=	IC50	nM	7.6	CHEMBL4142	Homo sapiens	IC50	nM	7.6
	16760043	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2nc[nH]c2c1		CHEMBL3934547	=	IC50	nM	150.0	CHEMBL4142	Homo sapiens	IC50	nM	150.0
	16760044	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3cc(CN4CCOCC4)ccc3[nH]2)cnn1-c1cc(O)ccc1Cl		CHEMBL3984621	=	IC50	nM	4.2	CHEMBL4142	Homo sapiens	IC50	nM	4.2
	16760045	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccccc1Cl		CHEMBL3956001	=	IC50	nM	920.0	CHEMBL4142	Homo sapiens	IC50	nM	920.0
	16760046	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1cc(O)ccc1Cl		CHEMBL3976548	=	IC50	nM	30.0	CHEMBL4142	Homo sapiens	IC50	nM	30.0
	16760047	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2ccc3ncccc3c2)cnn1-c1cc(O)ccc1Cl		CHEMBL3947281	=	IC50	nM	230.0	CHEMBL4142	Homo sapiens	IC50	nM	230.0
	16760048	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Nc1c(C(=O)c2cc3ccccc3o2)cnn1-c1cc(O)ccc1Cl		CHEMBL3981956	=	IC50	nM	140.0	CHEMBL4142	Homo sapiens	IC50	nM	140.0
	16760049	CHEMBL3861871	Inhibition of human FGFR2 by time-resolved fluorescence or time-resolved fluorescence assay	B	Cc1cccc(C(=O)c2cnn(-c3cc(O)ccc3Cl)c2N)c1		CHEMBL3905685	=	IC50	nM	940.0	CHEMBL4142	Homo sapiens	IC50	nM	940.0
Active	16760157	CHEMBL3861901	Binding affinity to wild type human partial length FGFR2 expressed in bacterial system at 100 nM by KINOMEscan panel assay	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479		Activity			CHEMBL4142	Homo sapiens	Activity		
	16837390	CHEMBL3876048	Inhibition of human recombinant His-tagged FGFR2 cytoplasmic domain (403 to 822 residues) expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	591.0	CHEMBL4142	Homo sapiens	IC50	nM	591.0
	16872039	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3931533	=	IC50	nM	7.762	CHEMBL4142	Homo sapiens	pIC50		8.11
	16872040	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947740	=	IC50	nM	12.3	CHEMBL4142	Homo sapiens	pIC50		7.91
	16872041	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3963816	=	IC50	nM	19.5	CHEMBL4142	Homo sapiens	pIC50		7.71
	16872042	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3909951	=	IC50	nM	33.11	CHEMBL4142	Homo sapiens	pIC50		7.48
	16872043	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(C)C)c4)nc3c2)c1		CHEMBL3912630	=	IC50	nM	64.57	CHEMBL4142	Homo sapiens	pIC50		7.19
	16872044	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3933449	=	IC50	nM	11.75	CHEMBL4142	Homo sapiens	pIC50		7.93
	16872045	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898908	=	IC50	nM	3.467	CHEMBL4142	Homo sapiens	pIC50		8.46
	16872046	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3986163	=	IC50	nM	12.3	CHEMBL4142	Homo sapiens	pIC50		7.91
	16872047	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3898120	=	IC50	nM	4.786	CHEMBL4142	Homo sapiens	pIC50		8.32
	16872048	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3955288	=	IC50	nM	8.128	CHEMBL4142	Homo sapiens	pIC50		8.09
	16872049	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957914	=	IC50	nM	61.66	CHEMBL4142	Homo sapiens	pIC50		7.21
	16872050	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(OC(F)F)c4)cc3n2)cn1		CHEMBL3908978	=	IC50	nM	851.14	CHEMBL4142	Homo sapiens	pIC50		6.07
	16872051	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3906155	=	IC50	nM	9.333	CHEMBL4142	Homo sapiens	pIC50		8.03
	16872052	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940334	=	IC50	nM	13.18	CHEMBL4142	Homo sapiens	pIC50		7.88
	16872053	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958153	=	IC50	nM	3.89	CHEMBL4142	Homo sapiens	pIC50		8.41
	16872054	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)N(C)C)c4)nc3c2)c1		CHEMBL3925254	=	IC50	nM	7.079	CHEMBL4142	Homo sapiens	pIC50		8.15
	16872055	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3907600	=	IC50	nM	8.128	CHEMBL4142	Homo sapiens	pIC50		8.09
	16872056	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(S(C)(=O)=O)c4)nc3c2)c1		CHEMBL3954368	=	IC50	nM	100.0	CHEMBL4142	Homo sapiens	pIC50		7.0
	16872057	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)NCCN5CCCC5)c4)nc3c2)c1		CHEMBL3951714	=	IC50	nM	5.248	CHEMBL4142	Homo sapiens	pIC50		8.28
	16872058	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CC(C)Oc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3965364	=	IC50	nM	851.14	CHEMBL4142	Homo sapiens	pIC50		6.07
	16872059	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3969446	=	IC50	nM	3.802	CHEMBL4142	Homo sapiens	pIC50		8.42
	16872060	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951126	=	IC50	nM	3.236	CHEMBL4142	Homo sapiens	pIC50		8.49
	16872061	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(S(=O)(=O)N(C)C)c4)nc3c2)c1		CHEMBL3933015	=	IC50	nM	407.38	CHEMBL4142	Homo sapiens	pIC50		6.39
	16872062	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898881	=	IC50	nM	3.236	CHEMBL4142	Homo sapiens	pIC50		8.49
	16872063	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2OCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901644	=	IC50	nM	8.913	CHEMBL4142	Homo sapiens	pIC50		8.05
	16872064	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2C(=O)c3ccccc3C2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944665	=	IC50	nM	120.23	CHEMBL4142	Homo sapiens	pIC50		6.92
	16872065	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCN(c1cccc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3947293	=	IC50	nM	97.72	CHEMBL4142	Homo sapiens	pIC50		7.01
	16872066	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1OC		CHEMBL3947826	=	IC50	nM	239.88	CHEMBL4142	Homo sapiens	pIC50		6.62
	16872067	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCn1cc(-c2cnc3ccc(N(Cc4cc(C)no4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3985692	=	IC50	nM	3.631	CHEMBL4142	Homo sapiens	pIC50		8.44
	16872068	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947990	=	IC50	nM	14.79	CHEMBL4142	Homo sapiens	pIC50		7.83
	16872069	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCC5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3925306	=	IC50	nM	3.548	CHEMBL4142	Homo sapiens	pIC50		8.45
	16872070	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc(C)no2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3951245	=	IC50	nM	2.884	CHEMBL4142	Homo sapiens	pIC50		8.54
	16872071	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3948623	=	IC50	nM	8.511	CHEMBL4142	Homo sapiens	pIC50		8.07
	16872072	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3892018	=	IC50	nM	3.311	CHEMBL4142	Homo sapiens	pIC50		8.48
	16872073	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3987037	=	IC50	nM	3.981	CHEMBL4142	Homo sapiens	pIC50		8.4
	16872074	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3921313	=	IC50	nM	6.457	CHEMBL4142	Homo sapiens	pIC50		8.19
	16872075	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3927327	=	IC50	nM	7.244	CHEMBL4142	Homo sapiens	pIC50		8.14
	16872076	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCNCC5)c4)nc3c2)c1		CHEMBL3976280	=	IC50	nM	2.951	CHEMBL4142	Homo sapiens	pIC50		8.53
	16872077	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCNCCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3973820	=	IC50	nM	5.129	CHEMBL4142	Homo sapiens	pIC50		8.29
	16872078	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CCN(S(C)(=O)=O)CC5)c4)nc3c2)c1		CHEMBL3918011	=	IC50	nM	11.22	CHEMBL4142	Homo sapiens	pIC50		7.95
	16872079	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(C)(C)O)c4)nc3c2)c1		CHEMBL3915235	=	IC50	nM	15.14	CHEMBL4142	Homo sapiens	pIC50		7.82
	16872080	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(C#N)c4)cc3n2)cn1		CHEMBL3965673	<	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	pIC50		6.0
	16872081	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968094	=	IC50	nM	40.74	CHEMBL4142	Homo sapiens	pIC50		7.39
	16872082	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3918751	=	IC50	nM	2.692	CHEMBL4142	Homo sapiens	pIC50		8.57
	16872083	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN)c4)nc3c2)c1		CHEMBL3956164	=	IC50	nM	9.772	CHEMBL4142	Homo sapiens	pIC50		8.01
	16872084	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCCN5CCN(CCCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3908829	=	IC50	nM	6.457	CHEMBL4142	Homo sapiens	pIC50		8.19
	16872085	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5(O)CCNCC5)c4)nc3c2)c1		CHEMBL3911573	=	IC50	nM	2.951	CHEMBL4142	Homo sapiens	pIC50		8.53
	16872086	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(N)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969879	=	IC50	nM	46.77	CHEMBL4142	Homo sapiens	pIC50		7.33
	16872087	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(Cl)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972564	=	IC50	nM	102.33	CHEMBL4142	Homo sapiens	pIC50		6.99
	16872088	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.Cl		CHEMBL3927875	=	IC50	nM	2.692	CHEMBL4142	Homo sapiens	pIC50		8.57
	16872089	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(C#N)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930634	=	IC50	nM	109.65	CHEMBL4142	Homo sapiens	pIC50		6.96
	16872090	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3901627	=	IC50	nM	4.677	CHEMBL4142	Homo sapiens	pIC50		8.33
	16872091	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904329	=	IC50	nM	6.607	CHEMBL4142	Homo sapiens	pIC50		8.18
	16872092	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(CN)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969408	=	IC50	nM	1023.29	CHEMBL4142	Homo sapiens	pIC50		5.99
	16872093	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3985853	=	IC50	nM	3.162	CHEMBL4142	Homo sapiens	pIC50		8.5
	16872094	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5(OC)CCNCC5)c4)nc3c2)c1		CHEMBL3908326	=	IC50	nM	5.495	CHEMBL4142	Homo sapiens	pIC50		8.26
	16872095	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3918092	=	IC50	nM	1.66	CHEMBL4142	Homo sapiens	pIC50		8.78
	16872096	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(O)CN5CCCCC5)c4)nc3c2)c1		CHEMBL3964675	=	IC50	nM	3.02	CHEMBL4142	Homo sapiens	pIC50		8.52
	16872097	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955706	=	IC50	nM	2.455	CHEMBL4142	Homo sapiens	pIC50		8.61
	16872098	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCN(CCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3937533	=	IC50	nM	4.365	CHEMBL4142	Homo sapiens	pIC50		8.36
	16872099	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCN5CCCC5)c4)nc3c2)c1.Cl		CHEMBL3962814	=	IC50	nM	5.129	CHEMBL4142	Homo sapiens	pIC50		8.29
	16872100	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCOC)c4)nc3c2)c1		CHEMBL3931674	=	IC50	nM	9.55	CHEMBL4142	Homo sapiens	pIC50		8.02
	16872101	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)(C)C(=O)NCCO)c4)nc3c2)c1		CHEMBL3976219	=	IC50	nM	8.128	CHEMBL4142	Homo sapiens	pIC50		8.09
	16872102	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924872	=	IC50	nM	11.48	CHEMBL4142	Homo sapiens	pIC50		7.94
	16872103	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCOC)c4)nc3c2)c1		CHEMBL3908529	=	IC50	nM	4.898	CHEMBL4142	Homo sapiens	pIC50		8.31
	16872104	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCNC(=O)C(C)(C)n1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3962805	=	IC50	nM	8.318	CHEMBL4142	Homo sapiens	pIC50		8.08
	16872105	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)(C)C(=O)N5CCNCC5)c4)nc3c2)c1		CHEMBL3960128	=	IC50	nM	18.62	CHEMBL4142	Homo sapiens	pIC50		7.73
	16872106	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCO)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3909565	=	IC50	nM	3.311	CHEMBL4142	Homo sapiens	pIC50		8.48
	16872107	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC5CCN(C)CC5)c4)nc3c2)c1		CHEMBL3948321	=	IC50	nM	3.162	CHEMBL4142	Homo sapiens	pIC50		8.5
	16872108	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)NCCO)c4)nc3c2)c1		CHEMBL3985750	=	IC50	nM	4.677	CHEMBL4142	Homo sapiens	pIC50		8.33
	16872109	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCNC(=O)Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3983115	=	IC50	nM	6.457	CHEMBL4142	Homo sapiens	pIC50		8.19
	16872110	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3926311	=	IC50	nM	12.59	CHEMBL4142	Homo sapiens	pIC50		7.9
	16872111	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3926406	=	IC50	nM	3.02	CHEMBL4142	Homo sapiens	pIC50		8.52
	16872112	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc(C)on2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979490	=	IC50	nM	2.884	CHEMBL4142	Homo sapiens	pIC50		8.54
	16872113	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3898355	=	IC50	nM	3.388	CHEMBL4142	Homo sapiens	pIC50		8.47
	16872114	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940725	=	IC50	nM	26.3	CHEMBL4142	Homo sapiens	pIC50		7.58
	16872115	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943387	=	IC50	nM	3.802	CHEMBL4142	Homo sapiens	pIC50		8.42
	16872116	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)OCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3973531	=	IC50	nM	6.761	CHEMBL4142	Homo sapiens	pIC50		8.17
	16872117	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC#N)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3913757	=	IC50	nM	2.344	CHEMBL4142	Homo sapiens	pIC50		8.63
	16872118	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3961210	=	IC50	nM	3.09	CHEMBL4142	Homo sapiens	pIC50		8.51
	16872119	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNc1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936765	=	IC50	nM	275.42	CHEMBL4142	Homo sapiens	pIC50		6.56
	16872120	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951156	=	IC50	nM	11.75	CHEMBL4142	Homo sapiens	pIC50		7.93
	16872121	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H]2CCCN2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979170	=	IC50	nM	3.162	CHEMBL4142	Homo sapiens	pIC50		8.5
	16872122	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3969815	=	IC50	nM	2.455	CHEMBL4142	Homo sapiens	pIC50		8.61
	16872123	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3961872	=	IC50	nM	3.02	CHEMBL4142	Homo sapiens	pIC50		8.52
	16872124	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3985222	=	IC50	nM	1.778	CHEMBL4142	Homo sapiens	pIC50		8.75
	16872125	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC(=O)NC)c3)nc2c1		CHEMBL3935232	=	IC50	nM	2.57	CHEMBL4142	Homo sapiens	pIC50		8.59
	16872126	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC(=O)NC)c3)nc2c1.Cl		CHEMBL3909140	=	IC50	nM	2.399	CHEMBL4142	Homo sapiens	pIC50		8.62
	16872127	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974664	=	IC50	nM	6.457	CHEMBL4142	Homo sapiens	pIC50		8.19
	16872128	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCNS(=O)(=O)N(C)C)c4)nc3c2)c1		CHEMBL3972173	=	IC50	nM	19.95	CHEMBL4142	Homo sapiens	pIC50		7.7
	16872129	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNS(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919173	=	IC50	nM	1.82	CHEMBL4142	Homo sapiens	pIC50		8.74
	16872130	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC(C)C)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3956737	=	IC50	nM	363.08	CHEMBL4142	Homo sapiens	pIC50		6.44
	16872131	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCNS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3966022	=	IC50	nM	13.49	CHEMBL4142	Homo sapiens	pIC50		7.87
	16872132	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3968499	=	IC50	nM	1.778	CHEMBL4142	Homo sapiens	pIC50		8.75
	16872133	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912505	=	IC50	nM	81.28	CHEMBL4142	Homo sapiens	pIC50		7.09
	16872134	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCC2CC2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915158	=	IC50	nM	537.03	CHEMBL4142	Homo sapiens	pIC50		6.27
	16872135	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C=CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3950262	=	IC50	nM	13.8	CHEMBL4142	Homo sapiens	pIC50		7.86
	16872136	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3545376	=	IC50	nM	4.467	CHEMBL4142	Homo sapiens	pIC50		8.35
	16872137	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3949470	=	IC50	nM	3.467	CHEMBL4142	Homo sapiens	pIC50		8.46
	16872138	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3893008	=	IC50	nM	3.388	CHEMBL4142	Homo sapiens	pIC50		8.47
	16872139	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(O)CO)c4)nc3c2)c1		CHEMBL3889493	=	IC50	nM	10.23	CHEMBL4142	Homo sapiens	pIC50		7.99
	16872140	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCS(C)(=O)=O)c3)nc2c1		CHEMBL3984548	=	IC50	nM	4.571	CHEMBL4142	Homo sapiens	pIC50		8.34
	16872141	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cn[nH]c3)nc2c1		CHEMBL3920908	=	IC50	nM	5.012	CHEMBL4142	Homo sapiens	pIC50		8.3
	16872142	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3939278	=	IC50	nM	4.074	CHEMBL4142	Homo sapiens	pIC50		8.39
	16872143	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974693	=	IC50	nM	4.365	CHEMBL4142	Homo sapiens	pIC50		8.36
	16872144	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3972208	=	IC50	nM	223.87	CHEMBL4142	Homo sapiens	pIC50		6.65
	16872145	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.Cl		CHEMBL3935264	=	IC50	nM	2.818	CHEMBL4142	Homo sapiens	pIC50		8.55
	16872146	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3932577	=	IC50	nM	2.818	CHEMBL4142	Homo sapiens	pIC50		8.55
	16872147	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3950907	=	IC50	nM	7.244	CHEMBL4142	Homo sapiens	pIC50		8.14
	16872148	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C(C)=N\O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948270	=	IC50	nM	6.918	CHEMBL4142	Homo sapiens	pIC50		8.16
	16872149	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C(C)=N/O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955817	=	IC50	nM	7.413	CHEMBL4142	Homo sapiens	pIC50		8.13
	16872150	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3931421	=	IC50	nM	1.585	CHEMBL4142	Homo sapiens	pIC50		8.8
	16872151	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923296	=	IC50	nM	3.236	CHEMBL4142	Homo sapiens	pIC50		8.49
	16872152	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918495	=	IC50	nM	5.012	CHEMBL4142	Homo sapiens	pIC50		8.3
	16872153	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCOc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945369	=	IC50	nM	794.33	CHEMBL4142	Homo sapiens	pIC50		6.1
	16872154	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OCCO)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.Cl		CHEMBL3961267	=	IC50	nM	16.98	CHEMBL4142	Homo sapiens	pIC50		7.77
	16872155	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3984039	=	IC50	nM	1.95	CHEMBL4142	Homo sapiens	pIC50		8.71
	16872156	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3928627	=	IC50	nM	102.33	CHEMBL4142	Homo sapiens	pIC50		6.99
	16872157	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3908877	=	IC50	nM	3.981	CHEMBL4142	Homo sapiens	pIC50		8.4
	16872158	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3907488	=	IC50	nM	16.6	CHEMBL4142	Homo sapiens	pIC50		7.78
	16872159	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CC(=O)N5CCC(O)C5)c4)nc3c2)c1		CHEMBL3929803	=	IC50	nM	4.898	CHEMBL4142	Homo sapiens	pIC50		8.31
	16872160	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3970430	=	IC50	nM	2.455	CHEMBL4142	Homo sapiens	pIC50		8.61
	16872161	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969475	=	IC50	nM	2.951	CHEMBL4142	Homo sapiens	pIC50		8.53
	16872162	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cl.c1ccc(N(CC2CC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)cc1		CHEMBL3963728	=	IC50	nM	851.14	CHEMBL4142	Homo sapiens	pIC50		6.07
	16872163	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3944224	=	IC50	nM	4.467	CHEMBL4142	Homo sapiens	pIC50		8.35
	16872164	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3909318	=	IC50	nM	3.548	CHEMBL4142	Homo sapiens	pIC50		8.45
	16872165	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3982668	=	IC50	nM	5.888	CHEMBL4142	Homo sapiens	pIC50		8.23
	16872166	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C5CCCCO5)c4)nc3c2)c1		CHEMBL3980232	=	IC50	nM	4.571	CHEMBL4142	Homo sapiens	pIC50		8.34
	16872167	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3937633	=	IC50	nM	3.467	CHEMBL4142	Homo sapiens	pIC50		8.46
	16872168	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3955563	=	IC50	nM	1.905	CHEMBL4142	Homo sapiens	pIC50		8.72
	16872169	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3890607	=	IC50	nM	3.311	CHEMBL4142	Homo sapiens	pIC50		8.48
	16872170	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCO)c3)nc2c1		CHEMBL3893373	=	IC50	nM	15.14	CHEMBL4142	Homo sapiens	pIC50		7.82
	16872171	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCO)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3954298	=	IC50	nM	2.951	CHEMBL4142	Homo sapiens	pIC50		8.53
	16872172	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3900620	=	IC50	nM	6.166	CHEMBL4142	Homo sapiens	pIC50		8.21
	16872173	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3983996	=	IC50	nM	1.995	CHEMBL4142	Homo sapiens	pIC50		8.7
	16872174	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3935124	=	IC50	nM	14.45	CHEMBL4142	Homo sapiens	pIC50		7.84
	16872175	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3973645	=	IC50	nM	165.96	CHEMBL4142	Homo sapiens	pIC50		6.78
	16872176	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCF)c4)nc3c2)c1		CHEMBL3971073	=	IC50	nM	14.45	CHEMBL4142	Homo sapiens	pIC50		7.84
	16872177	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957264	=	IC50	nM	2.239	CHEMBL4142	Homo sapiens	pIC50		8.65
	16872178	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)NCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969096	=	IC50	nM	19.95	CHEMBL4142	Homo sapiens	pIC50		7.7
	16872179	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCc2nnn[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905212	=	IC50	nM	7.413	CHEMBL4142	Homo sapiens	pIC50		8.13
	16872180	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCO)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3897034	=	IC50	nM	8.913	CHEMBL4142	Homo sapiens	pIC50		8.05
	16872181	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(=O)C2CCCN(C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979885	=	IC50	nM	3.548	CHEMBL4142	Homo sapiens	pIC50		8.45
	16872182	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3982334	=	IC50	nM	77.62	CHEMBL4142	Homo sapiens	pIC50		7.11
	16872183	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919730	=	IC50	nM	1.95	CHEMBL4142	Homo sapiens	pIC50		8.71
	16872184	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC1CCN(CCCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)C1.Cl		CHEMBL3922453	=	IC50	nM	2.239	CHEMBL4142	Homo sapiens	pIC50		8.65
	16872185	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3959345	=	IC50	nM	2.138	CHEMBL4142	Homo sapiens	pIC50		8.67
	16872186	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2C(=O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3959201	=	IC50	nM	4.074	CHEMBL4142	Homo sapiens	pIC50		8.39
	16872187	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(Cl)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3915233	=	IC50	nM	63.1	CHEMBL4142	Homo sapiens	pIC50		7.2
	16872188	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCS(=O)(=O)NCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3912569	=	IC50	nM	1.445	CHEMBL4142	Homo sapiens	pIC50		8.84
	16872189	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccco2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975954	=	IC50	nM	3.162	CHEMBL4142	Homo sapiens	pIC50		8.5
	16872190	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3966748	=	IC50	nM	1.175	CHEMBL4142	Homo sapiens	pIC50		8.93
	16872191	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3929648	=	IC50	nM	6.457	CHEMBL4142	Homo sapiens	pIC50		8.19
	16872192	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCN)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926964	=	IC50	nM	398.11	CHEMBL4142	Homo sapiens	pIC50		6.4
	16872193	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1.Cl		CHEMBL3891619	=	IC50	nM	9.772	CHEMBL4142	Homo sapiens	pIC50		8.01
	16872194	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(CCO)c4)nc3c2)c1		CHEMBL3986661	=	IC50	nM	8.913	CHEMBL4142	Homo sapiens	pIC50		8.05
	16872195	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3943043	=	IC50	nM	2.512	CHEMBL4142	Homo sapiens	pIC50		8.6
	16872196	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOC(=O)C1CCN(CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)CC1		CHEMBL3904745	=	IC50	nM	3.388	CHEMBL4142	Homo sapiens	pIC50		8.47
	16872197	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(Cl)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3965614	=	IC50	nM	3.388	CHEMBL4142	Homo sapiens	pIC50		8.47
	16872198	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2nnc(N)o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968009	=	IC50	nM	3.09	CHEMBL4142	Homo sapiens	pIC50		8.51
	16872199	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C5CN(CCO)C5)c4)nc3c2)c1		CHEMBL3906122	=	IC50	nM	3.89	CHEMBL4142	Homo sapiens	pIC50		8.41
	16872200	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(Cc5ccc(Cl)s5)c4)nc3c2)c1		CHEMBL3900268	=	IC50	nM	281.84	CHEMBL4142	Homo sapiens	pIC50		6.55
	16872201	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3949132	=	IC50	nM	2.138	CHEMBL4142	Homo sapiens	pIC50		8.67
	16872202	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2C[C@H](C)O[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3951728	=	IC50	nM	12.3	CHEMBL4142	Homo sapiens	pIC50		7.91
	16872203	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(N(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962554	=	IC50	nM	5.129	CHEMBL4142	Homo sapiens	pIC50		8.29
	16872204	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H]2C[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3913970	=	IC50	nM	4.467	CHEMBL4142	Homo sapiens	pIC50		8.35
	16872205	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCN4CCCC4)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3972979	=	IC50	nM	2.884	CHEMBL4142	Homo sapiens	pIC50		8.54
	16872206	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3975447	=	IC50	nM	1.862	CHEMBL4142	Homo sapiens	pIC50		8.73
	16872207	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921243	=	IC50	nM	18.62	CHEMBL4142	Homo sapiens	pIC50		7.73
	16872208	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccs2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3911516	=	IC50	nM	8.318	CHEMBL4142	Homo sapiens	pIC50		8.08
	16872209	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccccc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958756	=	IC50	nM	61.66	CHEMBL4142	Homo sapiens	pIC50		7.21
	16872210	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956120	=	IC50	nM	8.71	CHEMBL4142	Homo sapiens	pIC50		8.06
	16872211	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cn1cc(-c2cnc3ccc(N(CC4CC4)c4ccccc4)cc3n2)cn1		CHEMBL3907551	=	IC50	nM	338.84	CHEMBL4142	Homo sapiens	pIC50		6.47
	16872212	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOC(=O)Cn1cc(CN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)nn1		CHEMBL3904777	=	IC50	nM	19.5	CHEMBL4142	Homo sapiens	pIC50		7.71
	16872213	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	OCCn1cc(-c2cnc3ccc(N(CC4CC4)c4ccccc4)cc3n2)cn1		CHEMBL3975007	=	IC50	nM	125.89	CHEMBL4142	Homo sapiens	pIC50		6.9
	16872214	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(OC)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972517	=	IC50	nM	4.266	CHEMBL4142	Homo sapiens	pIC50		8.37
	16872215	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928956	=	IC50	nM	97.72	CHEMBL4142	Homo sapiens	pIC50		7.01
	16872216	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccc(Cl)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919270	=	IC50	nM	26.92	CHEMBL4142	Homo sapiens	pIC50		7.57
	16872217	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941705	=	IC50	nM	21.38	CHEMBL4142	Homo sapiens	pIC50		7.67
	16872218	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(OC)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3982570	=	IC50	nM	38.02	CHEMBL4142	Homo sapiens	pIC50		7.42
	16872219	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2C(C)CCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920007	=	IC50	nM	5.495	CHEMBL4142	Homo sapiens	pIC50		8.26
	16872220	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3922698	=	IC50	nM	1.95	CHEMBL4142	Homo sapiens	pIC50		8.71
	16872221	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC(N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957533	=	IC50	nM	6.457	CHEMBL4142	Homo sapiens	pIC50		8.19
	16872222	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969373	=	IC50	nM	3.89	CHEMBL4142	Homo sapiens	pIC50		8.41
	16872223	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCCC2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3905485	=	IC50	nM	2.512	CHEMBL4142	Homo sapiens	pIC50		8.6
	16872224	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3904674	=	IC50	nM	1.38	CHEMBL4142	Homo sapiens	pIC50		8.86
	16872225	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945845	=	IC50	nM	10.23	CHEMBL4142	Homo sapiens	pIC50		7.99
	16872226	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CCS(C)(=O)=O)c4)nc3c2)c1		CHEMBL3951694	=	IC50	nM	1.995	CHEMBL4142	Homo sapiens	pIC50		8.7
	16872227	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3929914	=	IC50	nM	2.692	CHEMBL4142	Homo sapiens	pIC50		8.57
	16872228	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3CCCCC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3971277	=	IC50	nM	2.089	CHEMBL4142	Homo sapiens	pIC50		8.68
	16872229	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891892	=	IC50	nM	3.548	CHEMBL4142	Homo sapiens	pIC50		8.45
	16872230	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCO)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3985498	=	IC50	nM	10.72	CHEMBL4142	Homo sapiens	pIC50		7.97
	16872231	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912831	=	IC50	nM	2.57	CHEMBL4142	Homo sapiens	pIC50		8.59
	16872232	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(C(C)(C)O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3931154	=	IC50	nM	3.89	CHEMBL4142	Homo sapiens	pIC50		8.41
	16872233	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(N)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893718	=	IC50	nM	3.02	CHEMBL4142	Homo sapiens	pIC50		8.52
	16872234	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3909529	=	IC50	nM	2.042	CHEMBL4142	Homo sapiens	pIC50		8.69
	16872235	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973321	=	IC50	nM	2.884	CHEMBL4142	Homo sapiens	pIC50		8.54
	16872236	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936672	=	IC50	nM	1.38	CHEMBL4142	Homo sapiens	pIC50		8.86
	16872237	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960327	=	IC50	nM	5.248	CHEMBL4142	Homo sapiens	pIC50		8.28
	16872238	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956571	=	IC50	nM	16.98	CHEMBL4142	Homo sapiens	pIC50		7.77
	16872239	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CC(O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907314	=	IC50	nM	1.549	CHEMBL4142	Homo sapiens	pIC50		8.81
	16872240	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cn[nH]n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904561	=	IC50	nM	5.129	CHEMBL4142	Homo sapiens	pIC50		8.29
	16872241	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(C)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3945264	=	IC50	nM	3.548	CHEMBL4142	Homo sapiens	pIC50		8.45
	16872242	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3942594	=	IC50	nM	4.365	CHEMBL4142	Homo sapiens	pIC50		8.36
	16872243	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3915268	=	IC50	nM	2.57	CHEMBL4142	Homo sapiens	pIC50		8.59
	16872244	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925081	=	IC50	nM	4.266	CHEMBL4142	Homo sapiens	pIC50		8.37
	16872245	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])n1cc(-c2ccc3ncc(N(CCO)c4cc(OC)cc(OC)c4)nc3c2)cn1		CHEMBL3959849	=	IC50	nM	3.467	CHEMBL4142	Homo sapiens	pIC50		8.46
	16872246	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962549	=	IC50	nM	16.6	CHEMBL4142	Homo sapiens	pIC50		7.78
	16872247	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(OC)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3966626	=	IC50	nM	128.82	CHEMBL4142	Homo sapiens	pIC50		6.89
	16872248	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C=Cc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969192	=	IC50	nM	144.54	CHEMBL4142	Homo sapiens	pIC50		6.84
	16872249	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3975986	=	IC50	nM	181.97	CHEMBL4142	Homo sapiens	pIC50		6.74
	16872250	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3978453	=	IC50	nM	2.818	CHEMBL4142	Homo sapiens	pIC50		8.55
	16872251	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(C2OCCO2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979996	=	IC50	nM	177.83	CHEMBL4142	Homo sapiens	pIC50		6.75
	16872252	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2(OC)CCCNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3891474	=	IC50	nM	4.365	CHEMBL4142	Homo sapiens	pIC50		8.36
	16872253	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(Cl)c(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3892135	=	IC50	nM	3.162	CHEMBL4142	Homo sapiens	pIC50		8.5
	16872254	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3969824	=	IC50	nM	3.715	CHEMBL4142	Homo sapiens	pIC50		8.43
	16872255	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(C)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932285	=	IC50	nM	3.802	CHEMBL4142	Homo sapiens	pIC50		8.42
	16872256	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922586	=	IC50	nM	3.467	CHEMBL4142	Homo sapiens	pIC50		8.46
	16872257	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901682	=	IC50	nM	158.49	CHEMBL4142	Homo sapiens	pIC50		6.8
	16872258	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927733	=	IC50	nM	3.467	CHEMBL4142	Homo sapiens	pIC50		8.46
	16872259	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2ccc3ncc(N(CCN)c4cc(OC)cc(OC)c4)nc3c2)cn1		CHEMBL3976053	=	IC50	nM	3.981	CHEMBL4142	Homo sapiens	pIC50		8.4
	16872260	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973587	=	IC50	nM	10.0	CHEMBL4142	Homo sapiens	pIC50		8.0
	16872261	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936828	=	IC50	nM	4.898	CHEMBL4142	Homo sapiens	pIC50		8.31
	16872262	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(F)(F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934039	=	IC50	nM	14.79	CHEMBL4142	Homo sapiens	pIC50		7.83
	16872263	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cl.[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3981418	=	IC50	nM	2.818	CHEMBL4142	Homo sapiens	pIC50		8.55
	16872264	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cn1cc(-c2ccc3ncc(N(CCN)c4cc(F)cc(OCCO)c4)nc3c2)cn1		CHEMBL3972694	=	IC50	nM	16.6	CHEMBL4142	Homo sapiens	pIC50		7.78
	16872265	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cn(CCO)nn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921457	=	IC50	nM	3.981	CHEMBL4142	Homo sapiens	pIC50		8.4
	16872266	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3918739	=	IC50	nM	1.862	CHEMBL4142	Homo sapiens	pIC50		8.73
	16872267	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3968793	=	IC50	nM	12.88	CHEMBL4142	Homo sapiens	pIC50		7.89
	16872268	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3966305	=	IC50	nM	2.089	CHEMBL4142	Homo sapiens	pIC50		8.68
	16872269	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3935825	=	IC50	nM	2.818	CHEMBL4142	Homo sapiens	pIC50		8.55
	16872270	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3897101	=	IC50	nM	2.818	CHEMBL4142	Homo sapiens	pIC50		8.55
	16872271	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(OC)c(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3891115	=	IC50	nM	134.9	CHEMBL4142	Homo sapiens	pIC50		6.87
	16872272	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(OC)c(N(CCN)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3979662	=	IC50	nM	194.98	CHEMBL4142	Homo sapiens	pIC50		6.71
	16872273	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3983387	=	IC50	nM	4.786	CHEMBL4142	Homo sapiens	pIC50		8.32
	16872274	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3986068	=	IC50	nM	3.467	CHEMBL4142	Homo sapiens	pIC50		8.46
	16872275	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCN(CC)CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3916975	=	IC50	nM	3.02	CHEMBL4142	Homo sapiens	pIC50		8.52
	16872276	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])n1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3919709	=	IC50	nM	2.291	CHEMBL4142	Homo sapiens	pIC50		8.64
	16872277	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975791	=	IC50	nM	3.162	CHEMBL4142	Homo sapiens	pIC50		8.5
	16872278	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(=O)C2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3963323	=	IC50	nM	4.786	CHEMBL4142	Homo sapiens	pIC50		8.32
	16872279	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945373	=	IC50	nM	4.677	CHEMBL4142	Homo sapiens	pIC50		8.33
	16872280	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3933341	=	IC50	nM	3.89	CHEMBL4142	Homo sapiens	pIC50		8.41
	16872281	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCn1cc(-c2cnc3ccc(N(CCNC)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3893344	=	IC50	nM	3.548	CHEMBL4142	Homo sapiens	pIC50		8.45
	16872282	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3896052	=	IC50	nM	2.884	CHEMBL4142	Homo sapiens	pIC50		8.54
	16872283	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(C)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3947361	=	IC50	nM	6.457	CHEMBL4142	Homo sapiens	pIC50		8.19
	16872284	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(Cl)c(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3944739	=	IC50	nM	18.2	CHEMBL4142	Homo sapiens	pIC50		7.74
	16872285	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3909551	=	IC50	nM	3.388	CHEMBL4142	Homo sapiens	pIC50		8.47
	16872286	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(=O)C(C)(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899692	=	IC50	nM	3.715	CHEMBL4142	Homo sapiens	pIC50		8.43
	16872287	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(N3C[C@H](C)O[C@H](C)C3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3961400	=	IC50	nM	4.571	CHEMBL4142	Homo sapiens	pIC50		8.34
	16872288	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(N(C)C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3958708	=	IC50	nM	3.388	CHEMBL4142	Homo sapiens	pIC50		8.47
	16872289	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCN(C(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974080	=	IC50	nM	19.95	CHEMBL4142	Homo sapiens	pIC50		7.7
	16872290	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2csc(C)n2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1		CHEMBL3921197	=	IC50	nM	2.63	CHEMBL4142	Homo sapiens	pIC50		8.58
	16872291	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3898568	=	IC50	nM	4.898	CHEMBL4142	Homo sapiens	pIC50		8.31
	16872292	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3986036	=	IC50	nM	10.47	CHEMBL4142	Homo sapiens	pIC50		7.98
	16872293	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3914615	=	IC50	nM	10.47	CHEMBL4142	Homo sapiens	pIC50		7.98
	16872294	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(F)(F)C2)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3924422	=	IC50	nM	8.71	CHEMBL4142	Homo sapiens	pIC50		8.06
	16872295	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCF)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959193	=	IC50	nM	9.12	CHEMBL4142	Homo sapiens	pIC50		8.04
	16872296	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(C(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3936087	=	IC50	nM	2.239	CHEMBL4142	Homo sapiens	pIC50		8.65
	16872297	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCN(C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893070	=	IC50	nM	4.365	CHEMBL4142	Homo sapiens	pIC50		8.36
	16872298	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942763	=	IC50	nM	2.042	CHEMBL4142	Homo sapiens	pIC50		8.69
	16872299	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2nnc(NCCO)o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977904	=	IC50	nM	19.5	CHEMBL4142	Homo sapiens	pIC50		7.71
	16872300	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3906894	=	IC50	nM	1.738	CHEMBL4142	Homo sapiens	pIC50		8.76
	16872301	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3954671	=	IC50	nM	2.754	CHEMBL4142	Homo sapiens	pIC50		8.56
	16872302	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907195	=	IC50	nM	2.455	CHEMBL4142	Homo sapiens	pIC50		8.61
	16872303	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)s2)c2ccc3ncc(-c4cnn(CCN5CCNCC5)c4)nc3c2)c1.Cl		CHEMBL3904441	=	IC50	nM	3.311	CHEMBL4142	Homo sapiens	pIC50		8.48
	16872304	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCn1cc(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3945159	=	IC50	nM	1.778	CHEMBL4142	Homo sapiens	pIC50		8.75
	16872305	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3915021	=	IC50	nM	14.79	CHEMBL4142	Homo sapiens	pIC50		7.83
	16872306	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3892776	=	IC50	nM	2.512	CHEMBL4142	Homo sapiens	pIC50		8.6
	16872307	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3981077	=	IC50	nM	10.96	CHEMBL4142	Homo sapiens	pIC50		7.96
	16872308	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930819	=	IC50	nM	10.72	CHEMBL4142	Homo sapiens	pIC50		7.97
	16872309	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CC5CCOCC5)c4)nc3c2)c1.Cl		CHEMBL3926082	=	IC50	nM	2.188	CHEMBL4142	Homo sapiens	pIC50		8.66
	16872310	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC2CCN(C(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3970423	=	IC50	nM	2.291	CHEMBL4142	Homo sapiens	pIC50		8.64
	16872311	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3967739	=	IC50	nM	6.457	CHEMBL4142	Homo sapiens	pIC50		8.19
	16872312	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939764	=	IC50	nM	2.754	CHEMBL4142	Homo sapiens	pIC50		8.56
	16872313	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3900574	=	IC50	nM	3.236	CHEMBL4142	Homo sapiens	pIC50		8.49
	16872314	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCn1cc(-c2cnc3ccc(N(CCN)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3950089	=	IC50	nM	2.512	CHEMBL4142	Homo sapiens	pIC50		8.6
	16872315	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCCn1cc(-c2cnc3ccc(N(CCN)c4cc(OC)cc(OC)c4)cc3n2)cn1.Cl		CHEMBL3959573	=	IC50	nM	1.82	CHEMBL4142	Homo sapiens	pIC50		8.74
	16872316	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912310	=	IC50	nM	6.918	CHEMBL4142	Homo sapiens	pIC50		8.16
	16872317	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2C[C@H](C)O[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3914955	=	IC50	nM	3.548	CHEMBL4142	Homo sapiens	pIC50		8.45
	16872318	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973263	=	IC50	nM	4.365	CHEMBL4142	Homo sapiens	pIC50		8.36
	16872319	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975714	=	IC50	nM	13.18	CHEMBL4142	Homo sapiens	pIC50		7.88
	16872320	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC(S(C)(=O)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933707	=	IC50	nM	2.818	CHEMBL4142	Homo sapiens	pIC50		8.55
	16872321	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950069	=	IC50	nM	2.951	CHEMBL4142	Homo sapiens	pIC50		8.53
	16872322	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3979013	=	IC50	nM	2.291	CHEMBL4142	Homo sapiens	pIC50		8.64
	16872323	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCN2CCC(C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942811	=	IC50	nM	4.467	CHEMBL4142	Homo sapiens	pIC50		8.35
	16872324	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3940175	=	IC50	nM	3.388	CHEMBL4142	Homo sapiens	pIC50		8.47
	16872325	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)NCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968038	=	IC50	nM	12.88	CHEMBL4142	Homo sapiens	pIC50		7.89
	16872326	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3965640	=	IC50	nM	5.012	CHEMBL4142	Homo sapiens	pIC50		8.3
	16872327	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ncc[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928393	=	IC50	nM	1.905	CHEMBL4142	Homo sapiens	pIC50		8.72
	16872328	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918704	=	IC50	nM	5.012	CHEMBL4142	Homo sapiens	pIC50		8.3
	16872329	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3947189	=	IC50	nM	3.981	CHEMBL4142	Homo sapiens	pIC50		8.4
	16872330	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(F)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944438	=	IC50	nM	7.079	CHEMBL4142	Homo sapiens	pIC50		8.15
	16872331	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3965710	=	IC50	nM	1.778	CHEMBL4142	Homo sapiens	pIC50		8.75
	16872332	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3968124	=	IC50	nM	1.778	CHEMBL4142	Homo sapiens	pIC50		8.75
	16872333	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNS(=O)(=O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964574	=	IC50	nM	1.82	CHEMBL4142	Homo sapiens	pIC50		8.74
	16872334	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907047	=	IC50	nM	5.248	CHEMBL4142	Homo sapiens	pIC50		8.28
	16872335	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCN)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3942328	=	IC50	nM	1.514	CHEMBL4142	Homo sapiens	pIC50		8.82
	16872336	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951847	=	IC50	nM	4.677	CHEMBL4142	Homo sapiens	pIC50		8.33
	16872337	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC/C(CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)=N\O		CHEMBL3889890	=	IC50	nM	12.3	CHEMBL4142	Homo sapiens	pIC50		7.91
	16872338	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC/C(CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)=N/O		CHEMBL3892632	=	IC50	nM	6.026	CHEMBL4142	Homo sapiens	pIC50		8.22
	16872339	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2(C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930298	=	IC50	nM	12.88	CHEMBL4142	Homo sapiens	pIC50		7.89
	16872340	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(F)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3891464	=	IC50	nM	4.571	CHEMBL4142	Homo sapiens	pIC50		8.34
	16872341	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950910	=	IC50	nM	3.548	CHEMBL4142	Homo sapiens	pIC50		8.45
	16872342	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3901420	=	IC50	nM	7.413	CHEMBL4142	Homo sapiens	pIC50		8.13
	16872343	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3939200	=	IC50	nM	2.399	CHEMBL4142	Homo sapiens	pIC50		8.62
	16872344	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCC(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905866	=	IC50	nM	1.995	CHEMBL4142	Homo sapiens	pIC50		8.7
	16872345	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCOC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3903198	=	IC50	nM	2.754	CHEMBL4142	Homo sapiens	pIC50		8.56
	16872346	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2C[C@H](C)N[C@H](C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943933	=	IC50	nM	11.48	CHEMBL4142	Homo sapiens	pIC50		7.94
	16872347	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCS(=O)(=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925077	=	IC50	nM	6.026	CHEMBL4142	Homo sapiens	pIC50		8.22
	16872348	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OCCF)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3946674	=	IC50	nM	2.818	CHEMBL4142	Homo sapiens	pIC50		8.55
	16872349	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3931790	=	IC50	nM	2.399	CHEMBL4142	Homo sapiens	pIC50		8.62
	16872350	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CC3(COC3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934487	=	IC50	nM	3.388	CHEMBL4142	Homo sapiens	pIC50		8.47
	16872351	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3893786	=	IC50	nM	1.698	CHEMBL4142	Homo sapiens	pIC50		8.77
	16872352	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(CO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3917141	=	IC50	nM	3.09	CHEMBL4142	Homo sapiens	pIC50		8.51
	16872353	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975397	=	IC50	nM	3.802	CHEMBL4142	Homo sapiens	pIC50		8.42
	16872354	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)CNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891966	=	IC50	nM	4.074	CHEMBL4142	Homo sapiens	pIC50		8.39
	16872355	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3941700	=	IC50	nM	2.818	CHEMBL4142	Homo sapiens	pIC50		8.55
	16872356	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)CN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3980252	=	IC50	nM	3.715	CHEMBL4142	Homo sapiens	pIC50		8.43
	16872357	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)CN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3967065	=	IC50	nM	3.388	CHEMBL4142	Homo sapiens	pIC50		8.47
	16872358	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCn2ccnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969665	=	IC50	nM	5.495	CHEMBL4142	Homo sapiens	pIC50		8.26
	16872359	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCN(C(C)=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3981076	=	IC50	nM	6.166	CHEMBL4142	Homo sapiens	pIC50		8.21
	16872360	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCN(CCO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983529	=	IC50	nM	2.63	CHEMBL4142	Homo sapiens	pIC50		8.58
	16872361	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935457	=	IC50	nM	3.02	CHEMBL4142	Homo sapiens	pIC50		8.52
	16872362	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCN(C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905048	=	IC50	nM	2.57	CHEMBL4142	Homo sapiens	pIC50		8.59
	16872363	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CN(Cc3ccccc3)CCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3925610	=	IC50	nM	7.586	CHEMBL4142	Homo sapiens	pIC50		8.12
	16872364	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3928261	=	IC50	nM	2.138	CHEMBL4142	Homo sapiens	pIC50		8.67
	16872365	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C2COC2)c1		CHEMBL3985259	=	IC50	nM	5.129	CHEMBL4142	Homo sapiens	pIC50		8.29
	16872366	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2ccnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890205	=	IC50	nM	43.65	CHEMBL4142	Homo sapiens	pIC50		7.36
	16872367	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944610	=	IC50	nM	2.239	CHEMBL4142	Homo sapiens	pIC50		8.65
	16872368	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCN(CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)C(C)C.Cl		CHEMBL3944320	=	IC50	nM	2.188	CHEMBL4142	Homo sapiens	pIC50		8.66
	16872369	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3943860	=	IC50	nM	1.995	CHEMBL4142	Homo sapiens	pIC50		8.7
	16872370	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C(=N/O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941174	=	IC50	nM	46.77	CHEMBL4142	Homo sapiens	pIC50		7.33
	16872371	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C(=N\O)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982351	=	IC50	nM	7.244	CHEMBL4142	Homo sapiens	pIC50		8.14
	16872372	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C=CCN(c1cc(F)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3979908	=	IC50	nM	30.2	CHEMBL4142	Homo sapiens	pIC50		7.52
	16872373	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCNC(=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934355	=	IC50	nM	4.898	CHEMBL4142	Homo sapiens	pIC50		8.31
	16872374	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(CO)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919750	=	IC50	nM	7.943	CHEMBL4142	Homo sapiens	pIC50		8.1
	16872375	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(C(C)(C)O)CC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3969112	=	IC50	nM	2.754	CHEMBL4142	Homo sapiens	pIC50		8.56
	16872376	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)CN2CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966560	=	IC50	nM	5.248	CHEMBL4142	Homo sapiens	pIC50		8.28
	16872377	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC(C(N)=O)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3910444	=	IC50	nM	1.549	CHEMBL4142	Homo sapiens	pIC50		8.81
	16872378	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccc(Cl)nc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907642	=	IC50	nM	3.162	CHEMBL4142	Homo sapiens	pIC50		8.5
	16872379	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCC(CCO)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3973929	=	IC50	nM	2.884	CHEMBL4142	Homo sapiens	pIC50		8.54
	16872380	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCN(C(=O)C3CC3)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972617	=	IC50	nM	7.762	CHEMBL4142	Homo sapiens	pIC50		8.11
	16872381	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(F)CN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908149	=	IC50	nM	1.66	CHEMBL4142	Homo sapiens	pIC50		8.78
	16872382	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@@H](NC(C)C)CC2)c1		CHEMBL3911621	=	IC50	nM	1.778	CHEMBL4142	Homo sapiens	pIC50		8.75
	16872383	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H]2CC[C@H](NC(C)C)CC2)c1		CHEMBL3918800	=	IC50	nM	2.399	CHEMBL4142	Homo sapiens	pIC50		8.62
	16872384	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3902353	=	IC50	nM	2.512	CHEMBL4142	Homo sapiens	pIC50		8.6
	16872385	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3943080	=	IC50	nM	23.99	CHEMBL4142	Homo sapiens	pIC50		7.62
	16872386	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968139	=	IC50	nM	1.95	CHEMBL4142	Homo sapiens	pIC50		8.71
	16872387	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2=O)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3904294	=	IC50	nM	3.09	CHEMBL4142	Homo sapiens	pIC50		8.51
	16872388	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907063	=	IC50	nM	3.981	CHEMBL4142	Homo sapiens	pIC50		8.4
	16872389	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCC2CCCO2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3896623	=	IC50	nM	4.365	CHEMBL4142	Homo sapiens	pIC50		8.36
	16872390	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC[Si](C)(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3893950	=	IC50	nM	4.786	CHEMBL4142	Homo sapiens	pIC50		8.32
	16872391	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(F)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955745	=	IC50	nM	7.079	CHEMBL4142	Homo sapiens	pIC50		8.15
	16872392	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc(C)n(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953117	=	IC50	nM	7.586	CHEMBL4142	Homo sapiens	pIC50		8.12
	16872393	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951360	=	IC50	nM	2.754	CHEMBL4142	Homo sapiens	pIC50		8.56
	16872394	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@@H]2CC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3948744	=	IC50	nM	1.862	CHEMBL4142	Homo sapiens	pIC50		8.73
	16872395	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3941695	=	IC50	nM	2.455	CHEMBL4142	Homo sapiens	pIC50		8.61
	16872396	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)CNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3903811	=	IC50	nM	1.905	CHEMBL4142	Homo sapiens	pIC50		8.72
	16872397	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCOC2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930158	=	IC50	nM	12.59	CHEMBL4142	Homo sapiens	pIC50		7.9
	16872398	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2[C@@H](C)CC[C@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927451	=	IC50	nM	3.236	CHEMBL4142	Homo sapiens	pIC50		8.49
	16872399	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCn2c(C)cnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3911746	=	IC50	nM	4.467	CHEMBL4142	Homo sapiens	pIC50		8.35
	16872400	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC2CCN(S(N)(=O)=O)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3917295	=	IC50	nM	3.09	CHEMBL4142	Homo sapiens	pIC50		8.51
	16872401	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3902110	=	IC50	nM	5.248	CHEMBL4142	Homo sapiens	pIC50		8.28
	16872402	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cc(C)nc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3904814	=	IC50	nM	60.26	CHEMBL4142	Homo sapiens	pIC50		7.22
	16872403	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2c(C)cnc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3911948	=	IC50	nM	58.88	CHEMBL4142	Homo sapiens	pIC50		7.23
	16872404	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3928239	=	IC50	nM	2.239	CHEMBL4142	Homo sapiens	pIC50		8.65
	16872405	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979028	=	IC50	nM	15.49	CHEMBL4142	Homo sapiens	pIC50		7.81
	16872406	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cnccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890378	=	IC50	nM	2.138	CHEMBL4142	Homo sapiens	pIC50		8.67
	16872407	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC4CCOCC4)c3)nc2c1.Cl		CHEMBL3932363	=	IC50	nM	6.457	CHEMBL4142	Homo sapiens	pIC50		8.19
	16872408	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3934260	=	IC50	nM	1.122	CHEMBL4142	Homo sapiens	pIC50		8.95
	16872409	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2[C@@H](C)CC[C@@H]2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932756	=	IC50	nM	3.802	CHEMBL4142	Homo sapiens	pIC50		8.42
	16872410	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CC=CCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3919479	=	IC50	nM	1.259	CHEMBL4142	Homo sapiens	pIC50		8.9
	16872411	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCCC2(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3968818	=	IC50	nM	1.905	CHEMBL4142	Homo sapiens	pIC50		8.72
	16872412	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966316	=	IC50	nM	20.89	CHEMBL4142	Homo sapiens	pIC50		7.68
	16872413	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccc(Br)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3940940	=	IC50	nM	8.318	CHEMBL4142	Homo sapiens	pIC50		8.08
	16872414	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CCCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.O=C(O)C(=O)O		CHEMBL3982107	=	IC50	nM	4.365	CHEMBL4142	Homo sapiens	pIC50		8.36
	16872415	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CC=CCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3979670	=	IC50	nM	2.138	CHEMBL4142	Homo sapiens	pIC50		8.67
	16872416	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCN2CCC[C@H]2CC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3921476	=	IC50	nM	3.09	CHEMBL4142	Homo sapiens	pIC50		8.51
	16872417	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1.Cl		CHEMBL3911738	=	IC50	nM	6.31	CHEMBL4142	Homo sapiens	pIC50		8.2
	16872418	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(F)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3951090	=	IC50	nM	11.22	CHEMBL4142	Homo sapiens	pIC50		7.95
	16872419	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCCF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960571	=	IC50	nM	4.571	CHEMBL4142	Homo sapiens	pIC50		8.34
	16872420	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3949508	=	IC50	nM	12.3	CHEMBL4142	Homo sapiens	pIC50		7.91
	16872421	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901612	=	IC50	nM	3.162	CHEMBL4142	Homo sapiens	pIC50		8.5
	16872422	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(F)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3974206	=	IC50	nM	2.089	CHEMBL4142	Homo sapiens	pIC50		8.68
	16872423	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3911635	=	IC50	nM	2.818	CHEMBL4142	Homo sapiens	pIC50		8.55
	16872424	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3913322	=	IC50	nM	1.82	CHEMBL4142	Homo sapiens	pIC50		8.74
	16872425	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3916037	=	IC50	nM	3.981	CHEMBL4142	Homo sapiens	pIC50		8.4
	16872426	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2nccn2S(=O)(=O)N(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3889711	=	IC50	nM	6.166	CHEMBL4142	Homo sapiens	pIC50		8.21
	16872427	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2nccn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927585	=	IC50	nM	20.42	CHEMBL4142	Homo sapiens	pIC50		7.69
	16872428	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1		CHEMBL3984461	=	IC50	nM	5.012	CHEMBL4142	Homo sapiens	pIC50		8.3
	16872429	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCC(O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3981955	=	IC50	nM	5.012	CHEMBL4142	Homo sapiens	pIC50		8.3
	16872430	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(F)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3946103	=	IC50	nM	5.129	CHEMBL4142	Homo sapiens	pIC50		8.29
	16872431	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCn1ccnc1CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3936421	=	IC50	nM	28.18	CHEMBL4142	Homo sapiens	pIC50		7.55
	16872432	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2COCC(C)(C)N2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901119	=	IC50	nM	3.388	CHEMBL4142	Homo sapiens	pIC50		8.47
	16872433	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3898346	=	IC50	nM	7.586	CHEMBL4142	Homo sapiens	pIC50		8.12
	16872434	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895378	=	IC50	nM	7.413	CHEMBL4142	Homo sapiens	pIC50		8.13
	16872435	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@H](C)CN)c1		CHEMBL3957414	=	IC50	nM	6.166	CHEMBL4142	Homo sapiens	pIC50		8.21
	16872436	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)[C@@H](C)CN)c1		CHEMBL3922607	=	IC50	nM	7.586	CHEMBL4142	Homo sapiens	pIC50		8.12
	16872437	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2COCCN2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3919884	=	IC50	nM	4.266	CHEMBL4142	Homo sapiens	pIC50		8.37
	16872438	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CNC(C)C)c1		CHEMBL3942606	=	IC50	nM	4.898	CHEMBL4142	Homo sapiens	pIC50		8.31
	16872439	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3945277	=	IC50	nM	4.365	CHEMBL4142	Homo sapiens	pIC50		8.36
	16872440	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3897523	=	IC50	nM	8.128	CHEMBL4142	Homo sapiens	pIC50		8.09
	16872441	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3907327	=	IC50	nM	12.3	CHEMBL4142	Homo sapiens	pIC50		7.91
	16872442	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2(CNC(C)C)COC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956579	=	IC50	nM	10.0	CHEMBL4142	Homo sapiens	pIC50		8.0
	16872443	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)NCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959260	=	IC50	nM	11.48	CHEMBL4142	Homo sapiens	pIC50		7.94
	16872444	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CNCC(F)(F)F)c1		CHEMBL3890852	=	IC50	nM	9.333	CHEMBL4142	Homo sapiens	pIC50		8.03
	16872445	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893642	=	IC50	nM	5.248	CHEMBL4142	Homo sapiens	pIC50		8.28
	16872446	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950156	=	IC50	nM	8.511	CHEMBL4142	Homo sapiens	pIC50		8.07
	16872447	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3952866	=	IC50	nM	12.02	CHEMBL4142	Homo sapiens	pIC50		7.92
	16872448	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)Cn1cc(-c2cnc3ccc(N(CCCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cn1		CHEMBL3925114	=	IC50	nM	2.754	CHEMBL4142	Homo sapiens	pIC50		8.56
	16872449	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCCO)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1		CHEMBL3897155	=	IC50	nM	4.266	CHEMBL4142	Homo sapiens	pIC50		8.37
	16872450	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC(=O)NCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3937972	=	IC50	nM	2.042	CHEMBL4142	Homo sapiens	pIC50		8.69
	16872451	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3935177	=	IC50	nM	12.02	CHEMBL4142	Homo sapiens	pIC50		7.92
	16872452	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3962492	=	IC50	nM	3.89	CHEMBL4142	Homo sapiens	pIC50		8.41
	16872453	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3903823	=	IC50	nM	23.44	CHEMBL4142	Homo sapiens	pIC50		7.63
	16872454	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3964096	=	IC50	nM	2.455	CHEMBL4142	Homo sapiens	pIC50		8.61
	16872455	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(O)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.Cl		CHEMBL3948755	=	IC50	nM	14.13	CHEMBL4142	Homo sapiens	pIC50		7.85
	16872456	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.Cl		CHEMBL3892155	=	IC50	nM	5.754	CHEMBL4142	Homo sapiens	pIC50		8.24
	16872457	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3987162	=	IC50	nM	33.11	CHEMBL4142	Homo sapiens	pIC50		7.48
	16872458	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CCCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921441	=	IC50	nM	3.715	CHEMBL4142	Homo sapiens	pIC50		8.43
	16872459	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccc(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905015	=	IC50	nM	38.9	CHEMBL4142	Homo sapiens	pIC50		7.41
	16872460	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1.O=C(O)C(F)(F)F		CHEMBL3921817	=	IC50	nM	5.754	CHEMBL4142	Homo sapiens	pIC50		8.24
	16872461	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927219	=	IC50	nM	9.772	CHEMBL4142	Homo sapiens	pIC50		8.01
	16872462	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN(CCCN)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3902434	=	IC50	nM	5.012	CHEMBL4142	Homo sapiens	pIC50		8.3
	16872463	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927158	=	IC50	nM	41.69	CHEMBL4142	Homo sapiens	pIC50		7.38
	16872464	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3985182	=	IC50	nM	12.88	CHEMBL4142	Homo sapiens	pIC50		7.89
	16872465	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3933442	=	IC50	nM	7.244	CHEMBL4142	Homo sapiens	pIC50		8.14
	16872466	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934080	=	IC50	nM	4.365	CHEMBL4142	Homo sapiens	pIC50		8.36
	16872467	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNCCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895443	=	IC50	nM	8.128	CHEMBL4142	Homo sapiens	pIC50		8.09
	16872468	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cn1cc(-c2cnc3ccc(N(CCCNCC(F)(F)F)c4cc(Cl)cc(Cl)c4)cc3n2)cn1		CHEMBL3904736	=	IC50	nM	436.52	CHEMBL4142	Homo sapiens	pIC50		6.36
	16872469	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCN(CC)Cc1cc(OC)cc(N(CCCN2CCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3914473	=	IC50	nM	102.33	CHEMBL4142	Homo sapiens	pIC50		6.99
	16872470	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CC(C)NCCN(c1cc(Cl)cc(Cl)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3898926	=	IC50	nM	12.02	CHEMBL4142	Homo sapiens	pIC50		7.92
	16872471	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952277	=	IC50	nM	6.31	CHEMBL4142	Homo sapiens	pIC50		8.2
	16872472	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2C[C@@H]3C[C@H]2CN3C(=O)OC(C)(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926245	=	IC50	nM	31.62	CHEMBL4142	Homo sapiens	pIC50		7.5
	16872473	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(Cl)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1Cl		CHEMBL3978617	=	IC50	nM	6.607	CHEMBL4142	Homo sapiens	pIC50		8.18
	16872474	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4C)nc3c2)c1		CHEMBL3966071	=	IC50	nM	4.677	CHEMBL4142	Homo sapiens	pIC50		8.33
	16872475	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(C)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966200	=	IC50	nM	3.802	CHEMBL4142	Homo sapiens	pIC50		8.42
	16872476	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2C[C@@H]3C[C@H]2CN3)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3940672	=	IC50	nM	6.026	CHEMBL4142	Homo sapiens	pIC50		8.22
	16872477	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(Cl)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1Cl		CHEMBL3979328	=	IC50	nM	9.12	CHEMBL4142	Homo sapiens	pIC50		8.04
	16872478	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(=O)C(F)(F)F)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.O=C(O)C(F)(F)F		CHEMBL3983918	=	IC50	nM	2.951	CHEMBL4142	Homo sapiens	pIC50		8.53
	16872479	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975193	=	IC50	nM	15.85	CHEMBL4142	Homo sapiens	pIC50		7.8
	16872480	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC(C)(C)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924172	=	IC50	nM	4.169	CHEMBL4142	Homo sapiens	pIC50		8.38
	16872481	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNC(C)(C)CF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921469	=	IC50	nM	3.388	CHEMBL4142	Homo sapiens	pIC50		8.47
	16872482	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(F)c1F.Cl		CHEMBL3900551	=	IC50	nM	436.52	CHEMBL4142	Homo sapiens	pIC50		6.36
	16872483	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3897783	=	IC50	nM	6.31	CHEMBL4142	Homo sapiens	pIC50		8.2
	16872484	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCF)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891525	=	IC50	nM	6.607	CHEMBL4142	Homo sapiens	pIC50		8.18
	16872485	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCO)nc3c2)c1		CHEMBL3935838	=	IC50	nM	17.78	CHEMBL4142	Homo sapiens	pIC50		7.75
	16872486	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCN(C(=O)OC(C)(C)C)CC5)c4)nc3c2)c1		CHEMBL3977010	=	IC50	nM	7.586	CHEMBL4142	Homo sapiens	pIC50		8.12
	16872487	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C5CCN(C)CC5)c4)nc3c2)c1		CHEMBL3967761	=	IC50	nM	6.457	CHEMBL4142	Homo sapiens	pIC50		8.19
	16872488	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893556	=	IC50	nM	48.98	CHEMBL4142	Homo sapiens	pIC50		7.31
	16872489	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C(=O)OC(C)(C)C)CC5)c4)nc3c2)c1		CHEMBL3896249	=	IC50	nM	3.715	CHEMBL4142	Homo sapiens	pIC50		8.43
	16872490	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C#N)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952789	=	IC50	nM	12.3	CHEMBL4142	Homo sapiens	pIC50		7.91
	16872491	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(C#N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3955385	=	IC50	nM	33.88	CHEMBL4142	Homo sapiens	pIC50		7.47
	16872492	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccs2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977708	=	IC50	nM	10.23	CHEMBL4142	Homo sapiens	pIC50		7.99
	16872493	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCNCC5)c4)nc3c2)c1		CHEMBL3980069	=	IC50	nM	2.884	CHEMBL4142	Homo sapiens	pIC50		8.54
	16872494	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])O)c1		CHEMBL3946938	=	IC50	nM	5.623	CHEMBL4142	Homo sapiens	pIC50		8.25
	16872495	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941337	=	IC50	nM	407.38	CHEMBL4142	Homo sapiens	pIC50		6.39
	16872496	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983585	=	IC50	nM	309.03	CHEMBL4142	Homo sapiens	pIC50		6.51
	16872497	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])NC(C)C)c1		CHEMBL3918638	=	IC50	nM	1.738	CHEMBL4142	Homo sapiens	pIC50		8.76
	16872498	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCc2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920637	=	IC50	nM	7.244	CHEMBL4142	Homo sapiens	pIC50		8.14
	16872499	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C5CCN(C)CC5)c4)nc3c2)c1.Cl		CHEMBL3917908	=	IC50	nM	2.951	CHEMBL4142	Homo sapiens	pIC50		8.53
	16872500	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3980712	=	IC50	nM	398.11	CHEMBL4142	Homo sapiens	pIC50		6.4
	16872501	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CCCO)nc3c2)c1		CHEMBL3978349	=	IC50	nM	10.47	CHEMBL4142	Homo sapiens	pIC50		7.98
	16872502	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(CO)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3976721	=	IC50	nM	46.77	CHEMBL4142	Homo sapiens	pIC50		7.33
	16872503	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974273	=	IC50	nM	42.66	CHEMBL4142	Homo sapiens	pIC50		7.37
	16872504	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCO)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1		CHEMBL3898255	=	IC50	nM	44.67	CHEMBL4142	Homo sapiens	pIC50		7.35
	16872505	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1		CHEMBL3927794	=	IC50	nM	77.62	CHEMBL4142	Homo sapiens	pIC50		7.11
	16872506	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953833	=	IC50	nM	7.413	CHEMBL4142	Homo sapiens	pIC50		8.13
	16872507	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964043	=	IC50	nM	5.495	CHEMBL4142	Homo sapiens	pIC50		8.26
	16872508	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccnc(C#N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3945658	=	IC50	nM	229.09	CHEMBL4142	Homo sapiens	pIC50		6.64
	16872509	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(C)cn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3948306	=	IC50	nM	323.59	CHEMBL4142	Homo sapiens	pIC50		6.49
	16872510	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984035	=	IC50	nM	7.079	CHEMBL4142	Homo sapiens	pIC50		8.15
	16872511	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCc1c(-c2cnc3ccc(N(CCO)c4cc(OC)cc(OC)c4)cc3n2)cnn1C		CHEMBL3986725	=	IC50	nM	16.98	CHEMBL4142	Homo sapiens	pIC50		7.77
	16872512	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc2c1OCO2		CHEMBL3896142	=	IC50	nM	2.884	CHEMBL4142	Homo sapiens	pIC50		8.54
	16872513	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN(C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908707	=	IC50	nM	3.89	CHEMBL4142	Homo sapiens	pIC50		8.41
	16872514	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3941227	=	IC50	nM	7.244	CHEMBL4142	Homo sapiens	pIC50		8.14
	16872515	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(CC#Cc2ccncc2)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3943917	=	IC50	nM	9.55	CHEMBL4142	Homo sapiens	pIC50		8.02
	16872516	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccncc2C#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979972	=	IC50	nM	8.511	CHEMBL4142	Homo sapiens	pIC50		8.07
	16872517	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(N)nc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982399	=	IC50	nM	4.467	CHEMBL4142	Homo sapiens	pIC50		8.35
	16872518	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4c(C)nn(C)c4C)nc3c2)c1.Cl		CHEMBL3932817	=	IC50	nM	10.72	CHEMBL4142	Homo sapiens	pIC50		7.97
	16872519	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCc1c(-c2cnc3ccc(N(CCNCC(F)(F)F)c4cc(OC)cc(OC)c4)cc3n2)cnn1C		CHEMBL3930088	=	IC50	nM	17.78	CHEMBL4142	Homo sapiens	pIC50		7.75
	16872520	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972445	=	IC50	nM	288.4	CHEMBL4142	Homo sapiens	pIC50		6.54
	16872521	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCO)c2ccc3ncc(-c4cnn(C)c4CN(C)C)nc3c2)c1		CHEMBL3969747	=	IC50	nM	72.44	CHEMBL4142	Homo sapiens	pIC50		7.14
	16872522	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCc1c(-c2cnc3ccc(N(CCNC(C)C)c4cc(OC)cc(OC)c4)cc3n2)cnn1C.Cl		CHEMBL3918426	=	IC50	nM	3.388	CHEMBL4142	Homo sapiens	pIC50		8.47
	16872523	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3906938	=	IC50	nM	9.772	CHEMBL4142	Homo sapiens	pIC50		8.01
	16872524	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)nc1		CHEMBL3956028	=	IC50	nM	229.09	CHEMBL4142	Homo sapiens	pIC50		6.64
	16872525	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(Cl)nc(N)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964762	=	IC50	nM	16.22	CHEMBL4142	Homo sapiens	pIC50		7.79
	16872526	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cn(C)nc4C(F)(F)F)nc3c2)c1.Cl		CHEMBL3948234	=	IC50	nM	6.918	CHEMBL4142	Homo sapiens	pIC50		8.16
	16872527	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4CO)nc3c2)c1		CHEMBL3932022	=	IC50	nM	3.311	CHEMBL4142	Homo sapiens	pIC50		8.48
	16872528	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN5CCN(CCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3957473	=	IC50	nM	5.129	CHEMBL4142	Homo sapiens	pIC50		8.29
	16872529	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3926556	=	IC50	nM	3.467	CHEMBL4142	Homo sapiens	pIC50		8.46
	16872530	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl		CHEMBL3965482	=	IC50	nM	5.37	CHEMBL4142	Homo sapiens	pIC50		8.27
	16872531	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN(Cc2ccc(N)cc2)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950496	=	IC50	nM	5.888	CHEMBL4142	Homo sapiens	pIC50		8.23
	16872532	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(N)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3902961	=	IC50	nM	2.951	CHEMBL4142	Homo sapiens	pIC50		8.53
	16872533	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3o2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3905633	=	IC50	nM	12.88	CHEMBL4142	Homo sapiens	pIC50		7.89
	16872534	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4CN(C)C)nc3c2)c1		CHEMBL3937212	=	IC50	nM	15.14	CHEMBL4142	Homo sapiens	pIC50		7.82
	16872535	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])NCC(F)(F)F)c1		CHEMBL3966929	=	IC50	nM	7.586	CHEMBL4142	Homo sapiens	pIC50		8.12
	16872536	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CNC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922100	=	IC50	nM	3.715	CHEMBL4142	Homo sapiens	pIC50		8.43
	16872537	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])C([2H])([2H])O)c1		CHEMBL3906284	=	IC50	nM	3.388	CHEMBL4142	Homo sapiens	pIC50		8.47
	16872538	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2OC)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3921787	=	IC50	nM	43.65	CHEMBL4142	Homo sapiens	pIC50		7.36
	16872539	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](OC(C)=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3969405	=	IC50	nM	36.31	CHEMBL4142	Homo sapiens	pIC50		7.44
	16872540	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](OC(C)=O)C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964589	=	IC50	nM	58.88	CHEMBL4142	Homo sapiens	pIC50		7.23
	16872541	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@H](CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)OC(C)=O		CHEMBL3972998	=	IC50	nM	47.86	CHEMBL4142	Homo sapiens	pIC50		7.32
	16872542	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@@H](CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1)OC(C)=O		CHEMBL3908068	=	IC50	nM	25.7	CHEMBL4142	Homo sapiens	pIC50		7.59
	16872543	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3905276	=	IC50	nM	5.888	CHEMBL4142	Homo sapiens	pIC50		8.23
	16872544	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(C(C)C)c4)nc3c2)c1		CHEMBL3969414	=	IC50	nM	7.762	CHEMBL4142	Homo sapiens	pIC50		8.11
	16872545	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCCN5CCN(CCCO)CC5)c4)nc3c2)c1.Cl		CHEMBL3951171	=	IC50	nM	4.169	CHEMBL4142	Homo sapiens	pIC50		8.38
	16872546	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3983694	=	IC50	nM	15.14	CHEMBL4142	Homo sapiens	pIC50		7.82
	16872547	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(Cl)c(OC)cc(OC)c1Cl		CHEMBL3981207	=	IC50	nM	21.38	CHEMBL4142	Homo sapiens	pIC50		7.67
	16872548	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cnc(N)cn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3986631	=	IC50	nM	70.79	CHEMBL4142	Homo sapiens	pIC50		7.15
	16872549	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccnc1C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(Cl)c(OC)cc(OC)c1Cl		CHEMBL3969667	=	IC50	nM	12.3	CHEMBL4142	Homo sapiens	pIC50		7.91
	16872550	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3933908	=	IC50	nM	16.22	CHEMBL4142	Homo sapiens	pIC50		7.79
	16872551	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCc1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3936673	=	IC50	nM	43.65	CHEMBL4142	Homo sapiens	pIC50		7.36
	16872552	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(CO)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3980417	=	IC50	nM	4.571	CHEMBL4142	Homo sapiens	pIC50		8.34
	16872553	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(C(N)=O)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3921190	=	IC50	nM	5.888	CHEMBL4142	Homo sapiens	pIC50		8.23
	16872554	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2CCN(C(=O)OC(C)(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3920274	=	IC50	nM	257.04	CHEMBL4142	Homo sapiens	pIC50		6.59
	16872555	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccnc(C#CCN(c2ccc3ncc(-c4cnn(C)c4)nc3c2)c2c(Cl)c(OC)cc(OC)c2Cl)n1		CHEMBL3953771	=	IC50	nM	16.98	CHEMBL4142	Homo sapiens	pIC50		7.77
	16872556	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cnccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950292	=	IC50	nM	20.42	CHEMBL4142	Homo sapiens	pIC50		7.69
	16872557	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)ncn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3959787	=	IC50	nM	89.13	CHEMBL4142	Homo sapiens	pIC50		7.05
	16872558	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2CCNCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3986861	=	IC50	nM	5.754	CHEMBL4142	Homo sapiens	pIC50		8.24
	16872559	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCOCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891816	=	IC50	nM	14.13	CHEMBL4142	Homo sapiens	pIC50		7.85
	16872560	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3927140	=	IC50	nM	7.079	CHEMBL4142	Homo sapiens	pIC50		8.15
	16872561	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccnc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3929849	=	IC50	nM	89.13	CHEMBL4142	Homo sapiens	pIC50		7.05
	16872562	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCOC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966941	=	IC50	nM	21.88	CHEMBL4142	Homo sapiens	pIC50		7.66
	16872563	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CC4CCOCC4)c3)nc2c1		CHEMBL3939018	=	IC50	nM	7.762	CHEMBL4142	Homo sapiens	pIC50		8.11
	16872564	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912757	=	IC50	nM	20.42	CHEMBL4142	Homo sapiens	pIC50		7.69
	16872565	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C/c2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3915450	=	IC50	nM	25.12	CHEMBL4142	Homo sapiens	pIC50		7.6
	16872566	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3950510	=	IC50	nM	2.951	CHEMBL4142	Homo sapiens	pIC50		8.53
	16872567	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@@H](O)C(F)(F)F)c2ccc3ncc(-c4cnn(CCCN)c4)nc3c2)c1		CHEMBL3964701	=	IC50	nM	2.512	CHEMBL4142	Homo sapiens	pIC50		8.6
	16872568	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC(=O)N(C)OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3956493	=	IC50	nM	4.266	CHEMBL4142	Homo sapiens	pIC50		8.37
	16872569	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccnc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3964931	=	IC50	nM	15.85	CHEMBL4142	Homo sapiens	pIC50		7.8
	16872570	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2nc(OC)cc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918956	=	IC50	nM	28.18	CHEMBL4142	Homo sapiens	pIC50		7.55
	16872571	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.Cl		CHEMBL3916200	=	IC50	nM	3.631	CHEMBL4142	Homo sapiens	pIC50		8.44
	16872572	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC[C@@H](O)CN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(CCCN)c3)nc2c1.Cl		CHEMBL3942506	=	IC50	nM	7.244	CHEMBL4142	Homo sapiens	pIC50		8.14
	16872573	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C\c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939852	=	IC50	nM	39.81	CHEMBL4142	Homo sapiens	pIC50		7.4
	16872574	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C/c2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3904470	=	IC50	nM	46.77	CHEMBL4142	Homo sapiens	pIC50		7.33
	16872575	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOc1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3894754	=	IC50	nM	9.55	CHEMBL4142	Homo sapiens	pIC50		8.02
	16872576	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC(=O)c1cccnc1C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3963296	=	IC50	nM	23.44	CHEMBL4142	Homo sapiens	pIC50		7.63
	16872577	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)(C)C#Cc2nccc(OC)n2)c1		CHEMBL3890187	=	IC50	nM	177.83	CHEMBL4142	Homo sapiens	pIC50		6.75
	16872578	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C/c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3924891	=	IC50	nM	138.04	CHEMBL4142	Homo sapiens	pIC50		6.86
	16872579	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C\c2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3923190	=	IC50	nM	93.33	CHEMBL4142	Homo sapiens	pIC50		7.03
	16872580	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNc1cccnc1C#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1		CHEMBL3978313	=	IC50	nM	32.36	CHEMBL4142	Homo sapiens	pIC50		7.49
	16872581	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3889604	=	IC50	nM	21.38	CHEMBL4142	Homo sapiens	pIC50		7.67
	16872582	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939332	=	IC50	nM	10.72	CHEMBL4142	Homo sapiens	pIC50		7.97
	16872583	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3912250	=	IC50	nM	33.88	CHEMBL4142	Homo sapiens	pIC50		7.47
	16872584	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3901265	=	IC50	nM	8.128	CHEMBL4142	Homo sapiens	pIC50		8.09
	16872585	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(F)c(N(CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3903973	=	IC50	nM	2.57	CHEMBL4142	Homo sapiens	pIC50		8.59
	16872586	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3957928	=	IC50	nM	33.88	CHEMBL4142	Homo sapiens	pIC50		7.47
	16872587	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960591	=	IC50	nM	23.99	CHEMBL4142	Homo sapiens	pIC50		7.62
	16872588	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccnc2Br)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899721	=	IC50	nM	81.28	CHEMBL4142	Homo sapiens	pIC50		7.09
	16872589	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3934772	=	IC50	nM	25.7	CHEMBL4142	Homo sapiens	pIC50		7.59
	16872590	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3n2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3909752	=	IC50	nM	22.91	CHEMBL4142	Homo sapiens	pIC50		7.64
	16872591	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C/C=C\c2ncccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3906945	=	IC50	nM	16.6	CHEMBL4142	Homo sapiens	pIC50		7.78
	16872592	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(F)c(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3954396	=	IC50	nM	3.548	CHEMBL4142	Homo sapiens	pIC50		8.45
	16872593	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ncccc2C(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944937	=	IC50	nM	83.18	CHEMBL4142	Homo sapiens	pIC50		7.08
	16872594	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CCO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3895267	=	IC50	nM	2.344	CHEMBL4142	Homo sapiens	pIC50		8.63
	16872595	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)c(F)c(N(CCCNCC(F)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F		CHEMBL3892529	=	IC50	nM	2.951	CHEMBL4142	Homo sapiens	pIC50		8.53
	16872596	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(F)c(OC)cc(OC)c1F		CHEMBL3935597	=	IC50	nM	1.622	CHEMBL4142	Homo sapiens	pIC50		8.79
	16872597	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)Nc2ncccc2OC)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3932893	=	IC50	nM	120.23	CHEMBL4142	Homo sapiens	pIC50		6.92
	16872598	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)Nc2cc(C)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952706	=	IC50	nM	32.36	CHEMBL4142	Homo sapiens	pIC50		7.49
	16872599	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cc3ncccc3[nH]2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3939860	=	IC50	nM	5.754	CHEMBL4142	Homo sapiens	pIC50		8.24
	16872600	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cccnc1C#CCN(c1ccc2ncc(-c3cnn(C)c3)nc2c1)c1c(F)c(OC)cc(OC)c1F		CHEMBL3976275	=	IC50	nM	3.09	CHEMBL4142	Homo sapiens	pIC50		8.51
	16872601	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1ccnc(C#CCN(c2ccc3ncc(-c4cnn(C)c4)nc3c2)c2c(F)c(OC)cc(OC)c2F)n1		CHEMBL3978754	=	IC50	nM	3.388	CHEMBL4142	Homo sapiens	pIC50		8.47
	16872602	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942716	=	IC50	nM	5.248	CHEMBL4142	Homo sapiens	pIC50		8.28
	16872603	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2nccc(OC(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982718	=	IC50	nM	30.2	CHEMBL4142	Homo sapiens	pIC50		7.52
	16872604	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)Nc2nccc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3892005	=	IC50	nM	25.12	CHEMBL4142	Homo sapiens	pIC50		7.6
	16872605	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(=O)Nc2cc(O)ccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3894762	=	IC50	nM	1.95	CHEMBL4142	Homo sapiens	pIC50		8.71
	16872606	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)S(=O)(=O)N(C)C)c1		CHEMBL3896514	=	IC50	nM	20.42	CHEMBL4142	Homo sapiens	pIC50		7.69
	16872607	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC(=O)c1ccnc(C#CCN(c2cc(OC)cc(OC)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)n1		CHEMBL3906253	=	IC50	nM	10.0	CHEMBL4142	Homo sapiens	pIC50		8.0
	16872608	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2CCCCC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3946877	=	IC50	nM	245.47	CHEMBL4142	Homo sapiens	pIC50		6.61
	16872609	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CC2c2ccncc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3944241	=	IC50	nM	37.15	CHEMBL4142	Homo sapiens	pIC50		7.43
	16872610	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC(=O)NC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3947664	=	IC50	nM	5.623	CHEMBL4142	Homo sapiens	pIC50		8.25
	16872611	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCCC#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3899151	=	IC50	nM	1.413	CHEMBL4142	Homo sapiens	pIC50		8.85
	16872612	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCCNCC(N)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960877	=	IC50	nM	0.8913	CHEMBL4142	Homo sapiens	pIC50		9.05
	16872613	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(CCC#N)c4)nc3c2)c1		CHEMBL3958209	=	IC50	nM	1.047	CHEMBL4142	Homo sapiens	pIC50		8.98
	16872614	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Cl.Cn1cc(-c2cnc3ccc(N(CC4CC4)c4cccc(OC(F)(F)F)c4)cc3n2)cn1		CHEMBL3933492	=	IC50	nM	6309.57	CHEMBL4142	Homo sapiens	pIC50		5.2
	16872615	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(C(F)(F)F)c1		CHEMBL3982416	=	IC50	nM	3981.07	CHEMBL4142	Homo sapiens	pIC50		5.4
	16872616	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CN(C)c1cccc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3984969	=	IC50	nM	1584.89	CHEMBL4142	Homo sapiens	pIC50		5.8
	16872617	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(C(=O)N2CCCC2)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3953206	=	IC50	nM	501.19	CHEMBL4142	Homo sapiens	pIC50		6.3
	16872618	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CN(Cc3ccccc3)CCN2Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3946591	=	IC50	nM	120.23	CHEMBL4142	Homo sapiens	pIC50		6.92
	16872619	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3939494	=	IC50	nM	21.38	CHEMBL4142	Homo sapiens	pIC50		7.67
	16872620	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cnnc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3942179	=	IC50	nM	25.12	CHEMBL4142	Homo sapiens	pIC50		7.6
	16872621	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCN2CC(C)(C)N=C2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3930685	=	IC50	nM	85.11	CHEMBL4142	Homo sapiens	pIC50		7.07
	16872622	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CNC(=O)c1cc(OC)cc(N(CC(O)CO)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3910555	=	IC50	nM	4.169	CHEMBL4142	Homo sapiens	pIC50		8.38
	16872623	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCOCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918036	=	IC50	nM	239.88	CHEMBL4142	Homo sapiens	pIC50		6.62
	16872624	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(NC(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3920759	=	IC50	nM	37.15	CHEMBL4142	Homo sapiens	pIC50		7.43
	16872625	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(OCC(O)C(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3965805	=	IC50	nM	128.82	CHEMBL4142	Homo sapiens	pIC50		6.89
	16872626	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(CN(C)C)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3926088	=	IC50	nM	416.87	CHEMBL4142	Homo sapiens	pIC50		6.38
	16872627	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl		CHEMBL3948043	=	IC50	nM	186.21	CHEMBL4142	Homo sapiens	pIC50		6.73
	16872628	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2nccc2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3972657	=	IC50	nM	69.18	CHEMBL4142	Homo sapiens	pIC50		7.16
	16872629	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(C)N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3979172	=	IC50	nM	10.96	CHEMBL4142	Homo sapiens	pIC50		7.96
	16872630	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)CN)c1		CHEMBL3976752	=	IC50	nM	10.0	CHEMBL4142	Homo sapiens	pIC50		8.0
	16872631	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COCc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3918892	=	IC50	nM	234.42	CHEMBL4142	Homo sapiens	pIC50		6.63
	16872632	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cnn(C)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3966660	=	IC50	nM	165.96	CHEMBL4142	Homo sapiens	pIC50		6.78
	16872633	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)C(=O)NC(C)C)c1		CHEMBL3899891	=	IC50	nM	29.51	CHEMBL4142	Homo sapiens	pIC50		7.53
	16872634	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(C)C(N)=O)c1		CHEMBL3890118	=	IC50	nM	19.95	CHEMBL4142	Homo sapiens	pIC50		7.7
	16872635	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	Br.COc1cc(OC)cc(N(CCP(=O)(O)O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3950169	=	IC50	nM	4.677	CHEMBL4142	Homo sapiens	pIC50		8.33
	16872636	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2ncnc2C)c2ccc3ncc(-c4cnn(CC(C)C)c4)nc3c2)c1		CHEMBL3952885	=	IC50	nM	144.54	CHEMBL4142	Homo sapiens	pIC50		6.84
	16872637	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cnc(C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3890870	=	IC50	nM	54.95	CHEMBL4142	Homo sapiens	pIC50		7.26
	16872638	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	CCN(C)Cc1cc(OC)cc(N(CC2CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3893659	<	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	pIC50		6.0
	16872639	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(N(CCCN)c2ccc3ncc(-c4cnn(C)c4)nc3c2)cc(OC)c1C(O)C(F)(F)F		CHEMBL3928923	=	IC50	nM	61.66	CHEMBL4142	Homo sapiens	pIC50		7.21
	16872640	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(N)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3938712	=	IC50	nM	446.68	CHEMBL4142	Homo sapiens	pIC50		6.35
	16872641	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(C#N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975295	=	IC50	nM	281.84	CHEMBL4142	Homo sapiens	pIC50		6.55
	16872642	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cccc(N)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3977791	=	IC50	nM	147.91	CHEMBL4142	Homo sapiens	pIC50		6.83
	16872643	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccc(C#N)cc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3916904	=	IC50	nM	660.69	CHEMBL4142	Homo sapiens	pIC50		6.18
	16872644	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2ccccc2C#N)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3974131	=	IC50	nM	269.15	CHEMBL4142	Homo sapiens	pIC50		6.57
	16872645	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC1=CC(N(CCO)c2ccc3ncc(-c4cn(C)nc4C(F)(F)F)nc3c2)CC(OC)=C1		CHEMBL3925322	=	IC50	nM	77.62	CHEMBL4142	Homo sapiens	pIC50		7.11
	16872646	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cc(OC)nc(OC)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3922592	=	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	pIC50		6.0
	16872647	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#CC2(O)CCN(C(=O)OC(C)(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.O=C(O)C(=O)O		CHEMBL3985007	=	IC50	nM	190.55	CHEMBL4142	Homo sapiens	pIC50		6.72
	16872648	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC1=CC(N(CCO)c2ccc3ncc(-c4c(C(F)(F)F)nn(C)c4C(F)(F)F)nc3c2)CC(OC)=C1		CHEMBL3982466	<	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	pIC50		6.0
	16872649	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COC1=CC(N(CCN(Cc2ccccc2N)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)CC(OC)=C1		CHEMBL3910921	=	IC50	nM	20.42	CHEMBL4142	Homo sapiens	pIC50		7.69
	16872650	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cnc3[nH]ccc3n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3908141	<	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	pIC50		6.0
	16872651	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(Cc2cccc(N(C)C)n2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3971947	=	IC50	nM	102.33	CHEMBL4142	Homo sapiens	pIC50		6.99
	16872652	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCC#Cc2ccccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3960102	=	IC50	nM	295.12	CHEMBL4142	Homo sapiens	pIC50		6.53
	16872653	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC2CCN(CC(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3891736	=	IC50	nM	70.79	CHEMBL4142	Homo sapiens	pIC50		7.15
	16872654	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(C[C@H]2C[C@@H]2c2ccccn2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3975903	=	IC50	nM	61.66	CHEMBL4142	Homo sapiens	pIC50		7.21
	16872655	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CCn2cccc2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3896720	=	IC50	nM	21.38	CHEMBL4142	Homo sapiens	pIC50		7.67
	16872656	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(NC(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3984841	=	IC50	nM	37.15	CHEMBL4142	Homo sapiens	pIC50		7.43
	16872657	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC(OCC(O)C(C)C)C(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3982303	=	IC50	nM	128.82	CHEMBL4142	Homo sapiens	pIC50		6.89
	16872658	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C(CNC(C)C)C(C)C)c1		CHEMBL3932123	=	IC50	nM	186.21	CHEMBL4142	Homo sapiens	pIC50		6.73
	16875824	CHEMBL3880338	Inhibition of human FGFR2 using Btn-Flt3 as substrate after 60 mins by TR-FRET assay	B	COc1cc(OC)cc(N(CC#Cc2cncn2C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3952488	=	IC50	nM	11.75	CHEMBL4142	Homo sapiens	pIC50		7.93
	16894630	CHEMBL3882040	Inhibition of FGFR2 (unknown origin) at 5 uM relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	=	Inhibition	%	73.0	CHEMBL4142	Homo sapiens	INH	%	73.0
262807	17645299	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)C4=CC5C=CC=CC5N4)c3N)ccc2[nH]1		CHEMBL3676312	=	IC50	nM	23.0	CHEMBL4142	Homo sapiens	IC50	nM	23.0
262808	17645300	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCC(O)CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676313	=	IC50	nM	5.5	CHEMBL4142	Homo sapiens	IC50	nM	5.5
262809	17645301	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCNCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676314	=	IC50	nM	5.6	CHEMBL4142	Homo sapiens	IC50	nM	5.6
262810	17645302	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OCCN6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676315	=	IC50	nM	3.2	CHEMBL4142	Homo sapiens	IC50	nM	3.2
262811	17645303	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OC6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676316	=	IC50	nM	4.3	CHEMBL4142	Homo sapiens	IC50	nM	4.3
262812	17645304	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(F)c(Br)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676317	=	IC50	nM	8.5	CHEMBL4142	Homo sapiens	IC50	nM	8.5
262813	17645305	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccc(F)cc6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676318	=	IC50	nM	31.0	CHEMBL4142	Homo sapiens	IC50	nM	31.0
262814	17645306	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6cccc(C(F)(F)F)c6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676319	=	IC50	nM	64.0	CHEMBL4142	Homo sapiens	IC50	nM	64.0
262815	17645307	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)N6CCCC(F)(F)C6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676320	=	IC50	nM	5.4	CHEMBL4142	Homo sapiens	IC50	nM	5.4
262816	17645308	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)NCC(F)(F)F)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676321	=	IC50	nM	21.0	CHEMBL4142	Homo sapiens	IC50	nM	21.0
262817	17645309	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccc(C(F)(F)F)cn6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676322	=	IC50	nM	19.0	CHEMBL4142	Homo sapiens	IC50	nM	19.0
262818	17645310	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CO)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676323	=	IC50	nM	23.0	CHEMBL4142	Homo sapiens	IC50	nM	23.0
262819	17645311	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OCCN6CCN(C)CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676324	=	IC50	nM	15.0	CHEMBL4142	Homo sapiens	IC50	nM	15.0
262820	17645312	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OCC6(C)COC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676325	=	IC50	nM	12.0	CHEMBL4142	Homo sapiens	IC50	nM	12.0
262821	17645313	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COCCN(CCOC)Cc1ccc2cc(C(=O)C3C=NN(c4ccc5[nH]c(C)nc5c4)C3N)[nH]c2c1		CHEMBL3676326	=	IC50	nM	23.0	CHEMBL4142	Homo sapiens	IC50	nM	23.0
262822	17645314	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	C#CCN(C)Cc1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3676327	=	IC50	nM	17.0	CHEMBL4142	Homo sapiens	IC50	nM	17.0
262823	17645315	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCOC[C@@H]6C)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676328	=	IC50	nM	4.3	CHEMBL4142	Homo sapiens	IC50	nM	4.3
262824	17645316	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(Br)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676329	=	IC50	nM	8.9	CHEMBL4142	Homo sapiens	IC50	nM	8.9
262825	17645317	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ncccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676330	=	IC50	nM	26.0	CHEMBL4142	Homo sapiens	IC50	nM	26.0
262826	17645318	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(I)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676331	=	IC50	nM	8.6	CHEMBL4142	Homo sapiens	IC50	nM	8.6
262827	17645319	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(C)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676332	=	IC50	nM	21.0	CHEMBL4142	Homo sapiens	IC50	nM	21.0
262828	17645320	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(C(C)C)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676333	=	IC50	nM	42.0	CHEMBL4142	Homo sapiens	IC50	nM	42.0
262829	17645321	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(Cc6ccccc6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676334	=	IC50	nM	34.0	CHEMBL4142	Homo sapiens	IC50	nM	34.0
262830	17645322	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6=C(C(F)(F)F)CCC=C6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3676335	=	IC50	nM	86.0	CHEMBL4142	Homo sapiens	IC50	nM	86.0
262831	17645323	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	C#Cc1cccc2[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)cc12		CHEMBL3676336	=	IC50	nM	22.0	CHEMBL4142	Homo sapiens	IC50	nM	22.0
262832	17645324	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2c(F)cc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3676337	=	IC50	nM	16.0	CHEMBL4142	Homo sapiens	IC50	nM	16.0
262833	17645325	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CCCCOc1ccc2[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)cc2c1		CHEMBL3681236	=	IC50	nM	12.0	CHEMBL4142	Homo sapiens	IC50	nM	12.0
262834	17645326	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(NS(C)(=O)=O)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681237	=	IC50	nM	48.0	CHEMBL4142	Homo sapiens	IC50	nM	48.0
262835	17645327	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccc(N7CCOCC7)nc6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681238	=	IC50	nM	25.0	CHEMBL4142	Homo sapiens	IC50	nM	25.0
262836	17645328	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CCCCc1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681239	=	IC50	nM	200.0	CHEMBL4142	Homo sapiens	IC50	nM	200.0
262837	17645329	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6cnn(C)c6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681240	=	IC50	nM	16.0	CHEMBL4142	Homo sapiens	IC50	nM	16.0
262838	17645330	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1ncccc1-c1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681241	=	IC50	nM	27.0	CHEMBL4142	Homo sapiens	IC50	nM	27.0
262839	17645331	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(C6CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681242	=	IC50	nM	21.0	CHEMBL4142	Homo sapiens	IC50	nM	21.0
262840	17645332	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1ccccc1-c1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681243	=	IC50	nM	36.0	CHEMBL4142	Homo sapiens	IC50	nM	36.0
262841	17645333	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccccc6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681244	=	IC50	nM	26.0	CHEMBL4142	Homo sapiens	IC50	nM	26.0
262842	17645334	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6cncc(S(C)(=O)=O)c6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681245	=	IC50	nM	22.0	CHEMBL4142	Homo sapiens	IC50	nM	22.0
262843	17645335	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6cccnn6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681246	=	IC50	nM	10.0	CHEMBL4142	Homo sapiens	IC50	nM	10.0
262844	17645336	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COCCOc1ccc2[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)cc2c1		CHEMBL3681247	=	IC50	nM	12.0	CHEMBL4142	Homo sapiens	IC50	nM	12.0
262845	17645337	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(OCC6CC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681248	=	IC50	nM	8.3	CHEMBL4142	Homo sapiens	IC50	nM	8.3
262846	17645338	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc6c(cc5[nH]4)OC(F)(F)O6)c3N)ccc2[nH]1		CHEMBL3681249	=	IC50	nM	14.0	CHEMBL4142	Homo sapiens	IC50	nM	14.0
262847	17645339	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6ccc(F)cn6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681250	=	IC50	nM	5.5	CHEMBL4142	Homo sapiens	IC50	nM	5.5
262848	17645340	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(Cl)c(OCC6CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681251	=	IC50	nM	14.0	CHEMBL4142	Homo sapiens	IC50	nM	14.0
262849	17645341	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2ccc(-n3ncc(C(=O)c4[nH]c5ccccc5c4F)c3N)cc2[nH]1		CHEMBL3681262	=	IC50	nM	40.0	CHEMBL4142	Homo sapiens	IC50	nM	40.0
262850	17645342	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6CCN(C(C)C)CC6)c(C(F)(F)F)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681263	=	IC50	nM	18.0	CHEMBL4142	Homo sapiens	IC50	nM	18.0
262851	17645343	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)C4=CC5C=CC(C#N)=CC5N4)c3N)ccc2[nH]1		CHEMBL3681264	=	IC50	nM	6.2	CHEMBL4142	Homo sapiens	IC50	nM	6.2
262852	17645344	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6=CCNCC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681265	=	IC50	nM	39.0	CHEMBL4142	Homo sapiens	IC50	nM	39.0
262853	17645345	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6CCNCC6)c(F)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681266	=	IC50	nM	38.0	CHEMBL4142	Homo sapiens	IC50	nM	38.0
262854	17645346	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6CCN(C(C)C)CC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681267	=	IC50	nM	17.0	CHEMBL4142	Homo sapiens	IC50	nM	17.0
262855	17645347	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(-c6cccnc6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681268	=	IC50	nM	39.0	CHEMBL4142	Homo sapiens	IC50	nM	39.0
262856	17645348	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(-c6ccc(O)nc6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681269	=	IC50	nM	31.0	CHEMBL4142	Homo sapiens	IC50	nM	31.0
262857	17645349	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(C6CCN(C)CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681270	=	IC50	nM	8.4	CHEMBL4142	Homo sapiens	IC50	nM	8.4
262858	17645350	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(CN6C(C)CCC6C)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681271	=	IC50	nM	12.0	CHEMBL4142	Homo sapiens	IC50	nM	12.0
262859	17645351	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(CN6CCCC(F)C6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681272	=	IC50	nM	8.5	CHEMBL4142	Homo sapiens	IC50	nM	8.5
262860	17645352	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CN1CCC(c2ccc3[nH]c(C(=O)c4cnn(-c5ccc6[nH]c(C(F)F)nc6c5)c4N)cc3c2)CC1		CHEMBL3681273	=	IC50	nM	110.0	CHEMBL4142	Homo sapiens	IC50	nM	110.0
262861	17645353	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C6CCN(C7CCCC7)CC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681274	=	IC50	nM	12.0	CHEMBL4142	Homo sapiens	IC50	nM	12.0
262862	17645354	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc(Br)c[nH]4)c3N)ccc2[nH]1		CHEMBL3681275	=	IC50	nM	260.0	CHEMBL4142	Homo sapiens	IC50	nM	260.0
262863	17645355	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4ccc[nH]4)c3N)ccc2[nH]1		CHEMBL3681276	=	IC50	nM	510.0	CHEMBL4142	Homo sapiens	IC50	nM	510.0
262864	17645356	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc(-c5cccc(F)c5)c[nH]4)c3N)ccc2[nH]1		CHEMBL3681277	=	IC50	nM	67.0	CHEMBL4142	Homo sapiens	IC50	nM	67.0
262865	17645357	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681278	=	IC50	nM	3.4	CHEMBL4142	Homo sapiens	IC50	nM	3.4
262866	17645358	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(NCCN6CCOCC6)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681279	=	IC50	nM	26.0	CHEMBL4142	Homo sapiens	IC50	nM	26.0
262867	17645359	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)N6CCN(C)CC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681280	=	IC50	nM	12.0	CHEMBL4142	Homo sapiens	IC50	nM	12.0
262868	17645360	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COCCNc1cccc2[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)cc12		CHEMBL3681281	=	IC50	nM	19.0	CHEMBL4142	Homo sapiens	IC50	nM	19.0
262869	17645361	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(NC(CO)CO)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681282	=	IC50	nM	6.0	CHEMBL4142	Homo sapiens	IC50	nM	6.0
262870	17645362	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(NCCc6ccncc6)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681283	=	IC50	nM	29.0	CHEMBL4142	Homo sapiens	IC50	nM	29.0
262871	17645363	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(N6CCOCC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681284	=	IC50	nM	4.0	CHEMBL4142	Homo sapiens	IC50	nM	4.0
262872	17645364	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)N6CCOCC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681285	=	IC50	nM	9.1	CHEMBL4142	Homo sapiens	IC50	nM	9.1
262873	17645365	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2[nH]c(C(F)(F)F)nc2c1		CHEMBL3681286	=	IC50	nM	200.0	CHEMBL4142	Homo sapiens	IC50	nM	200.0
262874	17645366	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CCc1nc2cc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681287	=	IC50	nM	65.0	CHEMBL4142	Homo sapiens	IC50	nM	65.0
262875	17645367	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Nc1c(C(=O)c2cc3ccccc3[nH]2)cnn1-c1ccc2[nH]c(Cc3ccccc3)nc2c1		CHEMBL3681288	=	IC50	nM	320.0	CHEMBL4142	Homo sapiens	IC50	nM	320.0
262876	17645368	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2c([nH]1)CCC(n1ncc(C(=O)c3cc4cc(CN5CCN(S(C)(=O)=O)CC5)ccc4[nH]3)c1N)=C2		CHEMBL3681289	=	IC50	nM	11.0	CHEMBL4142	Homo sapiens	IC50	nM	11.0
262877	17645369	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(CN6CCNCC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3639801	=	IC50	nM	38.0	CHEMBL4142	Homo sapiens	IC50	nM	38.0
262878	17645370	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CC(=O)N1CCN(Cc2ccc3cc(C(=O)c4cnn(-c5ccc6[nH]c(C)nc6c5)c4N)[nH]c3c2)CC1		CHEMBL3681290	=	IC50	nM	6.3	CHEMBL4142	Homo sapiens	IC50	nM	6.3
262879	17645371	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(CN6CCN(C)CC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681291	=	IC50	nM	4.8	CHEMBL4142	Homo sapiens	IC50	nM	4.8
262880	17645372	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(CN6CCCC6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681292	=	IC50	nM	4.6	CHEMBL4142	Homo sapiens	IC50	nM	4.6
262881	17645373	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(F)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681293	=	IC50	nM	28.0	CHEMBL4142	Homo sapiens	IC50	nM	28.0
262882	17645374	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c([nH]4)=CC(CN4CCOCC4)C(F)C=5)c3N)ccc2[nH]1		CHEMBL3681294	=	IC50	nM	3.6	CHEMBL4142	Homo sapiens	IC50	nM	3.6
262883	17645375	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)O)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681295	=	IC50	nM	10.0	CHEMBL4142	Homo sapiens	IC50	nM	10.0
262884	17645376	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1cc(OC)c2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681296	=	IC50	nM	15.0	CHEMBL4142	Homo sapiens	IC50	nM	15.0
262885	17645377	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681297	=	IC50	nM	21.0	CHEMBL4142	Homo sapiens	IC50	nM	21.0
262886	17645378	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1cc(C)c2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681298	=	IC50	nM	15.0	CHEMBL4142	Homo sapiens	IC50	nM	15.0
262887	17645379	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(C)(C)C)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681299	=	IC50	nM	56.0	CHEMBL4142	Homo sapiens	IC50	nM	56.0
262888	17645380	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(Oc6ccccc6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681300	=	IC50	nM	110.0	CHEMBL4142	Homo sapiens	IC50	nM	110.0
262889	17645381	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	CSc1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681301	=	IC50	nM	20.0	CHEMBL4142	Homo sapiens	IC50	nM	20.0
262890	17645382	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(F)c(C(F)(F)F)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681302	=	IC50	nM	29.0	CHEMBL4142	Homo sapiens	IC50	nM	29.0
262891	17645383	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1cc2[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)cc2cc1Cl		CHEMBL3681303	=	IC50	nM	4.0	CHEMBL4142	Homo sapiens	IC50	nM	4.0
262892	17645384	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OCc6ccccc6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681304	=	IC50	nM	16.0	CHEMBL4142	Homo sapiens	IC50	nM	16.0
262893	17645385	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(OC(C)C)cccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681305	=	IC50	nM	26.0	CHEMBL4142	Homo sapiens	IC50	nM	26.0
262894	17645386	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc6c(cc5[nH]4)OCCO6)c3N)ccc2[nH]1		CHEMBL3681306	=	IC50	nM	7.6	CHEMBL4142	Homo sapiens	IC50	nM	7.6
262895	17645387	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(C(C)(C)C)cc(C(C)(C)C)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681307	=	IC50	nM	5.5	CHEMBL4142	Homo sapiens	IC50	nM	5.5
262896	17645388	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(-n6ccnc6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681308	=	IC50	nM	20.0	CHEMBL4142	Homo sapiens	IC50	nM	20.0
262897	17645389	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(SC(F)(F)F)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681309	=	IC50	nM	78.0	CHEMBL4142	Homo sapiens	IC50	nM	78.0
262898	17645390	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(CN6CCC(F)(F)CC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681314	=	IC50	nM	9.4	CHEMBL4142	Homo sapiens	IC50	nM	9.4
262899	17645391	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(OC6COC6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681315	=	IC50	nM	20.0	CHEMBL4142	Homo sapiens	IC50	nM	20.0
262900	17645392	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(O)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681316	=	IC50	nM	18.0	CHEMBL4142	Homo sapiens	IC50	nM	18.0
262901	17645393	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(S(C)(=O)=O)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681317	=	IC50	nM	21.0	CHEMBL4142	Homo sapiens	IC50	nM	21.0
262902	17645394	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc(Br)c(Br)[nH]4)c3N)ccc2[nH]1		CHEMBL3681318	=	IC50	nM	66.0	CHEMBL4142	Homo sapiens	IC50	nM	66.0
262903	17645395	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc(-c5cccnc5)c(-c5cccnc5)[nH]4)c3N)ccc2[nH]1		CHEMBL3681319	=	IC50	nM	393.0	CHEMBL4142	Homo sapiens	IC50	nM	393.0
262904	17645396	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(Cl)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681252	=	IC50	nM	57.0	CHEMBL4142	Homo sapiens	IC50	nM	57.0
262905	17645397	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4ccc5cc[nH]c5c4)c3N)ccc2[nH]1		CHEMBL3681253	=	IC50	nM	1900.0	CHEMBL4142	Homo sapiens	IC50	nM	1900.0
262906	17645398	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(F)(F)F)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681254	=	IC50	nM	37.0	CHEMBL4142	Homo sapiens	IC50	nM	37.0
262907	17645399	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5c(F)cc(Br)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681255	=	IC50	nM	26.0	CHEMBL4142	Homo sapiens	IC50	nM	26.0
262908	17645400	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1ccc(-c2ccc3cc(C(=O)c4cnn(-c5ccc6[nH]c(C)nc6c5)c4N)[nH]c3c2)cn1		CHEMBL3681256	=	IC50	nM	17.0	CHEMBL4142	Homo sapiens	IC50	nM	17.0
262909	17645401	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1ncc(Cl)cc1-c1ccc2cc(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)[nH]c2c1		CHEMBL3681257	=	IC50	nM	28.0	CHEMBL4142	Homo sapiens	IC50	nM	28.0
262910	17645402	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5ccc(-c6cccs6)cc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681258	=	IC50	nM	10.0	CHEMBL4142	Homo sapiens	IC50	nM	10.0
262911	17645403	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)C4=CC5C=C(C(=O)N6CCC(F)(F)C6)C=CC5N4)c3N)ccc2[nH]1		CHEMBL3681259	=	IC50	nM	220.0	CHEMBL4142	Homo sapiens	IC50	nM	220.0
262912	17645404	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)N6CC(C)OC(C)C6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681260	=	IC50	nM	350.0	CHEMBL4142	Homo sapiens	IC50	nM	350.0
262913	17645405	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cc5cc(C(=O)N6CC[C@H](F)C6)ccc5[nH]4)c3N)ccc2[nH]1		CHEMBL3681261	=	IC50	nM	538.0	CHEMBL4142	Homo sapiens	IC50	nM	538.0
262914	17645406	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	COc1ccc(-c2c[nH]c(C(=O)c3cnn(-c4ccc5[nH]c(C)nc5c4)c3N)c2)cc1		CHEMBL3681313	=	IC50	nM	180.0	CHEMBL4142	Homo sapiens	IC50	nM	180.0
262915	17645407	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4nc5ccccc5s4)c3N)ccc2[nH]1		CHEMBL3681310	=	IC50	nM	22.0	CHEMBL4142	Homo sapiens	IC50	nM	22.0
262916	17645408	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4ccc(F)cc4)c3N)ccc2[nH]1		CHEMBL3681311	=	IC50	nM	40.0	CHEMBL4142	Homo sapiens	IC50	nM	40.0
262917	17645409	CHEMBL3705409	Enzyme Inhibition Assay: The FGFR2-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR2 enzyme prepared using a baculovirus expression system. Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.	B	Cc1nc2cc(-n3ncc(C(=O)c4cccc(Cl)c4)c3N)ccc2[nH]1		CHEMBL3681312	=	IC50	nM	32.0	CHEMBL4142	Homo sapiens	IC50	nM	32.0
304693	17685554	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C=CC(=O)N1CCC(n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701237	=	IC50	nM	2.4	CHEMBL4142	Homo sapiens	IC50	nM	2.4
304694	17685555	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C=CC(=O)N1CC[C@H](n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701238	=	IC50	nM	1.1	CHEMBL4142	Homo sapiens	IC50	nM	1.1
304695	17685556	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C#CC(=O)N1CC[C@H](n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701239	=	IC50	nM	1.1	CHEMBL4142	Homo sapiens	IC50	nM	1.1
304696	17685557	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C=CC(=O)N1CC[C@H](n2nc(C#Cc3cc(OCC)cc(OCC)c3)c3c(N)ncnc32)C1		CHEMBL3701240	=	IC50	nM	6.9	CHEMBL4142	Homo sapiens	IC50	nM	6.9
304697	17685558	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C=CC(=O)N1CC(n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701241	=	IC50	nM	1.1	CHEMBL4142	Homo sapiens	IC50	nM	1.1
304698	17685559	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2nn(C3CN(C(=O)C#CCO)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701242	=	IC50	nM	1.2	CHEMBL4142	Homo sapiens	IC50	nM	1.2
304699	17685560	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2nn(C3CN(C(=O)/C=C/CN(C)C)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701243	=	IC50	nM	2.2	CHEMBL4142	Homo sapiens	IC50	nM	2.2
304700	17685561	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2nn(C3CN(C(=O)/C=C/CNC(C)C)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701244	=	IC50	nM	3.8	CHEMBL4142	Homo sapiens	IC50	nM	3.8
304701	17685562	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	CCN(C)C/C=C/C(=O)N1CC(n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701245	=	IC50	nM	3.0	CHEMBL4142	Homo sapiens	IC50	nM	3.0
304702	17685563	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2nn(C3CN(C(=O)/C=C/CNC4CCC4)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701246	=	IC50	nM	3.8	CHEMBL4142	Homo sapiens	IC50	nM	3.8
304703	17685564	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	CCN(CC)C/C=C/C(=O)N1CC(n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701247	=	IC50	nM	4.1	CHEMBL4142	Homo sapiens	IC50	nM	4.1
304704	17685565	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2nn(C3CN(C(=O)/C=C/CNC(C)(C)C)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701248	=	IC50	nM	4.3	CHEMBL4142	Homo sapiens	IC50	nM	4.3
304705	17685566	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2nn(C3CN(C(=O)/C=C/CN(C)C(C)C)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701249	=	IC50	nM	2.7	CHEMBL4142	Homo sapiens	IC50	nM	2.7
304706	17685567	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2nn(C3CN(C(=O)/C=C/CN4CCCCC4)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701250	=	IC50	nM	3.3	CHEMBL4142	Homo sapiens	IC50	nM	3.3
304707	17685568	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2nn(C3CN(C(=O)/C=C/CN4CC[C@H](F)C4)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701251	=	IC50	nM	5.6	CHEMBL4142	Homo sapiens	IC50	nM	5.6
304708	17685569	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2nn(C3CN(C(=O)/C=C/CN4CC[C@@H](F)C4)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701252	=	IC50	nM	6.8	CHEMBL4142	Homo sapiens	IC50	nM	6.8
304709	17685570	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C=CC(=O)N1CC(n2nc(C#Cc3cc(OCC)cc(OCC)c3)c3c(N)ncnc32)C1		CHEMBL3701253	=	IC50	nM	7.2	CHEMBL4142	Homo sapiens	IC50	nM	7.2
304710	17685571	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C=CC(=O)N1CC(n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C[C@H]1CO		CHEMBL3701254	=	IC50	nM	3.7	CHEMBL4142	Homo sapiens	IC50	nM	3.7
304711	17685572	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C=CC(=O)N1CC(Cn2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701255	=	IC50	nM	9.3	CHEMBL4142	Homo sapiens	IC50	nM	9.3
304712	17685573	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C#C[C@@H]1C[C@H](n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)CN1C(=O)C=C		CHEMBL3701256	=	IC50	nM	0.4	CHEMBL4142	Homo sapiens	IC50	nM	0.4
304713	17685574	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#CC2=CC([C@H]3CCN(C(=O)/C=C/CN(C)C)C3)c3ncnc(N)c32)cc(OC)c1		CHEMBL3701257	=	IC50	nM	4.7	CHEMBL4142	Homo sapiens	IC50	nM	4.7
304714	17685575	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C=CC(=O)N1CC[C@H](n2cc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701258	=	IC50	nM	0.4	CHEMBL4142	Homo sapiens	IC50	nM	0.4
304715	17685576	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2cn([C@H]3CCN(C(=O)/C=C/CN4CCCC4)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701259	=	IC50	nM	3.2	CHEMBL4142	Homo sapiens	IC50	nM	3.2
304716	17685577	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2cn([C@H]3CCN(C(=O)/C=C/CN4CCC(O)CC4)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701260	=	IC50	nM	6.6	CHEMBL4142	Homo sapiens	IC50	nM	6.6
304717	17685578	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	CC#CC(=O)N1CC[C@H](n2cc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701261	=	IC50	nM	4.3	CHEMBL4142	Homo sapiens	IC50	nM	4.3
304718	17685579	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2cn([C@H]3CCN(C(=O)C#CC(C)(C)O)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701262	=	IC50	nM	2.0	CHEMBL4142	Homo sapiens	IC50	nM	2.0
304719	17685580	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2cn([C@H]3CCN(C(=O)/C=C/CN4CC[C@@H](F)C4)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701263	=	IC50	nM	6.8	CHEMBL4142	Homo sapiens	IC50	nM	6.8
304720	17685581	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2cn([C@H]3CCN(C(=O)/C=C/CN4CC[C@H](F)C4)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701264	=	IC50	nM	7.0	CHEMBL4142	Homo sapiens	IC50	nM	7.0
304721	17685582	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2cn([C@H]3CCN(C(=O)/C=C/CN4CCCCC4)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701265	=	IC50	nM	5.8	CHEMBL4142	Homo sapiens	IC50	nM	5.8
304722	17685583	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C=CC(=O)N1CC(N2C=C(C#Cc3cc(OC)cc(OC)c3)C3C(N)=NC=NC32)C1		CHEMBL3701266	<	IC50	nM	0.3	CHEMBL4142	Homo sapiens	IC50	nM	0.3
304723	17685584	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2cn(C3CN(C(=O)/C=C/CN(C)C)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701267	=	IC50	nM	1.0	CHEMBL4142	Homo sapiens	IC50	nM	1.0
304724	17685585	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2cn(C3CN(C(=O)/C=C/CN4CCCC4)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701268	=	IC50	nM	0.6	CHEMBL4142	Homo sapiens	IC50	nM	0.6
304725	17685586	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2cn(C3CN(C(=O)/C=C/CN4CCC4)C3)c3ncncc23)cc(OC)c1		CHEMBL3701269	=	IC50	nM	2.5	CHEMBL4142	Homo sapiens	IC50	nM	2.5
304726	17685587	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2cn(C3CN(C(=O)/C=C/CN(C)C)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701267	=	IC50	nM	1.5	CHEMBL4142	Homo sapiens	IC50	nM	1.5
304727	17685588	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2cn(C3CN(C(=O)/C=C/CNC(C)C)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701270	=	IC50	nM	1.5	CHEMBL4142	Homo sapiens	IC50	nM	1.5
304728	17685589	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	CCN(CC)C/C=C/C(=O)N1CC(n2cc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701271	=	IC50	nM	1.2	CHEMBL4142	Homo sapiens	IC50	nM	1.2
304729	17685590	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COCCN(C)C/C=C/C(=O)N1CC(n2cc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701272	=	IC50	nM	1.5	CHEMBL4142	Homo sapiens	IC50	nM	1.5
304730	17685591	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2cn(C3CN(C(=O)/C=C/CN4CCC(O)CC4)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701273	=	IC50	nM	2.3	CHEMBL4142	Homo sapiens	IC50	nM	2.3
304731	17685592	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2cn(C3CN(C(=O)/C=C/CN4CC[C@@H](O)C4)C3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701275	=	IC50	nM	1.0	CHEMBL4142	Homo sapiens	IC50	nM	1.0
304732	17685593	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C=CC(=O)N1CCC(n2cc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)CC1		CHEMBL3701276	=	IC50	nM	7.9	CHEMBL4142	Homo sapiens	IC50	nM	7.9
304733	17685594	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cc(C#Cc2cn(C3CCN(C(=O)/C=C/CN(C)C)CC3)c3ncnc(N)c23)cc(OC)c1		CHEMBL3701277	=	IC50	nM	7.0	CHEMBL4142	Homo sapiens	IC50	nM	7.0
304734	17685595	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C=CC(=O)N1C[C@@H](n2cc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C[C@H]1C(=O)OC		CHEMBL3701278	<	IC50	nM	0.3	CHEMBL4142	Homo sapiens	IC50	nM	0.3
304735	17685596	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C=CC(=O)N1C[C@@H](n2cc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C[C@H]1c1nnco1		CHEMBL3701279	=	IC50	nM	1.2	CHEMBL4142	Homo sapiens	IC50	nM	1.2
304736	17685597	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C=CC(=O)N1C[C@@H](n2cc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C[C@H]1c1nnc(C)o1		CHEMBL3701280	=	IC50	nM	8.8	CHEMBL4142	Homo sapiens	IC50	nM	8.8
304737	17685598	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C=CC(=O)N1CC[C@H](n2cc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701258	=	IC50	nM	4.9	CHEMBL4142	Homo sapiens	IC50	nM	4.9
304738	17685599	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	280.0	CHEMBL4142	Homo sapiens	IC50	nM	280.0
304739	17685600	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	Nc1nccn2c(C3CCC3)nc(C#Cc3ccccc3)c12		CHEMBL3701281	=	IC50	nM	270.0	CHEMBL4142	Homo sapiens	IC50	nM	270.0
304740	17685601	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	CCC(=O)N1CC[C@H](n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1		CHEMBL3701282	=	IC50	nM	190.0	CHEMBL4142	Homo sapiens	IC50	nM	190.0
304741	17685602	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	CC(C)c1cc(C#Cc2nn([C@H]3CCN(C(=O)/C=C/CN(C)C)C3)c3ncnc(N)c23)cc(C(C)C)c1		CHEMBL3701283	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
304742	17685603	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	COc1cccc(C#Cc2nn([C@H]3CCN(C(=O)/C=C/CN(C)C)C3)c3ncnc(N)c23)c1		CHEMBL3701284	=	IC50	nM	190.0	CHEMBL4142	Homo sapiens	IC50	nM	190.0
304743	17685604	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	CC(=O)Nc1cccc(C#Cc2nn([C@H]3CCN(C(=O)/C=C/CN(C)C)C3)c3ncnc(N)c23)c1		CHEMBL3701285	=	IC50	nM	110.0	CHEMBL4142	Homo sapiens	IC50	nM	110.0
304744	17685605	CHEMBL3705582	Inhibition Assay: When setting conditions for the measurement of the inhibitory effect of the compounds on FGFR2 kinase activity, FL-Peptide 22 (Caliper Life Sciences, Inc.) was used as a substrate. The purified recombinant human FGFR2 protein used in the test was purchased from Carna Biosciences, Inc. In the measurement of the inhibitory effect of the compounds, first, a test compound was gradually diluted with dimethylsulfoxide (DMSO) to a concentration that was 20 times higher than the final concentration. Next, the purified human FGFR2 protein, FL-Peptide 22 (final concentration: 1.5 .mu.M), magnesium chloride (final concentration: 5 mM), ATP (final concentration: 75 .mu.M), and the test compound DMSO solution (final concentration of DMSO: 5%) were added to a reaction buffer (15 mM Tris-HCl pH 7.5, 0.01% Tween-20, 2 mM DTT), and the mixture was incubated at 25.degree. C. for 120 minutes to perform a kinase reaction. EDTA (final concentration: 30 mM) diluted with a separation buffer.	B	CN(C)C/C=C/C(=O)N1CC[C@H](n2nc(C#Cc3cccnc3)c3c(N)ncnc32)C1		CHEMBL3701286	=	IC50	nM	1600.0	CHEMBL4142	Homo sapiens	IC50	nM	1600.0
364062	17739255	CHEMBL3887939	Competitive Binding Assay (KINOMEscan): For the competitive binding assay, test compounds were screened at 10 uM against 70 diverse kinase targets for competitive binding using the KINOMEscan technology (Ambit Biosciences) (Karaman, et al. (2008) Nature biotechnology 26:127-132). 11-point Kd curves were determined for hits identified during the initial screen.	B	CSc1nc(N)cc(Oc2ccc(-c3nnc(Nc4cccc(C(F)(F)F)c4)[nH]3)cc2)n1		CHEMBL3932957	>	Kd	nM	10000.0	CHEMBL4142	Homo sapiens	Kd	nM	10000.0
415928	17779509	CHEMBL3888792	Inhibition Assay: In a similar manner to Experimental Example 1, the % inhibitory activity (concentration of the compound 1.0 μM) and the IC50 values of the inventive compound of Example 1 against various kinases were obtained by using Kinase Profiling Service (Invitrogen) according to the manufacturer's instructions.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1NC(=O)c1cccc2c(N)nccc12		CHEMBL3967980	>	IC50	nM	2500.0	CHEMBL4142	Homo sapiens	IC50	nM	2500.0
431422	17791530	CHEMBL3889032	Inhibition Assay: Inhibition of recombinant FGFR-2 tyrosine kinase using exogenous substrate.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	IC50	nM	8.79	CHEMBL4142	Homo sapiens	IC50	nM	8.79
431429	17791537	CHEMBL3889039	In Vitro Inhibition Assay: In Vitro Inhibition of Tyrosine Kinases using a 10-point Titration Curve.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	IC50	nM	3.08	CHEMBL4142	Homo sapiens	IC50	nM	3.08
435232	17795193	CHEMBL3889131	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1ccccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3961994	=	IC50	nM	4180.0	CHEMBL4142	Homo sapiens	IC50	nM	4180.0
435233	17795194	CHEMBL3889131	Kinase HotSpotâ¿¢ Assay: Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 uM, FGFR1 substrate); and Poly [E,Y]4:1 (0.2 mg/ml, FGFR2,3,4 substrate)] in kinase reaction buffer (20 mM HEPES-HCl, pH 7.5, 10 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 0.02% Brij35, 0.1 mM Na3VO4, 0.02 mg/ml BSA, 2 mM DTT, and 1% DMSO). Compound was added to the enzyme/substrate mixture using acoustic technology (Labcyte Echo 550, Sunnyvale, Calif.) (see, Olechno et al., 2006, Improving IC50 results with acoustic droplet ejection. JALA 11, 240-246) and pre-incubated for 0, 15, or 60 minutes at room temperature. After compound pre-incubation, a mixture of ATP (Sigma-Aldrich) and 33P-γ-ATP (PerkinElmer) was added to a final concentration of 10 uM to initiate kinase reactions. Reactions were incubated for 120 minutes at room temperature and then spotted onto Whatman P81 ion exchange filter paper. Unbound phosphate was removed by extensively washing filters in 0.75% phosphoric acid. See, Anastassiadis et al., 2011, Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol 29, 1039-1045.	B	C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3939295	=	IC50	nM	1980.0	CHEMBL4142	Homo sapiens	IC50	nM	1980.0
	17979923	CHEMBL3998328	Inhibition of recombinant FGFR2 (unknown origin) using peptidic substrates in presence of ATP by Kinase-Glo luminescent kinase assay	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1		CHEMBL1852688	=	IC50	nM	1.0	CHEMBL4142	Homo sapiens	IC50	nM	1.0
	17979925	CHEMBL3998326	Inhibition of FGFR2 (unknown origin)	B	C=CC(=O)Nc1ccc(CN(C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)cc1		CHEMBL4092990	<	IC50	nM	1.0	CHEMBL4142	Homo sapiens	IC50	nM	1.0
	17979926	CHEMBL3998326	Inhibition of FGFR2 (unknown origin)	B	C=CC(=O)Nc1ccc(CN2C(=O)N(c3cc(OC)cc(OC)c3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)cc1		CHEMBL4065323	=	IC50	nM	4.0	CHEMBL4142	Homo sapiens	IC50	nM	4.0
	17979927	CHEMBL3998326	Inhibition of FGFR2 (unknown origin)	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	IC50	nM	82.5	CHEMBL4142	Homo sapiens	IC50	nM	82.5
	17979928	CHEMBL3998326	Inhibition of FGFR2 (unknown origin)	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584	=	IC50	nM	5.0	CHEMBL4142	Homo sapiens	IC50	nM	5.0
	17979929	CHEMBL3998326	Inhibition of FGFR2 (unknown origin)	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	=	IC50	nM	7.6	CHEMBL4142	Homo sapiens	IC50	nM	7.6
	17979964	CHEMBL3998354	Inhibition of FGFR2 V564M mutant (unknown origin)	B	C=CC(=O)Nc1ccc(CN2C(=O)N(c3cc(OC)cc(OC)c3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)cc1		CHEMBL4065323	=	IC50	nM	58.0	CHEMBL4142	Homo sapiens	IC50	nM	58.0
	17979965	CHEMBL3998354	Inhibition of FGFR2 V564M mutant (unknown origin)	B	C=CC(=O)Nc1ccc(CN(C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)cc1		CHEMBL4092990	=	IC50	nM	64.0	CHEMBL4142	Homo sapiens	IC50	nM	64.0
	17979969	CHEMBL3998358	Inhibition of recombinant His6-tagged FGFR2 (unknown origin) expressed in Escherichia coli BL21(DE3)-RILP using peptidic substrate by ELISA	B	Nc1ncc2c(n1)-c1ccccc1[C@H](c1ccccc1)C2		CHEMBL1738735	=	IC50	nM	1230.0	CHEMBL4142	Homo sapiens	IC50	uM	1.23
	17979977	CHEMBL3998362	Inhibition of human N-terminal GST-tagged FGFR2 cytoplasmic domain (399 to 821 end residues) expressed in baculovirus expression system using CSKtide as substrate after 90 mins	B	C=CC(=O)Nc1ccccc1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4090527	=	IC50	nM	493.0	CHEMBL4142	Homo sapiens	IC50	nM	493.0
	17979979	CHEMBL3998335	Inhibition of recombinant human FGFR2 in presence of ATP	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	2.5	CHEMBL4142	Homo sapiens	IC50	nM	2.5
	17990957	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4061083	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990958	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc(NCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4061383	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990959	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1c(C)cccc1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4091534	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990960	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cc(C)ccc1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4077138	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990961	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1ccc(C)cc1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4099268	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990962	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1ccccc1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4082818	=	IC50	nM	311.9	CHEMBL4142	Homo sapiens	IC50	nM	311.9
	17990963	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CC)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4060935	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990964	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(OC)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4067483	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990965	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(OCC)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4086040	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990966	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(OC(C)C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4084175	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990967	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(F)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4102146	=	IC50	nM	396.8	CHEMBL4142	Homo sapiens	IC50	nM	396.8
	17990968	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4073826	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990969	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(C(F)(F)F)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4094408	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990970	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cc(F)cc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4065231	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990971	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cc(Cl)cc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4086669	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990972	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cc(C(F)(F)F)cc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4103091	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990973	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	CCC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4078819	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990974	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OC(C)c2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4070060	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990975	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2c(Cl)ccc(OC)c2Cl)cn1		CHEMBL4091031	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990976	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2cc(OC)cc(OC)c2Cl)cn1		CHEMBL4082121	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990977	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2c(Cl)cccc2Cl)cn1		CHEMBL4060226	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990978	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2cccc(OC)c2Cl)cn1		CHEMBL4071593	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990979	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2cc(OC)ccc2Cl)cn1		CHEMBL4098624	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990980	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2cc(OC)cc(OC)c2)cn1		CHEMBL4097713	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990981	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2ccccc2Cl)cn1		CHEMBL4079677	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990982	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(Cl)c1Nc1ncc(OCc2cccc(OC)c2)cn1		CHEMBL4089981	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	17990983	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	=	IC50	nM	246.9	CHEMBL4142	Homo sapiens	IC50	nM	246.9
	17990984	CHEMBL4000067	Inhibition of His-tagged cytoplasmic recombinant human FGFR2 (403 to 822 residues) expressed in baculovirus expression system using Tyr 4 peptide as substrate incubated for 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830	=	IC50	nM	2.3	CHEMBL4142	Homo sapiens	IC50	nM	2.3
	18002354	CHEMBL4002766	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cncc(N5CCOCC5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL4091628	=	IC50	nM	0.3	CHEMBL4142	Homo sapiens	IC50	nM	0.3
	18002372	CHEMBL4002766	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	1.3	CHEMBL4142	Homo sapiens	IC50	nM	1.3
Dose-dependent effect	18002393	CHEMBL4002787	Inhibition of FGFR2 in FGFR2-amplified human SNU16 cells assessed as suppression of FGFR2 phosphorylation after 2 hrs by Western blot analysis	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cncc(N5CCOCC5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL4091628		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Dose-dependent effect	18002394	CHEMBL4002788	Inhibition of FGFR2 in FGFR2-amplified human SNU16 cells assessed as suppression of phosphorylated PLCgamma after 2 hrs by Western blot analysis	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cncc(N5CCOCC5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL4091628		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Dose-dependent effect	18002395	CHEMBL4002789	Inhibition of FGFR2 in FGFR2-amplified human SNU16 cells assessed as suppression of phosphorylated ERK after 2 hrs by Western blot analysis	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cncc(N5CCOCC5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL4091628		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	18012386	CHEMBL4004206	Inhibition of recombinant human N-terminal GST-tagged FGFR2 cytoplasmic domain (399 to 821 residues) expressed in baculovirus expression system	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12		CHEMBL3822972	>	IC50	nM	50000.0	CHEMBL4142	Homo sapiens	IC50	uM	50.0
	18052955	CHEMBL4011860	Inhibition of FGFR2 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-5.9	CHEMBL4142	Homo sapiens	INH	%	-5.9
	18064115	CHEMBL4013817	Inhibition of human FGFR2 preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)NCc1cccc(Cn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL4101091	=	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18064116	CHEMBL4013817	Inhibition of human FGFR2 preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(Cn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)cc1		CHEMBL4065736	=	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18064117	CHEMBL4013817	Inhibition of human FGFR2 preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1cccc(CCn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL4093349	=	IC50	nM	369.0	CHEMBL4142	Homo sapiens	IC50	nM	369.0
	18064118	CHEMBL4013817	Inhibition of human FGFR2 preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)Nc1ccc(CCn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)cc1		CHEMBL4103536	=	IC50	nM	34.0	CHEMBL4142	Homo sapiens	IC50	nM	34.0
	18064129	CHEMBL4013821	Inhibition of human FGFR2 at 1 uM preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method relative to control	B	C=CC(=O)NCc1cccc(Cn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL4101091	=	Inhibition	%	66.0	CHEMBL4142	Homo sapiens	INH	%	66.0
	18064130	CHEMBL4013821	Inhibition of human FGFR2 at 1 uM preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method relative to control	B	C=CC(=O)Nc1ccc(Cn2c(=O)c(-c3ccccc3Cl)cc3cnc(NCCCCN(CC)CC)nc32)cc1		CHEMBL4065736	=	Inhibition	%	58.0	CHEMBL4142	Homo sapiens	INH	%	58.0
	18064294	CHEMBL4013849	Inhibition of human FGFR2 at 1 uM preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method relative to control	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	>	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
Active	18064336	CHEMBL4013891	Time dependent inhibition of human FGFR2 preincubated with enzyme followed by peptide substrate addition by caliper capillary electrophoresis method	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509		TDI			CHEMBL4142	Homo sapiens	TDI		
	18064340	CHEMBL4013895	Irreversible inhibition of human FGFR2 preincubated with enzyme followed by peptide substrate addition by caliper capillary electrophoresis method	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	Kinact	/s	0.00092	CHEMBL4142	Homo sapiens	Kinact	/s	0.00092
	18064344	CHEMBL4013899	Ratio of Kinact to Ki for human FGFR2	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	Ratio	/uM/s	0.75	CHEMBL4142	Homo sapiens	Ratio	/uM/s	0.75
	18064368	CHEMBL4013817	Inhibition of human FGFR2 preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	IC50	nM	1.3	CHEMBL4142	Homo sapiens	IC50	nM	1.3
	18064372	CHEMBL4013821	Inhibition of human FGFR2 at 1 uM preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method relative to control	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	>	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	18064378	CHEMBL4013895	Irreversible inhibition of human FGFR2 preincubated with enzyme followed by peptide substrate addition by caliper capillary electrophoresis method	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	Ki	nM	1.3	CHEMBL4142	Homo sapiens	Ki	nM	1.3
	18085856	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)cc(F)c3O)cc12		CHEMBL4077448	=	IC50	nM	3.4	CHEMBL4142	Homo sapiens	IC50	nM	3.4
	18085857	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)c(F)cc3O)cc12		CHEMBL4074407	=	IC50	nM	2.8	CHEMBL4142	Homo sapiens	IC50	nM	2.8
	18085858	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccc(F)c3O)cc12		CHEMBL4076118	=	IC50	nM	2.5	CHEMBL4142	Homo sapiens	IC50	nM	2.5
	18085859	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccc(F)cc3O)cc12		CHEMBL4075917	=	IC50	nM	4.7	CHEMBL4142	Homo sapiens	IC50	nM	4.7
	18085860	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	=	IC50	nM	1.6	CHEMBL4142	Homo sapiens	IC50	nM	1.6
	18085861	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(C(C)C)ccc3O)cc12		CHEMBL4102355	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18085862	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1ccc(O)c(-c2ncc(N[C@@H](CO)c3ccccc3)cc2-c2ccc3[nH]nc(C)c3c2)c1		CHEMBL4084388	=	IC50	nM	16.1	CHEMBL4142	Homo sapiens	IC50	nM	16.1
	18085863	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(NC[C@H](O)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4095830	=	IC50	nM	71.9	CHEMBL4142	Homo sapiens	IC50	nM	71.9
	18085864	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(NCCCO)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4068491	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18085865	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(NCCO)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4100109	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18085866	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](C)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4101681	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18085867	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4091460	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18085868	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3[nH]ccc3c2)c1)c1ccccc1		CHEMBL4075768	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18085869	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(=O)Nc1ccc(-c2cc(N[C@@H](CO)c3ccccc3)cnc2-c2cc(Cl)ccc2O)cc1		CHEMBL4063010	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18085870	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	O=C1Cc2cc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)ccc2N1		CHEMBL4077119	=	IC50	nM	153.5	CHEMBL4142	Homo sapiens	IC50	nM	153.5
	18085871	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3cnccc3c2)c1)c1ccccc1		CHEMBL4067871	=	IC50	nM	2.0	CHEMBL4142	Homo sapiens	IC50	nM	2.0
	18085872	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ncc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4082721	=	IC50	nM	6.6	CHEMBL4142	Homo sapiens	IC50	nM	6.6
	18085873	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	1.1	CHEMBL4142	Homo sapiens	IC50	nM	1.1
	18085874	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4105329	=	IC50	nM	8.6	CHEMBL4142	Homo sapiens	IC50	nM	8.6
	18085875	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccc(O)c3)cc12		CHEMBL4100031	=	IC50	nM	21.4	CHEMBL4142	Homo sapiens	IC50	nM	21.4
	18085876	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	COc1ccccc1-c1ncc(N[C@@H](CO)c2ccccc2)cc1-c1ccc2[nH]nc(C)c2c1		CHEMBL4082023	=	IC50	nM	100.0	CHEMBL4142	Homo sapiens	IC50	nM	100.0
	18085877	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3O)cc12		CHEMBL4073545	=	IC50	nM	3.0	CHEMBL4142	Homo sapiens	IC50	nM	3.0
	18085878	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3C(N)=O)cc12		CHEMBL4094883	=	IC50	nM	72.9	CHEMBL4142	Homo sapiens	IC50	nM	72.9
	18085879	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3CO)cc12		CHEMBL4084547	=	IC50	nM	50.5	CHEMBL4142	Homo sapiens	IC50	nM	50.5
	18085880	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	CC(=O)Nc1ccccc1-c1ncc(N[C@@H](CO)c2ccccc2)cc1-c1ccc2[nH]nc(C)c2c1		CHEMBL4062871	=	IC50	nM	250.2	CHEMBL4142	Homo sapiens	IC50	nM	250.2
	18085881	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3C(F)(F)F)cc12		CHEMBL4092280	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18085882	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3F)cc12		CHEMBL4071491	=	IC50	nM	44.6	CHEMBL4142	Homo sapiens	IC50	nM	44.6
	18085883	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccc4cc[nH]c34)cc12		CHEMBL4060706	=	IC50	nM	56.4	CHEMBL4142	Homo sapiens	IC50	nM	56.4
	18085884	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccc4cccnc34)cc12		CHEMBL4082577	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18085885	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccnc3)cc12		CHEMBL4064545	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18085886	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3)cc12		CHEMBL4086068	=	IC50	nM	26.3	CHEMBL4142	Homo sapiens	IC50	nM	26.3
	18085887	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccs3)cc12		CHEMBL4102447	=	IC50	nM	100.0	CHEMBL4142	Homo sapiens	IC50	nM	100.0
	18085888	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccsc3)cc12		CHEMBL4078176	=	IC50	nM	56.9	CHEMBL4142	Homo sapiens	IC50	nM	56.9
	18085889	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccco3)cc12		CHEMBL4083543	=	IC50	nM	100.0	CHEMBL4142	Homo sapiens	IC50	nM	100.0
	18085890	CHEMBL4018626	Inhibition of recombinant human FGFR2 using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccoc3)cc12		CHEMBL4101542	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18086077	CHEMBL4018686	Inhibition of FGFR2 in human KATO III cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	14.1	CHEMBL4142	Homo sapiens	IC50	nM	14.1
	18086078	CHEMBL4018686	Inhibition of FGFR2 in human KATO III cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	=	IC50	nM	155.7	CHEMBL4142	Homo sapiens	IC50	nM	155.7
	18086089	CHEMBL4018695	Inhibition of FGFR2 in human SNU16 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3)cc12		CHEMBL4086068	=	IC50	nM	677.7	CHEMBL4142	Homo sapiens	IC50	nM	677.7
	18086090	CHEMBL4018695	Inhibition of FGFR2 in human SNU16 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccccc3O)cc12		CHEMBL4073545	=	IC50	nM	57.5	CHEMBL4142	Homo sapiens	IC50	nM	57.5
	18086091	CHEMBL4018695	Inhibition of FGFR2 in human SNU16 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccc(O)c3)cc12		CHEMBL4100031	=	IC50	nM	36.2	CHEMBL4142	Homo sapiens	IC50	nM	36.2
	18086092	CHEMBL4018695	Inhibition of FGFR2 in human SNU16 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4105329	=	IC50	nM	24.8	CHEMBL4142	Homo sapiens	IC50	nM	24.8
	18086093	CHEMBL4018695	Inhibition of FGFR2 in human SNU16 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	25.4	CHEMBL4142	Homo sapiens	IC50	nM	25.4
	18086094	CHEMBL4018695	Inhibition of FGFR2 in human SNU16 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	Cc1n[nH]c2ncc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4082721	=	IC50	nM	2281.3	CHEMBL4142	Homo sapiens	IC50	nM	2281.3
	18086095	CHEMBL4018695	Inhibition of FGFR2 in human SNU16 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3cnccc3c2)c1)c1ccccc1		CHEMBL4067871	=	IC50	nM	249.0	CHEMBL4142	Homo sapiens	IC50	nM	249.0
	18086096	CHEMBL4018695	Inhibition of FGFR2 in human SNU16 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	=	IC50	nM	24.8	CHEMBL4142	Homo sapiens	IC50	nM	24.8
	18086097	CHEMBL4018695	Inhibition of FGFR2 in human SNU16 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccc(F)cc3O)cc12		CHEMBL4075917	=	IC50	nM	313.3	CHEMBL4142	Homo sapiens	IC50	nM	313.3
	18086098	CHEMBL4018695	Inhibition of FGFR2 in human SNU16 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cccc(F)c3O)cc12		CHEMBL4076118	=	IC50	nM	293.5	CHEMBL4142	Homo sapiens	IC50	nM	293.5
	18086099	CHEMBL4018695	Inhibition of FGFR2 in human SNU16 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)c(F)cc3O)cc12		CHEMBL4074407	=	IC50	nM	288.6	CHEMBL4142	Homo sapiens	IC50	nM	288.6
	18086100	CHEMBL4018695	Inhibition of FGFR2 in human SNU16 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)cc(F)c3O)cc12		CHEMBL4077448	=	IC50	nM	280.1	CHEMBL4142	Homo sapiens	IC50	nM	280.1
Dose-dependent effect	18086102	CHEMBL4018698	Inhibition of FGFR2 phosphorylation in human KatoIII cells after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	18086105	CHEMBL4018700	Inhibition of FGFR2 in human KATOIII cells assessed as decrease in phosphorylation of PLCgamma at 0.5 to 2 uM after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	18086109	CHEMBL4018704	Inhibition of FGFR2 in human KATOIII cells assessed as decrease in phosphorylation of ERK at 0.5 to 2 uM after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Dose-dependent effect	18086117	CHEMBL4018719	Inhibition of FGFR2 in human KatoIII cells assessed as decrease in FRS2alpha phosphorylation after 2 hrs by Western blot method	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	18114354	CHEMBL4025140	Inhibition of wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	74.0	CHEMBL4142	Homo sapiens	Activity	%	74.0
	18149651	CHEMBL4033344	Inhibition of human FGFR2 at 0.5 uM relative to control	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(CN5CCOCC5)c(C(F)(F)F)c4)c4ccccc34)c2cc1OC		CHEMBL4075561	>	Inhibition	%	96.0	CHEMBL4142	Homo sapiens	INH	%	96.0
	18172174	CHEMBL4038030	Inhibition of cytoplasmic recombinant human His-tagged FGFR2 (403 to 822 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay	B	CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C6COC6)CC5)c(C)c4)nc32)C1		CHEMBL4066141	=	IC50	nM	27.0	CHEMBL4142	Homo sapiens	IC50	nM	27.0
Not Active	18203440	CHEMBL4043789	Inhibition of FGFR2 in human FGFR2-amplified SUM52 cells assessed as decrease in FGF-induced phosphorylated ERK1/2 expression levels at 100 nM preincubated for 30 mins followed by compound washout and incubated under drug free condition for 120 mins and subsequent FGF stimulation measured after 15 mins by Western blot analysis	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	18203441	CHEMBL4043789	Inhibition of FGFR2 in human FGFR2-amplified SUM52 cells assessed as decrease in FGF-induced phosphorylated ERK1/2 expression levels at 100 nM preincubated for 30 mins followed by compound washout and incubated under drug free condition for 120 mins and subsequent FGF stimulation measured after 15 mins by Western blot analysis	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	18203442	CHEMBL4043789	Inhibition of FGFR2 in human FGFR2-amplified SUM52 cells assessed as decrease in FGF-induced phosphorylated ERK1/2 expression levels at 100 nM preincubated for 30 mins followed by compound washout and incubated under drug free condition for 120 mins and subsequent FGF stimulation measured after 15 mins by Western blot analysis	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccccc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096041		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	18203447	CHEMBL4043786	Inhibition of FGFR2 in human FGFR2-amplified SUM52 cells assessed as decrease in FGF-induced ERK1/2 phosphorylated expression levels at 100 nM preincubated for 30 mins followed by FGF stimulation measured after 15 mins by Western blot analysis	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccccc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096041		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Dose-dependent effect	18203448	CHEMBL4043785	Inhibition of FGFR2 in human FGFR2-amplified SUM52 cells assessed as decrease in FGF-induced FGFR2 phosphorylation levels preincubated for 30 mins followed by FGF stimulation measured after 15 mins by Western blot analysis	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccccc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096041		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Dose-dependent effect	18203449	CHEMBL4043784	Inhibition of FGFR2 in human FGFR2-amplified SUM52 cells assessed as decrease in FGF-induced phosphorylated ERK1/2 expression levels preincubated for 30 mins followed by FGF stimulation measured after 15 mins by Western blot analysis	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccccc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096041		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	18203509	CHEMBL4043778	Inhibition of human recombinant cytoplasmic His-tagged FGFR2 (403 to 822 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830	=	IC50	nM	2.29	CHEMBL4142	Homo sapiens	IC50	nM	2.29
	18203510	CHEMBL4043778	Inhibition of human recombinant cytoplasmic His-tagged FGFR2 (403 to 822 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1ccc(Nc2ncc3c(n2)N(C2CCN(C(=O)/C=C/CN(C)C)CC2)C(=O)N(c2c(Cl)c(OC)cc(OC)c2Cl)C3)cc1		CHEMBL4100258	=	IC50	nM	1.21	CHEMBL4142	Homo sapiens	IC50	nM	1.21
	18203511	CHEMBL4043778	Inhibition of human recombinant cytoplasmic His-tagged FGFR2 (403 to 822 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1ccccc1Nc1ncc2c(n1)N(C1CCN(C(=O)/C=C/CN(C)C)CC1)C(=O)N(c1c(Cl)c(OC)cc(OC)c1Cl)C2		CHEMBL4077029	=	IC50	nM	2.73	CHEMBL4142	Homo sapiens	IC50	nM	2.73
	18203512	CHEMBL4043778	Inhibition of human recombinant cytoplasmic His-tagged FGFR2 (403 to 822 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	IC50	nM	1.45	CHEMBL4142	Homo sapiens	IC50	nM	1.45
	18203513	CHEMBL4043778	Inhibition of human recombinant cytoplasmic His-tagged FGFR2 (403 to 822 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4cccc(F)c4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4079538	=	IC50	nM	1.77	CHEMBL4142	Homo sapiens	IC50	nM	1.77
	18203514	CHEMBL4043778	Inhibition of human recombinant cytoplasmic His-tagged FGFR2 (403 to 822 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4cccc(C)c4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4103795	=	IC50	nM	1.65	CHEMBL4142	Homo sapiens	IC50	nM	1.65
	18203515	CHEMBL4043778	Inhibition of human recombinant cytoplasmic His-tagged FGFR2 (403 to 822 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cccc(Nc2ncc3c(n2)N(C2CCN(C(=O)/C=C/CN(C)C)CC2)C(=O)N(c2c(Cl)c(OC)cc(OC)c2Cl)C3)c1		CHEMBL4068733	=	IC50	nM	1.58	CHEMBL4142	Homo sapiens	IC50	nM	1.58
	18203516	CHEMBL4043778	Inhibition of human recombinant cytoplasmic His-tagged FGFR2 (403 to 822 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccccc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096041	=	IC50	nM	0.84	CHEMBL4142	Homo sapiens	IC50	nM	0.84
	18203517	CHEMBL4043778	Inhibition of human recombinant cytoplasmic His-tagged FGFR2 (403 to 822 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(NC4CCOCC4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4060079	=	IC50	nM	2.39	CHEMBL4142	Homo sapiens	IC50	nM	2.39
	18203518	CHEMBL4043778	Inhibition of human recombinant cytoplasmic His-tagged FGFR2 (403 to 822 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(NC4CCCCC4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4088313	=	IC50	nM	1.39	CHEMBL4142	Homo sapiens	IC50	nM	1.39
	18203519	CHEMBL4043778	Inhibition of human recombinant cytoplasmic His-tagged FGFR2 (403 to 822 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(NC4CCOC4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096738	=	IC50	nM	3.63	CHEMBL4142	Homo sapiens	IC50	nM	3.63
	18203520	CHEMBL4043778	Inhibition of human recombinant cytoplasmic His-tagged FGFR2 (403 to 822 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(NC(C)C)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4069509	=	IC50	nM	2.61	CHEMBL4142	Homo sapiens	IC50	nM	2.61
	18203521	CHEMBL4043778	Inhibition of human recombinant cytoplasmic His-tagged FGFR2 (403 to 822 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(N(C)C)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4084614	=	IC50	nM	414.0	CHEMBL4142	Homo sapiens	IC50	nM	414.0
	18203522	CHEMBL4043778	Inhibition of human recombinant cytoplasmic His-tagged FGFR2 (403 to 822 residues) expressed in baculovirus using Tyr-4 peptide after 1 hr by FRET-based Z'-Lyte assay	B	CNc1ncc2c(n1)N(C1CCN(C(=O)/C=C/CN(C)C)CC1)C(=O)N(c1c(Cl)c(OC)cc(OC)c1Cl)C2		CHEMBL4092354	=	IC50	nM	1.62	CHEMBL4142	Homo sapiens	IC50	nM	1.62
	18203664	CHEMBL4043951	Inhibition of wild-type human partial length FGFR2 (D457 to E769 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	2.0	CHEMBL4142	Homo sapiens	Activity	%	2.0
Active	18203981	CHEMBL4044268	Inhibition of FGFR2 in human FGFR2-amplified SUM52 cells assessed as decrease in FGF-induced FGFR2 phosphorylated expression levels at 100 nM preincubated for 30 mins followed by FGF stimulation measured after 15 mins by Western blot analysis	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccccc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096041		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	18203983	CHEMBL4044270	Inhibition of FGFR2 in human FGFR2-amplified SUM52 cells assessed as decrease in FGF-induced FGFR2 phosphorylated expression levels at 100 nM preincubated for 30 mins followed by compound washout and incubated under drug free condition for 120 mins and subsequent FGF stimulation measured after 15 mins by Western blot analysis	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccccc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4096041		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	18203984	CHEMBL4044270	Inhibition of FGFR2 in human FGFR2-amplified SUM52 cells assessed as decrease in FGF-induced FGFR2 phosphorylated expression levels at 100 nM preincubated for 30 mins followed by compound washout and incubated under drug free condition for 120 mins and subsequent FGF stimulation measured after 15 mins by Western blot analysis	B	C=CC(=O)Nc1cccc(CN2C(=O)N(c3c(Cl)c(OC)cc(OC)c3Cl)Cc3cnc(NCCCCN(CC)CC)nc32)c1		CHEMBL2216830		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Not Active	18203985	CHEMBL4044270	Inhibition of FGFR2 in human FGFR2-amplified SUM52 cells assessed as decrease in FGF-induced FGFR2 phosphorylated expression levels at 100 nM preincubated for 30 mins followed by compound washout and incubated under drug free condition for 120 mins and subsequent FGF stimulation measured after 15 mins by Western blot analysis	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	18253813	CHEMBL4055191	Inhibition of wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL4142	Homo sapiens	Activity	%	100.0
	18253814	CHEMBL4055191	Inhibition of wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	89.0	CHEMBL4142	Homo sapiens	Activity	%	89.0
	18264500	CHEMBL4056996	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5cccc(OC)c5F)c(F)cc34)cc2)CC1		CHEMBL4079317	=	IC50	nM	9.5	CHEMBL4142	Homo sapiens	IC50	nM	9.5
	18264501	CHEMBL4056996	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5cccc(OC)c5F)cc(F)c34)cc2)CC1		CHEMBL4105046	=	IC50	nM	132.7	CHEMBL4142	Homo sapiens	IC50	nM	132.7
	18264502	CHEMBL4056996	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COc1cccc(-c2ccc3c(NC(=O)c4ccc(N5CCN(C)CC5)c(F)c4)n[nH]c3c2)c1F		CHEMBL4087200	=	IC50	nM	108.5	CHEMBL4142	Homo sapiens	IC50	nM	108.5
	18264503	CHEMBL4056996	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COc1cccc(-c2ccc3c(NC(=O)c4ccc(N5CCN(C)CC5)cc4F)n[nH]c3c2)c1F		CHEMBL4092994	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18264504	CHEMBL4056996	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5cccc(OC)c5F)ccc34)cc2C(F)(F)F)CC1		CHEMBL4072232	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18264505	CHEMBL4056996	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5c(F)cc(F)c(OC)c5F)ccc34)cc2)CC1		CHEMBL4076490	=	IC50	nM	35.1	CHEMBL4142	Homo sapiens	IC50	nM	35.1
	18264506	CHEMBL4056996	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COCCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5c(F)cc(F)c(OC)c5F)ccc34)cc2)CC1		CHEMBL4099060	=	IC50	nM	91.0	CHEMBL4142	Homo sapiens	IC50	nM	91.0
	18264507	CHEMBL4056996	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5c(F)ccc(OC)c5F)ccc34)cc2)CC1		CHEMBL4105407	=	IC50	nM	2.0	CHEMBL4142	Homo sapiens	IC50	nM	2.0
	18264508	CHEMBL4056996	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COc1ccc(F)c(-c2ccc3c(NC(=O)c4ccc(N5C[C@H](C)N[C@H](C)C5)cc4)n[nH]c3c2)c1F		CHEMBL4081153	=	IC50	nM	7.0	CHEMBL4142	Homo sapiens	IC50	nM	7.0
	18264509	CHEMBL4056996	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COc1ccc(F)c(-c2ccc3c(NC(=O)c4ccc(N5CCCN(C)CC5)cc4)n[nH]c3c2)c1F		CHEMBL4086560	=	IC50	nM	2.0	CHEMBL4142	Homo sapiens	IC50	nM	2.0
	18264510	CHEMBL4056996	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COc1ccc(F)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(C(C)=O)CC5)cc4)n[nH]c3c2)c1F		CHEMBL4104460	=	IC50	nM	2.9	CHEMBL4142	Homo sapiens	IC50	nM	2.9
	18264511	CHEMBL4056996	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COCCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5c(F)ccc(OC)c5F)ccc34)cc2)CC1		CHEMBL4078715	=	IC50	nM	16.6	CHEMBL4142	Homo sapiens	IC50	nM	16.6
	18264512	CHEMBL4056996	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COc1ccc(F)c(-c2ccc3c(NC(=O)c4ccc(N5CCN(C)CC5)cc4)n[nH]c3c2)c1F		CHEMBL4096740	<	IC50	nM	4.1	CHEMBL4142	Homo sapiens	IC50	nM	4.1
	18264513	CHEMBL4056996	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COc1ccc(F)c(-c2ccc3c(NC(=O)c4ccc(N(C)CCN(C)C)cc4)n[nH]c3c2)c1F		CHEMBL4090974	=	IC50	nM	35.1	CHEMBL4142	Homo sapiens	IC50	nM	35.1
	18264514	CHEMBL4056996	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	CCN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(-c5cccc(OC)c5F)ccc34)cc2)CC1		CHEMBL4076610	=	IC50	nM	4.0	CHEMBL4142	Homo sapiens	IC50	nM	4.0
	18264515	CHEMBL4056996	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA based spectrophotometric analysis	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	0.6	CHEMBL4142	Homo sapiens	IC50	nM	0.6
	18265789	CHEMBL4057239	Inhibition of FGFR2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	21.7	CHEMBL4142	Homo sapiens	INH	%	21.7
	18265790	CHEMBL4057240	Inhibition of FGFR2 N549H mutant (unknown origin) at 0.45 uM	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	40.0	CHEMBL4142	Homo sapiens	INH	%	40.0
	18266049	CHEMBL4057499	Inhibition of FGFR2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-0.7	CHEMBL4142	Homo sapiens	INH	%	-0.7
	18266050	CHEMBL4057500	Inhibition of FGFR2 N549H mutant (unknown origin) at 0.49 uM	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	18282800	CHEMBL4120385	Inhibition of FGFR2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	21.7	CHEMBL4142	Homo sapiens	INH	%	21.7
	18282817	CHEMBL4120402	Inhibition of FGFR2 N549H mutant (unknown origin) at 0.45 uM	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	40.0	CHEMBL4142	Homo sapiens	INH	%	40.0
	18282969	CHEMBL4120554	Inhibition of FGFR2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	4.0	CHEMBL4142	Homo sapiens	INH	%	4.0
	18283193	CHEMBL4120778	Inhibition of FGFR2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-5.3	CHEMBL4142	Homo sapiens	INH	%	-5.3
	18283268	CHEMBL4120853	Inhibition of FGFR2 N549H mutant (unknown origin) at 0.164 uM	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-3.3	CHEMBL4142	Homo sapiens	INH	%	-3.3
	18283309	CHEMBL4120893	Inhibition of FGFR2 N549H mutant (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	19.7	CHEMBL4142	Homo sapiens	INH	%	19.7
	18333456	CHEMBL4136630	Inhibition of recombinant human His-tagged FGFR2 cytoplasmic domain (403 to 822 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	B	CCOc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4172184	=	IC50	nM	800.0	CHEMBL4142	Homo sapiens	IC50	uM	0.8
	18333457	CHEMBL4136630	Inhibition of recombinant human His-tagged FGFR2 cytoplasmic domain (403 to 822 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	B	Oc1ccc(-c2ccc3cn[nH]c3c2)cc1		CHEMBL4061296	=	IC50	nM	3000.0	CHEMBL4142	Homo sapiens	IC50	uM	3.0
	18333458	CHEMBL4136630	Inhibition of recombinant human His-tagged FGFR2 cytoplasmic domain (403 to 822 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	B	CCOc1cc(F)cc(-c2ccc3cn[nH]c3c2)c1		CHEMBL4163123	=	IC50	nM	12000.0	CHEMBL4142	Homo sapiens	IC50	uM	12.0
	18333459	CHEMBL4136630	Inhibition of recombinant human His-tagged FGFR2 cytoplasmic domain (403 to 822 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	B	CCOc1cccc(-c2ccc3cn[nH]c3c2)c1F		CHEMBL4171043	=	IC50	nM	6400.0	CHEMBL4142	Homo sapiens	IC50	uM	6.4
	18333460	CHEMBL4136630	Inhibition of recombinant human His-tagged FGFR2 cytoplasmic domain (403 to 822 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	B	CCOc1ccc(F)c(-c2ccc3cn[nH]c3c2)c1F		CHEMBL4173432	=	IC50	nM	52000.0	CHEMBL4142	Homo sapiens	IC50	uM	52.0
	18333461	CHEMBL4136630	Inhibition of recombinant human His-tagged FGFR2 cytoplasmic domain (403 to 822 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	B	Oc1ccc(-c2ccc3cn[nH]c3c2)c(F)c1		CHEMBL4162722	=	IC50	nM	5400.0	CHEMBL4142	Homo sapiens	IC50	uM	5.4
	18333462	CHEMBL4136630	Inhibition of recombinant human His-tagged FGFR2 cytoplasmic domain (403 to 822 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	B	Oc1ccc(-c2ccc3cn[nH]c3c2)cc1F		CHEMBL4169984	=	IC50	nM	7300.0	CHEMBL4142	Homo sapiens	IC50	uM	7.3
Not Determined	18333463	CHEMBL4136630	Inhibition of recombinant human His-tagged FGFR2 cytoplasmic domain (403 to 822 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	B	Cc1cc(O)ccc1-c1ccc2cn[nH]c2c1		CHEMBL4159347		IC50			CHEMBL4142	Homo sapiens	IC50		
Not Determined	18333464	CHEMBL4136630	Inhibition of recombinant human His-tagged FGFR2 cytoplasmic domain (403 to 822 residues) expressed in baculovirus expression system using Tyr 04 as substrate measured after 1 hr by Z'-LYTE assay	B	Cc1cc(-c2ccc3cn[nH]c3c2)ccc1O		CHEMBL4171437		IC50			CHEMBL4142	Homo sapiens	IC50		
	18333477	CHEMBL4136634	Inhibition of FGFR2 (unknown origin)	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	=	IC50	nM	7.6	CHEMBL4142	Homo sapiens	IC50	nM	7.6
	18440206	CHEMBL4157030	Binding affinity to wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	83.0	CHEMBL4142	Homo sapiens	Activity	%	83.0
	18484646	CHEMBL4185809	Binding affinity to wild-type human partial length FGFR2 (D457 to E769 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	89.0	CHEMBL4142	Homo sapiens	Activity	%	89.0
	18484983	CHEMBL4185809	Binding affinity to wild-type human partial length FGFR2 (D457 to E769 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	88.0	CHEMBL4142	Homo sapiens	Activity	%	88.0
	18489513	CHEMBL4187254	Inhibition of wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	90.0	CHEMBL4142	Homo sapiens	Activity	%	90.0
	18507789	CHEMBL4190973	Inhibition of recombinant human FGFR2 N549H mutant (456 to 770 residues) at 1 uM using GGEEEEYFELVKKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	70.0	CHEMBL4142	Homo sapiens	INH	%	70.0
	18507790	CHEMBL4190972	Inhibition of recombinant human FGFR2 (456 to 770 residues) at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	17.0	CHEMBL4142	Homo sapiens	INH	%	17.0
	18558675	CHEMBL4201078	Inhibition of human FGFR2 at 1 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	Inhibition	%	93.5	CHEMBL4142	Homo sapiens	INH	%	93.5
	18653635	CHEMBL4230086	Inhibition of FGFR2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	99.0	CHEMBL4142	Homo sapiens	INH	%	99.0
	18653636	CHEMBL4230086	Inhibition of FGFR2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	96.0	CHEMBL4142	Homo sapiens	INH	%	96.0
	18655526	CHEMBL4230709	Binding affinity to wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	80.0	CHEMBL4142	Homo sapiens	Activity	%	80.0
	18663909	CHEMBL4232893	Inhibition of partial length human FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	76.0	CHEMBL4142	Homo sapiens	Activity	%	76.0
	18664006	CHEMBL4232990	Binding affinity to partial length human FGFR2 (D457 to E769 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL4142	Homo sapiens	Kd	uM	5.0
	18665424	CHEMBL4233323	Inhibition of FGFR2 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18674667	CHEMBL4235356	Inhibition of FGFR2 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL4142	Homo sapiens	Ki	nM	2000.0
	18674668	CHEMBL4235356	Inhibition of FGFR2 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL4142	Homo sapiens	Ki	nM	2000.0
Not Determined	18674669	CHEMBL4235356	Inhibition of FGFR2 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL4142	Homo sapiens	Ki		
	18745401	CHEMBL4262864	Inhibition of phosphorylated FGFR2 (406 to 821 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	O=Cc1ccc2cccc(C(=O)Nc3ccc(C(F)(F)F)cn3)c2n1		CHEMBL4277111	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	18745402	CHEMBL4262864	Inhibition of phosphorylated FGFR2 (406 to 821 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	O=[N+]([O-])c1ccc(Cl)nc1Nc1ncc(C(F)(F)F)cc1Cl		CHEMBL4294665	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	18745403	CHEMBL4262864	Inhibition of phosphorylated FGFR2 (406 to 821 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	C=CC(=O)Nc1ccccc1C(=O)Nc1cc(CCc2cc(OC)cc(OC)c2)[nH]n1		CHEMBL4284069	=	IC50	nM	2.2	CHEMBL4142	Homo sapiens	IC50	nM	2.2
	18745404	CHEMBL4262864	Inhibition of phosphorylated FGFR2 (406 to 821 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	CC(C)COc1cc(N2CCC(N(C)C)CC2)ccc1Nc1ncc(C#N)c(N[C@H]2[C@@H](C(N)=O)[C@@H]3C=C[C@H]2C3)n1		CHEMBL4279514	=	IC50	nM	363.0	CHEMBL4142	Homo sapiens	IC50	nM	363.0
Not Determined	18745405	CHEMBL4262864	Inhibition of phosphorylated FGFR2 (406 to 821 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032		IC50			CHEMBL4142	Homo sapiens	IC50		
	18745406	CHEMBL4262864	Inhibition of phosphorylated FGFR2 (406 to 821 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	CC(C)Oc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL2403844	=	IC50	nM	4433.0	CHEMBL4142	Homo sapiens	IC50	nM	4433.0
	18745407	CHEMBL4262864	Inhibition of phosphorylated FGFR2 (406 to 821 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	=	IC50	nM	1700.0	CHEMBL4142	Homo sapiens	IC50	nM	1700.0
	18745408	CHEMBL4262864	Inhibition of phosphorylated FGFR2 (406 to 821 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	1.1	CHEMBL4142	Homo sapiens	IC50	nM	1.1
	18745409	CHEMBL4262864	Inhibition of phosphorylated FGFR2 (406 to 821 residues) (unknown origin) using 5-Fluo-Ahx-EEPLYWSFPAKKKCONH2 as substrate after 60 mins by microfluidic mobility shift assay	A	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1		CHEMBL1852688	=	IC50	nM	1.2	CHEMBL4142	Homo sapiens	IC50	nM	1.2
	18751110	CHEMBL4263804	Inhibition of FGFR2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	26.0	CHEMBL4142	Homo sapiens	INH	%	26.0
	18751605	CHEMBL4264298	Binding affinity to wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	93.0	CHEMBL4142	Homo sapiens	Activity	%	93.0
	18761511	CHEMBL4266564	Inhibition of recombinant human N-terminal His6-tagged FGFR2 (456 to 770 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	1.0	CHEMBL4142	Homo sapiens	INH	%	1.0
	18761782	CHEMBL4266564	Inhibition of recombinant human N-terminal His6-tagged FGFR2 (456 to 770 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	1.0	CHEMBL4142	Homo sapiens	INH	%	1.0
	18761945	CHEMBL4266564	Inhibition of recombinant human N-terminal His6-tagged FGFR2 (456 to 770 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	3.0	CHEMBL4142	Homo sapiens	INH	%	3.0
	18763717	CHEMBL4266998	Inhibition of FGFR2 (unknown origin)	B	CN1CCN(c2ccc(-c3c(-c4cc(F)c(O)c(F)c4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4292020	<	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	uM	1.0
	18765525	CHEMBL4267266	Inhibition of N-terminal GST-tagged human FGFR2 cytoplasmic domain (399 to 821 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(Nc3cc(OC)ccc3OC)ncn2)c1		CHEMBL4288300	=	Inhibition	%	9.8	CHEMBL4142	Homo sapiens	INH	%	9.8
	18765526	CHEMBL4267266	Inhibition of N-terminal GST-tagged human FGFR2 cytoplasmic domain (399 to 821 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)cc1		CHEMBL4283823	=	Inhibition	%	8.3	CHEMBL4142	Homo sapiens	INH	%	8.3
	18765527	CHEMBL4267266	Inhibition of N-terminal GST-tagged human FGFR2 cytoplasmic domain (399 to 821 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1		CHEMBL4282460	=	Inhibition	%	16.5	CHEMBL4142	Homo sapiens	INH	%	16.5
	18765528	CHEMBL4267266	Inhibition of N-terminal GST-tagged human FGFR2 cytoplasmic domain (399 to 821 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)c1ccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)cc1		CHEMBL4290750	=	Inhibition	%	7.2	CHEMBL4142	Homo sapiens	INH	%	7.2
	18765529	CHEMBL4267266	Inhibition of N-terminal GST-tagged human FGFR2 cytoplasmic domain (399 to 821 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)c1		CHEMBL4294156	=	Inhibition	%	21.4	CHEMBL4142	Homo sapiens	INH	%	21.4
	18765530	CHEMBL4267266	Inhibition of N-terminal GST-tagged human FGFR2 cytoplasmic domain (399 to 821 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(N2CCOCC2)ncn1		CHEMBL4283970	=	Inhibition	%	5.9	CHEMBL4142	Homo sapiens	INH	%	5.9
	18786380	CHEMBL4271711	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)c3)ccc12		CHEMBL4290371	=	IC50	nM	4.5	CHEMBL4142	Homo sapiens	IC50	nM	4.5
	18786399	CHEMBL4271730	Inhibition of FGFR2 (unknown origin)	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	IC50	nM	82.5	CHEMBL4142	Homo sapiens	IC50	nM	82.5
	18786402	CHEMBL4271733	Inhibition of human N-terminal GST-tagged FGFR2 (399 to 821 residues) cytoplasmic domain expressed in baculovirus expression system after 60 mins by off-chip mobility shift assay	B	CNC(=O)n1ccc2cc(Oc3ccnc(NC(=O)c4ccc(C5CCN(CCO)CC5)cc4)c3)c(OCCO)cc21		CHEMBL4294625	=	IC50	nM	0.5	CHEMBL4142	Homo sapiens	IC50	nM	0.5
Not Active	18847318	CHEMBL4304902	Inhibition of wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	18854795	CHEMBL4307249	Inhibition of FGFR2 (unknown origin) relative to control	B	COc1cc(/C=C/C(=O)O)ccc1O		CHEMBL32749	=	Inhibition	%	64.0	CHEMBL4142	Homo sapiens	INH	%	64.0
	18857967	CHEMBL4307813	Binding affinity to wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL4142	Homo sapiens	Activity	%	100.0
	18885080	CHEMBL4313068	Inhibition of human FGFR2 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835	=	IC50	nM	1.5	CHEMBL4142	Homo sapiens	IC50	nM	1.5
	18885081	CHEMBL4313068	Inhibition of human FGFR2 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	C=CC(=O)NCc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4541330	=	IC50	nM	6.6	CHEMBL4142	Homo sapiens	IC50	nM	6.6
	18885082	CHEMBL4313068	Inhibition of human FGFR2 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	0.4	CHEMBL4142	Homo sapiens	IC50	nM	0.4
	18885083	CHEMBL4313068	Inhibition of human FGFR2 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(Cl)cc3c2C)cc1		CHEMBL4467025	=	IC50	nM	1.1	CHEMBL4142	Homo sapiens	IC50	nM	1.1
	18885084	CHEMBL4313068	Inhibition of human FGFR2 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	Cc1ccc2oc(-c3c4c(N)n[nH]c(=O)c4nn3-c3ccc(NC(=O)/C=C/CN(C)C)cc3)c(C)c2c1		CHEMBL4463714	=	IC50	nM	1.9	CHEMBL4142	Homo sapiens	IC50	nM	1.9
	18885085	CHEMBL4313068	Inhibition of human FGFR2 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	Cc1ccc2oc(-c3c4c(N)n[nH]c(=O)c4nn3-c3ccc(NC(=O)/C=C/CN4CCOCC4)cc3)c(C)c2c1		CHEMBL4447110	=	IC50	nM	8.0	CHEMBL4142	Homo sapiens	IC50	nM	8.0
	18885086	CHEMBL4313068	Inhibition of human FGFR2 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	Cc1c(-c2c3c(N)n[nH]c(=O)c3nn2-c2ccc(NC(=O)/C=C/CN(C)C)cc2)oc2ccc(Cl)cc12		CHEMBL4462946	=	IC50	nM	7.2	CHEMBL4142	Homo sapiens	IC50	nM	7.2
	18885087	CHEMBL4313068	Inhibition of human FGFR2 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	B	Cc1c(-c2c3c(N)n[nH]c(=O)c3nn2-c2ccc(NC(=O)/C=C/CN(C)C)cc2)oc2ccc(Br)cc12		CHEMBL4448252	=	IC50	nM	2.0	CHEMBL4142	Homo sapiens	IC50	nM	2.0
Active	18885131	CHEMBL4313090	Inhibition of FGFR2 in FGFR2-amplified human SNU16 cells assessed as reduction in ERK phosphorylation at 1 to 100 nM measured after 2 hrs by Western blot analysis	B	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	18885132	CHEMBL4313091	Inhibition of FGFR2 phosphorylation in FGFR2-amplified human SNU16 cells at 1 to 100 nM measured after 2 hrs by Western blot analysis	B	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	18892617	CHEMBL4314684	Inhibition of recombinant human FGFR2 (456 to 770 residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	106.5	CHEMBL4142	Homo sapiens	Activity	%	106.5
	18892618	CHEMBL4314683	Inhibition of recombinant human FGFR2 N549H mutant (456 to 770 residues) assessed as residual activity at 10 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	88.0	CHEMBL4142	Homo sapiens	Activity	%	88.0
	18919427	CHEMBL4322786	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged FGFR2 (unknown origin) (399 to 821 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	242.0	CHEMBL4142	Homo sapiens	Kd	nM	242.0
	18919615	CHEMBL4322786	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged FGFR2 (unknown origin) (399 to 821 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	361.0	CHEMBL4142	Homo sapiens	Kd	nM	361.0
	18930924	CHEMBL4325584	Inhibition of recombinant human N-terminal His6-tagged FGFR2 (456 to 770 residues) expressed in baculovirus infected Sf21 insect cells using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA	B	COc1cc(NC(=O)c2ccc(C)c(C#Cc3cncc4ccccc34)c2)cc(OC)c1		CHEMBL4475726	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18930925	CHEMBL4325584	Inhibition of recombinant human N-terminal His6-tagged FGFR2 (456 to 770 residues) expressed in baculovirus infected Sf21 insect cells using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	18930947	CHEMBL4325605	Inhibition of recombinant human N-terminal His6-tagged FGFR2 (456 to 770 residues) expressed in baculovirus infected Sf21 insect cells at 1000 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	20.7	CHEMBL4142	Homo sapiens	INH	%	20.7
	18930971	CHEMBL4325629	Inhibition of recombinant human N-terminal His6-tagged FGFR2 (456 to 770 residues) expressed in baculovirus infected Sf21 insect cells at 100 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	16.2	CHEMBL4142	Homo sapiens	INH	%	16.2
	18937931	CHEMBL4327694	Inhibition of human FGFR2 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	100.86	CHEMBL4142	Homo sapiens	Activity	%	100.86
	18937932	CHEMBL4327694	Inhibition of human FGFR2 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	103.78	CHEMBL4142	Homo sapiens	Activity	%	103.78
	18938536	CHEMBL4328056	Inhibition of human FGFR2 assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4142	Homo sapiens	Activity	%	65.0
	18938914	CHEMBL4328420	Inhibition of human FGFR2 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.09	CHEMBL4142	Homo sapiens	IC50	10'-9M	2.09
	18951025	CHEMBL4331423	Inhibition of human FGFR2 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	Cc1ccc(C(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)cc1NC(=O)C1(c2ncnc3[nH]cnc23)CC1		CHEMBL4466555	=	IC50	nM	39.2	CHEMBL4142	Homo sapiens	IC50	nM	39.2
	18958884	CHEMBL4333403	Binding affinity to wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	99.0	CHEMBL4142	Homo sapiens	Activity	%	99.0
	18964293	CHEMBL4335084	Inhibition of recombinant human FGFR2 (456 to 770 residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	102.0	CHEMBL4142	Homo sapiens	Activity	%	102.0
	18964294	CHEMBL4335084	Inhibition of recombinant human FGFR2 (456 to 770 residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	98.0	CHEMBL4142	Homo sapiens	Activity	%	98.0
	18964295	CHEMBL4335085	Inhibition of recombinant human FGFR2 N549H mutant (456 to 770 residues) assessed as residual activity at 1 uM using GGEEEEYFELVKKKK as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	96.0	CHEMBL4142	Homo sapiens	Activity	%	96.0
	18964296	CHEMBL4335085	Inhibition of recombinant human FGFR2 N549H mutant (456 to 770 residues) assessed as residual activity at 1 uM using GGEEEEYFELVKKKK as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	100.0	CHEMBL4142	Homo sapiens	Activity	%	100.0
	18971901	CHEMBL4336911	Inhibition of recombinant human FGFR2 (456 to 770 residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	32.0	CHEMBL4142	Homo sapiens	Activity	%	32.0
	18971902	CHEMBL4336912	Inhibition of recombinant human FGFR2 N549H mutant (456 to 765 residues) assessed as residual activity at 10 uM using KKKSPGEYVNIEF as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	27.0	CHEMBL4142	Homo sapiens	Activity	%	27.0
	18985720	CHEMBL4340019	Inhibition of FGFR2 (unknown origin)	B	COC[C@@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4475216	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	18989190	CHEMBL4340734	Inhibition of recombinant human N-terminal GST-His6-fused FGFR2 C-terminal domain (R400 to T822 residues) expressed in Sf9 insect cells using TRK-C derived peptide as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12		CHEMBL4446681	=	IC50	nM	23000.0	CHEMBL4142	Homo sapiens	IC50	uM	23.0
	19009316	CHEMBL4345223	Inhibition of wild type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CCN(C)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4531680	>	Inhibition	%	80.0	CHEMBL4142	Homo sapiens	INH	%	80.0
	19021488	CHEMBL4347711	Inhibition of recombinant human FGFR2 at 20 nM using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 15 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	9.0	CHEMBL4142	Homo sapiens	INH	%	9.0
	19021489	CHEMBL4347712	Inhibition of recombinant human FGFR2 at 200 nM using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 15 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	79.0	CHEMBL4142	Homo sapiens	INH	%	79.0
Not Active	19039779	CHEMBL4351863	Inhibition of recombinant human FGFR2 N549H mutant (456 to 770 residues) at 10 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Not Active	19039780	CHEMBL4351862	Inhibition of recombinant human FGFR2 (456 to 770 residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	19041112	CHEMBL4352373	Inhibition of human FGFR2 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	19052183	CHEMBL4355250	Inhibition of FGFR2 (unknown origin)	B	Cc1ccc2c(c1)nc(CCN1C(=O)c3cccc4cccc(c34)C1=O)n2-c1ccncc1		CHEMBL4558162	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	19059586	CHEMBL4357887	Binding affinity to wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	95.0	CHEMBL4142	Homo sapiens	Activity	%	95.0
	19090157	CHEMBL4365731	Inhibition of wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	89.0	CHEMBL4142	Homo sapiens	Activity	%	89.0
	19091929	CHEMBL4366403	Inhibition of human FGFR2 at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	Outside typical range	CHEMBL4528675	=	Inhibition	%	-16.75	CHEMBL4142	Homo sapiens	INH	%	-16.75
	19099836	CHEMBL4368285	Inhibition of recombinant His-tagged FGFR2 (unknown origin) expressed in Escherichia coli BL21 (DE3) measured after 2 hrs by LC-MS/MS analysis relative to control	B	C=CC(=O)Nc1cccc(F)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4102146	=	Inhibition	%	10.0	CHEMBL4142	Homo sapiens	INH	%	10.0
	19099837	CHEMBL4368285	Inhibition of recombinant His-tagged FGFR2 (unknown origin) expressed in Escherichia coli BL21 (DE3) measured after 2 hrs by LC-MS/MS analysis relative to control	B	C=CC(=O)Nc1cc(F)cc(Cl)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4065231	=	Inhibition	%	10.0	CHEMBL4142	Homo sapiens	INH	%	10.0
	19099838	CHEMBL4368285	Inhibition of recombinant His-tagged FGFR2 (unknown origin) expressed in Escherichia coli BL21 (DE3) measured after 2 hrs by LC-MS/MS analysis relative to control	B	C=CC(=O)Nc1cccc(C(F)(F)F)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4094408	=	Inhibition	%	10.0	CHEMBL4142	Homo sapiens	INH	%	10.0
	19099839	CHEMBL4368285	Inhibition of recombinant His-tagged FGFR2 (unknown origin) expressed in Escherichia coli BL21 (DE3) measured after 2 hrs by LC-MS/MS analysis relative to control	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4061083	=	Inhibition	%	10.0	CHEMBL4142	Homo sapiens	INH	%	10.0
	19099840	CHEMBL4368285	Inhibition of recombinant His-tagged FGFR2 (unknown origin) expressed in Escherichia coli BL21 (DE3) measured after 2 hrs by LC-MS/MS analysis relative to control	B	C=CC(=O)N[C@H]1CCOC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4514636	=	Inhibition	%	10.0	CHEMBL4142	Homo sapiens	INH	%	10.0
	19144800	CHEMBL4377816	Inhibition of recombinant human FGFR2 (456 to 770 residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	27.0	CHEMBL4142	Homo sapiens	INH	%	27.0
	19144801	CHEMBL4377817	Inhibition of recombinant human FGFR2 N549H mutant (456 to 770 residues) at 1 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	76.0	CHEMBL4142	Homo sapiens	INH	%	76.0
	19146915	CHEMBL4378877	Inhibition of recombinant human FGFR2 (456 to 770 residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	-4.0	CHEMBL4142	Homo sapiens	INH	%	-4.0
	19147852	CHEMBL4379326	Inhibition of recombinant human FGFR2 (456 to 770 residues) using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	19147853	CHEMBL4379327	Inhibition of recombinant human FGFR2 N549H mutant (456 to 765 residues) using GGEEEEYFELVKK as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	19159414	CHEMBL4382518	Binding affinity to wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	15.0	CHEMBL4142	Homo sapiens	Activity	%	15.0
	19159834	CHEMBL4382846	Inhibition of recombinant FGFR2 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243	=	IC50	nM	0.8	CHEMBL4142	Homo sapiens	IC50	nM	0.8
Active	19159866	CHEMBL4382872	Inhibition of FGFR2 phosphorylation in human SNU16 cells at 0.1 to 10 nM after 2 hrs by Western blot analysis	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	19159867	CHEMBL4382873	Inhibition of FGFR2 in human SNU16 cells assessed as reduction in PLCgamma phosphorylation at 0.1 to 10 nM after 2 hrs by Western blot analysis	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	19159868	CHEMBL4382874	Inhibition of FGFR2 in human SNU16 cells assessed as reduction in ERK phosphorylation at 0.1 to 10 nM after 2 hrs by Western blot analysis	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	19161576	CHEMBL4383422	Inhibition of wild type C-terminal FLAG-tagged human TEL fused FGFR2 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay	B	CN1CCN(Cc2ccc(NC(=O)CCSc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)cc2C(F)(F)F)CC1		CHEMBL4439424	=	GI50	nM	36.0	CHEMBL4142	Homo sapiens	GI50	uM	0.036
	19191593	CHEMBL4389237	Inhibition of wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	24.0	CHEMBL4142	Homo sapiens	INH	%	24.0
	19191900	CHEMBL4389714	Inhibition of wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	54.0	CHEMBL4142	Homo sapiens	INH	%	54.0
	19199882	CHEMBL4391340	Binding affinity to wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	21.0	CHEMBL4142	Homo sapiens	Activity	%	21.0
	19225464	CHEMBL4395884	Inhibition of human recombinant FGFR2 at 1 uM using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 15 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	74.38	CHEMBL4142	Homo sapiens	INH	%	74.38
	19236742	CHEMBL4398815	Inhibition of FGFR2 (unknown origin) at 100 nM relative to control	B	COc1cc2c(Nc3ccc(NC(=O)C(c4cc(F)ccc4F)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL4443483	<	Inhibition	%	25.0	CHEMBL4142	Homo sapiens	INH	%	25.0
	19237280	CHEMBL4398956	Inhibition of FGFR2 (unknown origin) at 10 uM using peptide as substrate incubated for 10 mins by caliper assay relative to control	B	O=C(Nc1nc(NCc2ccc(Cl)cc2)c2nc[nH]c2n1)c1ccccc1		CHEMBL4474543	=	Inhibition	%	7.3	CHEMBL4142	Homo sapiens	INH	%	7.3
	19245625	CHEMBL4400607	Inhibition of human FGFR2 using Poly [E,Y] 4:1 substrate pre-incubated for 15 to 60 mins followed by ATP and [gamma33P]-ATP addition	B	C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3939295	=	IC50	nM	1290.0	CHEMBL4142	Homo sapiens	IC50	uM	1.29
	19245629	CHEMBL4400603	Inhibition of N-terminal GST-fused human FGFR2 cytoplasmic domain (399 to 821(end) amino acids) using CSKtide substrate incubated for 90 mins	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	=	IC50	nM	493.0	CHEMBL4142	Homo sapiens	IC50	nM	493.0
	19245633	CHEMBL4400599	Inhibition of human FGFR2 incubated for 30 mins by time-resolved fluorescence kinase assay	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3545376	=	IC50	nM	2.5	CHEMBL4142	Homo sapiens	IC50	nM	2.5
	19245641	CHEMBL4400591	Inhibition of FGFR2 (unknown origin) using poly[Glu:Tyr] (4:1) substrate and ATP and [gamma33P]-ATP incubated for 30 mins	B	C[C@@H](Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3828009	=	IC50	nM	2.6	CHEMBL4142	Homo sapiens	IC50	nM	2.6
	19245646	CHEMBL4400586	Inhibition of human FGFR2 using poly[Glu:Tyr] (4:1) substrate and ATP and [gamma33P]-ATP	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	2.0	CHEMBL4142	Homo sapiens	IC50	nM	2.0
	19266425	CHEMBL4405375	Inhibition of wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4142	Homo sapiens	INH	%	50.0
	19272025	CHEMBL4406970	Inhibition of wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as enzyme remaining activity at 1000 nM by Kinomescan method relative to control	B	O=C(Nc1cccc(Br)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4465561	=	Activity	%	22.0	CHEMBL4142	Homo sapiens	Activity	%	22.0
	19275995	CHEMBL4407998	Inhibition of recombinant human FGFR2 N549H mutant (456 to 770 residues) at 1 uM using GGEEEEYFELVKKKK as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	7.0	CHEMBL4142	Homo sapiens	INH	%	7.0
	19276177	CHEMBL4408180	Inhibition of recombinant human FGFR2 (456 to 770 residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	4.0	CHEMBL4142	Homo sapiens	INH	%	4.0
	19295872	CHEMBL4412349	Inhibition of FGFR2 (unknown origin) at 1000 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	100.4	CHEMBL4142	Homo sapiens	INH	%	100.4
	19295902	CHEMBL4412379	Inhibition of FGFR2 (unknown origin) at 100 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	95.0	CHEMBL4142	Homo sapiens	INH	%	95.0
	19295932	CHEMBL4412409	Inhibition of FGFR2 (unknown origin) at 10 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	67.8	CHEMBL4142	Homo sapiens	INH	%	67.8
Dose-dependent effect	19295945	CHEMBL4412422	Inhibition of FGFR2 phosphorylation in human SNU-16 cells after 2 hrs by Western blot analysis	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	19295946	CHEMBL4412423	Inhibition of FGFR2 in human SNU-16 cells assessed as decrease in ERK phosphorylation at 25 to 200 nM after 2 hrs by Western blot analysis	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	19295971	CHEMBL4412451	Inhibition of FGFR2 phosphorylation in human SNU-16 cells at 50 nM after 2 hrs by Western blot analysis	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	19319987	CHEMBL4417581	Inhibition of N-terminal GST tagged human FGFR2 cytoplasmic domain (399 to 821 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4548481	=	Inhibition	%	82.51	CHEMBL4142	Homo sapiens	INH	%	82.51
	19406183	CHEMBL4426417	Inhibition of human FGFR2 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COCCN1CCN(c2ccc(C(=O)Nc3n[nH]c4nc(-c5c(Cl)c(OC)cc(OC)c5Cl)ccc34)cc2)CC1		CHEMBL4447359	=	IC50	nM	0.7	CHEMBL4142	Homo sapiens	IC50	nM	0.7
Dose-dependent effect	19406189	CHEMBL4426423	Inhibition of FGFR2 phosphorylation in human KATO III cells after 2 hrs by Western blot analysis	B	COCCN1CCN(c2ccc(C(=O)Nc3n[nH]c4nc(-c5c(Cl)c(OC)cc(OC)c5Cl)ccc34)cc2)CC1		CHEMBL4447359		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Dose-dependent effect	19406190	CHEMBL4426424	Inhibition of FGFR2 in human KATO III cells assessed as suppression of PLCgamma phosphorylation after 2 hrs by Western blot analysis	B	COCCN1CCN(c2ccc(C(=O)Nc3n[nH]c4nc(-c5c(Cl)c(OC)cc(OC)c5Cl)ccc34)cc2)CC1		CHEMBL4447359		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Dose-dependent effect	19406191	CHEMBL4426425	Inhibition of FGFR2 in human KATO III cells assessed as suppression of ERK phosphorylation after 2 hrs by Western blot analysis	B	COCCN1CCN(c2ccc(C(=O)Nc3n[nH]c4nc(-c5c(Cl)c(OC)cc(OC)c5Cl)ccc34)cc2)CC1		CHEMBL4447359		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	19406214	CHEMBL4426417	Inhibition of human FGFR2 using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	0.4	CHEMBL4142	Homo sapiens	IC50	nM	0.4
	19406224	CHEMBL4426439	Inhibition of human FGFR2	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	2.5	CHEMBL4142	Homo sapiens	IC50	nM	2.5
	19476572	CHEMBL4479720	Inhibition of recombinant human His-tagged cytoplasmic FGFR2 expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	70.0	CHEMBL4142	Homo sapiens	IC50	nM	70.0
	19476672	CHEMBL4479720	Inhibition of recombinant human His-tagged cytoplasmic FGFR2 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	170.0	CHEMBL4142	Homo sapiens	IC50	nM	170.0
	19476772	CHEMBL4479720	Inhibition of recombinant human His-tagged cytoplasmic FGFR2 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	11.0	CHEMBL4142	Homo sapiens	IC50	nM	11.0
	19476872	CHEMBL4479720	Inhibition of recombinant human His-tagged cytoplasmic FGFR2 expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	17000.0	CHEMBL4142	Homo sapiens	IC50	nM	17000.0
	20600529	CHEMBL4603481	Inhibition of recombinant His-tagged human FGFR2 (403 to 822 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4142	Homo sapiens	IC50	uM	100.0
	20609534	CHEMBL4605797	Inhibition of FGFR2 (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4ccccc4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4640601	=	IC50	nM	3700.0	CHEMBL4142	Homo sapiens	IC50	uM	3.7
	20609535	CHEMBL4605797	Inhibition of FGFR2 (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COC(=O)Nc1ccc(-c2c(OC3CCN(C)CC3)nc3c(-c4ccc(OC)c(OC)c4)cnn3c2N)cc1		CHEMBL4634073	=	IC50	nM	8.0	CHEMBL4142	Homo sapiens	IC50	uM	0.008
	20609536	CHEMBL4605797	Inhibition of FGFR2 (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4nccs4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4636995	=	IC50	nM	3000.0	CHEMBL4142	Homo sapiens	IC50	uM	3.0
	20683659	CHEMBL4623638	Inhibition of FGFR2 (unknown origin) at 10 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl	Outside typical range	CHEMBL4644985	=	Inhibition	%	-11.0	CHEMBL4142	Homo sapiens	INH	%	-11.0
	20683660	CHEMBL4623639	Inhibition of FGFR2 (unknown origin) at 100 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	0.0	CHEMBL4142	Homo sapiens	INH	%	0.0
	20711795	CHEMBL4629242	Inhibition of N-terminal GST-tagged human FGFR2 cytoplasmic domain (399-821 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1ncnc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)n1		CHEMBL4641667	=	IC50	nM	5.1	CHEMBL4142	Homo sapiens	IC50	nM	5.1
	20711818	CHEMBL4629242	Inhibition of N-terminal GST-tagged human FGFR2 cytoplasmic domain (399-821 end amino acids residues) expressed in baculovirus expression system preincubated for 30 to 120 mins followed by incubation with substrate and ATP for 30 mins by off-chip mobility shift assay	B	CCNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)ncc1NC(=O)c1cc(OC)cc(OC)c1		CHEMBL4642080	=	IC50	nM	3.1	CHEMBL4142	Homo sapiens	IC50	nM	3.1
	22423613	CHEMBL4674382	Inhibition of human FGFR2 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	91.5	CHEMBL4142	Homo sapiens	Activity	%	91.5
	22423614	CHEMBL4674382	Inhibition of human FGFR2 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	72.04	CHEMBL4142	Homo sapiens	Activity	%	72.04
	22425188	CHEMBL4674895	Inhibition of human FGFR2 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	Nc1nc2[nH]c(CN3CCN(c4cc(Cl)cc(Cl)c4)CC3)c(CN3CCN(c4cc(Cl)cc(Cl)c4)CC3)c2c(=O)[nH]1		CHEMBL4790677	=	Inhibition	%	-0.49	CHEMBL4142	Homo sapiens	INH	%	-0.49
	22425189	CHEMBL4674895	Inhibition of human FGFR2 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4ccc(F)cc4)CC3)c(CN3CCN(Cc4ccc(F)cc4)CC3)c2c(=O)[nH]1		CHEMBL4742745	=	Inhibition	%	14.67	CHEMBL4142	Homo sapiens	INH	%	14.67
	22425190	CHEMBL4674895	Inhibition of human FGFR2 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4cccc(F)c4)CC3)c(CN3CCN(Cc4cccc(F)c4)CC3)c2c(=O)[nH]1		CHEMBL4786524	=	Inhibition	%	25.93	CHEMBL4142	Homo sapiens	INH	%	25.93
	22425191	CHEMBL4674895	Inhibition of human FGFR2 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4ccccc4F)CC3)c(CN3CCN(Cc4ccccc4F)CC3)c2c(=O)[nH]1		CHEMBL4788342	=	Inhibition	%	22.99	CHEMBL4142	Homo sapiens	INH	%	22.99
	22425192	CHEMBL4674895	Inhibition of human FGFR2 at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4ccccc4)CC3)c(CN3CCN(Cc4ccccc4)CC3)c2c(=O)[nH]1		CHEMBL4787439	=	Inhibition	%	24.04	CHEMBL4142	Homo sapiens	INH	%	24.04
	22446618	CHEMBL4679673	Inhibition of wild type FGFR2 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR2-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)N1CCC(c2ccc(-c3nc(Nc4cc(C)[nH]n4)cc(N4CCN(C)CC4)n3)cc2)CC1		CHEMBL4783926	=	GI50	nM	11.2	CHEMBL4142	Homo sapiens	GI50	nM	11.2
	22446619	CHEMBL4679673	Inhibition of wild type FGFR2 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in FGFR2-induced cell viability after 72 hrs by CellTiterGlo assay	B	C=CC(=O)Nc1ccc(/C=C/c2nc(Nc3cc(C(C)C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1	Outside typical range	CHEMBL4776177	=	GI50	nM	0.1	CHEMBL4142	Homo sapiens	GI50	nM	0.1
	22766971	CHEMBL4703350	Inhibition of FGFR2 (unknown origin) at 100 nM	B	C=CC(=O)Nc1cccc(C)c1Nc1cc(-c2cccnc2Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL4744686	=	Inhibition	%	-1.0	CHEMBL4142	Homo sapiens	INH	%	-1.0
	22810541	CHEMBL4713589	Inhibition of FGFR2 (unknown origin)	B	C=CC(=O)NCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4753933	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	22816210	CHEMBL4714830	Inhibition of recombinant human His-tagged FGFR2 (403 to 822 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	C=CS(=O)(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4785949	=	IC50	nM	2710.0	CHEMBL4142	Homo sapiens	IC50	uM	2.71
	22816211	CHEMBL4714830	Inhibition of recombinant human His-tagged FGFR2 (403 to 822 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NC#N)nc2)c1Cl		CHEMBL4750816	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	22816212	CHEMBL4714830	Inhibition of recombinant human His-tagged FGFR2 (403 to 822 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NCC#N)nc2)c1Cl		CHEMBL4748301	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	22816213	CHEMBL4714830	Inhibition of recombinant human His-tagged FGFR2 (403 to 822 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NC(=O)CC#N)nc2)c1Cl		CHEMBL4739914	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	22816214	CHEMBL4714830	Inhibition of recombinant human His-tagged FGFR2 (403 to 822 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	C#CCNc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4799486	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	22816215	CHEMBL4714830	Inhibition of recombinant human His-tagged FGFR2 (403 to 822 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NC(=O)CCl)nc2)c1Cl		CHEMBL4763652	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	22816216	CHEMBL4714830	Inhibition of recombinant human His-tagged FGFR2 (403 to 822 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NC(=O)C3CO3)nc2)c1Cl		CHEMBL4740775	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	22816217	CHEMBL4714830	Inhibition of recombinant human His-tagged FGFR2 (403 to 822 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	C=C(F)C(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4757810	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	22816218	CHEMBL4714830	Inhibition of recombinant human His-tagged FGFR2 (403 to 822 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	COc1cc(OC)c(Cl)c(COc2cnc(Nc3c(C)cccc3NCC=O)nc2)c1Cl		CHEMBL4742889	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	22816219	CHEMBL4714830	Inhibition of recombinant human His-tagged FGFR2 (403 to 822 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	C=C(C#N)C(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4796512	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	22816220	CHEMBL4714830	Inhibition of recombinant human His-tagged FGFR2 (403 to 822 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(Cl)c(OC)cc(OC)c2Cl)cn1		CHEMBL4061083	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	22816221	CHEMBL4714830	Inhibition of recombinant human His-tagged FGFR2 (403 to 822 residues) cytoplasmic domain expressed in baculovirus expression system using Tyr 04 peptide as substrate after 1 hr in presence of ATP by Z'-LYTE assay	A	COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N		CHEMBL3908979	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	uM	10.0
	22826326	CHEMBL4717511	Inhibition of N-terminal His6-tagged human FGFR2 (456 to 770 residues) expressed in baculovirus-infected Sf21 cells assessed as residual activity at 10 uM relative to control	B	CN1CCN(CCCOc2cccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)ccc23)CC1		CHEMBL4797203	<	Activity	%	60.0	CHEMBL4142	Homo sapiens	Activity	%	60.0
	22843744	CHEMBL4720730	Inhibition of human FGFR2 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.757	CHEMBL4142	Homo sapiens	IC50	10^-10M	7.57
	22844096	CHEMBL4721082	Inhibition of human FGFR2 assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	75.29	CHEMBL4142	Homo sapiens	Activity	%	75.29
	22844710	CHEMBL4721385	Inhibition of wild type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	111.27	CHEMBL4142	Homo sapiens	Activity	%	111.27
	22849868	CHEMBL4723270	Inhibition of FGFR2 kinase domain (406 to 821) (unknown origin) using 5-FluoAhx-EEPLYWSFPAKKKCO-NH2 peptide as substrate in presence of ATP measured after 60 mins by caliper microfluidic mobility shift assay	A	COCCOc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N		CHEMBL3973674	>	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	22854957	CHEMBL4724603	Inhibition of human N-terminal GST-tagged FGFR2 (399 to end residues) expressed in baculovirus expression system using CSKtide as substrate incubated for 30 mins in presence of ATP by off-chip mobility shift assay	B	COc1cc(Nc2ncc(CCc3c(F)c(OC)cc(OC)c3F)cn2)ccc1N1CCC(N2CCN(C)CC2)CC1		CHEMBL4763773	=	IC50	nM	1.2	CHEMBL4142	Homo sapiens	IC50	nM	1.2
Not Active	22889510	CHEMBL4729029	Inhibition of wild-type human partial length FGFR2 (D457 to E769 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	22897320	CHEMBL4730828	Inhibition of recombinant human tagged FGFR2 using Y10-Sox as substrate in presence of 250 uM ATP by Omnia kinase method	B	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)c(=O)n(C)c2n1		CHEMBL4761518	=	IC50	nM	505.0	CHEMBL4142	Homo sapiens	IC50	nM	505.0
	22897321	CHEMBL4730828	Inhibition of recombinant human tagged FGFR2 using Y10-Sox as substrate in presence of 250 uM ATP by Omnia kinase method	B	CCC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)c(=O)n(C)c2n1		CHEMBL4799328	=	IC50	nM	394.0	CHEMBL4142	Homo sapiens	IC50	nM	394.0
	22897322	CHEMBL4730828	Inhibition of recombinant human tagged FGFR2 using Y10-Sox as substrate in presence of 250 uM ATP by Omnia kinase method	B	C=CC(=O)N[C@@H]1COC[C@@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)c(=O)n(C)c2n1		CHEMBL4764222	=	IC50	nM	776.0	CHEMBL4142	Homo sapiens	IC50	nM	776.0
	22897323	CHEMBL4730828	Inhibition of recombinant human tagged FGFR2 using Y10-Sox as substrate in presence of 250 uM ATP by Omnia kinase method	B	C=CC(=O)N[C@H]1CCC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)c(=O)n(C)c2n1		CHEMBL4793510	=	IC50	nM	247.0	CHEMBL4142	Homo sapiens	IC50	nM	247.0
	22897324	CHEMBL4730828	Inhibition of recombinant human tagged FGFR2 using Y10-Sox as substrate in presence of 250 uM ATP by Omnia kinase method	B	C=CS(=O)(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)c(=O)n(C)c2n1		CHEMBL4759172	=	IC50	nM	102.0	CHEMBL4142	Homo sapiens	IC50	nM	102.0
	22897325	CHEMBL4730828	Inhibition of recombinant human tagged FGFR2 using Y10-Sox as substrate in presence of 250 uM ATP by Omnia kinase method	B	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3cc(OC)cc(OC)c3Cl)c(=O)n(C)c2n1		CHEMBL4790124	=	IC50	nM	2156.0	CHEMBL4142	Homo sapiens	IC50	nM	2156.0
	22897326	CHEMBL4730828	Inhibition of recombinant human tagged FGFR2 using Y10-Sox as substrate in presence of 250 uM ATP by Omnia kinase method	B	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3cc(OC)cc(OC)c3)c(=O)n(C)c2n1		CHEMBL4753393	=	IC50	nM	10000.0	CHEMBL4142	Homo sapiens	IC50	nM	10000.0
	22897327	CHEMBL4730828	Inhibition of recombinant human tagged FGFR2 using Y10-Sox as substrate in presence of 250 uM ATP by Omnia kinase method	B	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3c(C)c(OC)cc(OC)c3C)c(=O)n(C)c2n1		CHEMBL4788621	=	IC50	nM	5132.0	CHEMBL4142	Homo sapiens	IC50	nM	5132.0
	22897328	CHEMBL4730828	Inhibition of recombinant human tagged FGFR2 using Y10-Sox as substrate in presence of 250 uM ATP by Omnia kinase method	B	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3c(F)c(OC)cc(OC)c3F)c(=O)n(C)c2n1		CHEMBL4752717	=	IC50	nM	672.0	CHEMBL4142	Homo sapiens	IC50	nM	672.0
	22897329	CHEMBL4730828	Inhibition of recombinant human tagged FGFR2 using Y10-Sox as substrate in presence of 250 uM ATP by Omnia kinase method	B	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3c(F)c(OC)cc(OC)c3Cl)c(=O)n(C)c2n1		CHEMBL4793545	=	IC50	nM	563.0	CHEMBL4142	Homo sapiens	IC50	nM	563.0
	22897350	CHEMBL4730831	Inhibition of FGFR2 (unknown origin) expressed in KATO -III cells assessed as autophosphorylation after 1 hr incubation measured by Mesoscale discovery (MSD) assay	B	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)c(=O)n(C)c2n1		CHEMBL4761518	=	IC50	nM	842.0	CHEMBL4142	Homo sapiens	IC50	nM	842.0
	22897351	CHEMBL4730831	Inhibition of FGFR2 (unknown origin) expressed in KATO -III cells assessed as autophosphorylation after 1 hr incubation measured by Mesoscale discovery (MSD) assay	B	CCC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)c(=O)n(C)c2n1		CHEMBL4799328	=	IC50	nM	377.0	CHEMBL4142	Homo sapiens	IC50	nM	377.0
	22897352	CHEMBL4730831	Inhibition of FGFR2 (unknown origin) expressed in KATO -III cells assessed as autophosphorylation after 1 hr incubation measured by Mesoscale discovery (MSD) assay	B	C=CC(=O)N[C@@H]1COC[C@@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)c(=O)n(C)c2n1		CHEMBL4764222	=	IC50	nM	1219.0	CHEMBL4142	Homo sapiens	IC50	nM	1219.0
	22897353	CHEMBL4730831	Inhibition of FGFR2 (unknown origin) expressed in KATO -III cells assessed as autophosphorylation after 1 hr incubation measured by Mesoscale discovery (MSD) assay	B	C=CC(=O)N[C@H]1CCC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)c(=O)n(C)c2n1		CHEMBL4793510	=	IC50	nM	359.0	CHEMBL4142	Homo sapiens	IC50	nM	359.0
	22897354	CHEMBL4730831	Inhibition of FGFR2 (unknown origin) expressed in KATO -III cells assessed as autophosphorylation after 1 hr incubation measured by Mesoscale discovery (MSD) assay	B	C=CS(=O)(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)c(=O)n(C)c2n1		CHEMBL4759172	=	IC50	nM	218.0	CHEMBL4142	Homo sapiens	IC50	nM	218.0
	22897355	CHEMBL4730831	Inhibition of FGFR2 (unknown origin) expressed in KATO -III cells assessed as autophosphorylation after 1 hr incubation measured by Mesoscale discovery (MSD) assay	B	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3cc(OC)cc(OC)c3Cl)c(=O)n(C)c2n1		CHEMBL4790124	=	IC50	nM	36042.0	CHEMBL4142	Homo sapiens	IC50	nM	36042.0
	22897356	CHEMBL4730831	Inhibition of FGFR2 (unknown origin) expressed in KATO -III cells assessed as autophosphorylation after 1 hr incubation measured by Mesoscale discovery (MSD) assay	B	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3cc(OC)cc(OC)c3)c(=O)n(C)c2n1		CHEMBL4753393	=	IC50	nM	5000.0	CHEMBL4142	Homo sapiens	IC50	nM	5000.0
	22897357	CHEMBL4730831	Inhibition of FGFR2 (unknown origin) expressed in KATO -III cells assessed as autophosphorylation after 1 hr incubation measured by Mesoscale discovery (MSD) assay	B	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3c(C)c(OC)cc(OC)c3C)c(=O)n(C)c2n1		CHEMBL4788621	=	IC50	nM	5000.0	CHEMBL4142	Homo sapiens	IC50	nM	5000.0
	22897358	CHEMBL4730831	Inhibition of FGFR2 (unknown origin) expressed in KATO -III cells assessed as autophosphorylation after 1 hr incubation measured by Mesoscale discovery (MSD) assay	B	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3c(F)c(OC)cc(OC)c3F)c(=O)n(C)c2n1		CHEMBL4752717	=	IC50	nM	1172.0	CHEMBL4142	Homo sapiens	IC50	nM	1172.0
	22897359	CHEMBL4730831	Inhibition of FGFR2 (unknown origin) expressed in KATO -III cells assessed as autophosphorylation after 1 hr incubation measured by Mesoscale discovery (MSD) assay	B	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc2cc(-c3c(F)c(OC)cc(OC)c3Cl)c(=O)n(C)c2n1		CHEMBL4793545	=	IC50	nM	617.0	CHEMBL4142	Homo sapiens	IC50	nM	617.0
	22930967	CHEMBL4738760	Inhibition of FGFR2 (unknown origin)	B	COc1cc(OC)cc(-c2ccc3c(NC(=O)c4cccc(NC(=O)CCl)c4)n[nH]c3c2)c1		CHEMBL4757428	=	IC50	nM	15.0	CHEMBL4142	Homo sapiens	IC50	nM	15.0
	22930968	CHEMBL4738760	Inhibition of FGFR2 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	7.4	CHEMBL4142	Homo sapiens	IC50	nM	7.4
	22930969	CHEMBL4738760	Inhibition of FGFR2 (unknown origin)	B	COc1cccc(-c2ccc3c(NC(=O)c4cccc(NC(=O)CCl)c4)n[nH]c3c2)c1F		CHEMBL4779598	=	IC50	nM	15.0	CHEMBL4142	Homo sapiens	IC50	nM	15.0
	22930970	CHEMBL4738760	Inhibition of FGFR2 (unknown origin)	B	COc1ccc(F)c(-c2ccc3c(NC(=O)c4cccc(NC(=O)CCl)c4)n[nH]c3c2)c1		CHEMBL4748343	=	IC50	nM	27.0	CHEMBL4142	Homo sapiens	IC50	nM	27.0
	22950596	CHEMBL4766163	Inhibition of human recombinant FGFR2 N549H mutant (456 to 770 residues) using GGEEEEYFELVKKKK as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	40.0	CHEMBL4142	Homo sapiens	IC50	uM	0.04
	22952839	CHEMBL4766776	Inhibition of recombinant human FGFR2 (456 to 770 residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	17.0	CHEMBL4142	Homo sapiens	Activity	%	17.0
	23122572	CHEMBL4804923	Inhibition of human FGFR2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	98.0	CHEMBL4142	Homo sapiens	Activity	%	98.0
	23123267	CHEMBL4805511	Inhibition of human FGFR2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL4142	Homo sapiens	Activity	%	100.0
	23123624	CHEMBL4805868	Inhibition of DNA-tagged human FGFR2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	89.0	CHEMBL4142	Homo sapiens	Activity	%	89.0
	23124624	CHEMBL4806528	Inhibition of human FGFR2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	99.0	CHEMBL4142	Homo sapiens	Activity	%	99.0
	23124625	CHEMBL4806528	Inhibition of human FGFR2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	98.0	CHEMBL4142	Homo sapiens	Activity	%	98.0
	23127437	CHEMBL4807609	Inhibition of FGF-R2 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	74.0	CHEMBL4142	Homo sapiens	Activity	%	74.0
	23127438	CHEMBL4807609	Inhibition of FGF-R2 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	47.0	CHEMBL4142	Homo sapiens	Activity	%	47.0
	23128107	CHEMBL4807844	Inhibition of FGFR2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL4142	Homo sapiens	Activity	%	25.0
	23128108	CHEMBL4807844	Inhibition of FGFR2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	50.0	CHEMBL4142	Homo sapiens	Activity	%	50.0
	23128109	CHEMBL4807844	Inhibition of FGFR2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	25.0	CHEMBL4142	Homo sapiens	Activity	%	25.0
	23128910	CHEMBL4808089	Inhibition of FGFR2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(S(C)(=O)=O)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4850066	=	Inhibition	%	11.0	CHEMBL4142	Homo sapiens	INH	%	11.0
	23149475	CHEMBL4810138	Inhibition of human FGFR2 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)cc(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1		CHEMBL4856613	=	IC50	nM	4.4	CHEMBL4142	Homo sapiens	IC50	nM	4.4
	23149476	CHEMBL4810138	Inhibition of human FGFR2 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1		CHEMBL4847441	=	IC50	nM	1.4	CHEMBL4142	Homo sapiens	IC50	nM	1.4
	23149477	CHEMBL4810138	Inhibition of human FGFR2 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1Cl		CHEMBL4863146	=	IC50	nM	1.0	CHEMBL4142	Homo sapiens	IC50	nM	1.0
	23149478	CHEMBL4810138	Inhibition of human FGFR2 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c(Cl)c(OC)c1Cl		CHEMBL4868291	=	IC50	nM	97.0	CHEMBL4142	Homo sapiens	IC50	nM	97.0
	23149479	CHEMBL4810138	Inhibition of human FGFR2 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(F)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1		CHEMBL4863224	=	IC50	nM	1.4	CHEMBL4142	Homo sapiens	IC50	nM	1.4
	23149480	CHEMBL4810138	Inhibition of human FGFR2 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(F)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1F		CHEMBL4870179	=	IC50	nM	0.15	CHEMBL4142	Homo sapiens	IC50	nM	0.15
	23149481	CHEMBL4810138	Inhibition of human FGFR2 using biotinylated-EQEDEPEGDYFEWLE peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cc(OC)c(Cl)c(N2Cc3cnc4[nH]ccc4c3N(C)C2=O)c1F		CHEMBL4862823	=	IC50	nM	0.3	CHEMBL4142	Homo sapiens	IC50	nM	0.3
	23158837	CHEMBL4812089	Inhibition of N-terminal GST-tagged FGFR2 (399 to 821 residues) (unknown origin) expressed in Sf21 cells at 10 uM preincubated for 10 mins followed by peptide substrate addition relative to control	B	CC(C)(C)OC(=O)c1ccc(NC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)cc1		CHEMBL4860361	=	Inhibition	%	5.28	CHEMBL4142	Homo sapiens	INH	%	5.28
	23261795	CHEMBL4833169	Inhibition of FGFR2 (unknown origin)	A	C=CC(=O)Nc1cc(SC)ccc1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4879303	=	IC50	nM	24.0	CHEMBL4142	Homo sapiens	IC50	nM	24.0
	23261796	CHEMBL4833169	Inhibition of FGFR2 (unknown origin)	A	C=CC(=O)Nc1cc(S(C)(=O)=O)cc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4862742	=	IC50	nM	379.0	CHEMBL4142	Homo sapiens	IC50	nM	379.0
	23261797	CHEMBL4833169	Inhibition of FGFR2 (unknown origin)	A	C=CC(=O)Nc1cc(S(C)(=O)=O)ccc1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4877857	=	IC50	nM	15.0	CHEMBL4142	Homo sapiens	IC50	nM	15.0
	23261798	CHEMBL4833169	Inhibition of FGFR2 (unknown origin)	A	C=CC(=O)Nc1cc(S(N)(=O)=O)cc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4872856	=	IC50	nM	341.0	CHEMBL4142	Homo sapiens	IC50	nM	341.0
	23261799	CHEMBL4833169	Inhibition of FGFR2 (unknown origin)	A	C=CC(=O)N[C@H]1CCOC[C@H]1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4514636	=	IC50	nM	1202.0	CHEMBL4142	Homo sapiens	IC50	nM	1202.0
	23261800	CHEMBL4833169	Inhibition of FGFR2 (unknown origin)	A	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	=	IC50	nM	493.0	CHEMBL4142	Homo sapiens	IC50	nM	493.0
	23261801	CHEMBL4833169	Inhibition of FGFR2 (unknown origin)	A	C=CC(=O)Nc1cc(N2CCN(CC)CC2)ccc1Nc1cc(N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)ncn1		CHEMBL3939295	=	IC50	nM	1290.0	CHEMBL4142	Homo sapiens	IC50	nM	1290.0
	23265608	CHEMBL4834267	Inhibition of FGFR2 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CO)C1		CHEMBL4858720	=	IC50	nM	27.0	CHEMBL4142	Homo sapiens	IC50	uM	0.027000000000000003
	23265609	CHEMBL4834267	Inhibition of FGFR2 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCCC1		CHEMBL169390	=	IC50	nM	190.0	CHEMBL4142	Homo sapiens	IC50	uM	0.19
	23265610	CHEMBL4834267	Inhibition of FGFR2 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(O)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL4854822	>	IC50	nM	2900.0	CHEMBL4142	Homo sapiens	IC50	uM	2.9
	23284721	CHEMBL4838031	Inhibition of human N-terminal GST fusion tagged FGFR2 cytoplasmic domain (399 to 821 end residues) expressed in baculovirus infected Sf21 insect cells	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576	=	IC50	nM	0.2	CHEMBL4142	Homo sapiens	IC50	nM	0.2
Dose-Dependent Effect	23284729	CHEMBL4838039	Inhibition of FGFR2 phosphorylation in human SNU-16 cells measured after 24 hrs by Western blot analysis	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	23284730	CHEMBL4838040	Inhibition of FGFR2 assessed as reduction in FRS2 phosphorylation in human SNU-16 cells measured after 24 hrs by Western blot analysis	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	23284731	CHEMBL4838041	Inhibition of FGFR2 assessed as reduction in AKT phosphorylation in human SNU-16 cells at 5 uM measured after 24 hrs by Western blot analysis	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	23284732	CHEMBL4838042	Inhibition of FGFR2 assessed as reduction in ERK1/2 phosphorylation in human SNU-16 cells at 5 uM measured after 24 hrs by Western blot analysis	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	23284733	CHEMBL4838043	Inhibition of FGFR2 assessed as reduction in PI3K phosphorylation in human SNU-16 cells at 5 uM measured after 24 hrs by Western blot analysis	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
Active	23284734	CHEMBL4838044	Inhibition of FGFR2 assessed as reduction in MAPK phosphorylation in human SNU-16 cells at 5 uM measured after 24 hrs by Western blot analysis	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576		Inhibition	%		CHEMBL4142	Homo sapiens	INH		
	23284777	CHEMBL4838087	Inhibition of recombinant human FGFR2 (456 to 770 residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis relative to control	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576	>	Inhibition	%	90.0	CHEMBL4142	Homo sapiens	INH	%	90.0
	23284805	CHEMBL4838112	Inhibition of FGFR2 (unknown origin)	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1		CHEMBL1852688	=	IC50	nM	1.4	CHEMBL4142	Homo sapiens	IC50	nM	1.4
	23284806	CHEMBL4838112	Inhibition of FGFR2 (unknown origin)	B	C[C@@H](Oc1ccc2[nH]nc(/C=C/c3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3828009	=	IC50	nM	2.6	CHEMBL4142	Homo sapiens	IC50	nM	2.6
	23284807	CHEMBL4838112	Inhibition of FGFR2 (unknown origin)	B	CCN1C(=O)N(c2c(F)c(OC)cc(OC)c2F)Cc2cnc3[nH]c(CN4CCOCC4)cc3c21		CHEMBL4297522	=	IC50	nM	0.5	CHEMBL4142	Homo sapiens	IC50	nM	0.5
	23284808	CHEMBL4838112	Inhibition of FGFR2 (unknown origin)	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1		CHEMBL3545376	=	IC50	nM	2.5	CHEMBL4142	Homo sapiens	IC50	nM	2.5
	23284818	CHEMBL4838116	Inhibition of recombinant human FGFR2 in presence of ATP at Km concentration	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	IC50	nM	2.5	CHEMBL4142	Homo sapiens	IC50	nM	2.5
	23289740	CHEMBL4839230	Inhibition of FGFR2 (unknown origin)	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	140.0	CHEMBL4142	Homo sapiens	IC50	nM	140.0
	23289741	CHEMBL4839230	Inhibition of FGFR2 (unknown origin)	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	IC50	nM	82.5	CHEMBL4142	Homo sapiens	IC50	nM	82.5
	23297789	CHEMBL4841269	Inhibition of FGFR2 (unknown origin)	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3Cl)cc12		CHEMBL4876497	>	IC50	nM	1000.0	CHEMBL4142	Homo sapiens	IC50	nM	1000.0
	23299256	CHEMBL4841728	Inhibition of FGFR2 (unknown origin) at 1000 nM relative to control	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4860038	=	Inhibition	%	34.0	CHEMBL4142	Homo sapiens	INH	%	34.0
	23299257	CHEMBL4841728	Inhibition of FGFR2 (unknown origin) at 1000 nM relative to control	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Inhibition	%	72.0	CHEMBL4142	Homo sapiens	INH	%	72.0
Not Active	23317407	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	93.0	CHEMBL4142	Homo sapiens	% Control	%	93.0
Not Active	23317875	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23318544	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	86.0	CHEMBL4142	Homo sapiens	% Control	%	86.0
Not Active	23319025	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23319662	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23320137	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	83.2	CHEMBL4142	Homo sapiens	% Control	%	83.2
Not Active	23320815	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	96.0	CHEMBL4142	Homo sapiens	% Control	%	96.0
Not Active	23321283	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23321913	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23322381	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23323070	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	93.0	CHEMBL4142	Homo sapiens	% Control	%	93.0
Not Active	23323538	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	92.0	CHEMBL4142	Homo sapiens	% Control	%	92.0
Not Active	23324010	CHEMBL4880629	FGFR2 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	17.0	CHEMBL4142	Homo sapiens	% inhibition	%	17.0
Not Active	23324392	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	74.3	CHEMBL4142	Homo sapiens	% Control	%	74.3
Not Active	23325027	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23325495	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23326142	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	61.0	CHEMBL4142	Homo sapiens	% Control	%	61.0
Not Active	23326610	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23327310	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	86.0	CHEMBL4142	Homo sapiens	% Control	%	86.0
Not Active	23327778	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	98.0	CHEMBL4142	Homo sapiens	% Control	%	98.0
Not Active	23328365	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	88.0	CHEMBL4142	Homo sapiens	% Control	%	88.0
Not Active	23328833	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23329344	CHEMBL4881051	FGFR2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	107.0	CHEMBL4142	Homo sapiens	% residual kinase activity	%	107.0
Not Active	23329779	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23330247	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23331003	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	94.0	CHEMBL4142	Homo sapiens	% Control	%	94.0
Not Active	23331471	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	85.0	CHEMBL4142	Homo sapiens	% Control	%	85.0
Not Active	23332058	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	84.3	CHEMBL4142	Homo sapiens	% Control	%	84.3
Not Active	23332524	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	81.7	CHEMBL4142	Homo sapiens	% Control	%	81.7
Not Active	23333242	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23333881	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	85.0	CHEMBL4142	Homo sapiens	% Control	%	85.0
Not Active	23334349	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	94.0	CHEMBL4142	Homo sapiens	% Control	%	94.0
Not Active	23335328	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23335796	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	98.0	CHEMBL4142	Homo sapiens	% Control	%	98.0
Not Active	23336423	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23336891	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	78.0	CHEMBL4142	Homo sapiens	% Control	%	78.0
Not Active	23337595	CHEMBL4881966	FGFR2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	89.0	CHEMBL4142	Homo sapiens	% Ctrl	%	89.0
Not Active	23337972	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	85.0	CHEMBL4142	Homo sapiens	% Control	%	85.0
Not Active	23338440	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23339052	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23339520	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	95.0	CHEMBL4142	Homo sapiens	% Control	%	95.0
Not Active	23340157	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23340625	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23341282	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23341750	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	86.0	CHEMBL4142	Homo sapiens	% Control	%	86.0
Not Active	23342366	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	91.0	CHEMBL4142	Homo sapiens	% Control	%	91.0
Not Active	23342834	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	86.0	CHEMBL4142	Homo sapiens	% Control	%	86.0
Not Active	23343464	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	89.0	CHEMBL4142	Homo sapiens	% Control	%	89.0
Not Active	23343932	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	87.0	CHEMBL4142	Homo sapiens	% Control	%	87.0
Slightly Active	23344570	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	49.0	CHEMBL4142	Homo sapiens	% Control	%	49.0
Not Active	23345143	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	96.0	CHEMBL4142	Homo sapiens	% Control	%	96.0
Not Active	23345611	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	79.0	CHEMBL4142	Homo sapiens	% Control	%	79.0
Not Active	23346188	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	67.3	CHEMBL4142	Homo sapiens	% Control	%	67.3
Not Active	23346657	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23347262	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23347748	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	62.0	CHEMBL4142	Homo sapiens	% Control	%	62.0
Not Active	23348327	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23348795	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	92.0	CHEMBL4142	Homo sapiens	% Control	%	92.0
Not Active	23349382	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	84.0	CHEMBL4142	Homo sapiens	% Control	%	84.0
Not Active	23350000	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23350468	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23351073	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	80.0	CHEMBL4142	Homo sapiens	% Control	%	80.0
Not Active	23351541	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	89.0	CHEMBL4142	Homo sapiens	% Control	%	89.0
Not Active	23352046	CHEMBL4882737	FGFR2 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-3.349	CHEMBL4142	Homo sapiens	% Inhibition	%	-3.3487
Not Active	23352565	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	96.0	CHEMBL4142	Homo sapiens	% Control	%	96.0
Not Active	23353033	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23353915	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23354383	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23355115	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23355583	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23356219	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23356687	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23357296	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	74.0	CHEMBL4142	Homo sapiens	% Control	%	74.0
Not Active	23357943	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	96.0	CHEMBL4142	Homo sapiens	% Control	%	96.0
Not Active	23358411	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23358997	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Slightly Active	23359595	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	43.0	CHEMBL4142	Homo sapiens	% Control	%	43.0
Not Active	23360063	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	67.0	CHEMBL4142	Homo sapiens	% Control	%	67.0
Not Active	23360648	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23361116	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23361689	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23362225	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23362693	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23364335	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23364803	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23365542	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	98.0	CHEMBL4142	Homo sapiens	% Control	%	98.0
Not Active	23366085	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	86.0	CHEMBL4142	Homo sapiens	% Control	%	86.0
Not Active	23366675	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23367143	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23367572	CHEMBL4883925	FGF-R2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	125.0	CHEMBL4142	Homo sapiens	% Residual activity with Skepinone-L	%	125.0
Not Active	23368021	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	98.0	CHEMBL4142	Homo sapiens	% Control	%	98.0
Not Active	23368489	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	93.0	CHEMBL4142	Homo sapiens	% Control	%	93.0
Not Active	23369088	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23369556	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23370066	CHEMBL4884310	FGFR2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	58.0	CHEMBL4142	Homo sapiens	% residual kinase activity	%	58.0
Not Active	23370524	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	83.0	CHEMBL4142	Homo sapiens	% Control	%	83.0
Not Active	23370992	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	97.0	CHEMBL4142	Homo sapiens	% Control	%	97.0
Not Active	23371801	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23372269	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	97.0	CHEMBL4142	Homo sapiens	% Control	%	97.0
	23373719	CHEMBL4885496	FGFR2(FGF2LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4142	Homo sapiens	pIC50		6.0
Not Active	23375250	CHEMBL4886232	fibroblast growth factor receptor 2 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-5.0	CHEMBL4142	Homo sapiens	% inhibition	%	-5.0
Not Active	23375696	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23376164	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23376741	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23377210	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23378069	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	88.0	CHEMBL4142	Homo sapiens	% Control	%	88.0
Not Active	23378537	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	87.0	CHEMBL4142	Homo sapiens	% Control	%	87.0
Not Active	23379704	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23380172	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	91.0	CHEMBL4142	Homo sapiens	% Control	%	91.0
Not Active	23380866	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23381514	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23381982	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23382606	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL4142	Homo sapiens	% Control	%	100.0
Not Active	23383074	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	59.0	CHEMBL4142	Homo sapiens	% Control	%	59.0
Not Active	23383791	CHEMBL4887428	FGFR2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	94.0	CHEMBL4142	Homo sapiens	% Ctrl	%	94.0
Not Active	23384275	CHEMBL4887870	FGFR2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	9.63	CHEMBL4142	Homo sapiens	% inhibition	%	9.63
Not Active	23384989	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	91.0	CHEMBL4142	Homo sapiens	% Control	%	91.0
Not Active	23385456	CHEMBL4879713	KinomeScan assay: inhibition of FGFR2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	84.0	CHEMBL4142	Homo sapiens	% Control	%	84.0
